1	Eur	NNP	O	Eur	nn	5	SENT_1	[p1l54t82r92b107],
2	Arch	NNP	O	Arch	nn	5	SENT_1	[p1l99t81r152b107],
3	Psychiatry	NNP	O	Psychiatry	nn	5	SENT_1	[p1l162t81r284b114],
4	Clin	NNP	PERSON	Clin	nn	5	SENT_1	[p1l291t81r334b107],
5	Neurosci	NNP	PERSON	Neurosci	_	0	SENT_1	[p1l345t82r446b107],
6	(	CD	NUMBER	(	num	7	SENT_1	[p1l456t81r531b111],
7	2005	CD	DATE	2005	dep	5	SENT_1	[p1l456t81r531b111],
8	)	NN	O	)	dep	7	SENT_1	[p1l456t81r531b111],
9	255	CD	NUMBER	255	num	8	SENT_1	[p1l541t83r583b107],
10	:	:	O	:	_	0	SENT_1	[p1l591t89r595b107],
11	261	CD	NUMBER	261	num	12	SENT_1	[p1l602t83r642b107],
12	-268	CD	NUMBER	-268	dep	7	SENT_1	[p1l649t83r712b107],
13	DOI	NNP	O	DOI	dep	12	SENT_1	[p1l1711t82r1751b107],
14	10.1007	CD	NUMBER	10.1007	num	13	SENT_1	[p1l1762t82r2107b108],
15	/	:	O	/	punct	17	SENT_1	[p1l1762t82r2107b108],
16	s00406	CD	NUMBER	s00406	num	17	SENT_1	[p1l1762t82r2107b108],
17	—	NN	O	—	dep	13	SENT_1	[p1l1762t82r2107b108],
18	004	CD	NUMBER	004	number	19	SENT_1	[p1l1762t82r2107b108],
19	—	CD	NUMBER	—	dep	17	SENT_1	[p1l1762t82r2107b108],
20	0556	CD	DATE	0556	num	21	SENT_1	[p1l1762t82r2107b108],
21	—	NN	O	—	dep	19	SENT_1	[p1l1762t82r2107b108],
22	4	CD	NUMBER	4	dep	5	SENT_1	[p1l1762t82r2107b108],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l52t151r1044b234],
2	PAPER	NN	O	paper	_	0	SENT_2	[p1l363t171r533b214],

1	Michael	NNP	PERSON	Michael	_	0	SENT_3	[p1l53t309r196b341],
2	Riedel	NNP	PERSON	Riedel	dep	1	SENT_3	[p1l207t309r321b341],
3	-	:	O	-	_	0	SENT_3	[p1l332t325r339b333],
4	M.	NNP	PERSON	M.	nn	6	SENT_3	[p1l351t312r396b341],
5	I.	NNP	PERSON	I.	nn	6	SENT_3	[p1l405t312r427b348],
6	Schwarz	NNP	PERSON	Schwarz	dep	1	SENT_3	[p1l437t309r585b341],
7	-	:	O	-	_	0	SENT_3	[p1l596t325r603b333],
8	M.	NNP	PERSON	M.	nn	9	SENT_3	[p1l614t312r659b341],
9	Strassnig	NNP	PERSON	Strassnig	dep	6	SENT_3	[p1l669t310r836b351],
10	-	:	O	-	_	0	SENT_3	[p1l846t325r854b333],
11	I.	NN	PERSON	i.	dep	1	SENT_3	[p1l866t312r889b341],
12	Spellmann	NNP	PERSON	Spellmann	nn	14	SENT_3	[p1l899t309r1092b351],
13	A.	NNP	PERSON	A.	nn	14	SENT_3	[p1l1103t325r1111b333, p1l53t356r90b386],
14	Miiller-Arends	NNP	PERSON	Miiller-Arends	dep	11	SENT_3	[p1l99t354r364b386],
15	-	:	O	-	_	0	SENT_3	[p1l375t370r383b378],
16	K.	NNP	PERSON	K.	nn	17	SENT_3	[p1l395t357r431b386],
17	Weber	NNP	PERSON	Weber	dep	11	SENT_3	[p1l439t354r554b386],
18	-	:	O	-	_	0	SENT_3	[p1l565t370r572b378],
19	I.	NN	PERSON	i.	dep	17	SENT_3	[p1l583t357r605b393],
20	Zach	NNP	PERSON	Zach	dep	19	SENT_3	[p1l615t354r702b386],
21	-	:	O	-	_	0	SENT_3	[p1l713t370r721b378],
22	N.	NNP	PERSON	N.	nn	23	SENT_3	[p1l732t357r771b386],
23	Miiller	NNP	PERSON	Miiller	dep	17	SENT_3	[p1l780t354r900b386],
24	-	:	O	-	_	0	SENT_3	[p1l911t370r918b378],
25	H.	NNP	PERSON	H.	nn	28	SENT_3	[p1l930t357r970b386],
26	I.	NNP	PERSON	I.	nn	28	SENT_3	[p1l978t357r1001b393],
27	Miiller	NNP	PERSON	Miiller	nn	28	SENT_3	[p1l1010t354r1129b386],
28	Risperidone	NNP	PERSON	Risperidone	dep	11	SENT_3	[p1l57t423r415b496],
29	plasma	NN	O	plasma	nn	30	SENT_3	[p1l438t425r651b496],
30	levels	NNS	O	level	dep	28	SENT_3	[p1l676t424r865b490],
31	,	,	O	,	_	0	SENT_3	[p1l676t424r865b490],
32	clinical	JJ	O	clinical	amod	33	SENT_3	[p1l887t423r1093b481],
33	response	NN	O	response	conj_and	30	SENT_3	[p1l1119t440r1387b496],
34	and	CC	O	and	_	0	SENT_3	[p1l54t529r164b586],
35	side-effects	NNS	O	side-effect	dep	28	SENT_3	[p1l187t528r537b586],

1	Received	VBN	O	receive	_	0	SENT_4	[p1l53t661r187b687],
2	:	:	O	:	_	0	SENT_4	[p1l53t661r187b687],
3	14	CD	DATE	14	num	4	SENT_4	[p1l200t664r229b687],
4	July	NNP	DATE	July	dobj	1	SENT_4	[p1l239t661r295b696],
5	2004	CD	DATE	2004	num	4	SENT_4	[p1l303t664r368b687],
6	/	:	O	/	punct	7	SENT_4	[p1l378t663r388b689],
7	Accepted	JJ	O	accepted	dep	4	SENT_4	[p1l396t661r534b696],
8	:	:	O	:	_	0	SENT_4	[p1l396t661r534b696],
9	27	CD	DATE	27	num	10	SENT_4	[p1l545t664r576b687],
10	September	NNP	DATE	September	dep	7	SENT_4	[p1l587t661r741b696],
11	2004	CD	DATE	2004	num	10	SENT_4	[p1l750t663r835b689],
12	/	:	O	/	punct	7	SENT_4	[p1l750t663r835b689],
13	Published	VBN	O	publish	partmod	4	SENT_4	[p1l845t661r988b687],
14	online	NN	O	online	prep	13	SENT_4	[p1l997t661r1095b687],
15	:	:	O	:	_	0	SENT_4	[p1l997t661r1095b687],
16	22	CD	DATE	22	dep	4	SENT_4	[p1l1105t664r1136b687],
17	November	NNP	DATE	November	tmod	16	SENT_4	[p1l1146t661r1297b687],
18	2004	CD	DATE	2004	num	17	SENT_4	[p1l1306t664r1372b687],

1	_	NNP	O	_	nn	4	SENT_5	[p1l12t925r74b926],
2	Abstract	NNP	O	Abstract	nn	4	SENT_5	[p1l135t860r434b927],
3	Introduction	NN	O	introduction	nn	4	SENT_5	[p1l504t858r985b927],
4	Assessment	NNP	O	Assessment	nsubj	20	SENT_5	[p1l1004t863r1451b927],
5	of	IN	O	of	_	0	SENT_5	[p1l1473t858r1555b927],
6	the	DT	O	the	det	7	SENT_5	[p1l1568t858r1687b927],
7	relation	NN	O	relation	prep_of	4	SENT_5	[p1l1709t858r2005b927],
8	between	IN	O	between	_	0	SENT_5	[p1l2024t858r2145b927, p1l9t971r235b1028],
9	oral	JJ	O	oral	amod	11	SENT_5	[p1l259t959r408b1028],
10	risperidone	NN	O	risperidone	nn	11	SENT_5	[p1l429t959r874b1050],
11	dose	NN	O	dose	prep_between	7	SENT_5	[p1l898t959r1093b1039],
12	,	,	O	,	_	0	SENT_5	[p1l898t959r1093b1039],
13	serum	NN	O	serum	nn	15	SENT_5	[p1l1113t983r1353b1028],
14	drug	NN	O	drug	nn	15	SENT_5	[p1l1376t959r1558b1051],
15	levels	NNS	O	level	conj_and	11	SENT_5	[p1l1577t959r1786b1028],
16	and	CC	O	and	_	0	SENT_5	[p1l1811t959r1953b1028],
17	clinical	JJ	O	clinical	amod	18	SENT_5	[p1l1976t959r2145b1028, p1l10t1061r141b1130],
18	response	NN	O	response	conj_and	11	SENT_5	[p1l161t1085r499b1153],
19	may	MD	O	may	aux	20	SENT_5	[p1l520t1085r683b1154],
20	provide	VB	O	provide	_	0	SENT_5	[p1l699t1061r993b1153],
21	important	JJ	O	important	amod	22	SENT_5	[p1l1014t1064r1405b1153],
22	information	NN	O	information	dobj	20	SENT_5	[p1l1425t1061r1891b1130],
23	for	IN	O	for	_	0	SENT_5	[p1l1911t1061r2020b1130],
24	rational	JJ	O	rational	amod	26	SENT_5	[p1l2040t1086r2146b1130, p1l9t1161r232b1230],
25	treatment	NN	O	treatment	nn	26	SENT_5	[p1l264t1173r643b1230],
26	decisions	NNS	O	decision	prep_for	20	SENT_5	[p1l677t1161r1051b1230],
27	.	.	O	.	_	0	SENT_5	[p1l677t1161r1051b1230],

1	Inter-individual	JJ	O	inter-individual	amod	2	SENT_6	[p1l1083t1161r1696b1230],
2	differences	NNS	O	difference	nsubj	33	SENT_6	[p1l1730t1161r2148b1230],
3	in	IN	O	in	_	0	SENT_6	[p1l10t1265r84b1330],
4	the	DT	O	the	det	8	SENT_6	[p1l119t1262r238b1331],
5	liver	NN	O	liver	nn	8	SENT_6	[p1l273t1262r443b1331],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_6	[p1l479t1262r939b1355],
7	P450	NN	O	p450	nn	8	SENT_6	[p1l977t1268r1157b1331],
8	system	NN	O	system	prep_in	2	SENT_6	[p1l1196t1275r1478b1355],
9	,	,	O	,	_	0	SENT_6	[p1l1196t1275r1478b1355],
10	especially	RB	O	especially	advmod	2	SENT_6	[p1l1512t1262r1887b1355],
11	in	IN	O	in	amod	2	SENT_6	[p1l1920t1265r1993b1330],
12	the	DT	O	the	det	14	SENT_6	[p1l2029t1262r2147b1331],
13	CYPZD6	NN	O	cypzd6	nn	14	SENT_6	[p1l11t1368r331b1432],
14	subsystem	NN	O	subsystem	dep	2	SENT_6	[p1l356t1363r774b1455],
15	,	,	O	,	_	0	SENT_6	[p1l356t1363r774b1455],
16	which	WDT	O	which	nsubj	17	SENT_6	[p1l790t1363r1023b1432],
17	account	VBP	O	account	rcmod	14	SENT_6	[p1l1046t1375r1344b1432],
18	for	IN	O	for	_	0	SENT_6	[p1l1365t1363r1474b1432],
19	a	DT	O	a	det	21	SENT_6	[p1l1497t1387r1536b1432],
20	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_6	[p1l1558t1363r1963b1455],
21	portion	NN	O	portion	prep_for	17	SENT_6	[p1l1983t1386r2146b1454, p1l9t1467r163b1533],
22	of	IN	O	of	_	0	SENT_6	[p1l219t1464r301b1533],
23	risperidone	NN	O	risperidone	nn	24	SENT_6	[p1l349t1464r794b1556],
24	metabolism	NN	O	metabolism	prep_of	21	SENT_6	[p1l849t1464r1325b1545],
25	,	,	O	,	_	0	SENT_6	[p1l849t1464r1325b1545],
26	may	MD	O	may	aux	28	SENT_6	[p1l1376t1489r1540b1557],
27	also	RB	O	also	advmod	28	SENT_6	[p1l1591t1464r1739b1533],
28	inﬂuence	VB	O	inﬂuence	_	0	SENT_6	[p1l1796t1464r2148b1533],
29	plasma	NN	O	plasma	nn	31	SENT_6	[p1l9t1565r285b1656],
30	drug	NN	O	drug	nn	31	SENT_6	[p1l317t1565r499b1657],
31	levels	NNS	O	level	dobj	28	SENT_6	[p1l527t1565r736b1634],
32	and	CC	O	and	_	0	SENT_6	[p1l770t1565r913b1634],
33	alter	VB	O	alter	conj_and	28	SENT_6	[p1l945t1565r1115b1634],
34	clinical	JJ	O	clinical	amod	36	SENT_6	[p1l1147t1565r1422b1634],
35	response	NN	O	response	nn	36	SENT_6	[p1l1454t1588r1791b1656],
36	parameters	NNS	O	parameter	dobj	33	SENT_6	[p1l1823t1588r2146b1656, p1l9t1679r168b1735],
37	.	.	O	.	_	0	SENT_6	[p1l1823t1588r2146b1656, p1l9t1679r168b1735],

1	We	PRP	O	we	nsubj	16	SENT_7	[p1l220t1672r336b1735],
2	thus	RB	O	thus	advmod	4	SENT_7	[p1l393t1666r555b1735],
3	prospectively	RB	O	prospectively	advmod	4	SENT_7	[p1l614t1666r1131b1759],
4	investigated	VBN	O	investigate	_	0	SENT_7	[p1l1184t1666r1646b1759],
5	risperidone	NN	O	risperidone	nn	7	SENT_7	[p1l1703t1666r2148b1758],
6	serum	NN	O	serum	nn	7	SENT_7	[p1l11t1791r251b1836],
7	concentrations	NNS	O	concentration	dobj	4	SENT_7	[p1l277t1769r846b1836],
8	in	IN	O	in	_	0	SENT_7	[p1l872t1769r945b1835],
9	relation	NN	O	relation	prep_in	4	SENT_7	[p1l970t1767r1267b1836],
10	to	TO	O	to	_	0	SENT_7	[p1l1290t1779r1363b1836],
11	clinical	JJ	O	clinical	amod	12	SENT_7	[p1l1390t1767r1665b1836],
12	efficacy	NN	O	efficacy	prep_to	4	SENT_7	[p1l1690t1767r1986b1859],
13	and	CC	O	and	_	0	SENT_7	[p1l2007t1767r2150b1836],
14	side-effects	NNS	O	side-effect	conj_and	12	SENT_7	[p1l11t1868r442b1937],
15	and	CC	O	and	_	0	SENT_7	[p1l493t1868r636b1937],
16	genotyped	VBD	O	genotype	conj_and	4	SENT_7	[p1l683t1868r1091b1960],
17	major	JJ	O	major	amod	19	SENT_7	[p1l1138t1871r1366b1960],
18	CYPZD6	NN	O	cypzd6	nn	19	SENT_7	[p1l1415t1873r1734b1937],
19	polymorphisms	NNS	O	polymorphism	dobj	16	SENT_7	[p1l1783t1868r2146b1960, p1l9t1969r283b2060],
20	to	TO	O	to	aux	21	SENT_7	[p1l305t1981r378b2038],
21	determine	VB	O	determine	xcomp	16	SENT_7	[p1l402t1969r797b2038],
22	their	PRP$	O	they	poss	23	SENT_7	[p1l819t1969r1002b2038],
23	effect	NN	O	effect	dobj	21	SENT_7	[p1l1024t1969r1232b2038],
24	upon	IN	O	upon	_	0	SENT_7	[p1l1253t1992r1450b2060],
25	these	DT	O	these	det	26	SENT_7	[p1l1471t1969r1669b2038],
26	parameters	NNS	O	parameter	prep_upon	21	SENT_7	[p1l1690t1982r2146b2060],
27	.	.	O	.	_	0	SENT_7	[p1l1690t1982r2146b2060],

1	Methods	NNS	O	method	nn	3	SENT_8	[p1l7t2070r334b2139],
2	Neuroleptic	JJ	MISC	neuroleptic	amod	3	SENT_8	[p1l389t2070r843b2161],
3	monotherapy	NN	O	monotherapy	nsubjpass	7	SENT_8	[p1l899t2070r1423b2162],
4	with	IN	O	with	_	0	SENT_8	[p1l1473t2070r1646b2139],
5	risperidone	NN	O	risperidone	prep_with	3	SENT_8	[p1l1702t2070r2148b2161],
6	was	VBD	O	be	auxpass	7	SENT_8	[p1l7t2195r149b2240],
7	administered	VBN	O	administer	_	0	SENT_8	[p1l178t2171r688b2240],
8	to	TO	O	to	_	0	SENT_8	[p1l712t2184r785b2240],
9	schizophrenia	NN	O	schizophrenia	nn	10	SENT_8	[p1l815t2171r1355b2262],
10	patients	NNS	O	patient	prep_to	7	SENT_8	[p1l1380t2173r1684b2262],
11	in	IN	O	in	_	0	SENT_8	[p1l1713t2173r1786b2239],
12	a	DT	O	a	det	17	SENT_8	[p1l1815t2195r1854b2240],
13	6-week	JJ	DURATION	6-week	amod	17	SENT_8	[p1l1880t2171r2151b2240],
14	open	JJ	O	open	amod	17	SENT_8	[p1l10t2296r197b2363],
15	dose	NN	O	dose	nn	17	SENT_8	[p1l235t2272r409b2341],
16	clinical	JJ	O	clinical	amod	17	SENT_8	[p1l447t2272r722b2341],
17	trial	NN	O	trial	prep_in	10	SENT_8	[p1l757t2272r937b2341],
18	.	.	O	.	_	0	SENT_8	[p1l757t2272r937b2341],

1	Weekly	NNP	SET	Weekly	nn	2	SENT_9	[p1l967t2272r1249b2364],
2	assessments	NNS	O	assessment	nsubjpass	33	SENT_9	[p1l1282t2285r1746b2341],
3	including	VBG	O	include	_	0	SENT_9	[p1l1784t2272r2150b2364],
4	CGI	NNP	O	CGI	nn	7	SENT_9	[p1l11t2378r158b2442],
5	and	CC	O	and	_	0	SENT_9	[p1l188t2373r330b2442],
6	PANSS	NNP	O	PANSS	nn	7	SENT_9	[p1l357t2378r615b2442],
7	ratings	NNS	O	rating	prep_including	2	SENT_9	[p1l643t2375r908b2465],
8	to	TO	O	to	aux	9	SENT_9	[p1l936t2385r1008b2442],
9	assess	VB	O	assess	infmod	7	SENT_9	[p1l1037t2397r1264b2442],
10	psychopathology	NN	O	psychopathology	dobj	9	SENT_9	[p1l1291t2373r1974b2465],
11	;	:	O	;	_	0	SENT_9	[p1l1291t2373r1974b2465],
12	SAS	NNP	ORGANIZATION	SAS	conj_and	7	SENT_9	[p1l2002t2378r2147b2442],
13	to	TO	O	to	aux	14	SENT_9	[p1l9t2487r82b2543],
14	assess	VB	O	assess	infmod	12	SENT_9	[p1l125t2498r351b2543],
15	medication	NN	O	medication	nn	17	SENT_9	[p1l392t2474r826b2543],
16	side	JJ	O	side	amod	17	SENT_9	[p1l868t2474r1017b2543],
17	effects	NNS	O	effect	dobj	14	SENT_9	[p1l1059t2474r1324b2555],
18	;	:	O	;	_	0	SENT_9	[p1l1059t2474r1324b2555],
19	and	CC	O	and	_	0	SENT_9	[p1l1365t2474r1507b2543],
20	blood	NN	O	blood	conj_and	7	SENT_9	[p1l1544t2474r1770b2543],
21	draws	VBZ	O	draw	rcmod	20	SENT_9	[p1l1810t2474r2033b2543],
22	to	TO	O	to	aux	23	SENT_9	[p1l2073t2487r2146b2543],
23	quantify	VB	O	quantify	xcomp	21	SENT_9	[p1l11t2574r338b2667],
24	steady	JJ	O	steady	amod	27	SENT_9	[p1l371t2575r615b2667],
25	state	NN	O	state	nn	27	SENT_9	[p1l648t2588r822b2644],
26	plasma	NN	O	plasma	nn	27	SENT_9	[p1l857t2575r1134b2666],
27	levels	NNS	O	level	dobj	23	SENT_9	[p1l1167t2575r1375b2644],
28	of	IN	O	of	_	0	SENT_9	[p1l1413t2575r1495b2644],
29	risperidone	NN	O	risperidone	prep_of	27	SENT_9	[p1l1524t2575r1969b2666],
30	and	CC	O	and	_	0	SENT_9	[p1l2007t2575r2150b2644],
31	9-OH-risperidone	NN	O	9-oh-risperidone	prep_of	27	SENT_9	[p1l10t2676r703b2767],
32	were	VBD	O	be	auxpass	33	SENT_9	[p1l734t2700r914b2745],
33	carried	VBN	O	carry	_	0	SENT_9	[p1l950t2676r1225b2745],
34	out	RP	O	out	prt	33	SENT_9	[p1l1259t2689r1401b2745],
35	.	.	O	.	_	0	SENT_9	[p1l1259t2689r1401b2745],

1	In	IN	O	in	_	0	SENT_10	[p1l1433t2682r1511b2744],
2	addition	NN	O	addition	prep_in	18	SENT_10	[p1l1546t2676r1892b2757],
3	,	,	O	,	_	0	SENT_10	[p1l1546t2676r1892b2757],
4	major	JJ	O	major	amod	6	SENT_10	[p1l1921t2679r2149b2768],
5	CYPZD6	NN	O	cypzd6	nn	6	SENT_10	[p1l11t2782r331b2846],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	18	SENT_10	[p1l353t2777r965b2869],
7	including	VBG	O	include	_	0	SENT_10	[p1l988t2777r1354b2869],
8	alleles	NNS	O	allele	prep_including	6	SENT_10	[p1l1375t2777r1608b2846],
9	*	CD	NUMBER	*	number	10	SENT_10	[p1l1632t2782r1734b2857],
10	4	CD	NUMBER	4	dep	8	SENT_10	[p1l1632t2782r1734b2857],
11	,	,	O	,	_	0	SENT_10	[p1l1632t2782r1734b2857],
12	*	CD	NUMBER	*	number	13	SENT_10	[p1l1753t2782r1834b2846],
13	6	CD	NUMBER	6	appos	8	SENT_10	[p1l1753t2782r1834b2846],
14	and	CC	O	and	_	0	SENT_10	[p1l1858t2777r2001b2846],
15	*	CD	NUMBER	*	number	16	SENT_10	[p1l2022t2782r2149b2845],
16	14	CD	NUMBER	14	conj_and	13	SENT_10	[p1l2022t2782r2149b2845],
17	were	VBD	O	be	auxpass	18	SENT_10	[p1l7t2902r188b2947],
18	genotyped	VBN	O	genotype	_	0	SENT_10	[p1l261t2878r687b2970],
19	.	.	O	.	_	0	SENT_10	[p1l261t2878r687b2970],

1	Results	NNS	O	result	nsubjpass	5	SENT_11	[p1l755t2878r1022b2947],
2	Eighty-two	CD	NUMBER	eighty-two	num	3	SENT_11	[p1l1094t2878r1517b2970],
3	patients	NNS	O	patient	dep	1	SENT_11	[p1l1591t2881r1896b2969],
4	were	VBD	O	be	auxpass	5	SENT_11	[p1l1967t2902r2148b2947],
5	recruited	VBN	O	recruit	_	0	SENT_11	[p1l10t2979r381b3049],
6	.	.	O	.	_	0	SENT_11	[p1l10t2979r381b3049],

1	Mean	NN	O	mean	nn	3	SENT_12	[p1l473t2986r686b3049],
2	oral	JJ	O	oral	amod	3	SENT_12	[p1l782t2979r931b3049],
3	dose	NN	O	dose	nsubj	7	SENT_12	[p1l1027t2979r1200b3049],
4	of	IN	O	of	_	0	SENT_12	[p1l1297t2979r1379b3049],
5	risperidone	NN	O	risperidone	prep_of	3	SENT_12	[p1l1467t2979r1912b3071],
6	was	VBD	O	be	cop	7	SENT_12	[p1l2006t3004r2147b3049],
7	4.3	CD	NUMBER	4.3	_	0	SENT_12	[p1l9t3087r114b3149],
8	i	FW	O	i	dep	7	SENT_12	[p1l138t3091r188b3148],
9	0.9	CD	NUMBER	0.9	num	10	SENT_12	[p1l209t3087r315b3149],
10	mg	NN	O	mg	dep	8	SENT_12	[p1l334t3104r474b3172],
11	.	.	O	.	_	0	SENT_12	[p1l334t3104r474b3172],

1	Mean	NN	O	mean	nn	3	SENT_13	[p1l497t3086r709b3149],
2	plasma	NN	O	plasma	nn	3	SENT_13	[p1l734t3080r1010b3171],
3	level	NN	O	level	nsubj	18	SENT_13	[p1l1033t3080r1207b3149],
4	of	IN	O	of	_	0	SENT_13	[p1l1233t3080r1314b3149],
5	both	CC	O	both	preconj	6	SENT_13	[p1l1330t3080r1508b3149],
6	risperidone	NN	O	risperidone	prep_of	3	SENT_13	[p1l1534t3080r1979b3171],
7	and	CC	O	and	_	0	SENT_13	[p1l2006t3080r2149b3149],
8	9-OH-risperidone	NN	O	9-oh-risperidone	prep_of	3	SENT_13	[p1l10t3181r703b3273],
9	together	RB	O	together	advmod	18	SENT_13	[p1l789t3181r1111b3274],
10	(	CD	NUMBER	(	num	11	SENT_13	[p1l1200t3182r1490b3265],
11	“	CD	NUMBER	“	nsubj	18	SENT_13	[p1l1200t3182r1490b3265],
12	active	JJ	O	active	amod	15	SENT_13	[p1l1200t3182r1490b3265],
13	moiety	NN	O	moiety	nn	15	SENT_13	[p1l1577t3182r1916b3274],
14	”	NN	O	”	nn	15	SENT_13	[p1l1577t3182r1916b3274],
15	)	NN	O	)	dep	11	SENT_13	[p1l1577t3182r1916b3274],
16	was	VBD	O	be	cop	18	SENT_13	[p1l2005t3206r2147b3251],
17	41.6	CD	NUMBER	41.6	num	18	SENT_13	[p1l9t3289r406b3351],
18	i26	NN	O	i26	_	0	SENT_13	[p1l9t3289r406b3351],
19	.6	CD	NUMBER	.6	num	20	SENT_13	[p1l9t3289r406b3351],
20	ng/ml	NN	O	ng/ml	dep	18	SENT_13	[p1l425t3282r671b3374],
21	.	.	O	.	_	0	SENT_13	[p1l425t3282r671b3374],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_14	[p1l714t3282r1127b3374],
2	improvements	NNS	O	improvement	nsubj	10	SENT_14	[p1l1171t3285r1722b3373],
3	in	IN	O	in	_	0	SENT_14	[p1l1768t3285r1842b3350],
4	PANSS	NNP	O	PANSS	nn	5	SENT_14	[p1l1888t3287r2146b3351],
5	scales	NNS	O	scale	prep_in	2	SENT_14	[p1l11t3382r229b3451],
6	and	CC	O	and	_	0	SENT_14	[p1l273t3382r415b3451],
7	the	DT	O	the	det	9	SENT_14	[p1l455t3383r573b3451],
8	various	JJ	O	various	amod	9	SENT_14	[p1l612t3385r896b3451],
9	subscales	NNS	O	subscale	prep_in	2	SENT_14	[p1l940t3382r1295b3451],
10	ensued	VBN	O	ensue	_	0	SENT_14	[p1l1338t3382r1626b3451],
11	.	.	O	.	_	0	SENT_14	[p1l1338t3382r1626b3451],

1	There	EX	O	there	expl	2	SENT_15	[p1l1665t3382r1886b3451],
2	was	VBD	O	be	_	0	SENT_15	[p1l1925t3407r2067b3451],
3	a	DT	O	a	det	6	SENT_15	[p1l2111t3407r2150b3451],
4	positive	JJ	O	positive	amod	6	SENT_15	[p1l9t3486r310b3574],
5	linear	JJ	O	linear	amod	6	SENT_15	[p1l386t3483r609b3552],
6	correlation	NN	O	correlation	nsubj	2	SENT_15	[p1l686t3483r1109b3552],
7	between	IN	O	between	_	0	SENT_15	[p1l1184t3483r1504b3552],
8	active	JJ	O	active	amod	11	SENT_15	[p1l1583t3486r1804b3552],
9	moiety	NN	O	moiety	nn	11	SENT_15	[p1l1881t3486r2152b3575],
10	plasma	NN	O	plasma	nn	11	SENT_15	[p1l9t3584r285b3676],
11	levels	NNS	O	level	prep_between	6	SENT_15	[p1l330t3584r538b3654],
12	and	CC	O	and	_	0	SENT_15	[p1l588t3584r731b3654],
13	dose	NN	O	dose	nn	15	SENT_15	[p1l778t3584r952b3654],
14	(	NN	O	(	nn	15	SENT_15	[p1l1004t3585r1376b3668],
15	r	NN	O	r	conj_and	6	SENT_15	[p1l1004t3585r1376b3668],
16	=	JJ	O	=	amod	15	SENT_15	[p1l1004t3585r1376b3668],
17	0.291	CD	NUMBER	0.291	tmod	16	SENT_15	[p1l1004t3585r1376b3668],
18	,	,	O	,	_	0	SENT_15	[p1l1004t3585r1376b3668],
19	p	NN	O	p	conj_and	6	SENT_15	[p1l1418t3585r1784b3676],
20	=	JJ	O	=	amod	22	SENT_15	[p1l1418t3585r1784b3676],
21	0.015	CD	NUMBER	0.015	tmod	20	SENT_15	[p1l1418t3585r1784b3676],
22	)	NN	O	)	dep	19	SENT_15	[p1l1418t3585r1784b3676],
23	and	CC	O	and	_	0	SENT_15	[p1l1838t3584r1980b3654],
24	beM	NN	O	bem	conj_and	6	SENT_15	[p1l2024t3585r2146b3654, p2l9t129r87b179],
25	.	.	O	.	_	0	SENT_15	[p1l2024t3585r2146b3654, p2l9t129r87b179],

1	Riedel	NNP	PERSON	Riedel	_	0	SENT_16	[p2l106t124r301b179],
2	(	CD	NUMBER	(	num	1	SENT_16	[p2l325t124r446b191],
3	)	SYM	O	)	dep	1	SENT_16	[p2l325t124r446b191],
4	-	:	O	-	_	0	SENT_16	[p2l473t153r483b164],
5	M.	NNP	PERSON	M.	nn	7	SENT_16	[p2l506t128r584b179],
6	I.	NNP	PERSON	I.	nn	7	SENT_16	[p2l602t129r639b191],
7	Schwarz	NNP	PERSON	Schwarz	dep	1	SENT_16	[p2l659t124r914b179],
8	-	:	O	-	_	0	SENT_16	[p2l936t153r946b164],
9	I.	NN	PERSON	i.	dep	7	SENT_16	[p2l970t129r1008b179],
10	Spellmann	NNP	PERSON	Spellmann	dep	9	SENT_16	[p2l1028t124r1358b197],
11	-	:	O	-	_	0	SENT_16	[p2l1381t153r1392b164],
12	N.	NNP	PERSON	N.	nn	16	SENT_16	[p2l1414t128r1481b179],
13	Miiller	NNP	PERSON	Miiller	nn	16	SENT_16	[p2l1499t124r1708b179],
14	H.	NNP	PERSON	H.	nn	16	SENT_16	[p2l1731t153r1741b164, p2l9t211r78b262],
15	I.	NNP	PERSON	I.	nn	16	SENT_16	[p2l96t211r132b274],
16	Moller	NNP	PERSON	Moller	dep	10	SENT_16	[p2l151t206r358b262],
17	-	:	O	-	_	0	SENT_16	[p2l380t236r390b247],
18	A.	NN	O	a.	dep	16	SENT_16	[p2l411t211r475b262],
19	M1	NN	O	m1	nn	21	SENT_16	[p2l493t206r952b262],
20	'	''	O	'	_	0	SENT_16	[p2l493t206r952b262],
21	iller	NN	O	iller	dep	18	SENT_16	[p2l493t206r952b262],
22	.	.	O	.	_	0	SENT_16	[p2l493t206r952b262],

1	—	NN	O	—	_	0	SENT_17	[p2l493t206r952b262],
2	.	.	O	.	_	0	SENT_17	[p2l493t206r952b262],

1	Arends	NNP	PERSON	Arends	_	0	SENT_18	[p2l493t206r952b262],
2	-	:	O	-	_	0	SENT_18	[p2l976t236r986b247],
3	K.	NNP	PERSON	K.	nn	4	SENT_18	[p2l1010t211r1073b262],
4	Weber	NNP	PERSON	Weber	dep	1	SENT_18	[p2l1088t206r1288b262],
5	-	:	O	-	_	0	SENT_18	[p2l1310t236r1320b247],
6	I.	NN	PERSON	i.	nn	8	SENT_18	[p2l1343t211r1379b274],
7	Zach	NNP	PERSON	Zach	nn	8	SENT_18	[p2l1398t206r1550b262],
8	Dept.	NNP	PERSON	Dept.	dep	4	SENT_18	[p2l9t294r174b364],
9	of	IN	O	of	_	0	SENT_18	[p2l194t289r260b346],
10	Psychiatry	NNP	O	Psychiatry	nn	13	SENT_18	[p2l275t289r602b364],
11	and	CC	O	and	_	0	SENT_18	[p2l620t289r736b346],
12	Psychotherapy	NNP	ORGANIZATION	Psychotherapy	conj_and	10	SENT_18	[p2l756t289r1215b364],
13	University	NNP	ORGANIZATION	University	prep_of	8	SENT_18	[p2l9t374r334b447],
14	of	IN	ORGANIZATION	of	_	0	SENT_18	[p2l352t372r418b429],
15	Munich	NNP	ORGANIZATION	Munich	nn	16	SENT_18	[p2l433t372r671b429],
16	Nussbaumstrasse	NNP	ORGANIZATION	Nussbaumstrasse	prep_of	13	SENT_18	[p2l9t454r550b509],
17	7	CD	NUMBER	7	num	16	SENT_18	[p2l573t460r603b509],

1	80336	CD	NUMBER	80336	num	2	SENT_19	[p2l10t543r186b594],
2	Munich	NNP	LOCATION	Munich	_	0	SENT_19	[p2l208t537r464b603],
3	,	,	O	,	_	0	SENT_19	[p2l208t537r464b603],
4	Germany	NNP	LOCATION	Germany	nn	5	SENT_19	[p2l483t541r772b612],
5	Tel.	NNP	O	Tel.	appos	2	SENT_19	[p2l9t619r131b675],
6	:	:	O	:	_	0	SENT_19	[p2l9t619r131b675],
7	+49	CD	NUMBER	+49	number	8	SENT_19	[p2l155t623r739b677],
8	—	CD	NUMBER	—	dep	2	SENT_19	[p2l155t623r739b677],
9	89/5160	CD	DURATION	89/5160	num	10	SENT_19	[p2l155t623r739b677],
10	-5755	CD	DURATION	-5755	dep	8	SENT_19	[p2l155t623r739b677],

1	Fax	NN	O	fax	_	0	SENT_20	[p2l10t706r133b757],
2	:	:	O	:	_	0	SENT_20	[p2l10t706r133b757],
3	+49	CD	NUMBER	+49	number	4	SENT_20	[p2l157t705r742b759],
4	-89	CD	NUMBER	-89	dep	1	SENT_20	[p2l157t705r742b759],
5	/	:	O	/	punct	4	SENT_20	[p2l157t705r742b759],
6	5160-5188	CD	DURATION	5160-5188	dep	1	SENT_20	[p2l157t705r742b759],

1	E-Mailz	NN	O	e-mailz	_	0	SENT_21	[p2l9t783r251b839],
2	.	.	O	.	_	0	SENT_21	[p2l9t783r251b839],

1	Riedel@med.uni-muenchen.de	NN	O	riedel@med.uni-muenchen.de	_	0	SENT_22	[p2l270t783r1234b839],

1	M.	NNP	ORGANIZATION	M.	nn	5	SENT_23	[p2l9t912r87b963],
2	Strassnig	NNP	ORGANIZATION	Strassnig	nn	5	SENT_23	[p2l107t909r391b981],
3	Western	NNP	ORGANIZATION	Western	nn	5	SENT_23	[p2l8t995r263b1046],
4	Psychiatric	NNP	ORGANIZATION	Psychiatric	nn	5	SENT_23	[p2l285t990r626b1065],
5	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_23	[p2l647t992r909b1046],
6	and	CC	ORGANIZATION	and	_	0	SENT_23	[p2l931t990r1046b1046],
7	Clinic	NNP	ORGANIZATION	Clinic	nn	8	SENT_23	[p2l1068t990r1249b1046],
8	University	NNP	ORGANIZATION	University	conj_and	5	SENT_23	[p2l9t1074r334b1147],
9	of	IN	ORGANIZATION	of	_	0	SENT_23	[p2l352t1072r418b1129],
10	Pittsburgh	NNP	ORGANIZATION	Pittsburgh	nn	16	SENT_23	[p2l433t1072r759b1147],
11	Medical	NNP	ORGANIZATION	Medical	nn	16	SENT_23	[p2l780t1072r1026b1129],
12	Center	NNP	ORGANIZATION	Center	nn	16	SENT_23	[p2l1048t1076r1254b1129],
13	Pittsburgh	NNP	ORGANIZATION	Pittsburgh	nn	16	SENT_23	[p2l10t1155r335b1230],
14	(	CD	NUMBER	(	num	16	SENT_23	[p2l359t1156r511b1223],
15	PA	NN	ORGANIZATION	pa	nn	16	SENT_23	[p2l359t1156r511b1223],
16	)	NN	O	)	prep_of	5	SENT_23	[p2l359t1156r511b1223],
17	,	,	O	,	_	0	SENT_23	[p2l359t1156r511b1223],
18	USA	NNP	LOCATION	USA	nn	20	SENT_23	[p2l528t1159r668b1212],
19	tween	JJ	O	tween	amod	20	SENT_23	[p2l9t1254r223b1308],
20	risperidone	NN	O	risperidone	conj_and	16	SENT_23	[p2l323t1242r745b1329],
21	and	CC	O	and	_	0	SENT_23	[p2l847t1242r982b1308],
22	9	CD	NUMBER	9	prep_of	5	SENT_23	[p2l1082t1242r1738b1329],
23	.	.	O	.	_	0	SENT_23	[p2l1082t1242r1738b1329],

1	—	NN	O	—	_	0	SENT_24	[p2l1082t1242r1738b1329],
2	.	.	O	.	_	0	SENT_24	[p2l1082t1242r1738b1329],

1	OH	NN	O	oh	_	0	SENT_25	[p2l1082t1242r1738b1329],
2	.	.	O	.	_	0	SENT_25	[p2l1082t1242r1738b1329],

1	—	NN	O	—	_	0	SENT_26	[p2l1082t1242r1738b1329],
2	.	.	O	.	_	0	SENT_26	[p2l1082t1242r1738b1329],

1	risperidone	NN	O	risperidone	nn	2	SENT_27	[p2l1082t1242r1738b1329],
2	levels	NNS	O	level	nsubj	3	SENT_27	[p2l1837t1242r2035b1308],
3	(	VBP	O	(	_	0	SENT_27	[p2l13t1339r73b1417],
4	r	NN	O	r	dobj	3	SENT_27	[p2l13t1339r73b1417],
5	=	JJ	O	=	amod	4	SENT_27	[p2l92t1365r139b1389],
6	0.262	CD	NUMBER	0.262	tmod	5	SENT_27	[p2l159t1344r366b1414],
7	;	:	O	;	_	0	SENT_27	[p2l159t1344r366b1414],
8	p	NN	O	p	dep	4	SENT_27	[p2l396t1360r439b1424],
9	=	JJ	O	=	amod	11	SENT_27	[p2l460t1365r507b1389],
10	0.016	CD	NUMBER	0.016	tmod	9	SENT_27	[p2l528t1339r765b1417],
11	)	NN	O	)	dep	8	SENT_27	[p2l528t1339r765b1417],
12	.	.	O	.	_	0	SENT_27	[p2l528t1339r765b1417],

1	Nonresponders	NNS	O	nonresponder	_	0	SENT_28	[p2l793t1338r1352b1424],
2	to	TO	O	to	_	0	SENT_28	[p2l1383t1350r1452b1404],
3	pharmacother	JJ	O	pharmacother	amod	7	SENT_28	[p2l1483t1338r2033b1424],
4	—	NN	O	—	nn	7	SENT_28	[p2l1483t1338r2033b1424],
5	apy	NN	O	apy	nn	7	SENT_28	[p2l11t1456r140b1522],
6	(	CD	NUMBER	(	num	7	SENT_28	[p2l165t1435r972b1521],
7	PANSS	NN	O	panss	prep_to	1	SENT_28	[p2l165t1435r972b1521],
8	.	.	O	.	_	0	SENT_28	[p2l165t1435r972b1521],

1	—	NN	O	—	_	0	SENT_29	[p2l165t1435r972b1521],
2	.	.	O	.	_	0	SENT_29	[p2l165t1435r972b1521],

1	Improvement	NN	O	improvement	amod	5	SENT_30	[p2l165t1435r972b1521],
2	<	JJR	O	<	dep	1	SENT_30	[p2l1000t1449r1046b1498],
3	30	CD	PERCENT	30	num	4	SENT_30	[p2l1067t1441r1146b1500],
4	%	NN	PERCENT	%	dep	1	SENT_30	[p2l1163t1435r1259b1513],
5	)	CD	NUMBER	)	nsubj	6	SENT_30	[p2l1163t1435r1259b1513],
6	showed	VBD	O	show	dep	36	SENT_30	[p2l1290t1434r1563b1500],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_30	[p2l1588t1434r2040b1522],
8	higher	JJR	O	higher	amod	12	SENT_30	[p2l8t1530r247b1617],
9	active	JJ	O	active	amod	12	SENT_30	[p2l286t1532r495b1596],
10	moiety	NN	O	moiety	nn	12	SENT_30	[p2l535t1532r792b1617],
11	plasma	NN	O	plasma	nn	12	SENT_30	[p2l827t1530r1088b1616],
12	levels	NNS	O	level	nsubj	13	SENT_30	[p2l1125t1530r1322b1596],
13	(	VBP	O	(	ccomp	6	SENT_30	[p2l1367t1531r1607b1609],
14	49.9	CD	NUMBER	49.9	dobj	13	SENT_30	[p2l1367t1531r1607b1609],
15	:	:	O	:	_	0	SENT_30	[p2l1367t1531r1607b1609],
16	30.7	CD	NUMBER	30.7	num	18	SENT_30	[p2l1628t1537r1771b1596],
17	ng/ml	NN	O	ng/ml	nn	18	SENT_30	[p2l1789t1530r2031b1617],
18	)	NN	O	)	nsubj	21	SENT_30	[p2l1789t1530r2031b1617],
19	than	IN	O	than	_	0	SENT_30	[p2l9t1626r173b1692],
20	responders	NNS	O	responder	prep_than	18	SENT_30	[p2l215t1626r617b1713],
21	(	VBP	O	(	parataxis	6	SENT_30	[p2l663t1627r835b1705],
22	38.2	CD	NUMBER	38.2	nsubj	23	SENT_30	[p2l663t1627r835b1705],
23	i	FW	O	i	ccomp	21	SENT_30	[p2l856t1636r903b1691],
24	17.0	CD	NUMBER	17.0	num	25	SENT_30	[p2l930t1633r1067b1692],
25	ng/ml	NN	O	ng/ml	dobj	23	SENT_30	[p2l1085t1626r1320b1714],
26	;	:	O	;	_	0	SENT_30	[p2l1085t1626r1320b1714],
27	p	NN	O	p	dep	25	SENT_30	[p2l1361t1648r1404b1713],
28	=	JJ	O	=	amod	30	SENT_30	[p2l1425t1654r1472b1678],
29	0.045	CD	NUMBER	0.045	tmod	28	SENT_30	[p2l1493t1627r1707b1705],
30	)	NN	O	)	dep	27	SENT_30	[p2l1493t1627r1707b1705],
31	without	IN	O	without	_	0	SENT_30	[p2l1751t1626r2036b1692],
32	signiﬁcantly	RB	O	signiﬁcantly	advmod	33	SENT_30	[p2l11t1722r463b1809],
33	higher	JJR	O	higher	amod	35	SENT_30	[p2l483t1722r721b1809],
34	oral	JJ	O	oral	amod	35	SENT_30	[p2l746t1722r887b1788],
35	doses	NNS	O	dose	prep_without	23	SENT_30	[p2l913t1722r1111b1788],
36	(	VBP	O	(	_	0	SENT_30	[p2l1142t1723r1213b1808],
37	p	NN	O	p	nsubj	38	SENT_30	[p2l1142t1723r1213b1808],
38	=	JJ	O	=	xcomp	36	SENT_30	[p2l1234t1749r1281b1773],
39	0.601	CD	NUMBER	0.601	num	40	SENT_30	[p2l1301t1723r1539b1801],
40	)	NN	O	)	nsubj	36	SENT_30	[p2l1301t1723r1539b1801],
41	.	.	O	.	_	0	SENT_30	[p2l1301t1723r1539b1801],

1	Patients	NNS	O	patient	nsubj	10	SENT_31	[p2l1563t1724r1849b1788],
2	with	IN	O	with	_	0	SENT_31	[p2l1873t1722r2036b1788],
3	longer	JJR	O	longer	amod	5	SENT_31	[p2l8t1818r242b1906],
4	illness	NN	O	illness	nn	5	SENT_31	[p2l294t1818r520b1884],
5	duration	NN	O	duration	prep_with	1	SENT_31	[p2l576t1818r889b1884],
6	(	CD	NUMBER	(	number	7	SENT_31	[p2l946t1819r1072b1898],
7	23	CD	DURATION	23	num	8	SENT_31	[p2l946t1819r1072b1898],
8	years	NNS	NUMBER	year	tmod	5	SENT_31	[p2l1126t1819r1343b1906],
9	)	RB	O	)	advmod	10	SENT_31	[p2l1126t1819r1343b1906],
10	had	VBD	O	have	_	0	SENT_31	[p2l1399t1818r1536b1884],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_31	[p2l1589t1818r2041b1906],
12	higher	JJR	O	higher	amod	15	SENT_31	[p2l8t1914r247b2001],
13	plasma	NN	O	plasma	nn	15	SENT_31	[p2l288t1914r549b2000],
14	drug	NN	O	drug	nn	15	SENT_31	[p2l592t1914r764b2001],
15	levels	NNS	O	level	dobj	10	SENT_31	[p2l805t1914r1002b1979],
16	than	IN	O	than	_	0	SENT_31	[p2l1046t1914r1210b1979],
17	those	DT	O	those	prep_than	10	SENT_31	[p2l1252t1914r1446b1979],
18	with	IN	O	with	_	0	SENT_31	[p2l1487t1914r1650b1979],
19	a	DT	O	a	det	22	SENT_31	[p2l1694t1936r1731b1979],
20	shorter	JJR	O	shorter	amod	22	SENT_31	[p2l1774t1914r2037b1979],
21	course	NN	O	course	nn	22	SENT_31	[p2l11t2033r245b2076],
22	(	NN	O	(	prep_with	17	SENT_31	[p2l270t2011r347b2089],
23	<	JJR	O	<	amod	22	SENT_31	[p2l270t2011r347b2089],
24	3	CD	DURATION	3	num	25	SENT_31	[p2l369t2017r403b2076],
25	years	NNS	NUMBER	year	tmod	23	SENT_31	[p2l425t2033r634b2098],
26	;	:	O	;	_	0	SENT_31	[p2l425t2033r634b2098],
27	p	NN	O	p	dep	17	SENT_31	[p2l654t2032r698b2097],
28	=	JJ	O	=	amod	30	SENT_31	[p2l718t2038r766b2062],
29	0.039	CD	NUMBER	0.039	tmod	28	SENT_31	[p2l786t2011r1024b2090],
30	)	NN	O	)	dep	27	SENT_31	[p2l786t2011r1024b2090],
31	.	.	O	.	_	0	SENT_31	[p2l786t2011r1024b2090],

1	Extrapyramidal	JJ	O	extrapyramidal	amod	3	SENT_32	[p2l1042t2010r1619b2098],
2	side	JJ	O	side	amod	3	SENT_32	[p2l1640t2010r1783b2076],
3	effects	NNS	O	effect	nsubj	4	SENT_32	[p2l1805t2010r2035b2076],
4	(	VBP	O	(	dep	30	SENT_32	[p2l13t2106r209b2185],
5	EPS	NN	O	ep	nn	6	SENT_32	[p2l13t2106r209b2185],
6	)	NN	O	)	nsubjpass	12	SENT_32	[p2l13t2106r209b2185],
7	and	CC	O	and	_	0	SENT_32	[p2l245t2106r381b2171],
8	plasma	NN	O	plasma	nn	9	SENT_32	[p2l410t2106r671b2192],
9	levels	NNS	O	level	nsubjpass	12	SENT_32	[p2l700t2106r897b2171],
10	were	VBD	O	be	auxpass	12	SENT_32	[p2l927t2128r1097b2171],
11	not	RB	O	not	neg	12	SENT_32	[p2l1129t2118r1249b2171],
12	correlated	VBN	O	correlate	ccomp	4	SENT_32	[p2l1280t2106r1648b2171],
13	(	NN	O	(	nn	14	SENT_32	[p2l1682t2107r1741b2185],
14	r	NN	O	r	dobj	12	SENT_32	[p2l1682t2107r1741b2185],
15	=	JJ	O	=	amod	14	SENT_32	[p2l1760t2133r1807b2157],
16	0.028	CD	NUMBER	0.028	tmod	15	SENT_32	[p2l1827t2113r2034b2182],
17	;	:	O	;	_	0	SENT_32	[p2l1827t2113r2034b2182],
18	p	NN	O	p	dep	14	SENT_32	[p2l9t2224r52b2289],
19	=	JJ	O	=	amod	21	SENT_32	[p2l73t2230r120b2254],
20	0.843	CD	NUMBER	0.843	tmod	19	SENT_32	[p2l141t2203r380b2281],
21	)	NN	O	)	dep	18	SENT_32	[p2l141t2203r380b2281],
22	,	,	O	,	_	0	SENT_32	[p2l141t2203r380b2281],
23	but	CC	O	but	_	0	SENT_32	[p2l401t2202r523b2268],
24	higher	JJR	O	higher	amod	26	SENT_32	[p2l548t2202r786b2290],
25	plasma	NN	O	plasma	nn	26	SENT_32	[p2l812t2202r1074b2289],
26	levels	NNS	O	level	conj_but	14	SENT_32	[p2l1098t2202r1296b2268],
27	at	IN	O	at	_	0	SENT_32	[p2l1325t2214r1389b2268],
28	week	NN	DURATION	week	prep_at	26	SENT_32	[p2l1413t2202r1599b2268],
29	2	CD	NUMBER	2	num	28	SENT_32	[p2l1624t2209r1661b2267],
30	predicted	VBD	O	predict	_	0	SENT_32	[p2l1689t2202r2037b2289],
31	an	DT	O	a	det	32	SENT_32	[p2l11t2320r96b2363],
32	incidence	NN	O	incidence	nsubj	37	SENT_32	[p2l132t2298r480b2363],
33	for	IN	O	for	_	0	SENT_32	[p2l517t2298r620b2363],
34	EPS	NNP	O	EPS	prep_for	32	SENT_32	[p2l655t2302r793b2364],
35	(	CD	NUMBER	(	num	36	SENT_32	[p2l834t2298r905b2384],
36	p	NN	O	p	npadvmod	37	SENT_32	[p2l834t2298r905b2384],
37	<	JJR	O	<	xcomp	30	SENT_32	[p2l927t2312r972b2362],
38	0.050	CD	NUMBER	0.050	num	39	SENT_32	[p2l993t2298r1231b2377],
39	)	NN	O	)	nsubj	30	SENT_32	[p2l993t2298r1231b2377],
40	.	.	O	.	_	0	SENT_32	[p2l993t2298r1231b2377],

1	Accordingly	RB	O	accordingly	advmod	14	SENT_33	[p2l1261t2298r1715b2385],
2	,	,	O	,	_	0	SENT_33	[p2l1261t2298r1715b2385],
3	patients	NNS	O	patient	nsubj	14	SENT_33	[p2l1746t2300r2035b2384],
4	initially	RB	O	initially	advmod	5	SENT_33	[p2l10t2394r294b2482],
5	receiving	VBG	O	receive	partmod	3	SENT_33	[p2l315t2397r649b2482],
6	higher	JJR	O	higher	amod	8	SENT_33	[p2l671t2394r909b2482],
7	oral	JJ	O	oral	amod	8	SENT_33	[p2l934t2394r1075b2460],
8	doses	NNS	O	dose	dobj	5	SENT_33	[p2l1100t2394r1298b2460],
9	of	IN	O	of	_	0	SENT_33	[p2l1325t2394r1402b2460],
10	risperidone	NN	O	risperidone	prep_of	8	SENT_33	[p2l1420t2394r1842b2481],
11	were	VBD	O	be	cop	14	SENT_33	[p2l1864t2417r2035b2460],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_33	[p2l11t2490r463b2577],
13	more	RBR	O	more	advmod	14	SENT_33	[p2l480t2512r669b2555],
14	likely	JJ	O	likely	_	0	SENT_33	[p2l690t2490r888b2577],
15	to	TO	O	to	aux	16	SENT_33	[p2l905t2502r974b2555],
16	respond	VB	O	respond	xcomp	14	SENT_33	[p2l998t2490r1294b2576],
17	with	IN	O	with	_	0	SENT_33	[p2l1313t2490r1476b2555],
18	EPS	NN	O	ep	prep_with	16	SENT_33	[p2l1498t2494r1635b2556],
19	in	IN	O	in	_	0	SENT_33	[p2l1659t2492r1729b2554],
20	the	DT	O	the	det	22	SENT_33	[p2l1751t2490r1863b2555],
21	trial	NN	O	trial	nn	22	SENT_33	[p2l1885t2490r2037b2555],
22	course	NN	O	course	prep_in	18	SENT_33	[p2l11t2609r264b2652],
23	.	.	O	.	_	0	SENT_33	[p2l11t2609r264b2652],

1	Eight	CD	NUMBER	eight	num	2	SENT_34	[p2l293t2586r484b2674],
2	patients	NNS	O	patient	nsubj	9	SENT_34	[p2l514t2589r803b2673],
3	(	IN	O	(	_	0	SENT_34	[p2l839t2587r1083b2666],
4	9.8	CD	PERCENT	9.8	num	5	SENT_34	[p2l839t2587r1083b2666],
5	%	NN	PERCENT	%	prep_(	2	SENT_34	[p2l839t2587r1083b2666],
6	)	CD	NUMBER	)	dep	5	SENT_34	[p2l839t2587r1083b2666],
7	were	VBD	O	be	cop	9	SENT_34	[p2l1116t2609r1286b2652],
8	heterozygous	JJ	O	heterozygous	amod	9	SENT_34	[p2l1317t2586r1799b2674],
9	carriers	NNS	O	carrier	_	0	SENT_34	[p2l1833t2589r2034b2652, p2l10t2704r113b2747],
10	of	IN	O	of	_	0	SENT_34	[p2l133t2682r211b2747],
11	the	DT	O	the	det	13	SENT_34	[p2l222t2682r334b2747],
12	CYPZD6	NN	O	cypzd6	nn	13	SENT_34	[p2l354t2686r657b2748],
13	allele	NN	O	allele	prep_of	9	SENT_34	[p2l678t2682r864b2747],
14	*	CD	NUMBER	*	number	15	SENT_34	[p2l884t2687r979b2747],
15	4	CD	NUMBER	4	num	13	SENT_34	[p2l884t2687r979b2747],
16	.	.	O	.	_	0	SENT_34	[p2l884t2687r979b2747],

1	CYPZD6	NN	O	cypzd6	nn	2	SENT_35	[p2l997t2686r1300b2748],
2	polymorphisms	NNS	O	polymorphism	nsubj	10	SENT_35	[p2l1319t2682r1899b2769],
3	did	VBD	O	do	aux	5	SENT_35	[p2l1920t2682r2038b2747],
4	not	RB	O	not	neg	5	SENT_35	[p2l10t2790r130b2844],
5	predict	VB	O	predict	_	0	SENT_35	[p2l154t2778r414b2864],
6	clinical	JJ	O	clinical	amod	7	SENT_35	[p2l440t2778r701b2844],
7	response	NN	O	response	dobj	5	SENT_35	[p2l727t2800r1067b2864],
8	,	,	O	,	_	0	SENT_35	[p2l727t2800r1067b2864],
9	but	CC	O	but	_	0	SENT_35	[p2l1087t2778r1208b2844],
10	predicted	VBD	O	predict	conj_but	5	SENT_35	[p2l1233t2778r1580b2864],
11	a	DT	O	a	det	13	SENT_35	[p2l1606t2801r1643b2844],
12	tendential	JJ	O	tendential	amod	13	SENT_35	[p2l1668t2778r2037b2844],
13	increase	NN	O	increase	dobj	10	SENT_35	[p2l10t2876r307b2939],
14	in	IN	O	in	_	0	SENT_35	[p2l331t2876r400b2938],
15	the	DT	O	the	det	17	SENT_35	[p2l423t2874r535b2939],
16	plasma	NN	O	plasma	nn	17	SENT_35	[p2l558t2874r819b2960],
17	risperidone	NN	O	risperidone	prep_in	10	SENT_35	[p2l842t2874r1263b2960],
18	to	TO	O	to	_	0	SENT_35	[p2l1286t2886r1355b2939],
19	9	CD	NUMBER	9	prep_to	10	SENT_35	[p2l1380t2874r2036b2960],
20	.	.	O	.	_	0	SENT_35	[p2l1380t2874r2036b2960],

1	—	NN	O	—	_	0	SENT_36	[p2l1380t2874r2036b2960],
2	.	.	O	.	_	0	SENT_36	[p2l1380t2874r2036b2960],

1	OH	NN	O	oh	_	0	SENT_37	[p2l1380t2874r2036b2960],
2	.	.	O	.	_	0	SENT_37	[p2l1380t2874r2036b2960],

1	—	NN	O	—	_	0	SENT_38	[p2l1380t2874r2036b2960],
2	.	.	O	.	_	0	SENT_38	[p2l1380t2874r2036b2960],

1	risperidone	NN	O	risperidone	nn	2	SENT_39	[p2l1380t2874r2036b2960],
2	ratio	NN	O	ratio	_	0	SENT_39	[p2l10t2973r179b3036],
3	(	CD	NUMBER	(	number	4	SENT_39	[p2l229t2971r357b3049],
4	0.5	CD	NUMBER	0.5	amod	2	SENT_39	[p2l229t2971r357b3049],
5	1	LS	NUMBER	1	dep	4	SENT_39	[p2l379t2980r427b3035],
6	-	:	O	-	_	0	SENT_39	[p2l379t2980r427b3035],
7	0.6	CD	NUMBER	0.6	dep	2	SENT_39	[p2l447t2977r548b3036],
8	vs.	CC	O	vs.	prep	7	SENT_39	[p2l591t2993r685b3036],
9	1.9	CD	NUMBER	1.9	dep	8	SENT_39	[p2l712t2977r806b3036],
10	1	LS	NUMBER	1	dep	9	SENT_39	[p2l826t2980r874b3035],
11	-	:	O	-	_	0	SENT_39	[p2l826t2980r874b3035],
12	1.8	CD	NUMBER	1.8	dep	2	SENT_39	[p2l900t2977r1016b3046],
13	;	:	O	;	_	0	SENT_39	[p2l900t2977r1016b3046],
14	p	NN	O	p	dep	12	SENT_39	[p2l1060t2992r1103b3056],
15	=	JJ	O	=	amod	17	SENT_39	[p2l1124t2998r1171b3021],
16	0.120	CD	NUMBER	0.120	tmod	15	SENT_39	[p2l1192t2971r1429b3049],
17	)	NN	O	)	dep	14	SENT_39	[p2l1192t2971r1429b3049],
18	.	.	O	.	_	0	SENT_39	[p2l1192t2971r1429b3049],

1	Discussion	NN	O	discussion	nsubj	5	SENT_40	[p2l1470t2973r1852b3036],
2	The	DT	O	the	det	4	SENT_40	[p2l1898t2970r2035b3036],
3	major	JJ	O	major	amod	4	SENT_40	[p2l9t3068r225b3153],
4	finding	NN	O	finding	dep	1	SENT_40	[p2l250t3065r516b3153],
5	was	VBD	O	be	_	0	SENT_40	[p2l537t3088r671b3131],
6	that	IN	O	that	complm	11	SENT_40	[p2l698t3066r840b3131],
7	responders	NNS	O	responder	nsubj	11	SENT_40	[p2l865t3066r1267b3152],
8	to	TO	O	to	_	0	SENT_40	[p2l1294t3078r1362b3131],
9	risperidone	NN	O	risperidone	nn	10	SENT_40	[p2l1390t3066r1812b3152],
10	treatment	NN	O	treatment	prep_to	7	SENT_40	[p2l1838t3078r2033b3131, p2l9t3174r196b3228],
11	had	VBD	O	have	ccomp	5	SENT_40	[p2l216t3162r352b3228],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_40	[p2l375t3162r827b3249],
13	lower	JJR	O	lower	amod	15	SENT_40	[p2l844t3162r1045b3228],
14	blood	NN	O	blood	nn	15	SENT_40	[p2l1064t3162r1278b3228],
15	levels	NNS	O	level	dobj	11	SENT_40	[p2l1298t3162r1496b3228],
16	of	IN	O	of	_	0	SENT_40	[p2l1520t3162r1598b3228],
17	risperidone	NN	O	risperidone	nn	20	SENT_40	[p2l1614t3162r2035b3248],
18	and	CC	O	and	_	0	SENT_40	[p2l11t3258r146b3323],
19	9-OH	NN	O	9-oh	nn	20	SENT_40	[p2l186t3262r383b3324],
20	risperidone	NN	O	risperidone	prep_of	15	SENT_40	[p2l425t3258r847b3344],
21	than	IN	O	than	_	0	SENT_40	[p2l888t3258r1052b3323],
22	patients	NNS	O	patient	prep_than	11	SENT_40	[p2l1092t3260r1381b3344],
23	who	WP	O	who	nsubj	26	SENT_40	[p2l1421t3258r1574b3323],
24	did	VBD	O	do	aux	26	SENT_40	[p2l1618t3258r1736b3323],
25	not	RB	O	not	neg	26	SENT_40	[p2l1775t3270r1896b3323],
26	respond	VB	O	respond	rcmod	22	SENT_40	[p2l1936t3280r2033b3323, p2l11t3354r233b3440],
27	to	TO	O	to	_	0	SENT_40	[p2l260t3366r329b3420],
28	the	DT	O	the	det	29	SENT_40	[p2l359t3354r471b3420],
29	treatment	NN	O	treatment	prep_to	26	SENT_40	[p2l500t3366r859b3420],
30	despite	IN	O	despite	_	0	SENT_40	[p2l888t3354r1144b3440],
31	administration	NN	O	administration	prep_despite	26	SENT_40	[p2l1175t3354r1720b3420],
32	of	IN	O	of	_	0	SENT_40	[p2l1751t3354r1828b3420],
33	similar	JJ	O	similar	amod	35	SENT_40	[p2l1851t3357r2033b3420, p2l8t3450r105b3515],
34	oral	JJ	O	oral	amod	35	SENT_40	[p2l142t3450r283b3515],
35	doses	NNS	O	dose	prep_of	31	SENT_40	[p2l320t3450r538b3515],
36	.	.	O	.	_	0	SENT_40	[p2l320t3450r538b3515],

1	The	DT	O	the	det	4	SENT_41	[p2l573t3450r709b3515],
2	observed	VBN	O	observe	amod	4	SENT_41	[p2l747t3450r1078b3515],
3	CYPZD6	NN	O	cypzd6	nn	4	SENT_41	[p2l1115t3454r1418b3516],
4	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_41	[p2l1455t3450r2035b3537],
5	did	VBD	O	do	aux	7	SENT_41	[p2l10t3546r128b3612],
6	not	RB	O	not	neg	7	SENT_41	[p2l169t3558r289b3612],
7	contribute	VB	O	contribute	_	0	SENT_41	[p2l330t3546r706b3612],
8	to	TO	O	to	_	0	SENT_41	[p2l748t3558r817b3612],
9	altered	JJ	O	altered	amod	11	SENT_41	[p2l861t3546r1109b3612],
10	clinical	JJ	O	clinical	amod	11	SENT_41	[p2l1151t3546r1411b3612],
11	efﬁcacy	NN	O	efﬁcacy	prep_to	7	SENT_41	[p2l1453t3546r1743b3633],
12	,	,	O	,	_	0	SENT_41	[p2l1453t3546r1743b3633],
13	but	CC	O	but	_	0	SENT_41	[p2l1778t3546r1899b3612],
14	affected	VBD	O	affect	conj_but	7	SENT_41	[p2l1941t3546r2033b3612, p2l10t3642r228b3707],
15	risperidone	NN	O	risperidone	dobj	14	SENT_41	[p2l293t3642r715b3728],
16	to	TO	O	to	_	0	SENT_41	[p2l781t3654r849b3707],
17	9	CD	NUMBER	9	prep_to	14	SENT_41	[p2l918t3642r1574b3728],
18	.	.	O	.	_	0	SENT_41	[p2l918t3642r1574b3728],

1	—	NN	O	—	_	0	SENT_42	[p2l918t3642r1574b3728],
2	.	.	O	.	_	0	SENT_42	[p2l918t3642r1574b3728],

1	OH	NN	O	oh	_	0	SENT_43	[p2l918t3642r1574b3728],
2	.	.	O	.	_	0	SENT_43	[p2l918t3642r1574b3728],

1	—	NN	O	—	_	0	SENT_44	[p2l918t3642r1574b3728],
2	.	.	O	.	_	0	SENT_44	[p2l918t3642r1574b3728],

1	risperidone	NN	O	risperidone	nn	2	SENT_45	[p2l918t3642r1574b3728],
2	ratios	NNS	O	ratio	_	0	SENT_45	[p2l1641t3644r1866b3707],
3	.	.	O	.	_	0	SENT_45	[p2l1641t3644r1866b3707],

1	Increased	VBN	O	increase	amod	3	SENT_46	[p2l1930t3648r2033b3706, p2l11t3738r283b3804],
2	plasma	NN	O	plasma	nn	3	SENT_46	[p2l317t3738r579b3824],
3	levels	NNS	O	level	nsubj	14	SENT_46	[p2l613t3738r810b3804],
4	of	IN	O	of	_	0	SENT_46	[p2l848t3738r926b3804],
5	the	DT	O	the	det	7	SENT_46	[p2l954t3738r1066b3804],
6	active	JJ	O	active	amod	7	SENT_46	[p2l1104t3741r1314b3804],
7	moiety	NN	O	moiety	prep_of	3	SENT_46	[p2l1350t3741r1607b3825],
8	in	IN	O	in	_	0	SENT_46	[p2l1640t3741r1710b3803],
9	patients	NNS	O	patient	prep_in	7	SENT_46	[p2l1745t3741r2034b3824],
10	with	IN	O	with	_	0	SENT_46	[p3l7t11r171b77],
11	longer	JJR	O	longer	amod	12	SENT_46	[p3l197t11r431b99],
12	illness	NN	O	illness	prep_with	9	SENT_46	[p3l458t11r685b77],
13	may	MD	O	may	aux	14	SENT_46	[p3l714t34r869b99],
14	represent	VB	O	represent	_	0	SENT_46	[p3l893t23r1233b98],
15	general	JJ	O	general	amod	17	SENT_46	[p3l1260t11r1528b99],
16	aging	NN	O	aging	nn	17	SENT_46	[p3l1556t14r1756b99],
17	effects	NNS	O	effect	dobj	14	SENT_46	[p3l1783t11r2033b77],
18	.	.	O	.	_	0	SENT_46	[p3l1783t11r2033b77],

1	Conversely	RB	O	conversely	advmod	11	SENT_47	[p3l11t107r423b194],
2	,	,	O	,	_	0	SENT_47	[p3l11t107r423b194],
3	the	DT	O	the	nsubj	11	SENT_47	[p3l442t107r554b173],
4	observed	VBN	O	observe	partmod	3	SENT_47	[p3l579t107r910b173],
5	higher	JJR	O	higher	amod	7	SENT_47	[p3l931t107r1169b194],
6	plasma	NN	O	plasma	nn	7	SENT_47	[p3l1191t107r1453b193],
7	levels	NNS	O	level	dobj	4	SENT_47	[p3l1474t107r1672b173],
8	in	IN	O	in	_	0	SENT_47	[p3l1697t110r1767b172],
9	nonresponders	NNS	O	nonresponder	prep_in	7	SENT_47	[p3l1791t130r2033b173, p3l11t203r339b290],
10	may	MD	O	may	aux	11	SENT_47	[p3l366t226r522b291],
11	derive	VB	O	derive	_	0	SENT_47	[p3l545t203r768b269],
12	from	IN	O	from	_	0	SENT_47	[p3l794t203r971b269],
13	unaccounted	JJ	O	unaccounted	amod	16	SENT_47	[p3l998t203r1467b269],
14	genetic	JJ	O	genetic	amod	16	SENT_47	[p3l1492t206r1753b291],
15	metabolism	NN	O	metabolism	nn	16	SENT_47	[p3l1779t203r2033b269, p3l10t298r210b363],
16	abnormalities	NNS	O	abnormality	prep_from	11	SENT_47	[p3l260t298r765b363],
17	or	CC	O	or	_	0	SENT_47	[p3l817t321r893b363],
18	Phase	NN	O	phase	nn	21	SENT_47	[p3l943t298r1151b363],
19	II	CD	NUMBER	ii	num	21	SENT_47	[p3l1202t304r1258b362],
20	metabolism	NN	O	metabolism	nn	21	SENT_47	[p3l1309t298r1739b363],
21	disturbances	NNS	O	disturbance	prep_from	11	SENT_47	[p3l1790t298r2033b363, p3l7t394r273b460],
22	.	.	O	.	_	0	SENT_47	[p3l1790t298r2033b363, p3l7t394r273b460],

1	Patients	NNS	O	patient	nsubj	10	SENT_48	[p3l369t397r656b460],
2	initially	RB	O	initially	advmod	3	SENT_48	[p3l754t394r1039b482],
3	receiving	VBG	O	receive	partmod	1	SENT_48	[p3l1132t397r1466b482],
4	higher	JJR	O	higher	amod	7	SENT_48	[p3l1560t394r1798b482],
5	oral	JJ	O	oral	amod	7	SENT_48	[p3l1895t394r2036b460],
6	risperidone	NN	O	risperidone	nn	7	SENT_48	[p3l10t490r432b576],
7	doses	NNS	O	dose	dobj	3	SENT_48	[p3l460t490r659b556],
8	were	VBD	O	be	cop	10	SENT_48	[p3l684t513r855b556],
9	more	RBR	O	more	advmod	10	SENT_48	[p3l883t513r1071b556],
10	likely	JJ	O	likely	_	0	SENT_48	[p3l1098t490r1296b577],
11	to	TO	O	to	aux	12	SENT_48	[p3l1318t502r1387b556],
12	respond	VB	O	respond	xcomp	10	SENT_48	[p3l1416t490r1712b576],
13	with	IN	O	with	_	0	SENT_48	[p3l1735t490r1898b556],
14	extrapyramidal	JJ	O	extrapyramidal	amod	16	SENT_48	[p3l1927t513r2033b556, p3l9t586r492b674],
15	side	JJ	O	side	amod	16	SENT_48	[p3l526t586r668b652],
16	effects	NNS	O	effect	prep_with	12	SENT_48	[p3l702t586r932b652],
17	which	WDT	O	which	nsubj	18	SENT_48	[p3l963t586r1184b652],
18	reaffirms	VBZ	O	reaffirm	rcmod	16	SENT_48	[p3l1216t586r1549b652],
19	the	DT	O	the	det	20	SENT_48	[p3l1583t586r1695b652],
20	need	NN	O	need	dobj	18	SENT_48	[p3l1728t586r1901b652],
21	for	IN	O	for	_	0	SENT_48	[p3l1933t586r2037b652],
22	careful	JJ	O	careful	amod	23	SENT_48	[p3l11t682r259b748],
23	titration	NN	O	titration	prep_for	20	SENT_48	[p3l281t685r604b748],
24	.	.	O	.	_	0	SENT_48	[p3l281t685r604b748],

1	The	DT	O	the	det	4	SENT_49	[p3l625t682r762b748],
2	high	JJ	O	high	amod	4	SENT_49	[p3l784t682r948b769],
3	inter	NN	O	inter	nn	4	SENT_49	[p3l972t682r1547b748],
4	—	NN	O	—	_	0	SENT_49	[p3l972t682r1547b748],
5	individual	JJ	O	individual	amod	6	SENT_49	[p3l972t682r1547b748],
6	variability	NN	O	variability	dep	4	SENT_49	[p3l1568t682r1946b769],
7	in	IN	O	in	_	0	SENT_49	[p3l1966t685r2035b747],
8	risperidone	NN	O	risperidone	prep_in	6	SENT_49	[p3l10t778r432b865],
9	and	CC	O	and	_	0	SENT_49	[p3l465t779r600b844],
10	9	CD	NUMBER	9	conj_and	8	SENT_49	[p3l631t778r1287b865],
11	.	.	O	.	_	0	SENT_49	[p3l631t778r1287b865],

1	—	NN	O	—	_	0	SENT_50	[p3l631t778r1287b865],
2	.	.	O	.	_	0	SENT_50	[p3l631t778r1287b865],

1	OH-risperidone	JJ	O	oh-risperidone	amod	2	SENT_51	[p3l631t778r1287b865],
2	metabolization	NN	O	metabolization	_	0	SENT_51	[p3l1319t778r1869b844],
3	and	CC	O	and	_	0	SENT_51	[p3l1902t778r2037b844],
4	the	DT	O	the	det	5	SENT_51	[p3l9t874r121b940],
5	relationship	NN	O	relationship	conj_and	2	SENT_51	[p3l156t874r591b960],
6	between	IN	O	between	_	0	SENT_51	[p3l625t874r928b940],
7	clinical	JJ	O	clinical	amod	8	SENT_51	[p3l964t874r1224b940],
8	outcome	NN	O	outcome	prep_between	5	SENT_51	[p3l1259t886r1572b940],
9	and	CC	O	and	_	0	SENT_51	[p3l1608t874r1743b940],
10	plasma	NN	O	plasma	nn	12	SENT_51	[p3l1775t874r2037b960],
11	levels	NNS	O	level	nn	12	SENT_51	[p3l8t970r206b1036],
12	warrants	NNS	O	warrant	prep_between	5	SENT_51	[p3l229t982r551b1036],
13	regular	JJ	O	regular	amod	16	SENT_51	[p3l577t970r838b1058],
14	plasma	NN	O	plasma	nn	16	SENT_51	[p3l860t970r1122b1057],
15	level	NN	O	level	nn	16	SENT_51	[p3l1144t970r1309b1036],
16	monitoring	NN	O	monitoring	dep	2	SENT_51	[p3l1332t973r1750b1058],
17	of	IN	O	of	prep	16	SENT_51	[p3l1774t970r1851b1036],
18	both	CC	O	both	dep	16	SENT_51	[p3l1866t970r2036b1036],
19	compounds	NNS	O	compound	conj	16	SENT_51	[p3l11t1067r436b1153],
20	to	TO	O	to	aux	21	SENT_51	[p3l475t1079r543b1133],
21	assess	VB	O	assess	infmod	19	SENT_51	[p3l585t1090r799b1133],
22	for	IN	O	for	_	0	SENT_51	[p3l839t1067r943b1133],
23	the	DT	O	the	det	27	SENT_51	[p3l980t1067r1092b1133],
24	clinically	RB	O	clinically	advmod	25	SENT_51	[p3l1132t1067r1462b1154],
25	relevant	JJ	O	relevant	amod	27	SENT_51	[p3l1497t1067r1787b1133],
26	active	JJ	O	active	amod	27	SENT_51	[p3l1826t1069r2035b1133],
27	moiety	NN	O	moiety	prep_for	21	SENT_51	[p3l9t1166r275b1252],
28	.	.	O	.	_	0	SENT_51	[p3l9t1166r275b1252],

1	9	CD	NUMBER	9	num	3	SENT_52	[p3l2110t1316r2152b1342],
2	SS	NN	O	ss	nn	3	SENT_52	[p3l2110t1244r2151b1300],
3	NC	NN	O	nc	_	0	SENT_52	[p3l2110t1029r2153b1226],
4	)	CD	NUMBER	)	num	5	SENT_52	[p3l2110t1029r2153b1226],
5	dVH	NN	O	dvh	dep	3	SENT_52	[p3l2110t1029r2153b1226],

1	I	PRP	O	I	_	0	SENT_53	[p3l10t1651r75b1716],
2	Key	NN	O	key	nn	4	SENT_53	[p3l140t1652r266b1737],
3	words	NNS	O	word	nn	4	SENT_53	[p3l284t1650r501b1717],
4	9-Hydroxy-risperidone	NN	O	9-hydroxy-risperidone	dep	1	SENT_53	[p3l574t1648r1464b1741],
5	-	:	O	-	_	0	SENT_53	[p3l1493t1685r1506b1698],
6	risperidone	NN	O	risperidone	nn	7	SENT_53	[p3l1535t1648r1980b1740],
7	TDM	NN	O	tdm	dep	1	SENT_53	[p3l2008t1685r2021b1698, p3l10t1754r208b1818],
8	-	:	O	-	_	0	SENT_53	[p3l237t1786r250b1800],
9	therapeutic	JJ	O	therapeutic	amod	11	SENT_53	[p3l278t1750r719b1841],
10	drug	NN	O	drug	nn	11	SENT_53	[p3l745t1750r927b1842],
11	monitoring	NN	O	monitoring	dep	7	SENT_53	[p3l951t1752r1393b1842],
12	-	:	O	-	_	0	SENT_53	[p3l1419t1786r1432b1800],
13	CYP	NN	O	cyp	nn	15	SENT_53	[p3l1462t1755r1625b1819],
14	2D6	NN	O	2d6	nn	15	SENT_53	[p3l1653t1756r1803b1819],
15	schizophrenia	NN	O	schizophrenia	dep	11	SENT_53	[p3l1832t1786r1845b1800, p3l11t1851r550b1943],
16	-	:	O	-	_	0	SENT_53	[p3l577t1888r590b1901],
17	HPLC	NN	O	hplc	dep	7	SENT_53	[p3l619t1856r844b1921],

1	Introduction	NN	O	introduction	_	0	SENT_54	[p3l13t2148r529b2226],

1	Schizophrenia	NN	O	schizophrenia	nn	2	SENT_55	[p3l11t2361r560b2452],
2	treatment	NN	O	treatment	nsubjpass	4	SENT_55	[p3l622t2374r1001b2430],
3	was	VBD	O	be	auxpass	4	SENT_55	[p3l1062t2385r1204b2430],
4	revolutionized	VBN	O	revolutionize	_	0	SENT_55	[p3l1270t2361r1828b2430],
5	in	IN	O	in	_	0	SENT_55	[p3l1891t2363r1965b2429],
6	the	DT	DATE	the	det	7	SENT_55	[p3l2029t2361r2148b2430],
7	1950s	NNS	DATE	1950	prep_in	4	SENT_55	[p3l17t2470r220b2532],
8	with	IN	O	with	_	0	SENT_55	[p3l240t2462r412b2531],
9	the	DT	O	the	det	10	SENT_55	[p3l432t2462r551b2531],
10	advent	NN	O	advent	prep_with	4	SENT_55	[p3l574t2462r828b2531],
11	of	IN	O	of	_	0	SENT_55	[p3l849t2462r931b2531],
12	antipsychotic	JJ	O	antipsychotic	amod	13	SENT_55	[p3l946t2462r1461b2555],
13	medications	NNS	O	medication	prep_of	10	SENT_55	[p3l1482t2462r1951b2531],
14	such	JJ	O	such	_	0	SENT_55	[p3l1975t2462r2148b2531],
15	as	IN	O	as	_	0	SENT_55	[p3l10t2587r84b2632],
16	chlorpromazine	NN	O	chlorpromazine	prep_such_as	13	SENT_55	[p3l122t2563r736b2654],
17	and	CC	O	and	_	0	SENT_55	[p3l774t2563r917b2632],
18	haloperidol	NN	O	haloperidol	conj_and	16	SENT_55	[p3l950t2563r1416b2654],
19	.	.	O	.	_	0	SENT_55	[p3l950t2563r1416b2654],

1	Their	PRP$	O	they	poss	2	SENT_56	[p3l1449t2563r1657b2632],
2	efficacy	NN	O	efficacy	nsubj	5	SENT_56	[p3l1693t2563r1989b2655],
3	has	VBZ	O	have	aux	5	SENT_56	[p3l2020t2563r2147b2632],
4	been	VBN	O	be	cop	5	SENT_56	[p3l7t2664r192b2733],
5	well-established	JJ	O	well-established	_	0	SENT_56	[p3l216t2664r857b2745],
6	,	,	O	,	_	0	SENT_56	[p3l216t2664r857b2745],
7	although	IN	O	although	mark	9	SENT_56	[p3l881t2664r1220b2757],
8	they	PRP	O	they	nsubj	9	SENT_56	[p3l1246t2664r1414b2757],
9	have	VBP	O	have	advcl	5	SENT_56	[p3l1435t2664r1609b2733],
10	arguably	RB	O	arguably	advmod	12	SENT_56	[p3l1637t2664r1974b2757],
11	better	JJR	O	better	amod	12	SENT_56	[p3l1994t2664r2145b2733, p3l9t2780r113b2836],
12	efﬁcacy	NN	O	efﬁcacy	dobj	9	SENT_56	[p3l139t2767r435b2859],
13	against	IN	O	against	_	0	SENT_56	[p3l458t2769r731b2859],
14	positive	JJ	O	positive	amod	15	SENT_56	[p3l754t2769r1055b2858],
15	symptoms	NNS	O	symptom	prep_against	12	SENT_56	[p3l1083t2780r1480b2859],
16	of	IN	O	of	_	0	SENT_56	[p3l1508t2767r1589b2836],
17	schizophrenia	NN	O	schizophrenia	prep_of	15	SENT_56	[p3l1610t2767r2149b2858],
18	than	IN	O	than	prep	9	SENT_56	[p3l9t2894r182b2963],
19	against	IN	O	against	pcomp	18	SENT_56	[p3l211t2897r484b2987],
20	negative	JJ	O	negative	amod	21	SENT_56	[p3l511t2897r828b2987],
21	symptoms	NNS	O	symptom	pobj	19	SENT_56	[p3l858t2907r1275b2987],
22	.	.	O	.	_	0	SENT_56	[p3l858t2907r1275b2987],

1	However	RB	O	however	advmod	11	SENT_57	[p3l1301t2900r1653b2975],
2	,	,	O	,	_	0	SENT_57	[p3l1301t2900r1653b2975],
3	a	DT	O	a	det	5	SENT_57	[p3l1678t2919r1717b2963],
4	significant	JJ	O	significant	amod	5	SENT_57	[p3l1745t2894r2149b2987],
5	portion	NN	O	portion	nsubj	11	SENT_57	[p3l9t2997r301b3086],
6	of	IN	O	of	_	0	SENT_57	[p3l330t2995r412b3064],
7	patients	NNS	O	patient	prep_of	5	SENT_57	[p3l432t2997r737b3086],
8	do	VBP	O	do	aux	11	SENT_57	[p3l767t2995r860b3064],
9	not	RB	O	not	dep	10	SENT_57	[p3l890t3008r1018b3064],
10	sufficiently	RB	O	sufficiently	advmod	11	SENT_57	[p3l1046t2995r1474b3087],
11	respond	VB	O	respond	_	0	SENT_57	[p3l1498t2995r1810b3086],
12	to	TO	O	to	_	0	SENT_57	[p3l1836t3008r1909b3064],
13	treatment	NN	O	treatment	prep_to	11	SENT_57	[p3l1938t3008r2145b3064, p3l9t3109r206b3165],
14	with	IN	O	with	_	0	SENT_57	[p3l245t3096r417b3165],
15	these	DT	O	these	det	16	SENT_57	[p3l458t3096r656b3165],
16	agents	NNS	O	agent	prep_with	11	SENT_57	[p3l700t3109r963b3189],
17	,	,	O	,	_	0	SENT_57	[p3l700t3109r963b3189],
18	and	CC	O	and	_	0	SENT_57	[p3l1003t3096r1146b3165],
19	many	JJ	O	many	nsubj	20	SENT_57	[p3l1187t3121r1403b3189],
20	developed	VBD	O	develop	conj_and	11	SENT_57	[p3l1442t3096r1832b3188],
21	serious	JJ	O	serious	amod	24	SENT_57	[p3l1874t3099r2147b3165],
22	acute	JJ	O	acute	amod	24	SENT_57	[p3l10t3210r210b3266],
23	side	JJ	O	side	amod	24	SENT_57	[p3l276t3197r425b3266],
24	effects	NNS	O	effect	dep	34	SENT_57	[p3l490t3197r755b3277],
25	,	,	O	,	_	0	SENT_57	[p3l490t3197r755b3277],
26	such	JJ	O	such	_	0	SENT_57	[p3l816t3197r989b3266],
27	as	IN	O	as	_	0	SENT_57	[p3l1054t3221r1127b3266],
28	akathisia	NN	O	akathisium	prep_such_as	24	SENT_57	[p3l1193t3197r1556b3278],
29	,	,	O	,	_	0	SENT_57	[p3l1193t3197r1556b3278],
30	dystonia	NN	O	dystonium	conj_and	28	SENT_57	[p3l1616t3197r1943b3289],
31	and	CC	O	and	_	0	SENT_57	[p3l2006t3197r2149b3266],
32	parkinsonism	NN	O	parkinsonism	conj_and	28	SENT_57	[p3l9t3298r545b3390],
33	(	CD	NUMBER	(	dep	34	SENT_57	[p3l572t3298r969b3382],
34	Nasrallah	NNP	PERSON	Nasrallah	dep	38	SENT_57	[p3l572t3298r969b3382],
35	and	CC	O	and	_	0	SENT_57	[p3l993t3298r1136b3367],
36	Mulvihill	NNP	PERSON	Mulvihill	conj_and	34	SENT_57	[p3l1157t3298r1507b3367],
37	2001	CD	DATE	2001	num	38	SENT_57	[p3l1530t3299r1759b3382],
38	)	CD	NUMBER	)	dep	20	SENT_57	[p3l1530t3299r1759b3382],
39	.	.	O	.	_	0	SENT_57	[p3l1530t3299r1759b3382],

1	The	DT	O	the	det	3	SENT_58	[p3l1779t3298r1923b3367],
2	atypical	JJ	O	atypical	amod	3	SENT_58	[p3l1949t3311r2145b3391, p3l10t3399r141b3468],
3	antipsychotics	NNS	O	antipsychotic	nsubjpass	5	SENT_58	[p3l169t3399r720b3491],
4	are	VBP	O	be	auxpass	5	SENT_58	[p3l750t3423r864b3468],
5	presumed	VBN	O	presume	_	0	SENT_58	[p3l891t3399r1275b3490],
6	to	TO	O	to	aux	7	SENT_58	[p3l1301t3412r1373b3468],
7	have	VB	O	have	xcomp	5	SENT_58	[p3l1401t3399r1574b3468],
8	better	JJR	O	better	amod	9	SENT_58	[p3l1600t3399r1828b3468],
9	efﬁcacy	NN	O	efﬁcacy	dobj	7	SENT_58	[p3l1856t3399r2152b3491],
10	in	IN	O	in	_	0	SENT_58	[p3l10t3503r84b3568],
11	the	DT	O	the	det	12	SENT_58	[p3l124t3500r243b3569],
12	treatment	NN	O	treatment	prep_in	7	SENT_58	[p3l283t3513r663b3569],
13	of	IN	O	of	_	0	SENT_58	[p3l703t3500r785b3569],
14	negative	JJ	O	negative	amod	15	SENT_58	[p3l819t3503r1137b3593],
15	symptoms	NNS	O	symptom	prep_of	12	SENT_58	[p3l1180t3513r1577b3593],
16	than	IN	O	than	mark	19	SENT_58	[p3l1618t3500r1792b3569],
17	classical	JJ	O	classical	amod	18	SENT_58	[p3l1834t3500r2149b3569],
18	neuroleptics	NNS	O	neuroleptic	nsubj	19	SENT_58	[p3l9t3601r485b3692],
19	(	VBP	O	(	advcl	7	SENT_58	[p3l518t3601r803b3685],
20	Moller	NNP	PERSON	Moller	dobj	19	SENT_58	[p3l518t3601r803b3685],
21	1999	CD	DATE	1999	num	20	SENT_58	[p3l836t3608r1003b3670],
22	and	CC	DATE	and	_	0	SENT_58	[p3l1032t3601r1175b3670],
23	2003	CD	DATE	2003	num	24	SENT_58	[p3l1201t3601r1431b3685],
24	)	CD	NUMBER	)	conj_and	20	SENT_58	[p3l1201t3601r1431b3685],
25	,	,	O	,	_	0	SENT_58	[p3l1201t3601r1431b3685],
26	both	CC	O	both	dep	7	SENT_58	[p3l1452t3601r1630b3670],
27	due	JJ	O	due	conj	7	SENT_58	[p3l1658t3601r1795b3670],
28	to	TO	O	to	_	0	SENT_58	[p3l1821t3614r1894b3670],
29	better	JJR	O	better	amod	30	SENT_58	[p3l1921t3601r2149b3670],
30	tolerability	NN	O	tolerability	prep_to	27	SENT_58	[p3l9t3702r436b3795],
31	and	CC	O	and	_	0	SENT_58	[p3l457t3702r600b3771],
32	more	JJR	O	more	amod	35	SENT_58	[p3l624t3727r822b3771],
33	complex	JJ	O	complex	amod	35	SENT_58	[p3l849t3702r1174b3794],
34	neurotransmitter	NN	O	neurotransmitter	nn	35	SENT_58	[p3l1196t3705r1862b3771],
35	action	NN	O	action	conj_and	30	SENT_58	[p3l1887t3705r2145b3771],
36	.	.	O	.	_	0	SENT_58	[p3l1887t3705r2145b3771],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_59	[p4l10t11r529b91],
2	,	,	O	,	_	0	SENT_59	[p4l10t11r529b91],
3	atypical	JJ	O	atypical	amod	4	SENT_59	[p4l563t11r865b103],
4	drugs	NNS	O	drug	nsubj	10	SENT_59	[p4l902t11r1119b103],
5	with	IN	O	with	_	0	SENT_59	[p4l1154t11r1327b80],
6	favorable	JJ	O	favorable	amod	9	SENT_59	[p4l1363t11r1715b80],
7	side	JJ	O	side	amod	9	SENT_59	[p4l1753t11r1903b80],
8	effect	NN	O	effect	nn	9	SENT_59	[p4l1941t11r2149b80],
9	proﬁles	NNS	O	proﬁles	prep_with	4	SENT_59	[p4l9t113r296b205],
10	represent	VBP	O	represent	_	0	SENT_59	[p4l322t126r680b205],
11	important	JJ	O	important	amod	13	SENT_59	[p4l704t116r1095b205],
12	key	JJ	O	key	amod	13	SENT_59	[p4l1117t113r1251b206],
13	features	NNS	O	feature	nsubj	29	SENT_59	[p4l1272t113r1573b182],
14	in	IN	O	in	_	0	SENT_59	[p4l1599t116r1673b181],
15	schizophrenia	NN	O	schizophrenia	nn	16	SENT_59	[p4l1698t113r2145b205, p4l9t216r128b283],
16	care	NN	O	care	prep_in	13	SENT_59	[p4l159t238r336b294],
17	,	,	O	,	_	0	SENT_59	[p4l159t238r336b294],
18	since	IN	O	since	mark	23	SENT_59	[p4l364t216r556b283],
19	long-term	JJ	O	long-term	amod	20	SENT_59	[p4l586t214r974b306],
20	treatment	NN	O	treatment	nsubjpass	23	SENT_59	[p4l1005t226r1383b283],
21	is	VBZ	O	be	auxpass	23	SENT_59	[p4l1414t216r1471b283],
22	often	RB	O	often	advmod	23	SENT_59	[p4l1504t214r1701b283],
23	warranted	VBN	O	warrant	dep	16	SENT_59	[p4l1729t214r2147b294],
24	;	:	O	;	_	0	SENT_59	[p4l1729t214r2147b294],
25	signiﬁcant	JJ	O	signiﬁcant	amod	27	SENT_59	[p4l11t315r415b408],
26	side	JJ	O	side	amod	27	SENT_59	[p4l464t315r614b384],
27	effects	NNS	O	effect	nsubj	29	SENT_59	[p4l663t315r906b384],
28	only	RB	O	only	advmod	29	SENT_59	[p4l957t315r1125b408],
29	contribute	VBP	O	contribute	ccomp	10	SENT_59	[p4l1170t315r1568b384],
30	to	TO	O	to	_	0	SENT_59	[p4l1615t328r1688b384],
31	treatmentnoncompliance	NN	O	treatmentnoncompliance	prep_to	29	SENT_59	[p4l1737t328r2146b384, p4l9t416r601b507],
32	with	IN	O	with	_	0	SENT_59	[p4l646t416r818b485],
33	medication	NN	O	medication	prep_with	29	SENT_59	[p4l864t416r1318b496],
34	,	,	O	,	_	0	SENT_59	[p4l864t416r1318b496],
35	probably	RB	O	probably	advmod	36	SENT_59	[p4l1360t416r1705b508],
36	leading	VBG	O	lead	xcomp	10	SENT_59	[p4l1746t416r2029b508],
37	to	TO	O	to	_	0	SENT_59	[p4l2073t429r2146b485],
38	long-term	JJ	O	long-term	amod	40	SENT_59	[p4l8t517r396b610],
39	clinical	JJ	O	clinical	amod	40	SENT_59	[p4l423t517r698b586],
40	deterioration	NN	O	deterioration	prep_to	36	SENT_59	[p4l724t517r1231b586],
41	(	CD	NUMBER	(	num	42	SENT_59	[p4l1261t518r1556b601],
42	Fenton	NN	PERSON	fenton	dobj	36	SENT_59	[p4l1261t518r1556b601],
43	et	FW	O	et	nn	44	SENT_59	[p4l1583t530r1650b586],
44	al.	FW	O	al.	dep	42	SENT_59	[p4l1668t517r1750b586],
45	1997	CD	DATE	1997	num	46	SENT_59	[p4l1780t518r2002b601],
46	)	CD	NUMBER	)	dep	44	SENT_59	[p4l1780t518r2002b601],
47	.	.	O	.	_	0	SENT_59	[p4l1780t518r2002b601],

1	Risperidone	NNP	O	Risperidone	nsubj	7	SENT_60	[p4l125t618r613b709],
2	,	,	O	,	_	0	SENT_60	[p4l125t618r613b709],
3	a	DT	O	a	det	5	SENT_60	[p4l663t642r703b687],
4	benzisoxazole	NN	O	benzisoxazole	nn	5	SENT_60	[p4l752t618r1294b687],
5	derivative	NN	O	derivative	appos	1	SENT_60	[p4l1349t618r1747b698],
6	,	,	O	,	_	0	SENT_60	[p4l1349t618r1747b698],
7	has	VBZ	O	have	_	0	SENT_60	[p4l1795t618r1922b687],
8	high	JJ	O	high	amod	10	SENT_60	[p4l1976t618r2148b710],
9	binding	NN	O	binding	nn	10	SENT_60	[p4l7t719r309b812],
10	afﬁnity	NN	O	afﬁnity	dobj	7	SENT_60	[p4l334t719r615b812],
11	for	IN	O	for	_	0	SENT_60	[p4l636t719r745b788],
12	both	DT	O	both	det	14	SENT_60	[p4l767t719r946b788],
13	dopamine	NN	O	dopamine	nn	14	SENT_60	[p4l971t719r1358b811],
14	D2	NN	O	d2	prep_for	10	SENT_60	[p4l1384t726r1489b787],
15	and	CC	O	and	_	0	SENT_60	[p4l1517t719r1660b788],
16	serotonin	NN	O	serotonin	nn	18	SENT_60	[p4l1685t722r2049b788],
17	5HT2	NN	O	5ht2	nn	18	SENT_60	[p4l2075t728r2145b788, p4l10t823r175b888],
18	receptors	NNS	O	receptor	nsubj	19	SENT_60	[p4l227t832r581b911],
19	(	VBP	O	(	conj_and	7	SENT_60	[p4l636t820r950b904],
20	Marder	NNP	PERSON	Marder	nn	24	SENT_60	[p4l636t820r950b904],
21	and	CC	O	and	_	0	SENT_60	[p4l1001t820r1143b889],
22	Meibach	NNP	PERSON	Meibach	nn	24	SENT_60	[p4l1192t820r1518b889],
23	1994	CD	DATE	1994	num	24	SENT_60	[p4l1576t820r1773b903],
24	)	NNP	O	)	dobj	19	SENT_60	[p4l1576t820r1773b903],
25	and	CC	O	and	_	0	SENT_60	[p4l1829t820r1972b889],
26	has	VBZ	O	have	aux	27	SENT_60	[p4l2019t820r2147b889],
27	proven	VBN	O	prove	conj_and	7	SENT_60	[p4l9t945r275b1012],
28	efﬁcacy	NN	O	efﬁcacy	dobj	27	SENT_60	[p4l305t921r601b1013],
29	in	IN	O	in	prep	28	SENT_60	[p4l627t924r700b989],
30	the	DT	O	the	det	31	SENT_60	[p4l729t921r847b990],
31	treatment	NN	O	treatment	dep	39	SENT_60	[p4l876t934r1255b990],
32	of	IN	O	of	_	0	SENT_60	[p4l1285t921r1366b990],
33	schizophrenic	JJ	O	schizophrenic	amod	37	SENT_60	[p4l1390t921r1926b1012],
34	positive	JJ	O	positive	amod	37	SENT_60	[p4l1954t924r2145b1012, p4l9t1024r145b1091],
35	and	CC	O	and	_	0	SENT_60	[p4l178t1022r320b1091],
36	negative	JJ	O	negative	conj_and	34	SENT_60	[p4l350t1024r667b1114],
37	symptomatology	NN	O	symptomatology	prep_of	31	SENT_60	[p4l699t1022r1353b1114],
38	(	CD	NUMBER	(	dep	39	SENT_60	[p4l1382t1022r1723b1105],
39	Carman	NNP	PERSON	Carman	dep	42	SENT_60	[p4l1382t1022r1723b1105],
40	et	FW	O	et	nn	41	SENT_60	[p4l1755t1035r1822b1091],
41	al.	FW	O	al.	dep	39	SENT_60	[p4l1840t1022r1922b1091],
42	1995	CD	DATE	1995	dep	29	SENT_60	[p4l1957t1029r2147b1102],
43	;	:	O	;	_	0	SENT_60	[p4l1957t1029r2147b1102],
44	Marder	NNP	PERSON	Marder	nn	48	SENT_60	[p4l9t1123r293b1192],
45	and	CC	O	and	_	0	SENT_60	[p4l330t1123r472b1192],
46	Meibach	NNP	PERSON	Meibach	nn	48	SENT_60	[p4l506t1123r833b1192],
47	1994	CD	DATE	1994	num	48	SENT_60	[p4l875t1124r1097b1207],
48	)	NNP	O	)	dep	28	SENT_60	[p4l875t1124r1097b1207],
49	.	.	O	.	_	0	SENT_60	[p4l875t1124r1097b1207],

1	Risperidone	NNP	O	Risperidone	nsubjpass	4	SENT_61	[p4l1131t1123r1598b1214],
2	is	VBZ	O	be	auxpass	4	SENT_61	[p4l1634t1126r1692b1192],
3	readily	RB	O	readily	advmod	4	SENT_61	[p4l1729t1123r1996b1215],
4	absorbed	VBN	O	absorb	dep	20	SENT_61	[p4l2028t1123r2146b1192, p4l11t1224r274b1293],
5	orally	RB	O	orally	advmod	4	SENT_61	[p4l306t1224r538b1316],
6	,	,	O	,	_	0	SENT_61	[p4l306t1224r538b1316],
7	and	CC	O	and	_	0	SENT_61	[p4l568t1224r710b1293],
8	steady-state	JJ	O	steady-state	amod	10	SENT_61	[p4l743t1224r1196b1316],
9	plasma	NN	O	plasma	nn	10	SENT_61	[p4l1228t1224r1504b1315],
10	levels	NNS	O	level	nsubjpass	16	SENT_61	[p4l1534t1224r1742b1293],
11	of	IN	O	of	_	0	SENT_61	[p4l1777t1224r1858b1293],
12	the	DT	O	the	det	14	SENT_61	[p4l1883t1224r2002b1293],
13	active	JJ	O	active	amod	14	SENT_61	[p4l2036t1248r2145b1293, p4l9t1328r145b1394],
14	moiety	NN	O	moiety	prep_of	10	SENT_61	[p4l180t1328r451b1417],
15	are	VBP	O	be	auxpass	16	SENT_61	[p4l482t1349r597b1394],
16	reached	VBN	O	reach	conj_and	4	SENT_61	[p4l631t1325r934b1394],
17	after	IN	O	after	_	0	SENT_61	[p4l967t1325r1144b1394],
18	24	CD	DURATION	24	num	19	SENT_61	[p4l1177t1332r1262b1393],
19	hours	NNS	NUMBER	hour	prep_after	16	SENT_61	[p4l1295t1325r1514b1394],
20	(	VBP	O	(	_	0	SENT_61	[p4l1553t1325r1941b1417],
21	Heykants	NNS	O	heykant	dobj	20	SENT_61	[p4l1553t1325r1941b1417],
22	et	FW	O	et	nn	23	SENT_61	[p4l1978t1338r2044b1394],
23	al.	FW	O	al.	nsubj	20	SENT_61	[p4l2062t1325r2145b1394],
24	1994	CD	DATE	1994	num	25	SENT_61	[p4l17t1426r238b1509],
25	)	CD	NUMBER	)	dep	23	SENT_61	[p4l17t1426r238b1509],
26	.	.	O	.	_	0	SENT_61	[p4l17t1426r238b1509],

1	Metabolization	NN	O	metabolization	nsubjpass	4	SENT_62	[p4l283t1426r864b1495],
2	is	VBZ	O	be	auxpass	4	SENT_62	[p4l912t1428r969b1495],
3	largely	RB	O	largely	advmod	4	SENT_62	[p4l1017t1426r1279b1518],
4	effected	VBN	O	effect	conj_and	4	SENT_62	[p4l1324t1426r1624b1495],
5	through	IN	O	through	_	0	SENT_62	[p4l1670t1426r1979b1518],
6	hydroxylation	NN	O	hydroxylation	prep_through	4	SENT_62	[p4l2025t1426r2145b1518, p4l10t1527r454b1619],
7	and	CC	O	and	_	0	SENT_62	[p4l479t1527r622b1596],
8	N-dealkylation	NN	O	n-dealkylation	prep_through	4	SENT_62	[p4l643t1527r1221b1619],
9	by	IN	O	by	_	0	SENT_62	[p4l1241t1527r1337b1619],
10	the	DT	O	the	det	17	SENT_62	[p4l1355t1527r1473b1596],
11	liver	NN	O	liver	nn	17	SENT_62	[p4l1495t1527r1665b1596],
12	cytochrome	NN	O	cytochrome	nn	17	SENT_62	[p4l1688t1527r2148b1619],
13	P450	NN	O	p450	nn	17	SENT_62	[p4l10t1634r191b1697],
14	(	CD	NUMBER	(	num	17	SENT_62	[p4l220t1628r580b1712],
15	CYP450	NN	O	cyp450	nn	17	SENT_62	[p4l220t1628r580b1712],
16	)	NN	O	)	nn	17	SENT_62	[p4l220t1628r580b1712],
17	system	NN	O	system	agent	4	SENT_62	[p4l610t1641r892b1720],
18	,	,	O	,	_	0	SENT_62	[p4l610t1641r892b1720],
19	especially	RB	O	especially	advmod	22	SENT_62	[p4l912t1628r1287b1720],
20	CYPZD6	NN	O	cypzd6	nn	22	SENT_62	[p4l1308t1633r1628b1697],
21	(	CD	NUMBER	(	num	22	SENT_62	[p4l1657t1628r1951b1711],
22	Scordo	NNP	O	Scordo	rcmod	17	SENT_62	[p4l1657t1628r1951b1711],
23	et	FW	O	et	nn	24	SENT_62	[p4l1978t1640r2044b1697],
24	al.	FW	O	al.	dep	22	SENT_62	[p4l2062t1628r2145b1697],
25	1999	CD	DATE	1999	dep	24	SENT_62	[p4l17t1736r206b1810],
26	;	:	O	;	_	0	SENT_62	[p4l17t1736r206b1810],
27	Prior	JJ	O	prior	dep	24	SENT_62	[p4l231t1732r427b1798],
28	et	FW	O	et	nn	29	SENT_62	[p4l452t1742r519b1798],
29	al.	FW	O	al.	iobj	27	SENT_62	[p4l537t1729r619b1798],
30	2003	CD	DATE	2003	num	31	SENT_62	[p4l641t1730r871b1813],
31	)	CD	NUMBER	)	dobj	27	SENT_62	[p4l641t1730r871b1813],
32	,	,	O	,	_	0	SENT_62	[p4l641t1730r871b1813],
33	and	CC	O	and	_	0	SENT_62	[p4l892t1729r1035b1798],
34	to	TO	O	to	_	0	SENT_62	[p4l1058t1742r1130b1798],
35	a	DT	O	a	det	37	SENT_62	[p4l1157t1753r1197b1798],
36	lesser	JJR	O	lesser	amod	37	SENT_62	[p4l1219t1729r1435b1798],
37	extent	NN	O	extent	prep_to	4	SENT_62	[p4l1459t1742r1693b1798],
38	by	IN	O	by	_	0	SENT_62	[p4l1714t1729r1809b1821],
39	CYP3A4	NN	O	cyp3a4	nn	41	SENT_62	[p4l1831t1734r2148b1798],
40	(	CD	NUMBER	(	num	41	SENT_62	[p4l13t1830r230b1922],
41	Fang	NNP	PERSON	Fang	prep_by	37	SENT_62	[p4l13t1830r230b1922],
42	et	FW	O	et	nn	43	SENT_62	[p4l258t1843r325b1899],
43	al.	FW	O	al.	dep	41	SENT_62	[p4l343t1830r425b1899],
44	1999	CD	DATE	1999	num	45	SENT_62	[p4l459t1830r680b1913],
45	)	CD	NUMBER	)	dep	4	SENT_62	[p4l459t1830r680b1913],
46	.	.	O	.	_	0	SENT_62	[p4l459t1830r680b1913],

1	Risperidone	NNP	O	Risperidone	nsubj	11	SENT_63	[p4l707t1830r1174b1921],
2	and	CC	O	and	_	0	SENT_63	[p4l1204t1830r1346b1899],
3	its	PRP$	O	its	poss	5	SENT_63	[p4l1374t1832r1461b1899],
4	main	JJ	O	main	amod	5	SENT_63	[p4l1491t1832r1687b1899],
5	metabolite	NN	O	metabolite	conj_and	1	SENT_63	[p4l1716t1830r2147b1910],
6	,	,	O	,	_	0	SENT_63	[p4l1716t1830r2147b1910],
7	9-OH	NN	O	9-oh	nn	9	SENT_63	[p4l10t1931r724b2022],
8	—	CD	NUMBER	—	num	9	SENT_63	[p4l10t1931r724b2022],
9	risperidone	NN	O	risperidone	appos	1	SENT_63	[p4l10t1931r724b2022],
10	,	,	O	,	_	0	SENT_63	[p4l10t1931r724b2022],
11	form	VBP	O	form	_	0	SENT_63	[p4l768t1931r957b2000],
12	the	DT	O	the	det	16	SENT_63	[p4l1005t1931r1123b2000],
13	active	JJ	O	active	amod	16	SENT_63	[p4l1173t1934r1394b2000],
14	serum	NN	O	serum	nn	16	SENT_63	[p4l1444t1955r1684b2000],
15	compound	NN	O	compound	nn	16	SENT_63	[p4l1734t1931r2149b2022],
16	(	NN	O	(	dobj	11	SENT_63	[p4l13t2032r320b2116],
17	termed	VBN	O	term	partmod	16	SENT_63	[p4l13t2032r320b2116],
18	“	RB	O	“	advmod	19	SENT_63	[p4l349t2032r608b2101],
19	active	JJ	O	active	amod	20	SENT_63	[p4l349t2032r608b2101],
20	moiety	NN	O	moiety	dobj	17	SENT_63	[p4l644t2032r1007b2124],
21	”	CD	NUMBER	”	num	22	SENT_63	[p4l644t2032r1007b2124],
22	)	NN	O	)	dep	20	SENT_63	[p4l644t2032r1007b2124],
23	.	.	O	.	_	0	SENT_63	[p4l644t2032r1007b2124],

1	9-OH-risperidone	NN	O	9-oh-risperidone	nsubj	2	SENT_64	[p4l1041t2032r1734b2123],
2	exhibits	VBZ	O	exhibit	_	0	SENT_64	[p4l1772t2032r2071b2101],
3	a	DT	O	a	det	8	SENT_64	[p4l2110t2056r2149b2101],
4	similar	JJ	O	similar	amod	8	SENT_64	[p4l11t2134r279b2203],
5	CNS	NN	O	cn	nn	8	SENT_64	[p4l309t2139r473b2203],
6	receptor	NN	O	receptor	nn	8	SENT_64	[p4l504t2147r824b2225],
7	occupancy	NN	O	occupancy	nn	8	SENT_64	[p4l854t2158r1269b2226],
8	proﬁle	NN	O	proﬁle	dobj	2	SENT_64	[p4l1293t2134r1544b2225],
9	as	IN	O	as	_	0	SENT_64	[p4l1575t2158r1649b2203],
10	risperidone	NN	O	risperidone	prep_as	2	SENT_64	[p4l1680t2134r2147b2225],
11	,	,	O	,	_	0	SENT_64	[p4l1680t2134r2147b2225],
12	and	CC	O	and	_	0	SENT_64	[p4l10t2235r153b2305],
13	it	PRP	O	it	nsubj	17	SENT_64	[p4l177t2238r230b2305],
14	is	VBZ	O	be	cop	17	SENT_64	[p4l254t2238r311b2305],
15	presumably	RB	O	presumably	advmod	17	SENT_64	[p4l337t2235r792b2328],
16	equally	RB	O	equally	advmod	17	SENT_64	[p4l814t2235r1093b2328],
17	effective	JJ	O	effective	conj_and	2	SENT_64	[p4l1115t2235r1433b2305],
18	(	CD	NUMBER	(	num	20	SENT_64	[p4l1462t2236r1640b2319],
19	Van	NNP	PERSON	Van	nn	20	SENT_64	[p4l1462t2236r1640b2319],
20	Beijsterveldt	NNP	PERSON	Beijsterveldt	attr	17	SENT_64	[p4l1666t2235r2149b2328],
21	et	FW	O	et	nn	22	SENT_64	[p4l10t2349r77b2405],
22	al.	FW	O	al.	dep	20	SENT_64	[p4l95t2336r178b2405],
23	1998	CD	DATE	1998	num	24	SENT_64	[p4l210t2337r432b2420],
24	)	CD	NUMBER	)	dep	22	SENT_64	[p4l210t2337r432b2420],
25	.	.	O	.	_	0	SENT_64	[p4l210t2337r432b2420],

1	Elimination	NN	O	elimination	nn	2	SENT_65	[p4l457t2336r914b2405],
2	half-life	NN	O	half-life	nsubj	5	SENT_65	[p4l941t2336r1239b2405],
3	of	IN	O	of	_	0	SENT_65	[p4l1268t2336r1350b2405],
4	risperidone	NN	O	risperidone	prep_of	2	SENT_65	[p4l1371t2336r1815b2427],
5	is	VBZ	O	be	conj_and	5	SENT_65	[p4l1844t2339r1902b2405],
6	about	IN	O	about	_	0	SENT_65	[p4l1932t2336r2149b2405],
7	6-7	CD	NUMBER	6-7	num	8	SENT_65	[p4l10t2444r142b2507],
8	hours	NNS	NUMBER	hour	prep_about	5	SENT_65	[p4l168t2437r409b2518],
9	,	,	O	,	_	0	SENT_65	[p4l168t2437r409b2518],
10	and	CC	O	and	_	0	SENT_65	[p4l431t2437r574b2507],
11	of	IN	O	of	_	0	SENT_65	[p4l600t2437r681b2507],
12	9-OH-risperidone	NN	O	9-oh-risperidone	prep_of	5	SENT_65	[p4l701t2437r1393b2529],
13	about	IN	DURATION	about	_	0	SENT_65	[p4l1421t2437r1638b2507],
14	24	CD	DURATION	24	num	15	SENT_65	[p4l1663t2445r1748b2506],
15	hours	NNS	NUMBER	hour	prep_about	12	SENT_65	[p4l1773t2437r2012b2507],
16	.	.	O	.	_	0	SENT_65	[p4l1773t2437r2012b2507],

1	According	VBG	O	accord	_	0	SENT_66	[p4l123t2540r519b2632],
2	to	TO	O	to	prepc_according_to	10	SENT_66	[p4l538t2553r611b2609],
3	the	DT	O	the	det	4	SENT_66	[p4l633t2540r752b2609],
4	manufacturer	NN	O	manufacturer	poss	6	SENT_66	[p4l774t2540r1353b2609],
5	’s	POS	O	’s	_	0	SENT_66	[p4l774t2540r1353b2609],
6	suggestions	NNS	O	suggestion	pobj	10	SENT_66	[p4l1377t2543r1845b2632],
7	,	,	O	,	_	0	SENT_66	[p4l1377t2543r1845b2632],
8	risperidone	NN	O	risperidone	nsubjpass	10	SENT_66	[p4l1862t2543r2145b2631, p4l10t2641r197b2711],
9	is	VBZ	O	be	auxpass	10	SENT_66	[p4l227t2644r285b2711],
10	administered	VBN	O	administer	_	0	SENT_66	[p4l316t2641r826b2711],
11	in	IN	O	in	_	0	SENT_66	[p4l853t2644r927b2710],
12	daily	JJ	SET	daily	amod	14	SENT_66	[p4l957t2641r1146b2734],
13	oral	JJ	O	oral	amod	14	SENT_66	[p4l1172t2641r1320b2711],
14	doses	NNS	O	dose	prep_in	10	SENT_66	[p4l1349t2641r1559b2711],
15	between	IN	O	between	_	0	SENT_66	[p4l1587t2641r1907b2711],
16	4	CD	NUMBER	4	prep_between	14	SENT_66	[p4l1935t2649r1976b2710],
17	and	CC	NUMBER	and	_	0	SENT_66	[p4l2006t2641r2149b2711],
18	6	CD	NUMBER	6	num	19	SENT_66	[p4l10t2749r49b2811],
19	mg	NN	O	mg	prep_in	10	SENT_66	[p4l67t2766r189b2834],
20	for	IN	O	for	_	0	SENT_66	[p4l212t2742r321b2811],
21	the	DT	O	the	det	22	SENT_66	[p4l345t2742r464b2811],
22	treatment	NN	O	treatment	prep_for	19	SENT_66	[p4l489t2755r868b2811],
23	of	IN	O	of	_	0	SENT_66	[p4l893t2742r975b2811],
24	schizophrenia	NN	O	schizophrenia	prep_of	22	SENT_66	[p4l994t2742r1553b2833],
25	.	.	O	.	_	0	SENT_66	[p4l994t2742r1553b2833],

1	However	RB	O	however	advmod	10	SENT_67	[p4l1576t2748r1929b2823],
2	,	,	O	,	_	0	SENT_67	[p4l1576t2748r1929b2823],
3	studies	NNS	O	study	nsubj	10	SENT_67	[p4l1951t2742r2146b2811, p4l10t2847r109b2914],
4	of	IN	O	of	_	0	SENT_67	[p4l147t2844r228b2914],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_67	[p4l256t2844r916b2936],
6	properties	NNS	O	property	prep_of	3	SENT_67	[p4l951t2847r1346b2936],
7	of	IN	O	of	_	0	SENT_67	[p4l1384t2844r1465b2914],
8	risperidone	NN	O	risperidone	prep_of	6	SENT_67	[p4l1494t2844r1939b2936],
9	have	VBP	O	have	aux	10	SENT_67	[p4l1974t2844r2148b2914],
10	revealed	VBN	O	reveal	dep	21	SENT_67	[p4l10t2945r330b3014],
11	large	JJ	O	large	amod	13	SENT_67	[p4l366t2945r554b3037],
12	interindividual	JJ	O	interindividual	amod	13	SENT_67	[p4l593t2945r1173b3014],
13	variability	NN	O	variability	dobj	10	SENT_67	[p4l1208t2945r1608b3037],
14	between	IN	O	between	_	0	SENT_67	[p4l1640t2945r1960b3014],
15	oral	JJ	O	oral	amod	16	SENT_67	[p4l2000t2945r2148b3014],
16	dose	NN	O	dose	prep_between	13	SENT_67	[p4l10t3046r183b3116],
17	and	CC	O	and	_	0	SENT_67	[p4l212t3046r355b3116],
18	actual	JJ	O	actual	amod	20	SENT_67	[p4l381t3046r612b3116],
19	plasma	NN	O	plasma	nn	20	SENT_67	[p4l637t3046r912b3138],
20	levels	NNS	O	level	prep_between	13	SENT_67	[p4l937t3046r1145b3116],
21	(	VBP	O	(	_	0	SENT_67	[p4l1177t3046r1421b3130],
22	Odou	NNP	O	Odou	dobj	21	SENT_67	[p4l1177t3046r1421b3130],
23	et	FW	O	et	nn	24	SENT_67	[p4l1448t3059r1515b3116],
24	al.	FW	O	al.	nsubj	21	SENT_67	[p4l1533t3046r1615b3116],
25	2000	CD	DATE	2000	dep	24	SENT_67	[p4l1639t3054r1835b3127],
26	;	:	O	;	_	0	SENT_67	[p4l1639t3054r1835b3127],
27	de	FW	O	de	nn	28	SENT_67	[p4l1863t3046r1950b3116],
28	Iong	FW	O	iong	dep	24	SENT_67	[p4l1977t3053r2150b3139],
29	1997	CD	DATE	1997	num	30	SENT_67	[p4l17t3154r184b3216],
30	)	CD	NUMBER	)	dep	28	SENT_67	[p4l191t3148r238b3231],
31	.	.	O	.	_	0	SENT_67	[p4l191t3148r238b3231],

1	Environmental	JJ	O	environmental	amod	2	SENT_68	[p4l257t3147r833b3216],
2	factors	NNS	O	factor	nsubjpass	11	SENT_68	[p4l855t3147r1112b3216],
3	such	JJ	O	such	_	0	SENT_68	[p4l1137t3147r1310b3216],
4	as	IN	O	as	_	0	SENT_68	[p4l1333t3171r1407b3216],
5	age	NN	O	age	nn	8	SENT_68	[p4l1431t3171r1556b3239],
6	or	CC	O	or	_	0	SENT_68	[p4l1578t3171r1659b3216],
7	body	NN	O	body	nn	8	SENT_68	[p4l1678t3147r1876b3239],
8	weight	NN	O	weight	prep_such_as	2	SENT_68	[p4l1891t3147r2149b3239],
9	have	VBP	O	have	aux	11	SENT_68	[p4l8t3248r182b3318],
10	been	VBN	O	be	auxpass	11	SENT_68	[p4l221t3248r406b3318],
11	implicated	VBN	O	implicate	_	0	SENT_68	[p4l447t3248r853b3340],
12	(	CD	NUMBER	(	num	13	SENT_68	[p4l897t3248r1470b3341],
13	Balant-Gorgia	NNP	O	Balant-Gorgia	dobj	11	SENT_68	[p4l897t3248r1470b3341],
14	et	FW	O	et	nn	15	SENT_68	[p4l1511t3261r1578b3318],
15	al.	FW	O	al.	tmod	11	SENT_68	[p4l1596t3248r1678b3318],
16	1999	CD	DATE	1999	num	17	SENT_68	[p4l1724t3249r1945b3332],
17	)	CD	NUMBER	)	dep	15	SENT_68	[p4l1724t3249r1945b3332],
18	.	.	O	.	_	0	SENT_68	[p4l1724t3249r1945b3332],

1	Further	RB	O	further	advmod	13	SENT_69	[p4l1984t3255r2145b3318, p4l9t3349r180b3429],
2	,	,	O	,	_	0	SENT_69	[p4l1984t3255r2145b3318, p4l9t3349r180b3429],
3	genetic	JJ	O	genetic	amod	4	SENT_69	[p4l213t3351r488b3441],
4	inﬂuence	NN	O	inﬂuence	nsubj	13	SENT_69	[p4l525t3349r878b3418],
5	such	JJ	O	such	_	0	SENT_69	[p4l917t3349r1091b3418],
6	as	IN	O	as	_	0	SENT_69	[p4l1129t3373r1203b3418],
7	CYPZD6	NN	O	cypzd6	nn	8	SENT_69	[p4l1244t3354r1563b3418],
8	status	NN	O	status	prep_such_as	4	SENT_69	[p4l1603t3362r1824b3418],
9	may	MD	O	may	aux	13	SENT_69	[p4l1862t3373r2026b3441],
10	be	VB	O	be	cop	13	SENT_69	[p4l2057t3349r2147b3418],
11	important	JJ	O	important	amod	13	SENT_69	[p4l10t3453r400b3542],
12	(	NN	O	(	nn	13	SENT_69	[p4l428t3451r712b3534],
13	Berecz	NNP	PERSON	Berecz	_	0	SENT_69	[p4l428t3451r712b3534],
14	et	FW	O	et	nn	15	SENT_69	[p4l737t3463r804b3520],
15	al.	FW	O	al.	dep	13	SENT_69	[p4l822t3450r904b3520],
16	2002	CD	DATE	2002	num	17	SENT_69	[p4l926t3451r1155b3534],
17	)	CD	NUMBER	)	dep	15	SENT_69	[p4l926t3451r1155b3534],
18	.	.	O	.	_	0	SENT_69	[p4l926t3451r1155b3534],

1	CYPZD6	NN	O	cypzd6	nn	2	SENT_70	[p4l1179t3455r1498b3520],
2	activity	NN	O	activity	nsubjpass	16	SENT_70	[p4l1525t3453r1815b3543],
3	is	VBZ	O	be	auxpass	4	SENT_70	[p4l1836t3453r1893b3520],
4	determined	VBN	O	determine	ccomp	23	SENT_70	[p4l1920t3450r2145b3520, p4l9t3551r256b3620],
5	by	IN	O	by	_	0	SENT_70	[p4l275t3551r369b3643],
6	allelic	JJ	O	allelic	amod	7	SENT_70	[p4l388t3551r611b3620],
7	variants	NNS	O	variant	agent	4	SENT_70	[p4l630t3553r939b3620],
8	of	IN	O	of	_	0	SENT_70	[p4l964t3551r1045b3620],
9	the	DT	O	the	det	11	SENT_70	[p4l1059t3551r1178b3620],
10	CYPZD6	NN	O	cypzd6	nn	11	SENT_70	[p4l1202t3556r1521b3620],
11	gene	NN	O	gene	prep_of	7	SENT_70	[p4l1545t3575r1742b3643],
12	,	,	O	,	_	0	SENT_70	[p4l1545t3575r1742b3643],
13	and	CC	O	and	_	0	SENT_70	[p4l1761t3551r1924b3631],
14	,	,	O	,	_	0	SENT_70	[p4l1761t3551r1924b3631],
15	when	WRB	O	when	advmod	16	SENT_70	[p4l1939t3551r2148b3620],
16	compared	VBN	O	compare	conj_and	4	SENT_70	[p4l10t3653r395b3745],
17	to	TO	O	to	_	0	SENT_70	[p4l422t3666r494b3723],
18	the	DT	O	the	det	21	SENT_70	[p4l524t3653r642b3723],
19	wild	JJ	O	wild	amod	21	SENT_70	[p4l669t3653r838b3723],
20	type	NN	O	type	nn	21	SENT_70	[p4l864t3666r1032b3746],
21	allele	NN	O	allele	prep_to	16	SENT_70	[p4l1062t3653r1280b3734],
22	,	,	O	,	_	0	SENT_70	[p4l1062t3653r1280b3734],
23	ranges	VBZ	O	range	_	0	SENT_70	[p4l1304t3678r1555b3746],
24	from	IN	O	from	_	0	SENT_70	[p4l1585t3653r1771b3723],
25	complete	JJ	O	complete	amod	26	SENT_70	[p4l1801t3653r2147b3745],
26	deﬁciency	NN	O	deﬁciency	prep_from	23	SENT_70	[p5l10t11r406b103],
27	to	TO	O	to	_	0	SENT_70	[p5l456t24r529b80],
28	ultra-rapid	JJ	O	ultra-rapid	amod	29	SENT_70	[p5l587t11r1012b102],
29	metabolizer	NN	O	metabolizer	prep_to	23	SENT_70	[p5l1066t11r1526b80],
30	status	NN	O	status	nn	32	SENT_70	[p5l1582t24r1802b80],
31	(	CD	NUMBER	(	num	32	SENT_70	[p5l1863t11r2148b95],
32	Sachse	NNP	PERSON	Sachse	nsubj	23	SENT_70	[p5l1863t11r2148b95],
33	et	FW	O	et	nn	34	SENT_70	[p5l10t126r77b182],
34	al.	FW	O	al.	dep	32	SENT_70	[p5l95t113r178b182],
35	1997	CD	DATE	1997	num	36	SENT_70	[p5l215t114r437b196],
36	)	CD	NUMBER	)	dep	34	SENT_70	[p5l215t114r437b196],
37	.	.	O	.	_	0	SENT_70	[p5l215t114r437b196],

1	About	IN	O	about	_	0	SENT_71	[p5l463t113r701b182],
2	7	CD	PERCENT	7	num	3	SENT_71	[p5l734t119r860b184],
3	%	NN	PERCENT	%	prep_about	8	SENT_71	[p5l734t119r860b184],
4	of	IN	O	of	_	0	SENT_71	[p5l896t113r977b182],
5	the	DT	O	the	det	7	SENT_71	[p5l1002t113r1120b182],
6	Caucasian	JJ	MISC	caucasian	amod	7	SENT_71	[p5l1155t115r1545b182],
7	population	NN	O	population	prep_of	3	SENT_71	[p5l1577t113r1999b204],
8	are	VBP	O	be	_	0	SENT_71	[p5l2033t137r2148b182],
9	poor	JJ	O	poor	amod	10	SENT_71	[p5l9t239r192b306],
10	metabolizers	NNS	O	metabolizer	nsubj	8	SENT_71	[p5l225t215r742b296],
11	,	,	O	,	_	0	SENT_71	[p5l225t215r742b296],
12	which	WDT	O	which	nsubjpass	14	SENT_71	[p5l768t215r1001b284],
13	is	VBZ	O	be	auxpass	14	SENT_71	[p5l1035t218r1092b284],
14	inherited	VBN	O	inherit	rcmod	10	SENT_71	[p5l1127t215r1481b284],
15	as	IN	O	as	_	0	SENT_71	[p5l1515t239r1589b284],
16	an	DT	O	a	det	19	SENT_71	[p5l1625t239r1715b284],
17	autosomal	JJ	O	autosomal	amod	19	SENT_71	[p5l1750t215r2149b284],
18	recessive	JJ	O	recessive	amod	19	SENT_71	[p5l10t319r347b386],
19	trait	NN	O	trait	prep_as	14	SENT_71	[p5l386t319r550b386],
20	(	CD	NUMBER	(	num	21	SENT_71	[p5l591t317r843b401],
21	Alvan	NNP	PERSON	Alvan	dep	19	SENT_71	[p5l591t317r843b401],
22	et	FW	O	et	nn	23	SENT_71	[p5l883t329r950b386],
23	al.	FW	O	al.	dep	19	SENT_71	[p5l968t317r1051b386],
24	1990	CD	DATE	1990	num	25	SENT_71	[p5l1093t318r1291b400],
25	)	NN	O	)	dep	23	SENT_71	[p5l1093t318r1291b400],
26	and	CC	O	and	_	0	SENT_71	[p5l1335t317r1478b386],
27	effects	NNS	O	effect	prep_as	14	SENT_71	[p5l1516t316r1759b386],
28	relatively	RB	O	relatively	advmod	29	SENT_71	[p5l1799t317r2152b409],
29	higher	JJR	O	higher	amod	33	SENT_71	[p5l8t419r260b511],
30	steady-state	JJ	O	steady-state	amod	33	SENT_71	[p5l291t419r744b511],
31	plasma	NN	O	plasma	nn	33	SENT_71	[p5l775t419r1051b510],
32	drug	NN	O	drug	nn	33	SENT_71	[p5l1082t419r1264b511],
33	levels	NNS	O	level	dep	27	SENT_71	[p5l1292t419r1522b488],
34	.	.	O	.	_	0	SENT_71	[p5l1292t419r1522b488],

1	About	IN	O	about	_	0	SENT_72	[p5l1547t419r1784b488],
2	1	CD	PERCENT	1	num	3	SENT_72	[p5l1821t425r1942b491],
3	%	NN	PERCENT	%	prep_about	4	SENT_72	[p5l1821t425r1942b491],
4	have	VBP	O	have	_	0	SENT_72	[p5l1974t419r2147b488],
5	multiple	JJ	O	multiple	amod	6	SENT_72	[p5l9t521r331b612],
6	copies	NNS	O	copy	dobj	4	SENT_72	[p5l352t523r588b612],
7	of	IN	O	of	_	0	SENT_72	[p5l611t520r692b590],
8	a	DT	O	a	det	10	SENT_72	[p5l706t545r745b590],
9	functional	JJ	O	functional	amod	10	SENT_72	[p5l764t520r1162b590],
10	CYPZD6	NN	O	cypzd6	prep_of	6	SENT_72	[p5l1183t526r1502b590],
11	allele	NN	O	allele	nn	13	SENT_72	[p5l1524t521r1720b590],
12	(	CD	NUMBER	(	num	13	SENT_72	[p5l1745t521r1957b605],
13	Dahl	NNP	PERSON	Dahl	nsubj	4	SENT_72	[p5l1745t521r1957b605],
14	et	FW	O	et	nn	15	SENT_72	[p5l1978t533r2044b590],
15	al.	FW	O	al.	dep	13	SENT_72	[p5l2063t521r2145b590],
16	1995	CD	DATE	1995	num	17	SENT_72	[p5l17t624r214b707],
17	)	NN	O	)	nsubj	30	SENT_72	[p5l17t624r214b707],
18	with	IN	O	with	_	0	SENT_72	[p5l248t623r420b692],
19	a	DT	O	a	det	23	SENT_72	[p5l452t647r491b692],
20	relatively	RB	O	relatively	advmod	21	SENT_72	[p5l522t623r876b715],
21	high	JJ	O	high	amod	23	SENT_72	[p5l902t623r1074b715],
22	CYPZD6	NN	O	cypzd6	nn	23	SENT_72	[p5l1107t628r1427b692],
23	activity	NN	O	activity	prep_with	17	SENT_72	[p5l1461t626r1750b715],
24	and	CC	O	and	_	0	SENT_72	[p5l1779t623r1922b692],
25	comparably	RB	O	comparably	advmod	26	SENT_72	[p5l1953t647r2145b692, p5l9t725r302b818],
26	low	JJ	O	low	amod	29	SENT_72	[p5l321t725r457b795],
27	drug	NN	O	drug	nn	29	SENT_72	[p5l479t725r661b818],
28	plasma	NN	O	plasma	nn	29	SENT_72	[p5l682t725r958b817],
29	levels	NNS	O	level	conj_and	23	SENT_72	[p5l979t725r1188b795],
30	(	VBP	O	(	rcmod	15	SENT_72	[p5l1217t725r1711b817],
31	“	CD	NUMBER	“	num	33	SENT_72	[p5l1217t725r1711b817],
32	ultra-rapid	JJ	O	ultra-rapid	amod	33	SENT_72	[p5l1217t725r1711b817],
33	metabolizers	NNS	O	metabolizer	nsubj	34	SENT_72	[p5l1734t725r2145b795, p5l10t828r212b911],
34	”	VBP	O	”	ccomp	30	SENT_72	[p5l1734t725r2145b795, p5l10t828r212b911],
35	)	NN	O	)	dobj	34	SENT_72	[p5l1734t725r2145b795, p5l10t828r212b911],
36	.	.	O	.	_	0	SENT_72	[p5l1734t725r2145b795, p5l10t828r212b911],

1	The	DT	O	the	det	3	SENT_73	[p5l246t827r390b896],
2	remaining	VBG	O	remain	amod	3	SENT_73	[p5l427t830r826b919],
3	majority	NN	O	majority	nsubjpass	8	SENT_73	[p5l859t830r1194b919],
4	of	IN	O	of	_	0	SENT_73	[p5l1227t827r1309b896],
5	the	DT	O	the	det	6	SENT_73	[p5l1336t827r1455b896],
6	population	NN	O	population	prep_of	3	SENT_73	[p5l1490t827r1912b918],
7	is	VBZ	O	be	auxpass	8	SENT_73	[p5l1948t830r2006b896],
8	referred	VBN	O	refer	_	0	SENT_73	[p5l2043t851r2146b896, p5l9t929r243b999],
9	to	TO	O	to	_	0	SENT_73	[p5l280t942r353b999],
10	as	IN	O	as	mark	13	SENT_73	[p5l395t954r468b999],
11	extensive	JJ	O	extensive	amod	12	SENT_73	[p5l510t932r861b999],
12	metabolizers	NNS	O	metabolizer	nsubj	13	SENT_73	[p5l901t929r1395b999],
13	(	VBP	O	(	prepc_to	8	SENT_73	[p5l1439t929r1676b1022],
14	Broly	NNP	O	Broly	nsubj	16	SENT_73	[p5l1439t929r1676b1022],
15	et	FW	O	et	nn	16	SENT_73	[p5l1712t942r1779b999],
16	al.	FW	O	al.	xcomp	13	SENT_73	[p5l1797t929r1880b999],
17	1990	CD	DATE	1990	num	18	SENT_73	[p5l1923t930r2145b1013],
18	)	CD	NUMBER	)	dep	16	SENT_73	[p5l1923t930r2145b1013],
19	.	.	O	.	_	0	SENT_73	[p5l1923t930r2145b1013],

1	Similarly	RB	O	similarly	advmod	16	SENT_74	[p5l11t1031r370b1123],
2	,	,	O	,	_	0	SENT_74	[p5l11t1031r370b1123],
3	coadministration	NN	O	coadministration	nsubj	19	SENT_74	[p5l406t1031r1073b1100],
4	of	IN	O	of	_	0	SENT_74	[p5l1113t1031r1194b1100],
5	other	JJ	O	other	amod	7	SENT_74	[p5l1227t1031r1430b1100],
6	psychiatric	JJ	O	psychiatric	amod	7	SENT_74	[p5l1467t1031r1891b1123],
7	drugs	NNS	O	drug	prep_of	3	SENT_74	[p5l1930t1031r2147b1123],
8	such	JJ	O	such	_	0	SENT_74	[p5l11t1133r184b1203],
9	as	IN	O	as	_	0	SENT_74	[p5l220t1158r293b1203],
10	SSRI	NN	ORGANIZATION	ssrus	prep_such_as	7	SENT_74	[p5l331t1138r507b1203],
11	or	CC	O	or	_	0	SENT_74	[p5l544t1158r625b1203],
12	thiordiazine	NN	O	thiordiazine	conj_or	10	SENT_74	[p5l658t1133r1127b1203],
13	may	MD	O	may	aux	16	SENT_74	[p5l1162t1158r1326b1226],
14	also	RB	O	also	advmod	16	SENT_74	[p5l1358t1133r1505b1203],
15	potently	RB	O	potently	advmod	16	SENT_74	[p5l1541t1134r1862b1226],
16	inhibit	VB	O	inhibit	_	0	SENT_74	[p5l1893t1133r2149b1203],
17	CYP2D6	NN	O	cyp2d6	dobj	16	SENT_74	[p5l11t1240r331b1305],
18	and	CC	O	and	_	0	SENT_74	[p5l367t1235r509b1304],
19	increase	VB	O	increase	conj_and	16	SENT_74	[p5l543t1238r856b1304],
20	the	DT	O	the	det	22	SENT_74	[p5l890t1235r1008b1304],
21	plasma	NN	O	plasma	nn	22	SENT_74	[p5l1043t1235r1318b1326],
22	concentration	NN	O	concentration	dobj	19	SENT_74	[p5l1352t1238r1886b1304],
23	of	IN	O	of	_	0	SENT_74	[p5l1922t1235r2003b1304],
24	the	DT	O	the	det	26	SENT_74	[p5l2029t1235r2148b1304],
25	target	NN	O	target	nn	26	SENT_74	[p5l9t1350r233b1430],
26	drug	NN	O	drug	prep_of	22	SENT_74	[p5l258t1337r440b1430],
27	(	CD	NUMBER	(	npadvmod	28	SENT_74	[p5l468t1338r696b1421],
28	Prior	JJ	O	prior	dep	19	SENT_74	[p5l468t1338r696b1421],
29	and	CC	O	and	_	0	SENT_74	[p5l722t1337r865b1407],
30	Baker	NNP	PERSON	Baker	conj_and	28	SENT_74	[p5l890t1338r1110b1407],
31	2003	CD	DATE	2003	num	32	SENT_74	[p5l1134t1338r1363b1421],
32	)	CD	NUMBER	)	dobj	16	SENT_74	[p5l1134t1338r1363b1421],
33	.	.	O	.	_	0	SENT_74	[p5l1134t1338r1363b1421],

1	Current	JJ	DATE	current	amod	4	SENT_75	[p5l126t1444r425b1508],
2	oral	JJ	O	oral	amod	4	SENT_75	[p5l452t1439r601b1508],
3	dosage	NN	O	dosage	nn	4	SENT_75	[p5l628t1439r891b1531],
4	recommendations	NNS	O	recommendation	nsubj	6	SENT_75	[p5l918t1439r1617b1508],
5	largely	RB	O	largely	advmod	6	SENT_75	[p5l1644t1439r1906b1531],
6	fail	VBP	O	fail	_	0	SENT_75	[p5l1929t1439r2048b1508],
7	to	TO	O	to	aux	8	SENT_75	[p5l2074t1452r2147b1508],
8	incorporate	VB	O	incorporate	xcomp	6	SENT_75	[p5l10t1544r458b1633],
9	such	JJ	O	such	amod	10	SENT_75	[p5l487t1541r660b1611],
10	aspects	NNS	O	aspect	nsubj	11	SENT_75	[p5l688t1554r963b1633],
11	present	JJ	DATE	present	xcomp	8	SENT_75	[p5l991t1554r1274b1633],
12	in	IN	O	in	_	0	SENT_75	[p5l1300t1544r1373b1610],
13	individual	JJ	O	individual	amod	14	SENT_75	[p5l1400t1541r1794b1611],
14	patients	NNS	O	patient	prep_in	11	SENT_75	[p5l1819t1544r2146b1633],
15	.	.	O	.	_	0	SENT_75	[p5l1819t1544r2146b1633],

1	Thus	RB	O	thus	advmod	8	SENT_76	[p5l10t1670r220b1751],
2	,	,	O	,	_	0	SENT_76	[p5l10t1670r220b1751],
3	drug	NN	O	drug	nn	4	SENT_76	[p5l237t1670r419b1762],
4	plasma	NN	O	plasma	nsubj	8	SENT_76	[p5l436t1670r712b1761],
5	level	NN	O	level	nn	6	SENT_76	[p5l729t1670r904b1739],
6	monitoring	NN	O	monitoring	dep	4	SENT_76	[p5l923t1673r1364b1762],
7	may	MD	O	may	aux	8	SENT_76	[p5l1382t1694r1546b1762],
8	represent	VB	O	represent	_	0	SENT_76	[p5l1562t1683r1921b1761],
9	a	DT	O	a	det	12	SENT_76	[p5l1941t1694r1980b1739],
10	reasonable	JJ	O	reasonable	amod	12	SENT_76	[p5l1999t1694r2145b1739, p5l11t1772r301b1842],
11	alternative	JJ	O	alternative	amod	12	SENT_76	[p5l327t1772r732b1842],
12	approach	NN	O	approach	dobj	8	SENT_76	[p5l758t1772r1115b1864],
13	to	TO	O	to	aux	14	SENT_76	[p5l1139t1785r1211b1842],
14	establish	VB	O	establish	xcomp	8	SENT_76	[p5l1238t1772r1572b1842],
15	required	JJ	O	required	amod	17	SENT_76	[p5l1596t1772r1925b1864],
16	medication	NN	O	medication	nn	17	SENT_76	[p5l1948t1772r2145b1842, p5l10t1876r272b1943],
17	doses	NNS	O	dose	dobj	14	SENT_76	[p5l303t1874r513b1943],
18	and	CC	O	and	_	0	SENT_76	[p5l545t1874r688b1943],
19	account	NN	O	account	conj_and	17	SENT_76	[p5l717t1887r1015b1943],
20	for	IN	O	for	_	0	SENT_76	[p5l1044t1874r1153b1943],
21	these	DT	O	these	det	22	SENT_76	[p5l1181t1874r1379b1943],
22	differences	NNS	O	difference	prep_for	14	SENT_76	[p5l1410t1874r1848b1943],
23	.	.	O	.	_	0	SENT_76	[p5l1410t1874r1848b1943],

1	Importantly	RB	O	importantly	advmod	8	SENT_77	[p5l1876t1880r2145b1965, p5l9t1977r242b2069],
2	,	,	O	,	_	0	SENT_77	[p5l1876t1880r2145b1965, p5l9t1977r242b2069],
3	risperidone	NN	O	risperidone	nn	5	SENT_77	[p5l281t1976r726b2068],
4	plasma	NN	O	plasma	nn	5	SENT_77	[p5l769t1976r1046b2068],
5	levels	NNS	O	level	nsubj	26	SENT_77	[p5l1087t1976r1295b2046],
6	have	VBP	O	have	aux	8	SENT_77	[p5l1338t1976r1512b2046],
7	been	VBN	O	be	auxpass	8	SENT_77	[p5l1553t1976r1738b2046],
8	shown	VBN	O	show	_	0	SENT_77	[p5l1783t1976r2031b2046],
9	to	TO	O	to	aux	11	SENT_77	[p5l2074t1989r2146b2046],
10	directly	RB	O	directly	advmod	11	SENT_77	[p5l10t2078r305b2170],
11	correspond	VB	O	correspond	xcomp	8	SENT_77	[p5l338t2078r777b2169],
12	to	TO	O	to	_	0	SENT_77	[p5l811t2091r884b2147],
13	brain	NN	O	brain	nn	14	SENT_77	[p5l920t2078r1125b2147],
14	receptor	NN	O	receptor	prep_to	11	SENT_77	[p5l1162t2091r1482b2169],
15	occupancy	NN	O	occupancy	nn	18	SENT_77	[p5l1519t2101r1934b2170],
16	(	CD	NUMBER	(	num	18	SENT_77	[p5l1970t2079r2148b2162],
17	Van	NNP	PERSON	Van	nn	18	SENT_77	[p5l1970t2079r2148b2162],
18	Beijsterveldt	NNP	PERSON	Beijsterveldt	dobj	11	SENT_77	[p5l10t2180r493b2273],
19	et	FW	O	et	nn	20	SENT_77	[p5l517t2193r584b2250],
20	al.	FW	O	al.	dep	18	SENT_77	[p5l602t2180r684b2250],
21	1994	CD	DATE	1994	num	22	SENT_77	[p5l712t2181r909b2264],
22	)	NN	O	)	dep	20	SENT_77	[p5l712t2181r909b2264],
23	and	CC	O	and	_	0	SENT_77	[p5l938t2180r1081b2250],
24	may	MD	O	may	aux	26	SENT_77	[p5l1102t2205r1266b2273],
25	thus	RB	O	thus	advmod	26	SENT_77	[p5l1285t2180r1447b2250],
26	serve	VB	O	serve	conj_and	8	SENT_77	[p5l1472t2205r1669b2250],
27	as	RB	O	as	advmod	28	SENT_77	[p5l1694t2205r1768b2250],
28	better	JJR	O	better	amod	29	SENT_77	[p5l1790t2180r2018b2250],
29	indicators	NNS	O	indicator	dobj	26	SENT_77	[p5l2040t2183r2145b2249, p5l10t2282r314b2351],
30	of	IN	O	of	_	0	SENT_77	[p5l361t2282r443b2351],
31	optimal	JJ	O	optimal	amod	33	SENT_77	[p5l481t2282r779b2373],
32	therapeutic	JJ	O	therapeutic	amod	33	SENT_77	[p5l822t2282r1263b2373],
33	doses	NNS	O	dose	prep_of	29	SENT_77	[p5l1308t2282r1518b2351],
34	than	IN	O	than	_	0	SENT_77	[p5l1563t2282r1736b2351],
35	the	DT	O	the	det	37	SENT_77	[p5l1781t2282r1899b2351],
36	usual	JJ	O	usual	amod	37	SENT_77	[p5l1945t2282r2148b2351],
37	practice	NN	O	practice	prep_than	26	SENT_77	[p5l9t2387r316b2476],
38	of	IN	O	of	_	0	SENT_77	[p5l344t2384r425b2454],
39	oral	JJ	O	oral	amod	41	SENT_77	[p5l444t2384r593b2454],
40	dose	NN	O	dose	nn	41	SENT_77	[p5l619t2384r792b2454],
41	quantiﬁcation	NN	O	quantiﬁcation	prep_of	37	SENT_77	[p5l820t2384r1381b2476],
42	.	.	O	.	_	0	SENT_77	[p5l820t2384r1381b2476],

1	To	TO	O	to	aux	3	SENT_78	[p5l125t2489r213b2554],
2	further	RB	O	further	advmod	3	SENT_78	[p5l259t2485r535b2554],
3	establish	VB	O	establish	_	0	SENT_78	[p5l579t2485r914b2554],
4	the	DT	O	the	det	5	SENT_78	[p5l958t2485r1076b2554],
5	relation	NN	O	relation	dobj	3	SENT_78	[p5l1121t2485r1418b2554],
6	between	IN	O	between	_	0	SENT_78	[p5l1461t2485r1781b2554],
7	CYPZD6	NN	O	cypzd6	prep_between	5	SENT_78	[p5l1827t2490r2147b2554],

1	status	NN	O	status	ccomp	17	SENT_79	[p5l11t2600r253b2668],
2	,	,	O	,	_	0	SENT_79	[p5l11t2600r253b2668],
3	plasma	NN	O	plasma	nn	5	SENT_79	[p5l282t2587r558b2679],
4	drug	NN	O	drug	nn	5	SENT_79	[p5l591t2587r773b2680],
5	levels	NNS	O	level	ccomp	17	SENT_79	[p5l804t2587r1012b2657],
6	and	CC	O	and	_	0	SENT_79	[p5l1048t2587r1191b2657],
7	clinical	JJ	O	clinical	amod	8	SENT_79	[p5l1224t2587r1500b2657],
8	parameters	NNS	O	parameter	ccomp	17	SENT_79	[p5l1532t2600r1966b2679],
9	in	IN	O	in	_	0	SENT_79	[p5l2001t2590r2075b2656],
10	a	DT	O	a	det	13	SENT_79	[p5l2110t2612r2149b2657],
11	schizophrenia	NN	O	schizophrenia	nn	13	SENT_79	[p5l11t2689r551b2780],
12	patient	NN	O	patient	nn	13	SENT_79	[p5l584t2691r854b2780],
13	population	NN	O	population	prep_in	8	SENT_79	[p5l886t2689r1329b2780],
14	,	,	O	,	_	0	SENT_79	[p5l886t2689r1329b2780],
15	we	PRP	O	we	nsubj	26	SENT_79	[p5l1357t2713r1460b2758],
16	prospectively	RB	O	prospectively	advmod	17	SENT_79	[p5l1494t2689r2011b2781],
17	investigated	VBD	O	investigate	_	0	SENT_79	[p5l2041t2692r2145b2757, p5l7t2791r395b2884],
18	the	DT	O	the	det	20	SENT_79	[p5l464t2791r582b2861],
19	steady-state	JJ	O	steady-state	amod	20	SENT_79	[p5l653t2791r1106b2884],
20	risperidone	NN	O	risperidone	dobj	17	SENT_79	[p5l1177t2791r1622b2883],
21	and	CC	O	and	_	0	SENT_79	[p5l1693t2791r1836b2861],
22	9OHrisperidone	NN	O	9ohrisperidone	nn	24	SENT_79	[p5l1906t2796r2145b2861, p5l10t2893r455b2984],
23	plasma	NN	O	plasma	nn	24	SENT_79	[p5l481t2893r757b2984],
24	levels	NNS	O	level	conj_and	20	SENT_79	[p5l782t2893r990b2962],
25	and	CC	O	and	_	0	SENT_79	[p5l1020t2893r1162b2962],
26	assessed	VBN	O	assess	conj_and	17	SENT_79	[p5l1189t2893r1511b2962],
27	both	DT	O	both	det	29	SENT_79	[p5l1534t2893r1713b2962],
28	clinical	JJ	O	clinical	amod	29	SENT_79	[p5l1741t2893r2016b2962],
29	response	NN	O	response	dobj	26	SENT_79	[p5l2042t2917r2145b2962, p5l11t3019r270b3087],
30	and	CC	O	and	_	0	SENT_79	[p5l379t2995r522b3064],
31	extrapyramidal	JJ	O	extrapyramidal	amod	33	SENT_79	[p5l629t2995r1225b3088],
32	side	JJ	O	side	amod	33	SENT_79	[p5l1333t2995r1483b3064],
33	effects	NNS	O	effect	dobj	26	SENT_79	[p5l1592t2995r1835b3064],
34	while	IN	O	while	_	0	SENT_79	[p5l1941t2995r2147b3064],
35	accounting	VBG	O	account	prepc_while	26	SENT_79	[p5l10t3099r434b3189],
36	for	IN	O	for	_	0	SENT_79	[p5l458t3097r568b3166],
37	important	JJ	O	important	amod	39	SENT_79	[p5l592t3099r983b3188],
38	CYP2D6	NN	O	cyp2d6	nn	39	SENT_79	[p5l1010t3102r1329b3166],
39	genotypes	NNS	O	genotype	prep_for	35	SENT_79	[p5l1356t3110r1768b3189],
40	.	.	O	.	_	0	SENT_79	[p5l1356t3110r1768b3189],

1	Methods	NNS	O	method	_	0	SENT_80	[p5l11t3395r367b3471],

1	A	DT	O	a	det	5	SENT_81	[p6l8t75r57b127],
2	6	CD	DURATION	6	number	3	SENT_81	[p6l81t77r113b128],
3	week	NN	NUMBER	week	amod	5	SENT_81	[p6l135t71r294b128],
4	open-label	JJ	O	open-label	amod	5	SENT_81	[p6l318t71r647b146],
5	trial	NN	O	trial	_	0	SENT_81	[p6l670t71r800b128],
6	with	IN	O	with	_	0	SENT_81	[p6l822t71r961b128],
7	risperidone	NN	O	risperidone	nn	8	SENT_81	[p6l986t71r1346b146],
8	monotherapy	NN	O	monotherapy	prep_with	5	SENT_81	[p6l1371t71r1796b146],
9	in	IN	O	in	_	0	SENT_81	[p6l1816t73r1876b127],
10	patients	NNS	O	patient	prep_in	8	SENT_81	[p6l1900t73r2147b145],
11	carrying	VBG	O	carry	partmod	5	SENT_81	[p6l10t156r276b229],
12	a	DT	O	a	det	13	SENT_81	[p6l299t173r331b211],
13	DSM	NNP	O	DSM	dobj	11	SENT_81	[p6l353t158r611b211],
14	.	.	O	.	_	0	SENT_81	[p6l353t158r611b211],

1	—	NN	O	—	_	0	SENT_82	[p6l353t158r611b211],
2	.	.	O	.	_	0	SENT_82	[p6l353t158r611b211],

1	IV	CD	NUMBER	iv	num	2	SENT_83	[p6l353t158r611b211],
2	diagnosis	NN	O	diagnosis	nsubjpass	10	SENT_83	[p6l635t154r929b229],
3	of	IN	O	of	_	0	SENT_83	[p6l954t154r1020b211],
4	schizophrenia	NN	O	schizophrenia	prep_of	2	SENT_83	[p6l1038t154r1476b228],
5	(	CD	NUMBER	(	num	8	SENT_83	[p6l1501t154r1659b223],
6	APA	NNP	O	APA	nn	8	SENT_83	[p6l1501t154r1659b223],
7	1994	CD	DATE	1994	num	8	SENT_83	[p6l1688t155r1848b222],
8	)	NNP	O	)	dep	4	SENT_83	[p6l1688t155r1848b222],
9	was	VBD	O	be	auxpass	10	SENT_83	[p6l1872t173r1987b211],
10	conducted	VBN	O	conduct	_	0	SENT_83	[p6l2012t173r2146b211, p6l10t237r236b293],
11	.	.	O	.	_	0	SENT_83	[p6l2012t173r2146b211, p6l10t237r236b293],

1	Prior	RB	O	prior	_	0	SENT_84	[p6l258t239r418b293],
2	to	TO	O	to	_	0	SENT_84	[p6l440t247r499b293],
3	entering	VBG	O	enter	prepc_prior_to	9	SENT_84	[p6l525t239r785b312],
4	the	DT	O	the	det	5	SENT_84	[p6l807t237r903b293],
5	trial	NN	O	trial	dobj	3	SENT_84	[p6l927t237r1074b302],
6	,	,	O	,	_	0	SENT_84	[p6l927t237r1074b302],
7	patients	NNS	O	patient	nsubjpass	9	SENT_84	[p6l1094t239r1341b311],
8	were	VBD	O	be	auxpass	9	SENT_84	[p6l1364t256r1511b293],
9	required	VBN	O	require	_	0	SENT_84	[p6l1535t237r1802b311],
10	to	TO	O	to	aux	11	SENT_84	[p6l1824t247r1883b293],
11	sign	VB	O	sign	xcomp	9	SENT_84	[p6l1910t239r2037b312],
12	informed	JJ	O	informed	amod	13	SENT_84	[p6l2061t239r2146b293, p6l9t319r238b376],
13	consent	NN	O	consent	dobj	11	SENT_84	[p6l261t330r499b376],
14	according	VBG	O	accord	_	0	SENT_84	[p6l522t319r828b395],
15	to	TO	O	to	prepc_according_to	11	SENT_84	[p6l849t330r908b376],
16	procedures	NNS	O	procedure	pobj	11	SENT_84	[p6l931t319r1278b394],
17	approved	VBN	O	approve	partmod	16	SENT_84	[p6l1303t319r1592b394],
18	by	IN	O	by	_	0	SENT_84	[p6l1612t320r1689b395],
19	the	DT	O	the	det	20	SENT_84	[p6l1708t320r1804b376],
20	University	NNP	ORGANIZATION	University	agent	17	SENT_84	[p6l1828t322r2152b395],
21	of	IN	ORGANIZATION	of	_	0	SENT_84	[p6l10t402r75b458],
22	Munich	NNP	ORGANIZATION	Munich	nn	24	SENT_84	[p6l90t402r330b458],
23	Ethics	NNPS	ORGANIZATION	Ethics	nn	24	SENT_84	[p6l350t402r537b458],
24	Committee	NNP	ORGANIZATION	Committee	prep_of	20	SENT_84	[p6l560t405r921b458],
25	.	.	O	.	_	0	SENT_84	[p6l560t405r921b458],

1	Inclusion	NN	O	inclusion	nn	2	SENT_85	[p6l124t485r413b542],
2	criteria	NNS	O	criterion	nsubj	4	SENT_85	[p6l436t487r662b542],
3	were	VBD	O	be	cop	4	SENT_85	[p6l681t505r827b542],
4	age	NN	O	age	_	0	SENT_85	[p6l850t505r951b560],
5	between	IN	O	between	_	0	SENT_85	[p6l971t485r1230b542],
6	18	CD	NUMBER	18	nn	9	SENT_85	[p6l1258t491r1320b542],
7	and	CC	O	and	_	0	SENT_85	[p6l1344t485r1459b542],
8	65	CD	DURATION	65	nn	9	SENT_85	[p6l1480t491r1547b542],
9	years	NNS	NUMBER	year	prep_between	4	SENT_85	[p6l1569t505r1730b560],
10	and	CC	O	and	_	0	SENT_85	[p6l1753t485r1869b542],
11	DSM	NNP	ORGANIZATION	DSM	prep_between	4	SENT_85	[p6l1890t489r2148b542],
12	.	.	O	.	_	0	SENT_85	[p6l1890t489r2148b542],

1	—	NN	O	—	_	0	SENT_86	[p6l1890t489r2148b542],
2	.	.	O	.	_	0	SENT_86	[p6l1890t489r2148b542],

1	IV	CD	NUMBER	iv	num	2	SENT_87	[p6l1890t489r2148b542],
2	diagnosis	NN	O	diagnosis	_	0	SENT_87	[p6l9t568r304b643],
3	of	IN	O	of	_	0	SENT_87	[p6l333t568r399b624],
4	schizophrenia	NN	O	schizophrenia	prep_of	2	SENT_87	[p6l422t568r874b642],
5	.	.	O	.	_	0	SENT_87	[p6l422t568r874b642],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_88	[p6l899t568r1201b624],
2	criteria	NNS	O	criterion	nsubj	8	SENT_88	[p6l1229t570r1456b624],
3	were	VBD	O	be	cop	8	SENT_88	[p6l1480t587r1626b624],
4	serious	JJ	O	serious	amod	8	SENT_88	[p6l1655t570r1875b624],
5	medical	JJ	O	medical	amod	8	SENT_88	[p6l1903t568r2149b624],
6	co	NN	O	co	nn	8	SENT_88	[p6l10t651r488b716],
7	—	NN	O	—	nn	8	SENT_88	[p6l10t651r488b716],
8	morbidities	NNS	O	morbidity	_	0	SENT_88	[p6l10t651r488b716],
9	,	,	O	,	_	0	SENT_88	[p6l10t651r488b716],
10	ECG	NN	O	ecg	appos	8	SENT_88	[p6l517t655r655b707],
11	and/or	JJ	O	and/or	amod	13	SENT_88	[p6l688t651r897b710],
12	EEG	NN	O	eeg	nn	13	SENT_88	[p6l928t655r1061b707],
13	abnormalities	NNS	O	abnormality	dep	10	SENT_88	[p6l1094t651r1544b716],
14	,	,	O	,	_	0	SENT_88	[p6l1094t651r1544b716],
15	laboratory	NN	O	laboratory	nn	16	SENT_88	[p6l1572t651r1902b726],
16	studies	NNS	O	study	appos	8	SENT_88	[p6l1931t651r2148b707],
17	more	RBR	O	more	advmod	18	SENT_88	[p6l9t754r170b791],
18	than	IN	O	than	quantmod	19	SENT_88	[p6l186t734r326b791],
19	20	CD	PERCENT	20	num	20	SENT_88	[p6l343t740r411b791],
20	%	NN	PERCENT	%	npadvmod	16	SENT_88	[p6l426t740r482b793],
21	out	IN	O	out	_	0	SENT_88	[p6l501t745r601b791],
22	of	IN	O	of	_	0	SENT_88	[p6l618t734r684b791],
23	reference	NN	O	reference	nn	24	SENT_88	[p6l695t734r981b791],
24	range	NN	O	range	prep_out_of	16	SENT_88	[p6l998t754r1189b809],
25	,	,	O	,	_	0	SENT_88	[p6l998t754r1189b809],
26	positive	JJ	O	positive	amod	29	SENT_88	[p6l1201t737r1445b809],
27	urine	NN	O	urine	nn	29	SENT_88	[p6l1462t736r1627b791],
28	drug	NN	O	drug	nn	29	SENT_88	[p6l1645t734r1792b809],
29	screen	NN	O	screen	appos	8	SENT_88	[p6l1809t754r2023b800],
30	,	,	O	,	_	0	SENT_88	[p6l1809t754r2023b800],
31	Hepatitis	NNP	O	Hepatitis	appos	8	SENT_88	[p6l2036t739r2146b791, p6l8t819r221b892],
32	,	,	O	,	_	0	SENT_88	[p6l2036t739r2146b791, p6l8t819r221b892],
33	HIV	NN	MISC	hiv	appos	8	SENT_88	[p6l239t822r377b883],
34	,	,	O	,	_	0	SENT_88	[p6l239t822r377b883],
35	substance	NN	O	substance	nn	36	SENT_88	[p6l396t817r699b874],
36	dependence	NN	O	dependence	appos	8	SENT_88	[p6l721t817r1109b891],
37	,	,	O	,	_	0	SENT_88	[p6l721t817r1109b891],
38	pregnancy	NN	O	pregnancy	appos	8	SENT_88	[p6l1126t836r1465b892],
39	.	.	O	.	_	0	SENT_88	[p6l1126t836r1465b892],

1	Clinical	JJ	O	clinical	amod	2	SENT_89	[p6l123t1054r328b1110],
2	assessments	NNS	O	assessment	_	0	SENT_89	[p6l346t1062r706b1110],

1	Initially	RB	O	initially	advmod	29	SENT_90	[p6l10t1213r265b1288],
2	,	,	O	,	_	0	SENT_90	[p6l10t1213r265b1288],
3	every	DT	O	every	det	4	SENT_90	[p6l280t1233r450b1288],
4	patient	NN	O	patient	nsubj	5	SENT_90	[p6l464t1215r683b1288],
5	received	VBD	O	receive	parataxis	29	SENT_90	[p6l700t1213r958b1270],
6	a	DT	O	a	det	9	SENT_90	[p6l976t1233r1008b1270],
7	thorough	JJ	O	thorough	amod	9	SENT_90	[p6l1024t1213r1315b1288],
8	medical	JJ	O	medical	amod	9	SENT_90	[p6l1332t1213r1578b1270],
9	workup	NN	O	workup	dobj	5	SENT_90	[p6l1594t1213r1833b1288],
10	including	VBG	O	include	_	0	SENT_90	[p6l1853t1213r2150b1288],
11	physical	JJ	O	physical	amod	12	SENT_90	[p6l8t1296r262b1371],
12	examination	NN	O	examination	prep_including	9	SENT_90	[p6l288t1298r696b1362],
13	,	,	O	,	_	0	SENT_90	[p6l288t1298r696b1362],
14	measurement	NN	O	measurement	nsubj	29	SENT_90	[p6l719t1307r1144b1353],
15	of	IN	O	of	_	0	SENT_90	[p6l1170t1296r1235b1353],
16	vital	JJ	O	vital	amod	17	SENT_90	[p6l1254t1296r1392b1353],
17	signs	NNS	O	sign	prep_of	14	SENT_90	[p6l1418t1298r1574b1371],
18	and	CC	O	and	_	0	SENT_90	[p6l1602t1296r1718b1353],
19	body	NN	O	body	nn	24	SENT_90	[p6l1741t1296r1902b1371],
20	weight	NN	O	weight	nn	24	SENT_90	[p6l1923t1296r2147b1371],
21	,	,	O	,	_	0	SENT_90	[p6l1923t1296r2147b1371],
22	EEG	NN	O	eeg	dep	24	SENT_90	[p6l9t1383r159b1444],
23	,	,	O	,	_	0	SENT_90	[p6l9t1383r159b1444],
24	ECG	NN	O	ecg	prep_of	14	SENT_90	[p6l183t1383r338b1444],
25	,	,	O	,	_	0	SENT_90	[p6l183t1383r338b1444],
26	and	CC	O	and	_	0	SENT_90	[p6l362t1379r478b1435],
27	laboratory	NN	O	laboratory	nn	28	SENT_90	[p6l503t1379r832b1454],
28	studies	NNS	O	study	prep_of	14	SENT_90	[p6l856t1379r1073b1435],
29	(	VBP	O	(	_	0	SENT_90	[p6l1103t1379r1423b1447],
30	Bilirubin	NNP	O	Bilirubin	dobj	29	SENT_90	[p6l1103t1379r1423b1447],
31	,	,	O	,	_	0	SENT_90	[p6l1103t1379r1423b1447],
32	ALT	NNP	O	ALT	appos	30	SENT_90	[p6l1443t1382r1580b1444],
33	,	,	O	,	_	0	SENT_90	[p6l1443t1382r1580b1444],
34	AST	NNP	ORGANIZATION	AST	appos	30	SENT_90	[p6l1600t1382r1740b1444],
35	,	,	O	,	_	0	SENT_90	[p6l1600t1382r1740b1444],
36	g	NN	O	g	appos	30	SENT_90	[p6l1762t1382r1972b1454],
37	.	.	O	.	_	0	SENT_90	[p6l1762t1382r1972b1454],

1	—	NN	O	—	_	0	SENT_91	[p6l1762t1382r1972b1454],
2	.	.	O	.	_	0	SENT_91	[p6l1762t1382r1972b1454],

1	GPT	NNP	ORGANIZATION	GPT	_	0	SENT_92	[p6l1762t1382r1972b1454],
2	,	,	O	,	_	0	SENT_92	[p6l1762t1382r1972b1454],
3	TSH	NN	O	tsh	appos	1	SENT_92	[p6l1995t1382r2147b1444],
4	,	,	O	,	_	0	SENT_92	[p6l1995t1382r2147b1444],
5	T3	NN	O	t3	appos	1	SENT_92	[p6l9t1465r104b1527],
6	,	,	O	,	_	0	SENT_92	[p6l9t1465r104b1527],
7	T4	NN	O	t4	appos	1	SENT_92	[p6l133t1465r229b1527],
8	,	,	O	,	_	0	SENT_92	[p6l133t1465r229b1527],
9	CBC	NN	ORGANIZATION	cbc	appos	1	SENT_92	[p6l258t1466r394b1518],
10	with	IN	O	with	_	0	SENT_92	[p6l424t1462r563b1518],
11	differential	JJ	O	differential	amod	23	SENT_92	[p6l595t1461r955b1527],
12	,	,	O	,	_	0	SENT_92	[p6l595t1461r955b1527],
13	cholesterol	NN	O	cholesterol	dep	23	SENT_92	[p6l985t1462r1340b1527],
14	,	,	O	,	_	0	SENT_92	[p6l985t1462r1340b1527],
15	triglycerides	NNS	O	triglyceride	dep	23	SENT_92	[p6l1368t1462r1776b1537],
16	,	,	O	,	_	0	SENT_92	[p6l1368t1462r1776b1537],
17	LDL	NN	O	ldl	dep	23	SENT_92	[p6l1805t1467r1954b1527],
18	,	,	O	,	_	0	SENT_92	[p6l1805t1467r1954b1527],
19	HDL	NN	O	hdl	dep	23	SENT_92	[p6l1983t1467r2148b1527],
20	,	,	O	,	_	0	SENT_92	[p6l1983t1467r2148b1527],
21	urine	NN	O	urine	dep	23	SENT_92	[p6l9t1548r175b1602],
22	drug	NN	O	drug	nn	23	SENT_92	[p6l193t1545r340b1621],
23	screen	NN	O	screen	prep_with	9	SENT_92	[p6l357t1565r571b1611],
24	,	,	O	,	_	0	SENT_92	[p6l357t1565r571b1611],
25	urine	NN	O	urine	nn	27	SENT_92	[p6l585t1547r750b1602],
26	pregnancy	NN	O	pregnancy	nn	27	SENT_92	[p6l767t1564r1100b1621],
27	test	NN	O	test	appos	23	SENT_92	[p6l1113t1556r1222b1602],
28	for	IN	O	for	_	0	SENT_92	[p6l1239t1545r1327b1602],
29	females	NNS	O	female	prep_for	27	SENT_92	[p6l1344t1545r1623b1614],
30	)	CD	NUMBER	)	dep	27	SENT_92	[p6l1344t1545r1623b1614],
31	.	.	O	.	_	0	SENT_92	[p6l1344t1545r1623b1614],

1	Similar	JJ	O	similar	amod	2	SENT_93	[p6l1639t1545r1863b1602],
2	workups	NNS	O	workup	nsubjpass	4	SENT_93	[p6l1877t1545r2147b1620],
3	were	VBD	O	be	auxpass	4	SENT_93	[p6l7t1647r153b1685],
4	done	VBN	O	do	conj_and	4	SENT_93	[p6l184t1628r336b1685],
5	at	IN	O	at	_	0	SENT_93	[p6l368t1638r422b1685],
6	the	DT	DURATION	the	det	7	SENT_93	[p6l451t1628r547b1685],
7	end	NN	DURATION	end	prep_at	4	SENT_93	[p6l578t1628r693b1685],
8	of	IN	DURATION	of	_	0	SENT_93	[p6l723t1628r789b1685],
9	week	NN	DURATION	week	prep_of	7	SENT_93	[p6l811t1628r970b1685],
10	3	CD	NUMBER	3	num	9	SENT_93	[p6l999t1634r1048b1693],
11	;	:	O	;	_	0	SENT_93	[p6l999t1634r1048b1693],
12	and	CC	O	and	_	0	SENT_93	[p6l1080t1628r1195b1685],
13	upon	IN	O	upon	_	0	SENT_93	[p6l1225t1647r1385b1702],
14	study	NN	O	study	nn	15	SENT_93	[p6l1416t1628r1588b1703],
15	completion	NN	O	completion	prep_upon	4	SENT_93	[p6l1616t1628r1967b1702],
16	or	CC	O	or	cc	4	SENT_93	[p6l1999t1647r2064b1685],
17	at	IN	O	at	_	0	SENT_93	[p6l2094t1638r2149b1685],
18	dropout	NN	O	dropout	prep_at	4	SENT_93	[p6l9t1710r274b1783],
19	.	.	O	.	_	0	SENT_93	[p6l9t1710r274b1783],

1	A	DT	O	a	det	4	SENT_94	[p6l123t1797r171b1848],
2	medication	NN	O	medication	nn	4	SENT_94	[p6l193t1793r544b1849],
3	washout	NN	O	washout	nn	4	SENT_94	[p6l564t1792r825b1849],
4	period	NN	O	period	nsubjpass	11	SENT_94	[p6l846t1792r1053b1867],
5	lasting	VBG	O	last	partmod	4	SENT_94	[p6l1073t1793r1283b1868],
6	2	CD	DURATION	2	number	8	SENT_94	[p6l1304t1799r1335b1848],
7	to	TO	DURATION	to	dep	8	SENT_94	[p6l1358t1803r1417b1849],
8	7	CD	DURATION	7	num	9	SENT_94	[p6l1441t1799r1473b1849],
9	days	NNS	NUMBER	day	tmod	5	SENT_94	[p6l1495t1793r1631b1868],
10	was	VBD	O	be	auxpass	11	SENT_94	[p6l1652t1812r1767b1849],
11	followed	VBN	O	follow	_	0	SENT_94	[p6l1789t1792r2056b1849],
12	by	IN	O	by	_	0	SENT_94	[p6l2074t1793r2151b1868],
13	a	DT	O	a	det	16	SENT_94	[p6l10t1896r42b1933],
14	week-long	JJ	O	week-long	amod	16	SENT_94	[p6l55t1876r379b1952],
15	titration	NN	O	titration	nn	16	SENT_94	[p6l394t1879r654b1933],
16	phase	NN	O	phase	agent	11	SENT_94	[p6l670t1876r848b1951],
17	of	IN	O	of	_	0	SENT_94	[p6l867t1876r933b1933],
18	risperidone	NN	O	risperidone	prep_of	16	SENT_94	[p6l944t1876r1304b1951],
19	to	TO	O	to	_	0	SENT_94	[p6l1320t1887r1380b1933],
20	clinical	JJ	O	clinical	amod	21	SENT_94	[p6l1399t1876r1622b1933],
21	response	NN	O	response	prep_to	11	SENT_94	[p6l1638t1895r1928b1951],
22	.	.	O	.	_	0	SENT_94	[p6l1638t1895r1928b1951],

1	Thereafter	RB	O	thereafter	advmod	9	SENT_95	[p6l1942t1876r2147b1933, p6l10t1959r165b2025],
2	,	,	O	,	_	0	SENT_95	[p6l1942t1876r2147b1933, p6l10t1959r165b2025],
3	once	RB	DATE	once	advmod	9	SENT_95	[p6l178t1979r321b2016],
4	weekly	JJ	SET	weekly	amod	7	SENT_95	[p6l335t1959r553b2034],
5	risperidone	NN	O	risperidone	nn	7	SENT_95	[p6l566t1959r926b2034],
6	dose	NN	O	dose	nn	7	SENT_95	[p6l943t1959r1084b2016],
7	adjustments	NNS	O	adjustment	nsubjpass	9	SENT_95	[p6l1102t1959r1481b2034],
8	were	VBD	O	be	auxpass	9	SENT_95	[p6l1496t1979r1643b2016],
9	permitted	VBN	O	permit	_	0	SENT_95	[p6l1659t1959r1986b2034],
10	.	.	O	.	_	0	SENT_95	[p6l1659t1959r1986b2034],

1	During	IN	O	during	_	0	SENT_96	[p6l2000t1964r2146b2016, p6l9t2044r107b2117],
2	the	DT	O	the	det	4	SENT_96	[p6l124t2042r220b2099],
3	entire	JJ	O	entire	amod	4	SENT_96	[p6l241t2044r419b2099],
4	trial	NN	O	trial	prep_during	16	SENT_96	[p6l438t2042r585b2107],
5	,	,	O	,	_	0	SENT_96	[p6l438t2042r585b2107],
6	maximum	NN	O	maximum	nn	8	SENT_96	[p6l601t2044r921b2099],
7	daily	JJ	SET	daily	amod	8	SENT_96	[p6l941t2042r1095b2117],
8	doses	NNS	O	dose	nsubj	16	SENT_96	[p6l1111t2042r1281b2099],
9	of	IN	O	of	_	0	SENT_96	[p6l1302t2042r1368b2099],
10	up	RB	O	up	advmod	14	SENT_96	[p6l1382t2061r1459b2116],
11	to	TO	O	to	_	0	SENT_96	[p6l1479t2052r1538b2099],
12	4	CD	NUMBER	4	prep_to	10	SENT_96	[p6l1558t2048r1592b2098],
13	mg	NN	O	mg	nn	14	SENT_96	[p6l1606t2061r1704b2117],
14	Lorazepam	NN	O	lorazepam	prep_of	8	SENT_96	[p6l1722t2047r2069b2116],
15	to	TO	O	to	aux	16	SENT_96	[p6l2088t2052r2147b2099],
16	counteract	VB	O	counteract	_	0	SENT_96	[p6l10t2135r340b2181],
17	agitation	NN	O	agitation	dobj	16	SENT_96	[p6l379t2127r672b2200],
18	,	,	O	,	_	0	SENT_96	[p6l379t2127r672b2200],
19	15	CD	NUMBER	15	num	21	SENT_96	[p6l713t2131r775b2181],
20	mg	NN	O	mg	nn	21	SENT_96	[p6l791t2144r889b2200],
21	Zolpidem	NNP	O	Zolpidem	dobj	16	SENT_96	[p6l927t2125r1228b2199],
22	for	IN	O	for	_	0	SENT_96	[p6l1267t2124r1356b2181],
23	sleeplessness	NN	O	sleeplessness	prep_for	21	SENT_96	[p6l1395t2125r1815b2199],
24	,	,	O	,	_	0	SENT_96	[p6l1395t2125r1815b2199],
25	and	CC	O	and	_	0	SENT_96	[p6l1852t2125r1967b2181],
26	6	CD	NUMBER	6	num	28	SENT_96	[p6l2005t2130r2037b2181],
27	mg	NN	O	mg	nn	28	SENT_96	[p6l2052t2144r2150b2200],
28	Biperiden	NN	MISC	biperiden	dobj	16	SENT_96	[p6l9t2208r315b2283],
29	against	IN	O	against	_	0	SENT_96	[p6l334t2210r555b2284],
30	extrapyramidal	JJ	O	extrapyramidal	amod	31	SENT_96	[p6l573t2208r1056b2283],
31	symptoms	NNS	O	symptom	prep_against	28	SENT_96	[p6l1074t2219r1413b2283],
32	,	,	O	,	_	0	SENT_96	[p6l1074t2219r1413b2283],
33	but	CC	O	but	_	0	SENT_96	[p6l1425t2208r1529b2265],
34	no	DT	O	no	det	36	SENT_96	[p6l1546t2228r1623b2265],
35	other	JJ	O	other	amod	36	SENT_96	[p6l1643t2208r1808b2265],
36	comedication	NN	O	comedication	nsubjpass	38	SENT_96	[p6l1826t2208r2146b2265, p6l8t2293r133b2348],
37	were	VBD	O	be	auxpass	38	SENT_96	[p6l155t2311r301b2348],
38	allowed	VBN	O	allow	conj_but	16	SENT_96	[p6l326t2291r579b2348],
39	.	.	O	.	_	0	SENT_96	[p6l326t2291r579b2348],

1	Weekly	NNP	SET	Weekly	nn	2	SENT_97	[p6l597t2291r825b2366],
2	assessments	NNS	O	assessment	nsubjpass	9	SENT_97	[p6l846t2302r1221b2348],
3	of	IN	O	of	_	0	SENT_97	[p6l1247t2291r1313b2348],
4	psychopathology	NN	O	psychopathology	nn	7	SENT_97	[p6l1330t2291r1866b2366],
5	and	CC	O	and	_	0	SENT_97	[p6l1887t2291r2003b2348],
6	side	JJ	O	side	nn	7	SENT_97	[p6l2027t2291r2148b2348],
7	effects	NNS	O	effect	prep_of	2	SENT_97	[p6l10t2374r206b2431],
8	were	VBD	O	be	auxpass	9	SENT_97	[p6l232t2393r378b2431],
9	carried	VBN	O	carry	dep	15	SENT_97	[p6l406t2374r630b2431],
10	out	RP	O	out	prt	9	SENT_97	[p6l657t2384r757b2431],
11	and	CC	O	and	_	0	SENT_97	[p6l784t2374r900b2431],
12	incorporated	JJ	O	incorporated	conj_and	9	SENT_97	[p6l926t2374r1332b2448],
13	PANSS	NN	O	panss	nn	14	SENT_97	[p6l1359t2378r1568b2431],
14	ratings	NNS	O	rating	dobj	12	SENT_97	[p6l1597t2376r1811b2449],
15	(	VBP	O	(	_	0	SENT_97	[p6l1842t2375r1986b2449],
16	Kay	NNP	PERSON	Kay	dobj	15	SENT_97	[p6l1842t2375r1986b2449],
17	et	FW	O	et	nn	18	SENT_97	[p6l2010t2385r2065b2431],
18	al.	FW	O	al.	dep	16	SENT_97	[p6l2079t2374r2146b2431],
19	1987	CD	DATE	1987	num	20	SENT_97	[p6l14t2457r195b2525],
20	)	NN	O	)	nsubj	15	SENT_97	[p6l14t2457r195b2525],
21	,	,	O	,	_	0	SENT_97	[p6l14t2457r195b2525],
22	Simpson	NNP	PERSON	Simpson	appos	20	SENT_97	[p6l211t2459r720b2532],
23	.	.	O	.	_	0	SENT_97	[p6l211t2459r720b2532],

1	—	NN	O	—	_	0	SENT_98	[p6l211t2459r720b2532],
2	.	.	O	.	_	0	SENT_98	[p6l211t2459r720b2532],

1	Angus	NNP	PERSON	Angus	nn	4	SENT_99	[p6l211t2459r720b2532],
2	Scale	NNP	PERSON	Scale	nn	4	SENT_99	[p6l741t2457r895b2514],
3	(	CD	NUMBER	(	num	4	SENT_99	[p6l917t2457r1079b2525],
4	SAS	NNP	O	SAS	_	0	SENT_99	[p6l917t2457r1079b2525],
5	;	:	O	;	_	0	SENT_99	[p6l917t2457r1079b2525],
6	Simpson	NNP	PERSON	Simpson	dep	4	SENT_99	[p6l1099t2459r1367b2531],
7	and	CC	O	and	_	0	SENT_99	[p6l1386t2457r1502b2513],
8	Angus	NNP	PERSON	Angus	dep	4	SENT_99	[p6l1516t2461r1715b2532],
9	1970	CD	DATE	1970	num	10	SENT_99	[p6l1740t2458r1920b2525],
10	)	CD	NUMBER	)	dep	4	SENT_99	[p6l1740t2458r1920b2525],
11	,	,	O	,	_	0	SENT_99	[p6l1740t2458r1920b2525],
12	Barnes	NNP	ORGANIZATION	Barnes	nn	16	SENT_99	[p6l1936t2462r2148b2513],
13	Akathisia	NNP	ORGANIZATION	Akathisia	nn	16	SENT_99	[p6l8t2539r304b2594],
14	Scale	NNP	ORGANIZATION	Scale	nn	16	SENT_99	[p6l331t2539r485b2595],
15	(	NN	O	(	nn	16	SENT_99	[p6l516t2539r684b2606],
16	BAS	NN	O	ba	appos	4	SENT_99	[p6l516t2539r684b2606],
17	;	:	O	;	_	0	SENT_99	[p6l516t2539r684b2606],
18	Barnes	NNP	PERSON	Barnes	dep	16	SENT_99	[p6l711t2544r924b2594],
19	1989	CD	DATE	1989	num	18	SENT_99	[p6l957t2539r1138b2606],
20	)	NNP	O	)	dep	18	SENT_99	[p6l957t2539r1138b2606],
21	,	,	O	,	_	0	SENT_99	[p6l957t2539r1138b2606],
22	and	CC	O	and	_	0	SENT_99	[p6l1163t2539r1278b2594],
23	Clinical	JJ	O	clinical	amod	28	SENT_99	[p6l1306t2539r1543b2595],
24	Global	JJ	O	global	amod	28	SENT_99	[p6l1571t2539r1773b2595],
25	Impression	NN	O	impression	nn	28	SENT_99	[p6l1800t2541r2149b2612],
26	Scale	NNP	O	Scale	nn	28	SENT_99	[p6l9t2621r163b2677],
27	(	CD	NUMBER	(	num	28	SENT_99	[p6l193t2622r357b2689],
28	CGI	NNP	O	CGI	conj_and	18	SENT_99	[p6l193t2622r357b2689],
29	,	,	O	,	_	0	SENT_99	[p6l193t2622r357b2689],
30	Guy	NNP	O	Guy	appos	28	SENT_99	[p6l381t2625r507b2695],
31	et	FW	O	et	nn	32	SENT_99	[p6l530t2632r584b2677],
32	al.	FW	O	al.	dep	4	SENT_99	[p6l599t2621r666b2677],
33	1976	CD	DATE	1976	num	34	SENT_99	[p6l696t2622r875b2689],
34	)	CD	NUMBER	)	dep	32	SENT_99	[p6l696t2622r875b2689],
35	.	.	O	.	_	0	SENT_99	[p6l696t2622r875b2689],

1	All	DT	O	all	det	2	SENT_100	[p6l897t2621r986b2676],
2	assessments	NNS	O	assessment	nsubjpass	4	SENT_100	[p6l1013t2632r1387b2677],
3	were	VBD	O	be	auxpass	4	SENT_100	[p6l1413t2641r1559b2677],
4	done	VBN	O	do	_	0	SENT_100	[p6l1587t2621r1738b2677],
5	by	IN	O	by	_	0	SENT_100	[p6l1763t2621r1840b2695],
6	MD	NN	O	md	nn	8	SENT_100	[p6l1863t2626r1976b2676],
7	level	NN	O	level	nn	8	SENT_100	[p6l2004t2621r2145b2677],
8	staff	NN	O	staff	agent	4	SENT_100	[p6l9t2703r156b2759],
9	.	.	O	.	_	0	SENT_100	[p6l9t2703r156b2759],

1	Further	RB	O	further	advmod	7	SENT_101	[p6l175t2703r423b2768],
2	,	,	O	,	_	0	SENT_101	[p6l175t2703r423b2768],
3	weekly	JJ	SET	weekly	amod	4	SENT_101	[p6l437t2703r654b2777],
4	blood	NN	O	blood	nsubjpass	7	SENT_101	[p6l668t2703r851b2759],
5	draws	VBZ	O	draw	dep	4	SENT_101	[p6l871t2703r1051b2759],
6	were	VBD	O	be	auxpass	7	SENT_101	[p6l1070t2722r1216b2759],
7	carried	VBN	O	carry	_	0	SENT_101	[p6l1236t2703r1459b2759],
8	out	RP	O	out	prt	7	SENT_101	[p6l1479t2714r1595b2768],
9	;	:	O	;	_	0	SENT_101	[p6l1479t2714r1595b2768],
10	blood	NN	O	blood	nsubjpass	30	SENT_101	[p6l1613t2703r1796b2759],
11	was	VBD	O	be	auxpass	12	SENT_101	[p6l1812t2722r1927b2759],
12	drawn	VBN	O	draw	parataxis	7	SENT_101	[p6l1948t2703r2145b2759],
13	on	IN	O	on	_	0	SENT_101	[p6l9t2804r86b2841],
14	the	DT	O	the	det	16	SENT_101	[p6l104t2785r200b2841],
15	scheduled	VBN	O	schedule	amod	16	SENT_101	[p6l220t2785r531b2841],
16	morning	NN	TIME	morning	prep_on	12	SENT_101	[p6l549t2787r823b2859],
17	before	IN	TIME	before	_	0	SENT_101	[p6l838t2785r1035b2841],
18	breakfast	NN	O	breakfast	prep_before	16	SENT_101	[p6l1053t2785r1341b2841],
19	and	CC	O	and	_	0	SENT_101	[p6l1360t2785r1475b2841],
20	risperidone	NN	O	risperidone	nn	23	SENT_101	[p6l1493t2785r1853b2858],
21	morning	NN	TIME	morning	nn	23	SENT_101	[p6l1872t2787r2146b2859],
22	dose	NN	O	dose	nn	23	SENT_101	[p6l9t2867r149b2923],
23	administration	NN	O	administration	prep_before	16	SENT_101	[p6l171t2867r654b2931],
24	,	,	O	,	_	0	SENT_101	[p6l171t2867r654b2931],
25	centrifuged	VBN	O	centrifuge	conj_and	12	SENT_101	[p6l673t2867r1031b2941],
26	within	IN	O	within	_	0	SENT_101	[p6l1048t2867r1251b2923],
27	3	CD	DURATION	3	num	28	SENT_101	[p6l1273t2873r1302b2923],
28	hours	NNS	NUMBER	hour	prep_within	25	SENT_101	[p6l1324t2867r1501b2923],
29	and	CC	O	and	_	0	SENT_101	[p6l1524t2867r1639b2923],
30	stored	VBD	O	store	conj_and	12	SENT_101	[p6l1660t2867r1852b2923],
31	frozen	VBN	O	freeze	dep	30	SENT_101	[p6l1872t2867r2069b2923],
32	at	IN	O	at	_	0	SENT_101	[p6l2090t2877r2145b2923],
33	-80	CD	NUMBER	-80	number	34	SENT_101	[p6l9t2955r115b3005],
34	°	CD	NUMBER	°	num	35	SENT_101	[p6l131t2953r201b3005],
35	C	NN	O	c	prep_at	31	SENT_101	[p6l131t2953r201b3005],
36	until	IN	O	until	_	0	SENT_101	[p6l237t2949r383b3005],
37	further	JJ	O	further	amod	38	SENT_101	[p6l419t2949r641b3005],
38	examination	NN	O	examination	prep_until	31	SENT_101	[p6l677t2951r1082b3005],
39	.	.	O	.	_	0	SENT_101	[p6l677t2951r1082b3005],

1	Pending	VBG	O	pend	_	0	SENT_102	[p6l1117t2949r1372b3023],
2	dose	NN	O	dose	prep_pending	5	SENT_102	[p6l1407t2949r1547b3005],
3	adjustments	NNS	O	adjustment	nsubjpass	5	SENT_102	[p6l1584t2949r1963b3023],
4	were	VBD	O	be	auxpass	5	SENT_102	[p6l1998t2969r2143b3005],
5	done	VBN	O	do	_	0	SENT_102	[p6l9t3031r160b3087],
6	after	IN	O	after	mark	8	SENT_102	[p6l182t3031r324b3087],
7	blood	NN	O	blood	nsubj	8	SENT_102	[p6l342t3031r525b3087],
8	draws	VBZ	O	draw	advcl	5	SENT_102	[p6l544t3031r725b3087],
9	to	TO	O	to	aux	10	SENT_102	[p6l746t3042r804b3087],
10	ensure	VB	O	ensure	xcomp	8	SENT_102	[p6l826t3050r1030b3087],
11	stable	JJ	O	stable	amod	13	SENT_102	[p6l1052t3031r1229b3087],
12	plasma	NN	O	plasma	nn	13	SENT_102	[p6l1249t3031r1472b3105],
13	levels	NNS	O	level	dobj	10	SENT_102	[p6l1490t3031r1675b3087],
14	.	.	O	.	_	0	SENT_102	[p6l1490t3031r1675b3087],

1	Blood	NN	O	blood	nn	2	SENT_103	[p6l1694t3031r1878b3087],
2	levels	NNS	O	level	nsubjpass	19	SENT_103	[p6l1896t3031r2065b3087],
3	of	IN	O	of	_	0	SENT_103	[p6l2087t3031r2153b3087],
4	risperidone	NN	O	risperidone	prep_of	2	SENT_103	[p6l8t3113r368b3186],
5	and	CC	O	and	_	0	SENT_103	[p6l385t3113r501b3169],
6	9-OH-risperidone	NN	O	9-oh-risperidone	prep_of	2	SENT_103	[p6l517t3113r1076b3186],
7	were	VBD	O	be	auxpass	8	SENT_103	[p6l1091t3132r1237b3169],
8	measured	VBN	O	measure	_	0	SENT_103	[p6l1252t3113r1557b3169],
9	after	IN	O	after	_	0	SENT_103	[p6l1573t3113r1715b3169],
10	the	DT	O	the	det	11	SENT_103	[p6l1730t3113r1826b3169],
11	end	NN	O	end	prep_after	8	SENT_103	[p6l1843t3113r1957b3169],
12	of	IN	O	of	_	0	SENT_103	[p6l1973t3113r2039b3169],
13	the	DT	O	the	det	14	SENT_103	[p6l2048t3113r2144b3169],
14	study	NN	O	study	prep_of	11	SENT_103	[p6l9t3195r181b3269],
15	and	CC	O	and	_	0	SENT_103	[p6l199t3195r314b3251],
16	were	VBD	O	be	auxpass	19	SENT_103	[p6l332t3214r478b3251],
17	thus	RB	O	thus	advmod	18	SENT_103	[p6l499t3195r630b3251],
18	not	RB	O	not	neg	19	SENT_103	[p6l652t3205r755b3251],
19	reported	VBN	O	report	conj_and	8	SENT_103	[p6l775t3195r1045b3268],
20	to	TO	O	to	_	0	SENT_103	[p6l1064t3205r1123b3251],
21	the	DT	O	the	det	22	SENT_103	[p6l1145t3195r1240b3251],
22	investigators	NNS	O	investigator	prep_to	19	SENT_103	[p6l1262t3197r1673b3269],
23	.	.	O	.	_	0	SENT_103	[p6l1262t3197r1673b3269],

1	I	PRP	O	I	_	0	SENT_104	[p6l9t3433r61b3486],
2	Determination	NN	O	determination	dep	1	SENT_104	[p6l125t3431r546b3487],
3	of	IN	O	of	_	0	SENT_104	[p6l564t3432r624b3487],
4	drug	NN	O	drug	nn	6	SENT_104	[p6l638t3432r771b3502],
5	plasma	NN	O	plasma	nn	6	SENT_104	[p6l790t3432r994b3501],
6	levels	NNS	O	level	prep_of	2	SENT_104	[p6l1014t3432r1176b3487],

1	Sample	NN	O	sample	_	0	SENT_105	[p7l103t52r315b121],
2	extraction	NN	O	extraction	dep	1	SENT_105	[p7l328t51r642b106],
3	.	.	O	.	_	0	SENT_105	[p7l328t51r642b106],

1	Prior	RB	O	prior	advmod	2	SENT_106	[p7l683t53r842b107],
2	to	TO	O	to	advcl	15	SENT_106	[p7l857t61r916b107],
3	HPLC	NN	O	hplc	nn	4	SENT_106	[p7l934t55r1116b107],
4	determination	NN	O	determination	pobj	2	SENT_106	[p7l1133t51r1598b116],
5	,	,	O	,	_	0	SENT_106	[p7l1133t51r1598b116],
6	1	CD	NUMBER	1	num	7	SENT_106	[p7l1616t57r1638b106],
7	ml	NN	O	ml	nsubjpass	51	SENT_106	[p7l1658t51r1738b106],
8	of	IN	O	of	_	0	SENT_106	[p7l1755t51r1821b107],
9	ﬂuid	JJ	O	ﬂuid	amod	13	SENT_106	[p7l1831t51r2145b109],
10	/	:	O	/	punct	11	SENT_106	[p7l1831t51r2145b109],
11	ﬂuid	NN	O	ﬂuid	dep	9	SENT_106	[p7l1831t51r2145b109],
12	extracted	VBN	O	extract	partmod	11	SENT_106	[p7l9t133r299b188],
13	serum	NN	O	serum	prep_of	7	SENT_106	[p7l316t152r511b188],
14	were	VBD	O	be	auxpass	15	SENT_106	[p7l527t152r672b188],
15	enriched	VBN	O	enrich	_	0	SENT_106	[p7l691t133r965b188],
16	with	IN	O	with	_	0	SENT_106	[p7l979t133r1119b188],
17	100	CD	NUMBER	100	num	18	SENT_106	[p7l1141t138r1240b188],
18	pl	NN	O	pl	prep_with	15	SENT_106	[p7l1259t133r1314b206],
19	internal	JJ	O	internal	amod	20	SENT_106	[p7l1331t133r1575b188],
20	standard	NN	O	standard	dep	18	SENT_106	[p7l1593t133r1868b188],
21	and	CC	O	and	_	0	SENT_106	[p7l1885t133r2001b188],
22	1	CD	NUMBER	1	num	23	SENT_106	[p7l2023t139r2044b188],
23	ml	NN	O	ml	conj_and	18	SENT_106	[p7l2064t133r2145b188],
24	of	IN	O	of	_	0	SENT_106	[p7l9t215r75b271],
25	2	CD	TIME	2	num	27	SENT_106	[p7l87t221r118b270],
26	pM	NN	TIME	pm	nn	27	SENT_106	[p7l137t220r236b289],
27	NaHCO3	NN	O	nahco3	prep_of	23	SENT_106	[p7l255t219r519b282],
28	(	CD	NUMBER	(	num	29	SENT_106	[p7l542t216r660b289],
29	pH	NN	O	ph	tmod	15	SENT_106	[p7l542t216r660b289],
30	10.5	CD	NUMBER	10.5	num	31	SENT_106	[p7l684t216r847b283],
31	)	NN	O	)	nsubj	45	SENT_106	[p7l684t216r847b283],
32	,	,	O	,	_	0	SENT_106	[p7l684t216r847b283],
33	mixed	VBN	O	mix	partmod	31	SENT_106	[p7l862t215r1055b271],
34	with	IN	O	with	_	0	SENT_106	[p7l1070t215r1210b271],
35	6	CD	NUMBER	6	num	36	SENT_106	[p7l1228t221r1260b271],
36	ml	NN	O	ml	prep_with	33	SENT_106	[p7l1275t215r1355b270],
37	of	IN	O	of	_	0	SENT_106	[p7l1374t215r1440b271],
38	hexane	NN	O	hexane	prep_of	36	SENT_106	[p7l1451t215r1672b271],
39	containing	VBG	O	contain	xcomp	33	SENT_106	[p7l1691t218r2023b290],
40	1	CD	PERCENT	1	number	41	SENT_106	[p7l2045t221r2067b270],
41	%	NN	PERCENT	%	amod	43	SENT_106	[p7l2086t220r2143b273],
42	isoamyl	NN	O	isoamyl	nn	43	SENT_106	[p7l8t297r251b371],
43	alcohol	NN	O	alcohol	dobj	39	SENT_106	[p7l274t297r515b362],
44	,	,	O	,	_	0	SENT_106	[p7l274t297r515b362],
45	ﬂuffed	VBN	O	ﬂuffed	rcmod	29	SENT_106	[p7l535t297r737b353],
46	for	IN	O	for	_	0	SENT_106	[p7l760t297r848b353],
47	15	CD	DURATION	15	num	48	SENT_106	[p7l877t303r938b353],
48	minutes	NNS	NUMBER	minute	prep_for	45	SENT_106	[p7l963t299r1230b362],
49	,	,	O	,	_	0	SENT_106	[p7l963t299r1230b362],
50	and	CC	O	and	_	0	SENT_106	[p7l1251t297r1366b353],
51	centrifuged	VBD	O	centrifuge	conj_and	15	SENT_106	[p7l1390t297r1748b371],
52	at	IN	O	at	_	0	SENT_106	[p7l1771t308r1826b353],
53	3600	CD	NUMBER	3600	num	54	SENT_106	[p7l1849t303r1989b353],
54	rpm	NN	O	rpm	prep_at	51	SENT_106	[p7l2014t316r2144b371],
55	for	IN	O	for	_	0	SENT_106	[p7l8t379r97b435],
56	15	CD	DURATION	15	num	57	SENT_106	[p7l131t385r192b435],
57	minutes	NNS	NUMBER	minute	prep_for	51	SENT_106	[p7l223t381r488b435],
58	.	.	O	.	_	0	SENT_106	[p7l223t381r488b435],

1	Then	RB	O	then	advmod	12	SENT_107	[p7l515t379r691b444],
2	,	,	O	,	_	0	SENT_107	[p7l515t379r691b444],
3	5ml	NN	O	5ml	nsubjpass	12	SENT_107	[p7l718t379r844b435],
4	of	IN	O	of	_	0	SENT_107	[p7l874t379r940b435],
5	the	DT	O	the	det	10	SENT_107	[p7l962t379r1058b435],
6	supernatant	JJ	O	supernatant	amod	10	SENT_107	[p7l1088t389r1461b452],
7	(	NN	O	(	nn	10	SENT_107	[p7l1492t379r1736b446],
8	hexane	NN	O	hexane	nn	10	SENT_107	[p7l1492t379r1736b446],
9	phase	NN	O	phase	nn	10	SENT_107	[p7l1765t379r1967b452],
10	)	NN	O	)	prep_of	3	SENT_107	[p7l1765t379r1967b452],
11	were	VBD	O	be	auxpass	12	SENT_107	[p7l1998t398r2144b435],
12	pipetted	VBN	O	pipet	_	0	SENT_107	[p7l7t461r265b534],
13	into	IN	O	into	_	0	SENT_107	[p7l281t463r401b517],
14	100	CD	NUMBER	100	num	15	SENT_107	[p7l425t467r523b517],
15	pl	NN	O	pl	prep_into	12	SENT_107	[p7l542t461r597b534],
16	0.1	CD	NUMBER	0.1	num	18	SENT_107	[p7l613t467r694b517],
17	M	NN	O	m	nn	18	SENT_107	[p7l716t466r778b516],
18	H3PO4	NN	O	h3po4	dep	15	SENT_107	[p7l795t465r1009b528],
19	,	,	O	,	_	0	SENT_107	[p7l795t465r1009b528],
20	again	RB	O	again	advmod	21	SENT_107	[p7l1023t463r1189b535],
21	ﬂuffed	VBN	O	ﬂuffed	conj_and	12	SENT_107	[p7l1206t461r1408b517],
22	for	IN	O	for	_	0	SENT_107	[p7l1424t461r1512b517],
23	15	CD	DURATION	15	num	24	SENT_107	[p7l1534t467r1595b517],
24	minutes	NNS	NUMBER	minute	prep_for	21	SENT_107	[p7l1613t463r1862b517],
25	and	CC	O	and	_	0	SENT_107	[p7l1880t461r1996b517],
26	subsequently	RB	O	subsequently	advmod	27	SENT_107	[p7l2012t461r2142b517, p7l9t543r308b617],
27	centrifuged	VBN	O	centrifuge	conj_and	12	SENT_107	[p7l332t542r691b617],
28	for	IN	O	for	_	0	SENT_107	[p7l717t542r805b598],
29	30	CD	DURATION	30	num	30	SENT_107	[p7l833t548r900b598],
30	minutes	NNS	NUMBER	minute	prep_for	27	SENT_107	[p7l928t545r1176b598],
31	at	IN	O	at	_	0	SENT_107	[p7l1205t553r1260b598],
32	3600	CD	NUMBER	3600	num	33	SENT_107	[p7l1287t548r1427b598],
33	rpm	NN	O	rpm	prep_at	30	SENT_107	[p7l1455t561r1602b616],
34	.	.	O	.	_	0	SENT_107	[p7l1455t561r1602b616],

1	The	DT	O	the	det	6	SENT_108	[p7l1627t542r1744b598],
2	supernatant	JJ	O	supernatant	amod	6	SENT_108	[p7l1772t553r2145b616],
3	(	NN	O	(	nn	6	SENT_108	[p7l11t625r255b693],
4	hexane	NN	O	hexane	nn	6	SENT_108	[p7l11t625r255b693],
5	phase	NN	O	phase	nn	6	SENT_108	[p7l279t625r481b699],
6	)	NN	O	)	nsubjpass	8	SENT_108	[p7l279t625r481b699],
7	was	VBD	O	be	auxpass	8	SENT_108	[p7l507t644r621b681],
8	discarded	VBN	O	discard	_	0	SENT_108	[p7l647t625r950b681],
9	and	CC	O	and	_	0	SENT_108	[p7l974t625r1089b681],
10	100	CD	NUMBER	100	num	11	SENT_108	[p7l1118t631r1216b681],
11	pl	NN	O	pl	nsubjpass	17	SENT_108	[p7l1234t625r1290b699],
12	of	IN	O	of	_	0	SENT_108	[p7l1314t625r1380b681],
13	the	DT	O	the	det	15	SENT_108	[p7l1398t625r1493b681],
14	aqueous	JJ	O	aqueous	amod	15	SENT_108	[p7l1519t644r1774b699],
15	phase	NN	O	phase	prep_of	11	SENT_108	[p7l1798t625r1976b699],
16	were	VBD	O	be	auxpass	17	SENT_108	[p7l1999t644r2144b681],
17	transferred	VBN	O	transfer	conj_and	8	SENT_108	[p7l8t707r358b763],
18	to	TO	O	to	aux	19	SENT_108	[p7l378t717r436b763],
19	autosampler	VB	O	autosampler	xcomp	17	SENT_108	[p7l459t707r845b780],
20	vials	NNS	O	vial	dobj	19	SENT_108	[p7l863t707r1021b763],
21	.	.	O	.	_	0	SENT_108	[p7l863t707r1021b763],

1	/	:	O	/	punct	2	SENT_109	[p7l10t924r60b925],
2	HPLC	NN	O	hplc	_	0	SENT_109	[p7l105t874r249b927],
3	method	NN	O	method	dep	2	SENT_109	[p7l268t873r510b927],
4	.	.	O	.	_	0	SENT_109	[p7l268t873r510b927],

1	The	DT	O	the	det	3	SENT_110	[p7l550t872r667b927],
2	HPLC	NN	O	hplc	nn	3	SENT_110	[p7l690t876r872b927],
3	system	NN	O	system	nsubj	4	SENT_110	[p7l896t882r1107b946],
4	consisted	VBD	O	consist	_	0	SENT_110	[p7l1130t872r1420b927],
5	of	IN	O	of	_	0	SENT_110	[p7l1442t871r1507b927],
6	a	DT	O	a	det	17	SENT_110	[p7l1525t891r1557b927],
7	Waters	NNP	O	Waters	nn	17	SENT_110	[p7l1575t876r1785b927],
8	2690	CD	DATE	2690	num	17	SENT_110	[p7l1809t877r1949b927],
9	Separations	NNP	O	Separations	nn	17	SENT_110	[p7l1974t876r2142b945, p7l8t956r224b1010],
10	Module	NNP	O	Module	nn	17	SENT_110	[p7l257t954r493b1010],
11	(	NNP	O	(	nn	17	SENT_110	[p7l529t955r846b1022],
12	WATERS	NNP	O	WATERS	nn	17	SENT_110	[p7l529t955r846b1022],
13	,	,	O	,	_	0	SENT_110	[p7l529t955r846b1022],
14	Milford	NNP	LOCATION	Milford	appos	17	SENT_110	[p7l874t954r1127b1019],
15	,	,	O	,	_	0	SENT_110	[p7l874t954r1127b1019],
16	MA	NNP	LOCATION	MA	appos	17	SENT_110	[p7l1155t955r1312b1022],
17	)	NNP	O	)	prep_of	4	SENT_110	[p7l1155t955r1312b1022],
18	.	.	O	.	_	0	SENT_110	[p7l1155t955r1312b1022],

1	The	DT	O	the	det	5	SENT_111	[p7l1342t954r1459b1010],
2	operational	JJ	O	operational	amod	3	SENT_111	[p7l1492t954r1847b1028],
3	isocratic	JJ	O	isocratic	amod	5	SENT_111	[p7l1879t957r2144b1010],
4	chromatographic	JJ	O	chromatographic	amod	5	SENT_111	[p7l9t1036r546b1110],
5	conditions	NNS	O	condition	nsubjpass	11	SENT_111	[p7l563t1036r890b1092],
6	for	IN	O	for	_	0	SENT_111	[p7l908t1036r996b1092],
7	this	DT	O	this	det	9	SENT_111	[p7l1011t1036r1123b1092],
8	HPLC	NN	O	hplc	nn	9	SENT_111	[p7l1141t1040r1324b1092],
9	system	NN	O	system	prep_for	5	SENT_111	[p7l1341t1047r1552b1110],
10	were	VBD	O	be	auxpass	11	SENT_111	[p7l1566t1055r1712b1092],
11	set	VBN	O	set	_	0	SENT_111	[p7l1730t1047r1814b1092],
12	as	IN	O	as	mark	13	SENT_111	[p7l1830t1055r1890b1092],
13	follows	VBZ	O	follow	advcl	11	SENT_111	[p7l1907t1036r2142b1092],
14	:	:	O	:	_	0	SENT_111	[p7l1907t1036r2142b1092],
15	column	NN	O	column	nn	16	SENT_111	[p7l9t1118r242b1174],
16	temperature	NN	O	temperature	dep	11	SENT_111	[p7l304t1128r686b1191],
17	40	CD	NUMBER	40	num	19	SENT_111	[p7l748t1124r817b1174],
18	°	NN	O	°	nn	19	SENT_111	[p7l832t1122r920b1183],
19	C	NN	O	c	dep	16	SENT_111	[p7l832t1122r920b1183],
20	;	:	O	;	_	0	SENT_111	[p7l832t1122r920b1183],
21	injection	NN	O	injection	nn	22	SENT_111	[p7l983t1120r1258b1192],
22	volume	NN	O	volume	dep	16	SENT_111	[p7l1319t1118r1565b1174],
23	:	:	O	:	_	0	SENT_111	[p7l1319t1118r1565b1174],
24	75	CD	NUMBER	75	num	25	SENT_111	[p7l1630t1124r1696b1174],
25	pl	NN	O	pl	dep	22	SENT_111	[p7l1715t1118r1787b1191],
26	;	:	O	;	_	0	SENT_111	[p7l1715t1118r1787b1191],
27	ﬂow-rate	NN	O	ﬂow-rate	dep	25	SENT_111	[p7l1850t1118r2142b1174],
28	:	:	O	:	_	0	SENT_111	[p7l1850t1118r2142b1174],
29	0.8	CD	NUMBER	0.8	num	30	SENT_111	[p7l8t1205r94b1255],
30	ml/min	NN	O	ml/min	dep	22	SENT_111	[p7l110t1200r357b1258],
31	.	.	O	.	_	0	SENT_111	[p7l110t1200r357b1258],

1	The	DT	O	the	det	3	SENT_112	[p7l374t1200r490b1255],
2	mobile	JJ	O	mobile	amod	3	SENT_112	[p7l509t1200r723b1255],
3	phase	NN	O	phase	nsubj	4	SENT_112	[p7l742t1200r920b1273],
4	consisted	VBD	O	consist	_	0	SENT_112	[p7l940t1200r1230b1255],
5	of	IN	O	of	_	0	SENT_112	[p7l1248t1199r1314b1255],
6	50	CD	NUMBER	50	num	8	SENT_112	[p7l1329t1205r1396b1255],
7	mM	NN	O	mm	nn	8	SENT_112	[p7l1415t1205r1540b1255],
8	NaH2PO4	NN	O	nah2po4	prep_of	4	SENT_112	[p7l1559t1204r1861b1266],
9	,	,	O	,	_	0	SENT_112	[p7l1559t1204r1861b1266],
10	12.5	CD	NUMBER	12.5	num	11	SENT_112	[p7l1882t1205r1998b1255],
11	mM	NN	O	mm	appos	8	SENT_112	[p7l2019t1205r2144b1255],
12	octanesulfonic	JJ	O	octanesulfonic	amod	14	SENT_112	[p7l9t1282r463b1338],
13	(	NN	O	(	nn	14	SENT_112	[p7l508t1283r626b1356],
14	pH	NN	O	ph	dep	11	SENT_112	[p7l508t1283r626b1356],
15	2.2	CD	NUMBER	2.2	dobj	4	SENT_112	[p7l669t1288r773b1347],
16	,	,	O	,	_	0	SENT_112	[p7l669t1288r773b1347],
17	adjusted	VBN	O	adjust	partmod	15	SENT_112	[p7l812t1282r1075b1356],
18	with	IN	O	with	_	0	SENT_112	[p7l1114t1282r1253b1338],
19	H3PO4	NN	O	h3po4	nn	20	SENT_112	[p7l1295t1283r1536b1350],
20	)	NN	O	)	prep_with	17	SENT_112	[p7l1295t1283r1536b1350],
21	,	,	O	,	_	0	SENT_112	[p7l1295t1283r1536b1350],
22	27	CD	PERCENT	27	number	23	SENT_112	[p7l1575t1288r1643b1338],
23	%	NN	PERCENT	%	amod	24	SENT_112	[p7l1658t1288r1714b1340],
24	CH3CN	NN	O	ch3cn	appos	20	SENT_112	[p7l1759t1286r2001b1349],
25	,	,	O	,	_	0	SENT_112	[p7l1759t1286r2001b1349],
26	3	CD	PERCENT	3	number	27	SENT_112	[p7l2041t1288r2070b1338],
27	%	NN	PERCENT	%	amod	28	SENT_112	[p7l2086t1287r2143b1340],
28	MeOH	NN	O	meoh	appos	24	SENT_112	[p7l8t1368r228b1420],
29	.	.	O	.	_	0	SENT_112	[p7l8t1368r228b1420],

1	This	DT	O	this	det	2	SENT_113	[p7l249t1364r383b1420],
2	solution	NN	O	solution	nsubjpass	4	SENT_113	[p7l408t1364r661b1420],
3	was	VBD	O	be	auxpass	4	SENT_113	[p7l682t1383r797b1420],
4	filtered	VBN	O	filter	_	0	SENT_113	[p7l821t1364r1043b1420],
5	through	IN	O	through	_	0	SENT_113	[p7l1064t1364r1314b1438],
6	an	DT	O	a	det	10	SENT_113	[p7l1339t1383r1411b1420],
7	0.47	CD	NUMBER	0.47	num	10	SENT_113	[p7l1435t1370r1558b1420],
8	pm	NN	O	pm	nn	10	SENT_113	[p7l1576t1383r1673b1438],
9	membrane	NN	O	membrane	nn	10	SENT_113	[p7l1697t1364r2032b1420],
10	ﬁlter	NN	O	ﬁlter	prep_through	4	SENT_113	[p7l2056t1364r2142b1419, p7l7t1458r92b1504],
11	and	CC	O	and	_	0	SENT_113	[p7l118t1447r234b1504],
12	degassed	VBN	O	degas	conj_and	4	SENT_113	[p7l259t1447r538b1522],
13	before	IN	O	before	_	0	SENT_113	[p7l561t1447r758b1504],
14	use	NN	O	use	prep_before	12	SENT_113	[p7l785t1467r902b1504],
15	.	.	O	.	_	0	SENT_113	[p7l785t1467r902b1504],

1	A	DT	O	a	det	2	SENT_114	[p7l923t1451r971b1503],
2	Waters	NNP	O	Waters	nsubjpass	10	SENT_114	[p7l994t1452r1204b1504],
3	2487	CD	DATE	2487	num	2	SENT_114	[p7l1231t1453r1372b1504],
4	Dual	JJ	O	dual	dep	2	SENT_114	[p7l1399t1447r1546b1504],
5	7	CD	NUMBER	7	number	6	SENT_114	[p7l1572t1445r1612b1504],
6	»	CD	NUMBER	»	dep	2	SENT_114	[p7l1572t1445r1612b1504],
7	Absorbance	NNP	O	Absorbance	nn	8	SENT_114	[p7l1638t1447r2007b1504],
8	Detector	NNP	O	Detector	dep	6	SENT_114	[p7l2034t1452r2142b1504, p7l7t1539r189b1585],
9	was	VBD	O	be	auxpass	10	SENT_114	[p7l229t1548r344b1585],
10	used	VBN	O	use	_	0	SENT_114	[p7l388t1529r532b1585],
11	for	IN	O	for	_	0	SENT_114	[p7l574t1529r663b1585],
12	detection	NN	O	detection	nn	14	SENT_114	[p7l706t1529r995b1585],
13	(	NN	O	(	nn	14	SENT_114	[p7l1042t1529r1311b1596],
14	channel	NN	O	channel	prep_for	10	SENT_114	[p7l1042t1529r1311b1596],
15	1	CD	NUMBER	1	number	16	SENT_114	[p7l1359t1535r1381b1584],
16	7	CD	NUMBER	7	num	17	SENT_114	[p7l1429t1527r1470b1585],
17	»	NN	O	»	npadvmod	18	SENT_114	[p7l1429t1527r1470b1585],
18	=	JJ	O	=	amod	14	SENT_114	[p7l1485t1553r1526b1573],
19	210	CD	NUMBER	210	num	20	SENT_114	[p7l1542t1535r1646b1585],
20	nm	NN	O	nm	dep	14	SENT_114	[p7l1662t1548r1781b1594],
21	;	:	O	;	_	0	SENT_114	[p7l1662t1548r1781b1594],
22	channel	NN	O	channel	nn	24	SENT_114	[p7l1825t1529r2069b1585],
23	2	CD	NUMBER	2	num	24	SENT_114	[p7l2112t1535r2143b1584],
24	7t	NN	O	7t	dep	14	SENT_114	[p7l8t1610r225b1669],
25	=	JJ	O	=	amod	28	SENT_114	[p7l8t1610r225b1669],
26	280	CD	NUMBER	280	tmod	25	SENT_114	[p7l8t1610r225b1669],
27	nm	NN	O	nm	nn	28	SENT_114	[p7l241t1612r386b1680],
28	)	NN	O	)	dep	24	SENT_114	[p7l241t1612r386b1680],
29	.	.	O	.	_	0	SENT_114	[p7l241t1612r386b1680],

1	The	DT	O	the	det	3	SENT_115	[p7l419t1612r535b1668],
2	analytical	JJ	O	analytical	amod	3	SENT_115	[p7l571t1612r874b1687],
3	column	NN	O	column	nsubj	8	SENT_115	[p7l908t1612r1142b1668],
4	was	VBD	O	be	cop	8	SENT_115	[p7l1174t1631r1288b1668],
5	a	DT	O	a	det	8	SENT_115	[p7l1325t1631r1357b1668],
6	250	CD	NUMBER	250	num	8	SENT_115	[p7l1390t1618r1494b1668],
7	mm	NN	O	mm	nn	8	SENT_115	[p7l1510t1631r1633b1667],
8	x	NN	O	x	_	0	SENT_115	[p7l1666t1632r1703b1667],
9	4mm	CD	NUMBER	4mm	num	10	SENT_115	[p7l1734t1618r1905b1667],
10	Supersphere	NNP	O	Supersphere	nn	12	SENT_115	[p7l1941t1616r2142b1686, p7l9t1694r212b1768],
11	60	CD	NUMBER	60	num	10	SENT_115	[p7l236t1700r303b1750],
12	RP	NN	O	rp	dep	8	SENT_115	[p7l328t1694r614b1750],
13	—	NN	O	—	nn	15	SENT_115	[p7l328t1694r614b1750],
14	select	JJ	O	select	amod	15	SENT_115	[p7l328t1694r614b1750],
15	B	NN	O	b	dep	12	SENT_115	[p7l637t1699r694b1759],
16	,	,	O	,	_	0	SENT_115	[p7l637t1699r694b1759],
17	packed	VBN	O	pack	partmod	8	SENT_115	[p7l712t1694r934b1768],
18	with	IN	O	with	_	0	SENT_115	[p7l954t1694r1093b1750],
19	C8	NN	O	c8	prep_with	17	SENT_115	[p7l1117t1698r1195b1750],
20	(	CD	NUMBER	(	num	22	SENT_115	[p7l1223t1695r1496b1762],
21	MERCK	NNP	ORGANIZATION	MERCK	nn	22	SENT_115	[p7l1223t1695r1496b1762],
22	LiChroCART	NNP	O	LiChroCART	tmod	17	SENT_115	[p7l1519t1694r1921b1750],
23	250-4	CD	NUMBER	250-4	num	22	SENT_115	[p7l1945t1700r2143b1759],
24	,	,	O	,	_	0	SENT_115	[p7l1945t1700r2143b1759],
25	Darmstadt	NNP	LOCATION	Darmstadt	nn	27	SENT_115	[p7l8t1776r358b1841],
26	,	,	O	,	_	0	SENT_115	[p7l8t1776r358b1841],
27	Germany	NNP	LOCATION	Germany	appos	22	SENT_115	[p7l374t1777r703b1850],
28	)	CD	NUMBER	)	num	27	SENT_115	[p7l374t1777r703b1850],
29	.	.	O	.	_	0	SENT_115	[p7l374t1777r703b1850],

1	Approximate	JJ	O	approximate	amod	3	SENT_116	[p7l716t1778r1121b1849],
2	run	NN	O	run	nn	3	SENT_116	[p7l1140t1795r1250b1832],
3	time	NN	O	time	nsubj	11	SENT_116	[p7l1268t1778r1408b1832],
4	after	IN	O	after	_	0	SENT_116	[p7l1428t1776r1571b1832],
5	injection	NN	O	injection	prep_after	3	SENT_116	[p7l1588t1778r1864b1850],
6	until	IN	O	until	_	0	SENT_116	[p7l1882t1776r2028b1832],
7	detection	NN	O	detection	prep_until	3	SENT_116	[p7l2046t1776r2142b1832, p7l8t1860r224b1914],
8	of	IN	O	of	_	0	SENT_116	[p7l248t1858r314b1914],
9	the	DT	O	the	det	10	SENT_116	[p7l332t1858r428b1914],
10	compounds	NNS	O	compound	prep_of	7	SENT_116	[p7l452t1858r816b1931],
11	was	VBD	O	be	_	0	SENT_116	[p7l838t1877r953b1914],
12	about	IN	DURATION	about	_	0	SENT_116	[p7l979t1858r1155b1914],
13	16.2	CD	DURATION	16.2	num	14	SENT_116	[p7l1184t1863r1300b1914],
14	min	NN	DURATION	min	prep_about	11	SENT_116	[p7l1325t1860r1448b1913],
15	for	IN	O	for	_	0	SENT_116	[p7l1472t1858r1560b1914],
16	9	CD	NUMBER	9	prep_for	14	SENT_116	[p7l1584t1858r2143b1931],
17	.	.	O	.	_	0	SENT_116	[p7l1584t1858r2143b1931],

1	—	NN	O	—	_	0	SENT_117	[p7l1584t1858r2143b1931],
2	.	.	O	.	_	0	SENT_117	[p7l1584t1858r2143b1931],

1	OH-risperidone	NN	O	oh-risperidone	_	0	SENT_118	[p7l1584t1858r2143b1931],
2	and	CC	O	and	cc	3	SENT_118	[p7l9t1940r125b1995],
3	24.2	CD	DURATION	24.2	num	4	SENT_118	[p7l144t1945r266b1995],
4	min	NN	DURATION	min	dep	1	SENT_118	[p7l289t1942r412b1995],
5	for	IN	O	for	_	0	SENT_118	[p7l433t1939r521b1995],
6	risperidone	NN	O	risperidone	prep_for	4	SENT_118	[p7l542t1940r917b2013],
7	.	.	O	.	_	0	SENT_118	[p7l542t1940r917b2013],

1	In	IN	O	in	mark	4	SENT_119	[p7l9t2109r72b2159],
2	order	NN	O	order	dep	4	SENT_119	[p7l94t2104r262b2160],
3	to	TO	O	to	aux	4	SENT_119	[p7l282t2114r340b2160],
4	control	VB	O	control	dep	15	SENT_119	[p7l363t2104r584b2160],
5	the	DT	O	the	det	7	SENT_119	[p7l604t2104r700b2160],
6	extraction	NN	O	extraction	nn	7	SENT_119	[p7l722t2106r1039b2160],
7	process	NN	O	process	dobj	4	SENT_119	[p7l1059t2123r1309b2178],
8	,	,	O	,	_	0	SENT_119	[p7l1059t2123r1309b2178],
9	100	CD	NUMBER	100	num	10	SENT_119	[p7l1332t2110r1431b2160],
10	pl	NN	O	pl	nsubjpass	15	SENT_119	[p7l1449t2104r1504b2178],
11	of	IN	O	of	_	0	SENT_119	[p7l1525t2104r1591b2160],
12	internal	JJ	O	internal	amod	13	SENT_119	[p7l1606t2104r1850b2160],
13	standard	NN	O	standard	prep_of	10	SENT_119	[p7l1871t2104r2146b2160],
14	was	VBD	O	be	auxpass	15	SENT_119	[p7l6t2205r121b2242],
15	added	VBN	O	add	_	0	SENT_119	[p7l141t2186r330b2242],
16	to	TO	O	to	_	0	SENT_119	[p7l347t2196r405b2242],
17	every	DT	O	every	det	18	SENT_119	[p7l425t2205r594b2260],
18	probe	NN	O	probe	prep_to	15	SENT_119	[p7l608t2186r788b2259],
19	as	RB	O	as	_	0	SENT_119	[p7l807t2205r867b2242],
20	well	RB	O	well	_	0	SENT_119	[p7l884t2186r1009b2242],
21	as	IN	O	as	_	0	SENT_119	[p7l1027t2205r1087b2242],
22	to	TO	O	to	_	0	SENT_119	[p7l1105t2196r1164b2242],
23	every	DT	O	every	det	25	SENT_119	[p7l1184t2205r1353b2260],
24	calibration	NN	O	calibration	nn	25	SENT_119	[p7l1368t2186r1703b2242],
25	standard	NN	O	standard	conj_and	18	SENT_119	[p7l1722t2186r2012b2242],
26	.	.	O	.	_	0	SENT_119	[p7l1722t2186r2012b2242],

1	The	DT	O	the	det	8	SENT_120	[p7l2028t2186r2145b2242],
2	substance	NN	O	substance	nn	8	SENT_120	[p7l9t2268r312b2323],
3	Ly1701222	NN	O	ly1701222	nn	8	SENT_120	[p7l342t2272r672b2342],
4	(	CD	NUMBER	(	num	8	SENT_120	[p7l705t2268r861b2335],
5	[	NN	O	[	nn	8	SENT_120	[p7l705t2268r861b2335],
6	750	CD	NUMBER	750	num	8	SENT_120	[p7l705t2268r861b2335],
7	ng/ml	NN	O	ng/ml	nn	8	SENT_120	[p7l877t2268r1080b2342],
8	]	NN	O	]	nsubjpass	24	SENT_120	[p7l877t2268r1080b2342],
9	in	IN	O	in	_	0	SENT_120	[p7l1116t2270r1176b2323],
10	0.1	CD	NUMBER	0.1	prep_in	24	SENT_120	[p7l1205t2273r1368b2323],
11	M	NN	O	m	nn	13	SENT_120	[p7l1205t2273r1368b2323],
12	H3PO4	NN	O	h3po4	nn	13	SENT_120	[p7l1398t2269r1639b2335],
13	)	NN	O	)	nsubjpass	24	SENT_120	[p7l1398t2269r1639b2335],
14	,	,	O	,	_	0	SENT_120	[p7l1398t2269r1639b2335],
15	graciously	RB	O	graciously	advmod	16	SENT_120	[p7l1664t2268r1987b2342],
16	provided	VBN	O	provide	partmod	13	SENT_120	[p7l2012t2287r2142b2341, p7l6t2350r181b2406],
17	by	IN	O	by	_	0	SENT_120	[p7l196t2350r273b2424],
18	E.	NNP	ORGANIZATION	E.	nn	19	SENT_120	[p7l286t2355r342b2406],
19	Lilly	NNP	ORGANIZATION	Lilly	agent	16	SENT_120	[p7l357t2350r494b2424],
20	and	CC	ORGANIZATION	and	_	0	SENT_120	[p7l509t2350r625b2406],
21	Co.	NNP	ORGANIZATION	Co.	agent	16	SENT_120	[p7l642t2354r759b2415],
22	,	,	O	,	_	0	SENT_120	[p7l642t2354r759b2415],
23	was	VBD	O	be	auxpass	24	SENT_120	[p7l771t2370r886b2406],
24	used	VBN	O	use	_	0	SENT_120	[p7l904t2350r1064b2406],
25	.	.	O	.	_	0	SENT_120	[p7l904t2350r1064b2406],

1	The	DT	O	the	det	3	SENT_121	[p7l1079t2350r1196b2406],
2	calibration	NN	O	calibration	nn	3	SENT_121	[p7l1214t2350r1549b2406],
3	standards	NNS	O	standard	nsubjpass	5	SENT_121	[p7l1567t2350r1870b2406],
4	were	VBD	O	be	auxpass	5	SENT_121	[p7l1886t2370r2032b2406],
5	extracted	VBN	O	extract	_	0	SENT_121	[p7l2051t2370r2142b2406, p7l8t2432r228b2488],
6	from	IN	O	from	_	0	SENT_121	[p7l257t2432r408b2488],
7	healthy	JJ	O	healthy	amod	9	SENT_121	[p7l437t2432r666b2506],
8	blood	NN	O	blood	nn	9	SENT_121	[p7l691t2432r873b2488],
9	donors	NNS	O	donor	prep_from	5	SENT_121	[p7l903t2432r1136b2497],
10	,	,	O	,	_	0	SENT_121	[p7l903t2432r1136b2497],
11	to	TO	O	to	_	0	SENT_121	[p7l1163t2442r1221b2488],
12	which	WDT	O	which	rel	17	SENT_121	[p7l1250t2432r1438b2488],
13	the	DT	O	the	det	15	SENT_121	[p7l1468t2432r1563b2488],
14	native	JJ	O	native	amod	15	SENT_121	[p7l1594t2434r1780b2488],
15	substances	NNS	O	substance	nsubjpass	17	SENT_121	[p7l1811t2432r2143b2488],
16	were	VBD	O	be	auxpass	17	SENT_121	[p7l6t2533r152b2570],
17	added	VBN	O	add	rcmod	9	SENT_121	[p7l188t2514r378b2570],
18	in	IN	O	in	_	0	SENT_121	[p7l412t2516r471b2569],
19	deﬁned	JJ	O	deﬁned	amod	20	SENT_121	[p7l507t2514r741b2570],
20	quantities	NNS	O	quantity	prep_in	17	SENT_121	[p7l776t2516r1100b2587],
21	.	.	O	.	_	0	SENT_121	[p7l776t2516r1100b2587],

1	Controls	NNP	O	Controls	nsubjpass	3	SENT_122	[p7l1135t2514r1399b2570],
2	were	VBD	O	be	auxpass	3	SENT_122	[p7l1433t2533r1579b2570],
3	obtained	VBN	O	obtain	_	0	SENT_122	[p7l1615t2514r1889b2570],
4	via	IN	O	via	_	0	SENT_122	[p7l1921t2516r2014b2570],
5	the	DT	O	the	det	7	SENT_122	[p7l2048t2514r2143b2570],
6	same	JJ	O	same	amod	7	SENT_122	[p7l9t2615r166b2652],
7	procedure	NN	O	procedure	prep_via	3	SENT_122	[p7l189t2596r523b2669],
8	,	,	O	,	_	0	SENT_122	[p7l189t2596r523b2669],
9	and	CC	O	and	_	0	SENT_122	[p7l543t2596r658b2652],
10	used	VBN	O	use	conj_and	3	SENT_122	[p7l681t2596r824b2652],
11	prior	JJ	O	prior	dep	10	SENT_122	[p7l846t2598r1005b2669],
12	and	CC	O	and	_	0	SENT_122	[p7l1028t2596r1143b2652],
13	after	IN	O	after	dep	10	SENT_122	[p7l1166t2596r1309b2652],
14	every	DT	O	every	det	16	SENT_122	[p7l1331t2615r1501b2670],
15	analysis	NN	O	analysis	nn	16	SENT_122	[p7l1521t2596r1765b2670],
16	course	NN	O	course	pobj	13	SENT_122	[p7l1790t2615r2007b2652],
17	.	.	O	.	_	0	SENT_122	[p7l1790t2615r2007b2652],

1	The	DT	O	the	det	5	SENT_123	[p7l2027t2596r2144b2652],
2	5	CD	NUMBER	5	number	3	SENT_123	[p7l9t2684r39b2733],
3	point	NN	O	point	amod	5	SENT_123	[p7l60t2680r224b2751],
4	standard	JJ	O	standard	amod	5	SENT_123	[p7l244t2678r519b2733],
5	curves	NNS	O	curve	nsubj	6	SENT_123	[p7l539t2697r739b2733],
6	ranged	VBD	O	range	_	0	SENT_123	[p7l761t2678r977b2752],
7	from	IN	O	from	_	0	SENT_123	[p7l996t2677r1146b2733],
8	10	CD	NUMBER	10	number	10	SENT_123	[p7l1172t2683r1234b2733],
9	to	TO	NUMBER	to	dep	10	SENT_123	[p7l1255t2688r1313b2733],
10	200	CD	NUMBER	200	num	11	SENT_123	[p7l1335t2683r1439b2733],
11	ng/ml	NN	O	ng/ml	prep_from	6	SENT_123	[p7l1455t2678r1654b2752],
12	.	.	O	.	_	0	SENT_123	[p7l1455t2678r1654b2752],

1	The	DT	O	the	det	3	SENT_124	[p7l1672t2678r1789b2733],
2	entity	NN	O	entity	nn	3	SENT_124	[p7l1810t2680r1991b2752],
3	concentrations	NNS	O	concentration	nsubjpass	5	SENT_124	[p7l2008t2697r2142b2733, p7l9t2763r356b2816],
4	were	VBD	O	be	auxpass	5	SENT_124	[p7l378t2780r524b2816],
5	established	VBN	O	establish	_	0	SENT_124	[p7l548t2760r895b2816],
6	through	IN	O	through	_	0	SENT_124	[p7l917t2760r1167b2835],
7	comparison	NN	O	comparison	prep_through	5	SENT_124	[p7l1191t2763r1560b2834],
8	of	IN	O	of	_	0	SENT_124	[p7l1585t2760r1650b2816],
9	peak	JJ	O	peak	amod	10	SENT_124	[p7l1667t2760r1816b2834],
10	heights	NNS	O	height	prep_of	7	SENT_124	[p7l1836t2760r2061b2834],
11	of	IN	O	of	_	0	SENT_124	[p7l2086t2760r2152b2816],
12	the	DT	O	the	det	14	SENT_124	[p7l8t2842r103b2898],
13	single	JJ	O	single	amod	14	SENT_124	[p7l128t2842r307b2916],
14	substances	NNS	O	substance	prep_of	10	SENT_124	[p7l331t2842r664b2898],
15	with	IN	O	with	_	0	SENT_124	[p7l685t2842r825b2898],
16	the	DT	O	the	det	18	SENT_124	[p7l847t2842r942b2898],
17	peak	NN	O	peak	nn	18	SENT_124	[p7l965t2842r1114b2915],
18	heights	NNS	O	height	prep_with	5	SENT_124	[p7l1134t2842r1358b2916],
19	of	IN	O	of	_	0	SENT_124	[p7l1383t2842r1449b2898],
20	the	DT	O	the	det	22	SENT_124	[p7l1466t2842r1561b2898],
21	internal	JJ	O	internal	amod	22	SENT_124	[p7l1584t2842r1829b2898],
22	standard	NN	O	standard	prep_of	18	SENT_124	[p7l1852t2842r2141b2898],
23	.	.	O	.	_	0	SENT_124	[p7l1852t2842r2141b2898],

1	Assessment	NNP	O	Assessment	nn	2	SENT_125	[p7l7t2928r369b2980],
2	software	NN	O	software	nsubj	4	SENT_125	[p7l391t2924r653b2980],
3	was	VBD	O	be	cop	4	SENT_125	[p7l672t2943r787b2980],
4	Millenium	NNP	DURATION	Millenium	_	0	SENT_125	[p7l808t2924r1134b2980],
5	3.05	CD	NUMBER	3.05	dep	4	SENT_125	[p7l1155t2928r1669b2982],
6	/	:	O	/	punct	5	SENT_125	[p7l1155t2928r1669b2982],
7	EMPOWER	VB	O	empower	dep	5	SENT_125	[p7l1155t2928r1669b2982],
8	(	CD	NUMBER	(	num	10	SENT_125	[p7l1692t2924r1972b2991],
9	Waters	NNP	O	Waters	nn	10	SENT_125	[p7l1692t2924r1972b2991],
10	)	NN	O	)	dobj	7	SENT_125	[p7l1692t2924r1972b2991],
11	.	.	O	.	_	0	SENT_125	[p7l1692t2924r1972b2991],

1	The	DT	O	the	det	2	SENT_126	[p7l123t3006r240b3061],
2	accuracy	NN	O	accuracy	nsubjpass	7	SENT_126	[p7l269t3025r545b3080],
3	of	IN	O	of	_	0	SENT_126	[p7l571t3005r637b3061],
4	the	DT	O	the	det	5	SENT_126	[p7l658t3005r754b3061],
5	method	NN	O	method	prep_of	2	SENT_126	[p7l782t3005r1025b3061],
6	was	VBD	O	be	auxpass	7	SENT_126	[p7l1050t3025r1164b3061],
7	calculated	VBN	O	calculate	_	0	SENT_126	[p7l1194t3005r1507b3061],
8	with	IN	O	with	_	0	SENT_126	[p7l1532t3006r1671b3061],
9	control	JJ	O	control	amod	10	SENT_126	[p7l1700t3006r1921b3061],
10	serum	NN	O	serum	prep_with	7	SENT_126	[p7l1949t3025r2144b3061],
11	through	IN	O	through	_	0	SENT_126	[p7l8t3088r257b3162],
12	20	CD	NUMBER	20	num	14	SENT_126	[p7l275t3094r343b3144],
13	repeat	NN	O	repeat	nn	14	SENT_126	[p7l362t3099r554b3162],
14	measures	NNS	O	measure	prep_through	7	SENT_126	[p7l570t3108r861b3144],
15	of	IN	O	of	_	0	SENT_126	[p7l881t3088r947b3144],
16	the	DT	O	the	det	17	SENT_126	[p7l958t3088r1054b3144],
17	medication	NN	O	medication	prep_of	14	SENT_126	[p7l1071t3088r1422b3144],
18	and	CC	O	and	_	0	SENT_126	[p7l1441t3088r1556b3144],
19	its	PRP$	O	its	poss	20	SENT_126	[p7l1574t3091r1644b3144],
20	metabolite	NN	O	metabolite	prep_through	7	SENT_126	[p7l1662t3088r1994b3144],
21	over	IN	O	over	_	0	SENT_126	[p7l2013t3108r2145b3144],
22	a	DT	O	a	det	25	SENT_126	[p7l9t3189r41b3226],
23	median	JJ	O	median	amod	25	SENT_126	[p7l70t3170r303b3226],
24	concentration	NN	O	concentration	nn	25	SENT_126	[p7l334t3172r766b3226],
25	area	NN	O	area	prep_over	20	SENT_126	[p7l797t3189r941b3226],
26	.	.	O	.	_	0	SENT_126	[p7l797t3189r941b3226],

1	The	DT	O	the	det	4	SENT_127	[p7l969t3170r1086b3226],
2	average	JJ	O	average	amod	4	SENT_127	[p7l1117t3189r1349b3244],
3	mean	JJ	O	mean	amod	4	SENT_127	[p7l1380t3189r1550b3226],
4	deviation	NN	O	deviation	nsubj	10	SENT_127	[p7l1581t3170r1873b3226],
5	was	VBD	O	be	cop	10	SENT_127	[p7l1901t3189r2015b3226],
6	between	IN	O	between	quantmod	10	SENT_127	[p7l2044t3170r2142b3226, p7l8t3262r191b3308],
7	3.7	CD	NUMBER	3.7	number	10	SENT_127	[p7l213t3258r299b3308],
8	and	CC	O	and	_	0	SENT_127	[p7l323t3252r438b3308],
9	4.8	CD	PERCENT	4.8	conj_and	10	SENT_127	[p7l458t3258r545b3308],
10	%	NN	PERCENT	%	_	0	SENT_127	[p7l560t3257r634b3309],
11	.	.	O	.	_	0	SENT_127	[p7l560t3257r634b3309],

1	Mean	NN	O	mean	nn	3	SENT_128	[p7l654t3257r825b3308],
2	intraassay	JJ	O	intraassay	amod	3	SENT_128	[p7l847t3254r1163b3326],
3	variance	NN	O	variance	nsubjpass	5	SENT_128	[p7l1179t3254r1444b3308],
4	was	VBD	O	be	auxpass	5	SENT_128	[p7l1464t3271r1578b3308],
5	calculated	VBN	O	calculate	_	0	SENT_128	[p7l1602t3252r1915b3308],
6	during	IN	O	during	_	0	SENT_128	[p7l1936t3252r2146b3326],
7	eleven	NNS	NUMBER	eleven	prep_during	5	SENT_128	[p7l9t3334r203b3390],
8	15	CD	NUMBER	15	num	10	SENT_128	[p7l229t3340r291b3390],
9	h	NN	O	h	nn	10	SENT_128	[p7l312t3334r351b3389],
10	runs	NNS	O	run	dep	7	SENT_128	[p7l372t3353r529b3398],
11	,	,	O	,	_	0	SENT_128	[p7l372t3353r529b3398],
12	established	VBN	O	establish	dep	7	SENT_128	[p7l547t3334r893b3390],
13	initially	RB	O	initially	advmod	12	SENT_128	[p7l913t3334r1156b3408],
14	and	CC	O	and	_	0	SENT_128	[p7l1174t3334r1289b3390],
15	post-run	JJ	O	post-run	conj_and	12	SENT_128	[p7l1308t3344r1599b3407],
16	,	,	O	,	_	0	SENT_128	[p7l1308t3344r1599b3407],
17	and	CC	O	and	_	0	SENT_128	[p7l1618t3334r1733b3390],
18	was	VBD	O	be	cop	23	SENT_128	[p7l1751t3353r1865b3390],
19	between	IN	O	between	quantmod	23	SENT_128	[p7l1885t3334r2144b3390],
20	1.76	CD	NUMBER	1.76	number	23	SENT_128	[p7l14t3422r131b3472],
21	and	CC	O	and	_	0	SENT_128	[p7l154t3416r269b3472],
22	3.15	CD	PERCENT	3.15	conj_and	5	SENT_128	[p7l290t3422r410b3472],
23	%	NN	PERCENT	%	conj_and	5	SENT_128	[p7l426t3422r500b3474],
24	.	.	O	.	_	0	SENT_128	[p7l426t3422r500b3474],

1	The	DT	O	the	det	3	SENT_129	[p7l519t3416r635b3472],
2	control	NN	O	control	nn	3	SENT_129	[p7l658t3416r878b3472],
3	samples	NNS	O	sample	nsubj	5	SENT_129	[p7l900t3416r1146b3490],
4	used	VBN	O	use	partmod	3	SENT_129	[p7l1168t3416r1312b3472],
5	contained	VBD	O	contain	_	0	SENT_129	[p7l1333t3416r1639b3472],
6	a	DT	O	a	det	7	SENT_129	[p7l1660t3436r1692b3472],
7	concentration	NN	O	concentration	dobj	5	SENT_129	[p7l1713t3419r2144b3472],
8	of	IN	O	of	_	0	SENT_129	[p7l9t3498r75b3554],
9	80	CD	NUMBER	80	num	11	SENT_129	[p7l96t3504r164b3554],
10	ng/ml	JJ	O	ng/ml	amod	11	SENT_129	[p7l179t3498r363b3572],
11	risperidone	NN	O	risperidone	prep_of	7	SENT_129	[p7l389t3498r748b3572],
12	and	CC	O	and	_	0	SENT_129	[p7l776t3498r892b3554],
13	80	CD	NUMBER	80	num	14	SENT_129	[p7l918t3504r985b3554],
14	ng/ml	NN	O	ng/ml	dobj	5	SENT_129	[p7l1001t3498r1185b3572],
15	9	CD	NUMBER	9	dep	14	SENT_129	[p7l1211t3498r1787b3572],
16	.	.	O	.	_	0	SENT_129	[p7l1211t3498r1787b3572],

1	—	NN	O	—	_	0	SENT_130	[p7l1211t3498r1787b3572],
2	.	.	O	.	_	0	SENT_130	[p7l1211t3498r1787b3572],

1	OH-risperidone	NN	O	oh-risperidone	_	0	SENT_131	[p7l1211t3498r1787b3572],
2	.	.	O	.	_	0	SENT_131	[p7l1211t3498r1787b3572],

1	The	DT	O	the	det	2	SENT_132	[p7l1811t3498r1928b3554],
2	detection	NN	O	detection	nsubj	3	SENT_132	[p7l1956t3498r2142b3554, p7l8t3582r132b3636],
3	limit	NN	O	limit	_	0	SENT_132	[p7l184t3580r332b3636],
4	for	IN	O	for	_	0	SENT_132	[p7l385t3580r473b3636],
5	risperidone	NN	O	risperidone	prep_for	3	SENT_132	[p7l526t3580r885b3653],
6	and	CC	O	and	_	0	SENT_132	[p7l940t3580r1055b3636],
7	9	CD	NUMBER	9	prep_for	3	SENT_132	[p7l1108t3580r1668b3653],
8	.	.	O	.	_	0	SENT_132	[p7l1108t3580r1668b3653],

1	—	NN	O	—	_	0	SENT_133	[p7l1108t3580r1668b3653],
2	.	.	O	.	_	0	SENT_133	[p7l1108t3580r1668b3653],

1	OH-risperidone	NN	O	oh-risperidone	nsubj	5	SENT_134	[p7l1108t3580r1668b3653],
2	was	VBD	O	be	cop	5	SENT_134	[p7l1719t3599r1833b3636],
3	between	IN	O	between	quantmod	4	SENT_134	[p7l1885t3580r2145b3636],
4	0.63	CD	NUMBER	0.63	num	5	SENT_134	[p7l8t3667r129b3718],
5	ng/ml	NN	O	ng/ml	_	0	SENT_134	[p7l146t3662r330b3736],
6	and	CC	O	and	_	0	SENT_134	[p7l363t3662r479b3717],
7	1.25	CD	NUMBER	1.25	num	8	SENT_134	[p7l516t3668r632b3718],
8	ng/ml	NN	O	ng/ml	conj_and	5	SENT_134	[p7l649t3662r849b3736],
9	,	,	O	,	_	0	SENT_134	[p7l649t3662r849b3736],
10	respectively	RB	O	respectively	advmod	5	SENT_134	[p7l879t3662r1256b3736],
11	.	.	O	.	_	0	SENT_134	[p7l879t3662r1256b3736],

1	Recovery	NN	O	recovery	nsubj	7	SENT_135	[p7l1287t3667r1574b3736],
2	of	IN	O	of	advmod	7	SENT_135	[p7l1604t3662r1670b3718],
3	the	DT	O	the	det	5	SENT_135	[p7l1696t3662r1792b3718],
4	extraction	NN	O	extraction	nn	5	SENT_135	[p7l1826t3664r2144b3718],
5	method	NN	O	method	pobj	2	SENT_135	[p7l8t3744r250b3799],
6	was	VBD	O	be	cop	7	SENT_135	[p7l268t3763r383b3799],
7	86	CD	NUMBER	86	_	0	SENT_135	[p7l405t3749r473b3799],
8	"	``	O	"	punct	7	SENT_135	[p7l487t3749r544b3801],
9	/	:	O	/	punct	10	SENT_135	[p7l487t3749r544b3801],
10	o	NN	O	o	dep	12	SENT_135	[p7l487t3749r544b3801],
11	for	IN	O	for	prep	10	SENT_135	[p7l566t3743r654b3799],
12	risperidone	NN	O	risperidone	dep	16	SENT_135	[p7l675t3744r1034b3817],
13	and	CC	O	and	cc	14	SENT_135	[p7l1056t3744r1172b3799],
14	69	CD	PERCENT	69	num	15	SENT_135	[p7l1192t3749r1259b3799],
15	%	NN	PERCENT	%	dep	16	SENT_135	[p7l1274t3749r1331b3801],
16	for	IN	O	for	prep	7	SENT_135	[p7l1354t3743r1442b3799],
17	9	CD	NUMBER	9	dep	16	SENT_135	[p7l1463t3744r2039b3817],
18	.	.	O	.	_	0	SENT_135	[p7l1463t3744r2039b3817],

1	—	NN	O	—	_	0	SENT_136	[p7l1463t3744r2039b3817],
2	.	.	O	.	_	0	SENT_136	[p7l1463t3744r2039b3817],

1	OH-risperidone	NN	O	oh-risperidone	_	0	SENT_137	[p7l1463t3744r2039b3817],
2	.	.	O	.	_	0	SENT_137	[p7l1463t3744r2039b3817],

1	n	NN	O	n	_	0	SENT_138	[p8l10t213r60b214],
2	Genotyping	VBG	O	genotype	dep	1	SENT_138	[p8l122t160r459b231],

1	Fifty-nine	CD	NUMBER	fifty-nine	nsubj	6	SENT_139	[p8l9t318r318b393],
2	of	IN	O	of	_	0	SENT_139	[p8l341t318r407b374],
3	the	DT	O	the	det	5	SENT_139	[p8l423t319r519b374],
4	82	CD	NUMBER	82	num	5	SENT_139	[p8l542t324r609b374],
5	patients	NNS	O	patient	prep_of	1	SENT_139	[p8l631t321r878b392],
6	agreed	VBD	O	agree	_	0	SENT_139	[p8l902t319r1109b393],
7	to	TO	O	to	aux	8	SENT_139	[p8l1129t329r1188b374],
8	participate	VB	O	participate	xcomp	6	SENT_139	[p8l1211t321r1550b392],
9	in	IN	O	in	_	0	SENT_139	[p8l1573t321r1632b374],
10	the	DT	O	the	det	11	SENT_139	[p8l1654t319r1750b374],
11	genotyping	NN	O	genotyping	prep_in	8	SENT_139	[p8l1772t321r2141b393],
12	.	.	O	.	_	0	SENT_139	[p8l1772t321r2141b393],

1	Genotyping	VBG	O	genotype	_	0	SENT_140	[p8l9t404r377b475],
2	was	VBD	O	be	auxpass	3	SENT_140	[p8l395t421r510b457],
3	performed	VBN	O	perform	aux	1	SENT_140	[p8l532t401r866b475],
4	using	VBG	O	use	xcomp	3	SENT_140	[p8l887t403r1056b475],
5	the	DT	O	the	det	7	SENT_140	[p8l1076t401r1172b457],
6	pyrosequencing	NN	O	pyrosequencing	nn	7	SENT_140	[p8l1193t404r1693b476],
7	method	NN	O	method	dobj	4	SENT_140	[p8l1713t401r1955b457],
8	using	VBG	O	use	xcomp	4	SENT_140	[p8l1976t403r2145b476],
9	a	DT	O	a	det	12	SENT_140	[p8l9t502r41b539],
10	PSQ	NN	O	psq	nn	12	SENT_140	[p8l58t487r187b550],
11	96MA	NN	O	96ma	nn	12	SENT_140	[p8l204t487r389b539],
12	system	NN	O	system	dobj	8	SENT_140	[p8l407t494r618b557],
13	(	CD	NUMBER	(	num	14	SENT_140	[p8l638t484r1182b557],
14	Pyrosequencing	NN	O	pyrosequencing	nsubj	1	SENT_140	[p8l638t484r1182b557],
15	,	,	O	,	_	0	SENT_140	[p8l638t484r1182b557],
16	Uppsala	NNP	LOCATION	Uppsala	nn	18	SENT_140	[p8l1195t483r1462b557],
17	,	,	O	,	_	0	SENT_140	[p8l1195t483r1462b557],
18	Sweden	NNP	LOCATION	Sweden	appos	14	SENT_140	[p8l1476t483r1733b551],
19	)	CD	NUMBER	)	num	18	SENT_140	[p8l1476t483r1733b551],
20	described	VBN	O	describe	partmod	18	SENT_140	[p8l1755t483r2057b539],
21	by	IN	O	by	_	0	SENT_140	[p8l2071t483r2148b557],
22	Zackrisson	NNP	PERSON	Zackrisson	agent	20	SENT_140	[p8l8t565r352b621],
23	and	CC	O	and	_	0	SENT_140	[p8l370t565r485b621],
24	Lindblom	NNP	PERSON	Lindblom	agent	20	SENT_140	[p8l502t565r805b621],
25	(	CD	NUMBER	(	num	27	SENT_140	[p8l825t566r1034b633],
26	2003	CD	DATE	2003	num	27	SENT_140	[p8l825t566r1034b633],
27	)	NN	O	)	dobj	20	SENT_140	[p8l825t566r1034b633],
28	.	.	O	.	_	0	SENT_140	[p8l825t566r1034b633],

1	Primers	NNS	O	primer	nsubjpass	7	SENT_141	[p8l1050t567r1294b621],
2	for	IN	O	for	_	0	SENT_141	[p8l1312t565r1401b621],
3	the	DT	O	the	det	5	SENT_141	[p8l1416t565r1512b621],
4	initial	JJ	O	initial	amod	5	SENT_141	[p8l1530t565r1713b621],
5	ampliﬁcation	NN	O	ampliﬁcation	prep_for	1	SENT_141	[p8l1731t565r2145b638],
6	were	VBD	O	be	auxpass	7	SENT_141	[p8l6t666r152b702],
7	designed	VBN	O	design	_	0	SENT_141	[p8l188t647r468b721],
8	using	VBG	O	use	xcomp	7	SENT_141	[p8l502t649r671b721],
9	conventional	JJ	O	conventional	amod	11	SENT_141	[p8l707t647r1106b702],
10	standard	JJ	O	standard	amod	11	SENT_141	[p8l1142t647r1417b702],
11	criteria	NNS	O	criterion	dobj	8	SENT_141	[p8l1452t649r1678b702],
12	regarding	VBG	O	regard	_	0	SENT_141	[p8l1713t647r2015b721],
13	the	DT	O	the	det	15	SENT_141	[p8l2048t647r2144b702],
14	speciﬁc	NN	O	speciﬁc	nn	15	SENT_141	[p8l9t729r241b803],
15	amplification	NN	O	amplification	prep_regarding	11	SENT_141	[p8l268t729r682b803],
16	of	IN	O	of	_	0	SENT_141	[p8l709t729r775b785],
17	the	DT	O	the	det	19	SENT_141	[p8l795t729r890b785],
18	CYPZD6	NN	O	cypzd6	nn	19	SENT_141	[p8l918t733r1176b785],
19	gene	NN	O	gene	prep_of	15	SENT_141	[p8l1203t749r1362b803],
20	.	.	O	.	_	0	SENT_141	[p8l1203t749r1362b803],

1	In	IN	O	in	_	0	SENT_142	[p8l1386t734r1450b784],
2	a	DT	DURATION	a	det	4	SENT_142	[p8l1477t749r1508b785],
3	second	JJ	DURATION	second	amod	4	SENT_142	[p8l1535t729r1750b785],
4	PCR	NN	O	pcr	prep_in	20	SENT_142	[p8l1775t733r1911b785],
5	the	DT	O	the	det	6	SENT_142	[p8l1935t729r2031b785],
6	sequence	NN	O	sequence	nsubj	11	SENT_142	[p8l2059t749r2142b785, p8l9t830r227b885],
7	containing	VBG	O	contain	partmod	6	SENT_142	[p8l253t813r585b885],
8	the	DT	O	the	det	10	SENT_142	[p8l608t811r703b867],
9	CYPZD6	NN	O	cypzd6	nn	10	SENT_142	[p8l729t815r988b867],
10	alleles	NNS	O	allele	dobj	7	SENT_142	[p8l1014t811r1202b867],
11	*	VBP	O	*	rcmod	4	SENT_142	[p8l1229t815r1311b876],
12	4	CD	NUMBER	4	dobj	11	SENT_142	[p8l1229t815r1311b876],
13	,	,	O	,	_	0	SENT_142	[p8l1229t815r1311b876],
14	*	CD	NUMBER	*	number	18	SENT_142	[p8l1334t815r1399b867],
15	6	CD	NUMBER	6	number	18	SENT_142	[p8l1334t815r1399b867],
16	and	CC	O	and	_	0	SENT_142	[p8l1425t811r1541b867],
17	*	CD	NUMBER	*	nsubjpass	20	SENT_142	[p8l1565t815r1667b866],
18	14	CD	NUMBER	14	nsubjpass	20	SENT_142	[p8l1565t815r1667b866],
19	was	VBD	O	be	auxpass	20	SENT_142	[p8l1690t830r1805b867],
20	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_142	[p8l1831t811r2142b885],
21	.	.	O	.	_	0	SENT_142	[p8l1831t811r2142b885],

1	In	IN	O	in	_	0	SENT_143	[p8l9t898r72b948],
2	the	DT	O	the	det	4	SENT_143	[p8l93t893r189b949],
3	pyrosequencing	NN	O	pyrosequencing	nn	4	SENT_143	[p8l210t895r710b967],
4	assay	NN	O	assay	prep_in	10	SENT_143	[p8l732t912r903b967],
5	,	,	O	,	_	0	SENT_143	[p8l732t912r903b967],
6	three	CD	NUMBER	three	num	8	SENT_143	[p8l921t893r1079b949],
7	sequencing	NN	O	sequencing	nn	8	SENT_143	[p8l1102t895r1453b967],
8	primers	NNS	O	primer	nsubjpass	10	SENT_143	[p8l1472t895r1717b966],
9	were	VBD	O	be	auxpass	10	SENT_143	[p8l1737t912r1883b949],
10	used	VBN	O	use	_	0	SENT_143	[p8l1905t893r2050b949],
11	simultaneously	RB	O	simultaneously	advmod	10	SENT_143	[p8l2071t895r2142b949, p8l8t975r440b1049],
12	,	,	O	,	_	0	SENT_143	[p8l2071t895r2142b949, p8l8t975r440b1049],
13	annealing	NN	O	annealing	dobj	10	SENT_143	[p8l457t975r763b1049],
14	in	IN	O	in	_	0	SENT_143	[p8l781t977r841b1030],
15	the	DT	O	the	det	16	SENT_143	[p8l860t975r956b1031],
16	region	NN	O	region	prep_in	13	SENT_143	[p8l976t977r1175b1049],
17	of	IN	O	of	_	0	SENT_143	[p8l1196t975r1261b1031],
18	the	DT	O	the	det	19	SENT_143	[p8l1275t975r1370b1031],
19	SNP	NN	O	snp	prep_of	16	SENT_143	[p8l1392t979r1526b1031],
20	.	.	O	.	_	0	SENT_143	[p8l1392t979r1526b1031],

1	The	DT	O	the	det	3	SENT_144	[p8l1544t975r1660b1031],
2	resulting	VBG	O	result	amod	3	SENT_144	[p8l1681t975r1955b1049],
3	pyrograms	NNS	O	pyrogram	nsubjpass	12	SENT_144	[p8l1973t993r2142b1049, p8l8t1076r199b1131],
4	were	VBD	O	be	auxpass	5	SENT_144	[p8l220t1076r366b1112],
5	analyzed	VBN	O	analyze	_	0	SENT_144	[p8l390t1057r663b1131],
6	by	IN	O	by	_	0	SENT_144	[p8l683t1057r759b1131],
7	the	DT	O	the	det	10	SENT_144	[p8l778t1057r873b1112],
8	PSQ	NN	O	psq	nn	10	SENT_144	[p8l897t1061r1026b1124],
9	96MA	NN	O	96ma	nn	10	SENT_144	[p8l1049t1061r1233b1112],
10	software	NN	O	software	agent	5	SENT_144	[p8l1257t1056r1520b1112],
11	and	CC	O	and	_	0	SENT_144	[p8l1543t1057r1659b1112],
12	veriﬁed	VBD	O	veriﬁed	conj_and	5	SENT_144	[p8l1678t1056r1918b1112],
13	manually	RB	O	manually	advmod	12	SENT_144	[p8l1940t1076r2142b1112, p8l9t1139r127b1213],
14	.	.	O	.	_	0	SENT_144	[p8l1940t1076r2142b1112, p8l9t1139r127b1213],

1	Statistical	JJ	O	statistical	amod	2	SENT_145	[p8l124t1379r407b1435],
2	analysis	NN	O	analysis	_	0	SENT_145	[p8l425t1379r655b1451],

1	The	DT	O	the	det	2	SENT_146	[p8l9t1544r126b1600],
2	analysis	NN	O	analysis	nsubj	3	SENT_146	[p8l144t1544r388b1618],
3	encompassed	VBD	O	encompass	_	0	SENT_146	[p8l407t1544r825b1617],
4	all	DT	O	all	det	5	SENT_146	[p8l842t1544r914b1600],
5	patients	NNS	O	patient	dobj	3	SENT_146	[p8l930t1546r1177b1617],
6	randomized	VBN	O	randomize	partmod	5	SENT_146	[p8l1195t1544r1572b1600],
7	with	IN	O	with	_	0	SENT_146	[p8l1586t1544r1725b1600],
8	baseline	NN	O	baseline	nn	9	SENT_146	[p8l1740t1544r1994b1600],
9	data	NNS	O	datum	prep_with	6	SENT_146	[p8l2012t1544r2143b1600],
10	and	CC	O	and	_	0	SENT_146	[p8l10t1626r125b1681],
11	at	IN	O	at	advmod	5	SENT_146	[p8l148t1636r202b1681],
12	least	JJS	O	least	pobj	11	SENT_146	[p8l222t1626r364b1681],
13	one	CD	NUMBER	one	num	15	SENT_146	[p8l386t1645r496b1681],
14	post-baseline	JJ	O	post-baseline	amod	15	SENT_146	[p8l518t1626r933b1699],
15	measure	NN	O	measure	conj_and	5	SENT_146	[p8l955t1645r1216b1681],
16	(	CD	NUMBER	(	num	21	SENT_146	[p8l1242t1626r1300b1693],
17	i.	NNP	O	i.	nn	21	SENT_146	[p8l1242t1626r1300b1693],
18	e.	NNP	O	e.	nn	21	SENT_146	[p8l1318t1645r1363b1681],
19	intent-to-treat	JJ	O	intent-to-treat	amod	21	SENT_146	[p8l1383t1628r1826b1681],
20	subjects	NNS	O	subject	nn	21	SENT_146	[p8l1849t1626r2140b1700],
21	)	NN	O	)	dep	15	SENT_146	[p8l1849t1626r2140b1700],
22	.	.	O	.	_	0	SENT_146	[p8l1849t1626r2140b1700],

1	LOCF	NN	O	locf	nsubjpass	9	SENT_147	[p8l9t1712r186b1764],
2	(	CD	NUMBER	(	num	4	SENT_147	[p8l217t1708r348b1776],
3	last	JJ	O	last	amod	4	SENT_147	[p8l217t1708r348b1776],
4	observation	NN	O	observation	nsubj	5	SENT_147	[p8l376t1708r743b1764],
5	carried	VBD	O	carry	rcmod	1	SENT_147	[p8l772t1708r994b1764],
6	forward	RB	O	forward	advmod	5	SENT_147	[p8l1021t1708r1292b1776],
7	)	CD	NUMBER	)	pobj	6	SENT_147	[p8l1021t1708r1292b1776],
8	was	VBD	O	be	auxpass	9	SENT_147	[p8l1321t1728r1435b1764],
9	used	VBN	O	use	_	0	SENT_147	[p8l1464t1708r1608b1764],
10	to	TO	O	to	aux	11	SENT_147	[p8l1634t1719r1692b1764],
11	substitute	VB	O	substitute	xcomp	9	SENT_147	[p8l1723t1708r2026b1764],
12	for	IN	O	for	_	0	SENT_147	[p8l2055t1708r2143b1764],
13	missing	VBG	O	miss	amod	14	SENT_147	[p8l9t1792r251b1864],
14	values	NNS	O	value	prep_for	11	SENT_147	[p8l288t1790r496b1846],
15	.	.	O	.	_	0	SENT_147	[p8l288t1790r496b1846],

1	Main	NNP	O	Main	nn	3	SENT_148	[p8l534t1792r693b1846],
2	outcome	NN	O	outcome	nn	3	SENT_148	[p8l735t1801r1001b1846],
3	variables	NNS	O	variable	nsubj	5	SENT_148	[p8l1040t1790r1318b1846],
4	were	VBD	O	be	cop	5	SENT_148	[p8l1357t1809r1502b1846],
5	changes	NNS	O	change	_	0	SENT_148	[p8l1544t1790r1790b1864],
6	in	IN	O	in	_	0	SENT_148	[p8l1832t1792r1891b1845],
7	PANSS	NN	O	panss	nn	8	SENT_148	[p8l1932t1794r2141b1846],
8	scores	NNS	O	score	prep_in	5	SENT_148	[p8l10t1891r215b1928],
9	.	.	O	.	_	0	SENT_148	[p8l10t1891r215b1928],

1	Descriptive	JJ	O	descriptive	amod	2	SENT_149	[p8l232t1874r585b1945],
2	analysis	NN	O	analysis	nsubjpass	5	SENT_149	[p8l605t1872r848b1946],
3	was	VBD	O	be	auxpass	5	SENT_149	[p8l866t1891r981b1928],
4	also	RB	O	also	advmod	5	SENT_149	[p8l1002t1872r1121b1928],
5	carried	VBN	O	carry	_	0	SENT_149	[p8l1142t1872r1365b1928],
6	out	RP	O	out	prt	5	SENT_149	[p8l1383t1882r1500b1937],
7	;	:	O	;	_	0	SENT_149	[p8l1383t1882r1500b1937],
8	and	CC	O	and	_	0	SENT_149	[p8l1519t1872r1634b1928],
9	t-tests	NNS	O	t-test	nsubjpass	11	SENT_149	[p8l1652t1882r1840b1928],
10	were	VBD	O	be	auxpass	11	SENT_149	[p8l1858t1891r2003b1928],
11	employed	VBN	O	employ	conj_and	5	SENT_149	[p8l2023t1891r2140b1928, p8l8t1955r216b2029],
12	to	TO	O	to	aux	13	SENT_149	[p8l245t1965r303b2011],
13	compare	VB	O	compare	xcomp	11	SENT_149	[p8l335t1974r603b2028],
14	means	NNS	O	means	dobj	13	SENT_149	[p8l634t1974r832b2011],
15	of	IN	O	of	_	0	SENT_149	[p8l864t1955r930b2011],
16	two	CD	NUMBER	two	num	17	SENT_149	[p8l954t1965r1065b2011],
17	variables	NNS	O	variable	prep_of	14	SENT_149	[p8l1095t1955r1373b2011],
18	where	WRB	O	where	advmod	19	SENT_149	[p8l1401t1955r1589b2011],
19	appropriate	JJ	O	appropriate	dep	17	SENT_149	[p8l1621t1957r1997b2028],
20	.	.	O	.	_	0	SENT_149	[p8l1621t1957r1997b2028],

1	Primary	JJ	O	primary	amod	2	SENT_150	[p8l2026t1957r2140b2010, p8l9t2056r175b2111],
2	time-point	NN	O	time-point	nsubj	9	SENT_150	[p8l196t2039r530b2110],
3	for	IN	O	for	_	0	SENT_150	[p8l555t2036r643b2092],
4	efficacy	NN	O	efficacy	nn	7	SENT_150	[p8l669t2036r908b2111],
5	and	CC	O	and	_	0	SENT_150	[p8l931t2037r1046b2092],
6	safety	NN	O	safety	conj_and	4	SENT_150	[p8l1072t2036r1254b2111],
7	analysis	NN	O	analysis	prep_for	2	SENT_150	[p8l1276t2037r1520b2111],
8	was	VBD	O	be	cop	9	SENT_150	[p8l1545t2056r1659b2092],
9	end	NN	DURATION	end	_	0	SENT_150	[p8l1687t2037r1800b2092],
10	of	IN	DURATION	of	_	0	SENT_150	[p8l1826t2036r1892b2092],
11	week	NN	DURATION	week	prep_of	9	SENT_150	[p8l1909t2037r2068b2092],
12	6	CD	NUMBER	6	num	11	SENT_150	[p8l2092t2042r2140b2092],
13	.	.	O	.	_	0	SENT_150	[p8l2092t2042r2140b2092],

1	Risperidone	NNP	O	Risperidone	nn	4	SENT_151	[p8l10t2119r386b2193],
2	and	CC	O	and	_	0	SENT_151	[p8l411t2119r526b2175],
3	9-OH-risperidone	NN	O	9-oh-risperidone	conj_and	1	SENT_151	[p8l548t2119r1107b2193],
4	levels	NNS	O	level	nsubjpass	9	SENT_151	[p8l1129t2119r1297b2175],
5	were	VBD	O	be	auxpass	6	SENT_151	[p8l1319t2138r1464b2175],
6	quantified	VBN	O	quantify	_	0	SENT_151	[p8l1488t2119r1808b2193],
7	separately	RB	O	separately	advmod	6	SENT_151	[p8l1831t2119r2146b2193],
8	and	CC	O	and	_	0	SENT_151	[p8l10t2201r125b2257],
9	analyzed	VBN	O	analyze	conj_and	6	SENT_151	[p8l144t2201r416b2275],
10	cumulatively	RB	O	cumulatively	advmod	9	SENT_151	[p8l435t2201r835b2275],
11	as	IN	O	as	_	0	SENT_151	[p8l851t2220r911b2257],
12	the	DT	O	the	det	16	SENT_151	[p8l930t2201r1025b2257],
13	“	NN	O	“	nn	16	SENT_151	[p8l1039t2201r1247b2257],
14	active	JJ	O	active	amod	16	SENT_151	[p8l1039t2201r1247b2257],
15	moiety	NN	O	moiety	nn	16	SENT_151	[p8l1266t2202r1533b2275],
16	”	NN	O	”	prep_as	10	SENT_151	[p8l1266t2202r1533b2275],
17	,	,	O	,	_	0	SENT_151	[p8l1266t2202r1533b2275],
18	since	IN	O	since	mark	22	SENT_151	[p8l1549t2203r1703b2257],
19	both	DT	O	both	det	20	SENT_151	[p8l1720t2201r1864b2257],
20	metabolites	NNS	O	metabolite	nsubj	22	SENT_151	[p8l1882t2201r2140b2257, p8l8t2283r133b2339],
21	equally	RB	O	equally	advmod	22	SENT_151	[p8l168t2283r394b2357],
22	contribute	VBP	O	contribute	advcl	9	SENT_151	[p8l426t2283r746b2339],
23	to	TO	O	to	_	0	SENT_151	[p8l780t2293r838b2339],
24	drug	NN	O	drug	nn	25	SENT_151	[p8l875t2283r1021b2357],
25	efﬁcacy	NN	O	efﬁcacy	prep_to	22	SENT_151	[p8l1055t2283r1301b2357],
26	.	.	O	.	_	0	SENT_151	[p8l1055t2283r1301b2357],

1	Steady-state	JJ	O	steady-state	amod	4	SENT_152	[p8l1334t2283r1706b2357],
2	drug	NN	O	drug	nn	4	SENT_152	[p8l1742t2283r1888b2357],
3	plasma	NN	O	plasma	nn	4	SENT_152	[p8l1920t2283r2143b2356],
4	concentrations	NNS	O	concentration	nsubjpass	10	SENT_152	[p8l10t2367r469b2420],
5	corresponding	VBG	O	correspond	partmod	4	SENT_152	[p8l488t2365r943b2439],
6	to	TO	O	to	_	0	SENT_152	[p8l958t2375r1016b2420],
7	oral	JJ	O	oral	amod	8	SENT_152	[p8l1035t2365r1155b2420],
8	doses	NNS	O	dose	prep_to	5	SENT_152	[p8l1172t2365r1341b2420],
9	were	VBD	O	be	auxpass	10	SENT_152	[p8l1357t2384r1503b2420],
10	calculated	VBN	O	calculate	_	0	SENT_152	[p8l1521t2365r1833b2420],
11	at	IN	O	at	_	0	SENT_152	[p8l1850t2375r1904b2420],
12	week	NN	DURATION	week	prep_at	10	SENT_152	[p8l1918t2365r2076b2420],
13	5	CD	NUMBER	5	num	12	SENT_152	[p8l2093t2371r2141b2429],
14	,	,	O	,	_	0	SENT_152	[p8l2093t2371r2141b2429],
15	thereby	RB	O	thereby	advmod	16	SENT_152	[p8l9t2447r245b2521],
16	eliminating	VBG	O	eliminate	xcomp	10	SENT_152	[p8l267t2447r624b2521],
17	potential	JJ	O	potential	amod	19	SENT_152	[p8l648t2447r926b2521],
18	titration-phase	JJ	O	titration-phase	amod	19	SENT_152	[p8l949t2447r1416b2521],
19	inﬂuences	NNS	O	inﬂuences	dobj	16	SENT_152	[p8l1441t2447r1772b2503],
20	.	.	O	.	_	0	SENT_152	[p8l1441t2447r1772b2503],

1	Clinical	JJ	O	clinical	amod	2	SENT_153	[p8l1796t2447r2033b2503],
2	response	NN	O	response	nsubjpass	4	SENT_153	[p8l2057t2467r2140b2503, p8l10t2548r220b2603],
3	was	VBD	O	be	auxpass	4	SENT_153	[p8l252t2548r367b2585],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_153	[p8l403t2529r636b2585],
5	as	IN	O	as	_	0	SENT_153	[p8l670t2548r730b2585],
6	PANSS	NNP	O	PANSS	nn	9	SENT_153	[p8l766t2533r974b2585],
7	Total	NNP	O	Total	nn	9	SENT_153	[p8l1010t2529r1162b2585],
8	Score	NN	NUMBER	score	nn	9	SENT_153	[p8l1197t2533r1362b2585],
9	improvement	NN	O	improvement	prep_as	4	SENT_153	[p8l1397t2531r1814b2603],
10	of	IN	O	of	_	0	SENT_153	[p8l1848t2529r1914b2585],
11	>	JJR	O	>	prep_of	9	SENT_153	[p8l1945t2534r2140b2587],
12	30	CD	PERCENT	30	number	13	SENT_153	[p8l1945t2534r2140b2587],
13	%	NN	PERCENT	%	amod	11	SENT_153	[p8l1945t2534r2140b2587],
14	from	IN	O	from	_	0	SENT_153	[p8l9t2611r160b2667],
15	baseline	NN	O	baseline	prep_from	4	SENT_153	[p8l188t2611r458b2667],
16	.	.	O	.	_	0	SENT_153	[p8l188t2611r458b2667],

1	For	IN	O	for	_	0	SENT_154	[p8l487t2616r590b2667],
2	calculation	NN	O	calculation	prep_for	10	SENT_154	[p8l620t2611r960b2667],
3	of	IN	O	of	_	0	SENT_154	[p8l991t2611r1057b2667],
4	response	NN	O	response	prep_of	2	SENT_154	[p8l1081t2630r1354b2684],
5	to	TO	O	to	_	0	SENT_154	[p8l1384t2621r1442b2667],
6	treatment	NN	O	treatment	prep_to	4	SENT_154	[p8l1473t2621r1795b2676],
7	,	,	O	,	_	0	SENT_154	[p8l1473t2621r1795b2676],
8	LOCF	NN	ORGANIZATION	locf	nsubjpass	10	SENT_154	[p8l1822t2615r1998b2667],
9	was	VBD	O	be	auxpass	10	SENT_154	[p8l2027t2630r2141b2667],
10	used	VBN	O	use	_	0	SENT_154	[p8l9t2692r153b2748],
11	only	RB	O	only	advmod	10	SENT_154	[p8l175t2693r311b2767],
12	for	IN	O	for	_	0	SENT_154	[p8l330t2692r418b2748],
13	patients	NNS	O	patient	prep_for	10	SENT_154	[p8l439t2695r685b2766],
14	who	WP	O	who	nsubj	15	SENT_154	[p8l706t2693r837b2748],
15	participated	VBD	O	participate	rcmod	13	SENT_154	[p8l860t2693r1241b2766],
16	at	IN	DURATION	at	quantmod	18	SENT_154	[p8l1263t2703r1317b2748],
17	least	JJS	DURATION	least	mwe	16	SENT_154	[p8l1337t2693r1478b2748],
18	3	CD	DURATION	3	num	19	SENT_154	[p8l1500t2698r1530b2748],
19	weeks	NNS	NUMBER	week	tmod	15	SENT_154	[p8l1552t2693r1738b2748],
20	in	IN	O	in	_	0	SENT_154	[p8l1761t2695r1821b2748],
21	the	DT	O	the	det	22	SENT_154	[p8l1843t2693r1938b2748],
22	study	NN	O	study	prep_in	15	SENT_154	[p8l1961t2693r2139b2767],
23	.	.	O	.	_	0	SENT_154	[p8l1961t2693r2139b2767],

1	To	TO	O	to	aux	3	SENT_155	[p8l9t2778r81b2831],
2	further	RB	O	further	advmod	3	SENT_155	[p8l105t2775r327b2831],
3	elucidate	VB	O	elucidate	purpcl	24	SENT_155	[p8l349t2775r624b2831],
4	the	DT	O	the	det	5	SENT_155	[p8l646t2775r742b2831],
5	relation	NN	O	relation	dobj	3	SENT_155	[p8l764t2775r1004b2831],
6	of	IN	O	of	_	0	SENT_155	[p8l1027t2775r1093b2831],
7	illness	NN	O	illness	nn	8	SENT_155	[p8l1109t2775r1302b2831],
8	duration	NN	O	duration	prep_of	5	SENT_155	[p8l1326t2775r1593b2831],
9	and	CC	O	and	_	0	SENT_155	[p8l1616t2775r1731b2831],
10	drug	NN	O	drug	nn	12	SENT_155	[p8l1753t2775r1900b2849],
11	plasma	NN	O	plasma	nn	12	SENT_155	[p8l1920t2775r2143b2849],
12	levels	NNS	O	level	prep_of	5	SENT_155	[p8l8t2857r194b2922],
13	,	,	O	,	_	0	SENT_155	[p8l8t2857r194b2922],
14	a	DT	O	a	det	16	SENT_155	[p8l217t2876r248b2913],
15	random	JJ	O	random	amod	16	SENT_155	[p8l273t2857r519b2913],
16	cut-off	JJ	O	cut-off	nsubjpass	24	SENT_155	[p8l545t2857r759b2913],
17	of	IN	O	of	_	0	SENT_155	[p8l779t2857r845b2913],
18	3	CD	DURATION	3	num	19	SENT_155	[p8l865t2863r894b2913],
19	years	NNS	NUMBER	year	prep_of	16	SENT_155	[p8l920t2876r1080b2931],
20	of	IN	O	of	_	0	SENT_155	[p8l1106t2857r1172b2913],
21	illness	NN	O	illness	nn	22	SENT_155	[p8l1191t2857r1384b2913],
22	duration	NN	O	duration	prep_of	19	SENT_155	[p8l1411t2857r1678b2913],
23	was	VBD	O	be	auxpass	24	SENT_155	[p8l1701t2876r1815b2913],
24	chosen	VBN	O	choose	_	0	SENT_155	[p8l1843t2857r2058b2913],
25	to	TO	O	to	aux	26	SENT_155	[p8l2082t2867r2141b2913],
26	deﬁne	VB	O	deﬁne	xcomp	24	SENT_155	[p8l10t2939r200b2995],
27	longer	JJR	O	longer	dobj	26	SENT_155	[p8l222t2939r421b3013],
28	vs.	CC	O	vs.	prep	27	SENT_155	[p8l441t2958r522b2995],
29	shorter	JJR	O	shorter	amod	31	SENT_155	[p8l543t2939r767b2995],
30	illness	NN	O	illness	nn	31	SENT_155	[p8l789t2939r982b2995],
31	duration	NN	O	duration	dep	28	SENT_155	[p8l1006t2939r1274b2995],
32	and	CC	O	and	_	0	SENT_155	[p8l1297t2939r1413b2995],
33	resulting	VBG	O	result	amod	35	SENT_155	[p8l1435t2939r1709b3013],
34	plasma	NN	O	plasma	nn	35	SENT_155	[p8l1730t2939r1952b3012],
35	levels	NNS	O	level	nsubjpass	37	SENT_155	[p8l1973t2939r2141b2995],
36	were	VBD	O	be	auxpass	37	SENT_155	[p8l7t3040r153b3077],
37	compared	VBN	O	compare	conj_and	24	SENT_155	[p8l176t3021r501b3094],
38	.	.	O	.	_	0	SENT_155	[p8l176t3021r501b3094],

1	Similarly	RB	O	similarly	advmod	20	SENT_156	[p8l522t3021r813b3095],
2	,	,	O	,	_	0	SENT_156	[p8l522t3021r813b3095],
3	to	TO	O	to	aux	4	SENT_156	[p8l831t3031r889b3077],
4	quantify	VB	O	quantify	purpcl	20	SENT_156	[p8l914t3021r1178b3095],
5	possible	JJ	O	possible	amod	6	SENT_156	[p8l1195t3021r1447b3094],
6	contributions	NNS	O	contribution	dobj	4	SENT_156	[p8l1470t3021r1890b3077],
7	of	IN	O	of	_	0	SENT_156	[p8l1914t3021r1979b3077],
8	drug	NN	O	drug	nn	10	SENT_156	[p8l1996t3021r2143b3095],
9	plasma	NN	O	plasma	nn	10	SENT_156	[p8l8t3103r231b3176],
10	concentrations	NNS	O	concentration	prep_of	6	SENT_156	[p8l255t3105r714b3158],
11	to	TO	O	to	_	0	SENT_156	[p8l738t3113r797b3158],
12	extrapyramidal	JJ	O	extrapyramidal	amod	14	SENT_156	[p8l823t3103r1305b3177],
13	side	JJ	O	side	amod	14	SENT_156	[p8l1328t3103r1450b3158],
14	effects	NNS	O	effect	prep_to	4	SENT_156	[p8l1474t3102r1688b3167],
15	,	,	O	,	_	0	SENT_156	[p8l1474t3102r1688b3167],
16	the	DT	O	the	det	18	SENT_156	[p8l1708t3102r1803b3158],
17	SAS	NNP	ORGANIZATION	SAS	nn	18	SENT_156	[p8l1829t3107r1947b3158],
18	mean	NN	O	mean	nsubjpass	20	SENT_156	[p8l1972t3122r2142b3158],
19	was	VBD	O	be	auxpass	20	SENT_156	[p8l7t3204r121b3241],
20	calculated	VBN	O	calculate	_	0	SENT_156	[p8l145t3185r473b3250],
21	;	:	O	;	_	0	SENT_156	[p8l145t3185r473b3250],
22	this	DT	O	this	det	24	SENT_156	[p8l494t3185r606b3241],
23	mean	JJ	O	mean	amod	24	SENT_156	[p8l629t3204r800b3241],
24	value	NN	O	value	nsubjpass	27	SENT_156	[p8l819t3185r982b3241],
25	was	VBD	O	be	auxpass	27	SENT_156	[p8l1001t3204r1115b3241],
26	subsequently	RB	O	subsequently	advmod	27	SENT_156	[p8l1139t3185r1547b3259],
27	used	VBN	O	use	parataxis	20	SENT_156	[p8l1566t3185r1710b3241],
28	as	IN	O	as	_	0	SENT_156	[p8l1731t3204r1790b3241],
29	cut-off	JJ	O	cut-off	prep_as	27	SENT_156	[p8l1814t3185r2028b3241],
30	between	IN	O	between	_	0	SENT_156	[p8l2042t3185r2140b3241, p8l9t3277r191b3323],
31	two	CD	NUMBER	two	num	32	SENT_156	[p8l213t3277r325b3323],
32	groups	NNS	O	group	prep_between	29	SENT_156	[p8l348t3286r561b3341],
33	of	IN	O	of	_	0	SENT_156	[p8l585t3267r651b3323],
34	more	JJR	O	more	amod	39	SENT_156	[p8l668t3286r829b3323],
35	and	CC	O	and	_	0	SENT_156	[p8l852t3267r968b3323],
36	less	RBR	O	less	advmod	37	SENT_156	[p8l988t3267r1098b3323],
37	pronounced	JJ	O	pronounced	conj_and	34	SENT_156	[p8l1121t3267r1499b3340],
38	side	JJ	O	side	amod	39	SENT_156	[p8l1522t3267r1643b3323],
39	effects	NNS	O	effect	prep_of	32	SENT_156	[p8l1667t3267r1880b3323],
40	.	.	O	.	_	0	SENT_156	[p8l1667t3267r1880b3323],

1	According	VBG	O	accord	_	0	SENT_157	[p8l1897t3267r2139b3323, p8l9t3351r107b3423],
2	to	TO	O	to	prepc_according_to	8	SENT_157	[p8l130t3359r189b3405],
3	the	DT	O	the	det	4	SENT_157	[p8l215t3349r310b3405],
4	genotype	NN	O	genotype	pobj	8	SENT_157	[p8l335t3359r640b3423],
5	,	,	O	,	_	0	SENT_157	[p8l335t3359r640b3423],
6	metabolizers	NNS	O	metabolizer	nsubjpass	8	SENT_157	[p8l661t3349r1060b3405],
7	were	VBD	O	be	auxpass	8	SENT_157	[p8l1084t3368r1230b3405],
8	classified	VBN	O	classify	_	0	SENT_157	[p8l1256t3349r1542b3405],
9	as	IN	O	as	_	0	SENT_157	[p8l1567t3368r1627b3405],
10	either	DT	O	either	det	12	SENT_157	[p8l1653t3349r1833b3405],
11	extensive	JJ	O	extensive	amod	12	SENT_157	[p8l1858t3351r2142b3405],
12	metabolizers	NNS	O	metabolizer	prep_as	8	SENT_157	[p8l9t3431r425b3496],
13	,	,	O	,	_	0	SENT_157	[p8l9t3431r425b3496],
14	carrying	VBG	O	carry	xcomp	8	SENT_157	[p8l451t3433r717b3505],
15	the	DT	O	the	det	19	SENT_157	[p8l743t3431r839b3486],
16	wildtype	JJ	O	wildtype	amod	19	SENT_157	[p8l865t3431r1138b3505],
17	or	CC	O	or	_	0	SENT_157	[p8l1168t3450r1233b3486],
18	poor	JJ	O	poor	conj_or	16	SENT_157	[p8l1259t3449r1408b3504],
19	metabolizers	NNS	O	metabolizer	dobj	14	SENT_157	[p8l1435t3431r1852b3495],
20	,	,	O	,	_	0	SENT_157	[p8l1435t3431r1852b3495],
21	carrying	VBG	O	carry	partmod	19	SENT_157	[p8l1877t3433r2143b3505],
22	allele	NN	O	allele	nn	23	SENT_157	[p8l10t3513r169b3569],
23	*	NN	O	*	dobj	21	SENT_157	[p8l191t3518r256b3568],
24	4	CD	NUMBER	4	num	26	SENT_157	[p8l191t3518r256b3568],
25	(	NN	O	(	nn	26	SENT_157	[p8l280t3513r648b3581],
26	Zackrisson	NN	PERSON	zackrisson	dep	23	SENT_157	[p8l280t3513r648b3581],
27	and	CC	O	and	_	0	SENT_157	[p8l670t3513r785b3569],
28	Lindblom	NNP	PERSON	Lindblom	dobj	21	SENT_157	[p8l805t3513r1125b3579],
29	,	,	O	,	_	0	SENT_157	[p8l805t3513r1125b3579],
30	2003	CD	DATE	2003	num	31	SENT_157	[p8l1142t3514r1326b3581],
31	)	NN	O	)	appos	28	SENT_157	[p8l1142t3514r1326b3581],
32	.	.	O	.	_	0	SENT_157	[p8l1142t3514r1326b3581],

1	Results	NNS	O	result	_	0	SENT_158	[p9l13t27r305b102],

1	Eighty-two	CD	NUMBER	eighty-two	num	2	SENT_159	[p9l10t236r431b328],
2	patients	NNS	O	patient	nsubjpass	11	SENT_159	[p9l460t239r765b327],
3	(	IN	O	(	_	0	SENT_159	[p9l799t237r911b320],
4	43	CD	NUMBER	43	num	5	SENT_159	[p9l799t237r911b320],
5	males	NNS	O	male	prep_(	2	SENT_159	[p9l942t236r1161b305],
6	and	CC	O	and	_	0	SENT_159	[p9l1192t236r1335b305],
7	39	CD	NUMBER	39	num	8	SENT_159	[p9l1363t243r1446b305],
8	females	NNS	O	female	prep_(	2	SENT_159	[p9l1476t236r1795b320],
9	)	CD	NUMBER	)	dep	8	SENT_159	[p9l1476t236r1795b320],
10	were	VBD	O	be	auxpass	11	SENT_159	[p9l1826t260r2006b305],
11	included	VBN	O	include	_	0	SENT_159	[p9l2035t239r2139b304, p9l11t338r283b407],
12	.	.	O	.	_	0	SENT_159	[p9l2035t239r2139b304, p9l11t338r283b407],

1	Mean	NN	O	mean	nn	2	SENT_160	[p9l306t344r518b407],
2	age	NN	O	age	nsubj	3	SENT_160	[p9l545t362r669b430],
3	was	VBD	O	be	_	0	SENT_160	[p9l693t362r834b407],
4	36.2	CD	NUMBER	36.2	advmod	3	SENT_160	[p9l863t345r1012b407],
5	i	FW	O	i	tmod	3	SENT_160	[p9l1034t349r1084b406],
6	12.9	CD	DURATION	12.9	num	7	SENT_160	[p9l1112t345r1256b407],
7	years	NNS	NUMBER	year	dep	5	SENT_160	[p9l1281t362r1500b430],
8	.	.	O	.	_	0	SENT_160	[p9l1281t362r1500b430],

1	Mean	NN	O	mean	nn	2	SENT_161	[p9l1523t344r1734b407],
2	age	NN	O	age	nsubj	7	SENT_161	[p9l1761t362r1885b430],
3	of	IN	O	of	_	0	SENT_161	[p9l1913t337r1994b407],
4	onset	NN	O	onset	prep_of	2	SENT_161	[p9l2014t362r2139b407, p9l11t453r115b509],
5	was	VBD	O	be	cop	7	SENT_161	[p9l162t464r303b509],
6	31.7	CD	NUMBER	31.7	advmod	7	SENT_161	[p9l357t447r507b509],
7	i	FW	O	i	_	0	SENT_161	[p9l528t451r578b508],
8	16.5	CD	DURATION	16.5	num	9	SENT_161	[p9l606t447r749b509],
9	years	NNS	NUMBER	year	tmod	7	SENT_161	[p9l800t464r1020b532],
10	,	,	O	,	_	0	SENT_161	[p9l800t464r1020b532],
11	mean	VB	O	mean	dep	7	SENT_161	[p9l1067t464r1278b509],
12	illness	NN	O	illness	nn	13	SENT_161	[p9l1329t440r1567b509],
13	duration	NN	O	duration	nsubj	15	SENT_161	[p9l1621t440r1951b509],
14	was	VBD	O	be	cop	15	SENT_161	[p9l2000t464r2141b509],
15	6.7	CD	NUMBER	6.7	ccomp	11	SENT_161	[p9l10t549r117b611],
16	i	FW	O	i	dep	15	SENT_161	[p9l137t553r187b610],
17	8.7	CD	DURATION	8.7	num	18	SENT_161	[p9l209t549r315b611],
18	years	NNS	NUMBER	year	tmod	15	SENT_161	[p9l334t566r553b634],
19	.	.	O	.	_	0	SENT_161	[p9l334t566r553b634],

1	Fifty-three	CD	NUMBER	fifty-three	num	2	SENT_162	[p9l573t542r981b634],
2	patients	NNS	O	patient	nsubj	3	SENT_162	[p9l1002t544r1306b633],
3	carried	VBD	O	carry	_	0	SENT_162	[p9l1329t542r1604b611],
4	a	DT	O	a	det	5	SENT_162	[p9l1625t566r1664b611],
5	diagnosis	NN	O	diagnosis	dobj	3	SENT_162	[p9l1685t542r2048b634],
6	of	IN	O	of	_	0	SENT_162	[p9l2071t542r2152b611],
7	paranoid	JJ	O	paranoid	amod	10	SENT_162	[p9l9t644r359b734],
8	schizophrenia	NN	O	schizophrenia	dep	7	SENT_162	[p9l384t644r922b734],
9	(	CD	NUMBER	(	num	8	SENT_162	[p9l949t645r1297b727],
10	DSM	NNP	ORGANIZATION	DSM	prep_of	5	SENT_162	[p9l949t645r1297b727],
11	.	.	O	.	_	0	SENT_162	[p9l949t645r1297b727],

1	—	NN	O	—	_	0	SENT_163	[p9l949t645r1297b727],
2	.	.	O	.	_	0	SENT_163	[p9l949t645r1297b727],

1	IV	CD	NUMBER	iv	number	2	SENT_164	[p9l949t645r1297b727],
2	295.3	CD	NUMBER	295.3	num	3	SENT_164	[p9l1321t645r1573b727],
3	)	NN	O	)	nsubjpass	7	SENT_164	[p9l1321t645r1573b727],
4	,	,	O	,	_	0	SENT_164	[p9l1321t645r1573b727],
5	12	CD	NUMBER	12	appos	3	SENT_164	[p9l1600t651r1676b712],
6	were	VBD	O	be	auxpass	7	SENT_164	[p9l1700t668r1879b713],
7	classiﬁed	VBN	O	classiﬁed	ccomp	29	SENT_164	[p9l1905t644r2139b713, p9l10t744r154b814],
8	as	IN	O	as	_	0	SENT_164	[p9l222t769r296b814],
9	disorganized	JJ	O	disorganized	amod	12	SENT_164	[p9l366t745r862b837],
10	(	NN	O	(	nn	12	SENT_164	[p9l933t745r1215b829],
11	295.1	CD	NUMBER	295.1	num	12	SENT_164	[p9l933t745r1215b829],
12	)	NN	O	)	prep_as	7	SENT_164	[p9l933t745r1215b829],
13	,	,	O	,	_	0	SENT_164	[p9l933t745r1215b829],
14	10	CD	NUMBER	10	nsubj	29	SENT_164	[p9l1286t752r1363b814],
15	as	IN	O	as	_	0	SENT_164	[p9l1433t769r1507b814],
16	schizoaffective	JJ	O	schizoaffective	amod	19	SENT_164	[p9l1577t745r2141b814],
17	(	NN	O	(	nn	19	SENT_164	[p9l13t847r296b929],
18	295.7	CD	NUMBER	295.7	num	19	SENT_164	[p9l13t847r296b929],
19	)	NN	O	)	prep_as	14	SENT_164	[p9l13t847r296b929],
20	,	,	O	,	_	0	SENT_164	[p9l13t847r296b929],
21	4	CD	NUMBER	4	conj_and	14	SENT_164	[p9l322t854r363b914],
22	as	IN	O	as	_	0	SENT_164	[p9l396t870r469b915],
23	undifferentiated	JJ	O	undifferentiated	amod	26	SENT_164	[p9l502t846r1125b915],
24	(	NN	O	(	nn	26	SENT_164	[p9l1159t847r1416b930],
25	295.9	CD	NUMBER	295.9	num	26	SENT_164	[p9l1159t847r1416b930],
26	)	NN	O	)	prep_as	21	SENT_164	[p9l1159t847r1416b930],
27	and	CC	O	and	_	0	SENT_164	[p9l1453t846r1595b915],
28	3	CD	NUMBER	3	conj_and	14	SENT_164	[p9l1626t853r1662b915],
29	had	VBD	O	have	_	0	SENT_164	[p9l1695t846r1839b915],
30	schizophreniform	JJ	O	schizophreniform	amod	31	SENT_164	[p9l1871t846r2139b915, p9l9t948r454b1039],
31	disorder	NN	O	disorder	dobj	29	SENT_164	[p9l481t948r804b1017],
32	(	CD	NUMBER	(	num	34	SENT_164	[p9l833t948r1113b1032],
33	295.4	CD	NUMBER	295.4	num	34	SENT_164	[p9l833t948r1113b1032],
34	)	NN	O	)	dep	31	SENT_164	[p9l833t948r1113b1032],
35	.	.	O	.	_	0	SENT_164	[p9l833t948r1113b1032],

1	Oral	JJ	O	oral	amod	2	SENT_165	[p9l137t1201r286b1271],
2	dose	NN	O	dose	_	0	SENT_165	[p9l310t1201r506b1282],
3	,	,	O	,	_	0	SENT_165	[p9l310t1201r506b1282],
4	plasma	NN	O	plasma	nn	5	SENT_165	[p9l529t1201r793b1289],
5	levels	NNS	O	level	conj_and	2	SENT_165	[p9l819t1201r1052b1282],
6	,	,	O	,	_	0	SENT_165	[p9l819t1201r1052b1282],
7	and	CC	O	and	_	0	SENT_165	[p9l1073t1201r1210b1271],
8	genotypes	NNS	O	genotype	conj_and	2	SENT_165	[p9l1234t1209r1625b1291],

1	Mean	NN	O	mean	nn	3	SENT_166	[p9l9t1411r221b1474],
2	oral	JJ	O	oral	amod	3	SENT_166	[p9l256t1405r404b1474],
3	dose	NN	O	dose	nsubj	7	SENT_166	[p9l438t1405r610b1474],
4	of	IN	O	of	_	0	SENT_166	[p9l646t1405r727b1474],
5	risperidone	NN	O	risperidone	prep_of	3	SENT_166	[p9l753t1405r1197b1496],
6	was	VBD	O	be	cop	7	SENT_166	[p9l1229t1429r1370b1474],
7	4.3	CD	NUMBER	4.3	_	0	SENT_166	[p9l1404t1412r1509b1474],
8	i	FW	O	i	dep	7	SENT_166	[p9l1549t1416r1598b1473],
9	0.9	CD	NUMBER	0.9	num	10	SENT_166	[p9l1635t1412r1741b1474],
10	mg	NN	O	mg	dep	8	SENT_166	[p9l1760t1429r1900b1497],
11	.	.	O	.	_	0	SENT_166	[p9l1760t1429r1900b1497],

1	Mean	NN	O	mean	nn	3	SENT_167	[p9l1930t1411r2142b1474],
2	plasma	NN	O	plasma	nn	3	SENT_167	[p9l9t1508r284b1599],
3	level	NN	O	level	nsubj	9	SENT_167	[p9l308t1507r481b1577],
4	of	IN	O	of	_	0	SENT_167	[p9l508t1507r589b1577],
5	the	DT	O	the	det	7	SENT_167	[p9l607t1507r725b1577],
6	active	JJ	O	active	amod	7	SENT_167	[p9l753t1510r973b1577],
7	compound	NN	O	compound	prep_of	3	SENT_167	[p9l1001t1507r1414b1599],
8	was	VBD	O	be	cop	9	SENT_167	[p9l1437t1532r1578b1577],
9	45.8	CD	NUMBER	45.8	_	0	SENT_167	[p9l1605t1515r1756b1577],
10	i	FW	O	i	dep	9	SENT_167	[p9l1778t1518r1828b1575],
11	27.4	CD	NUMBER	27.4	num	12	SENT_167	[p9l1849t1515r2001b1577],
12	ng	NN	O	ng	dep	10	SENT_167	[p9l2019t1512r2142b1600],
13	/	:	O	/	punct	16	SENT_167	[p9l2019t1512r2142b1600],
14	ml	NN	O	ml	nn	16	SENT_167	[p9l9t1608r109b1676],
15	(	CD	NUMBER	(	num	16	SENT_167	[p9l165t1608r396b1691],
16	Table	NNP	O	Table	dep	12	SENT_167	[p9l165t1608r396b1691],
17	1	CD	NUMBER	1	num	18	SENT_167	[p9l422t1609r509b1691],
18	)	CD	NUMBER	)	dep	16	SENT_167	[p9l422t1609r509b1691],
19	.	.	O	.	_	0	SENT_167	[p9l422t1609r509b1691],

1	There	EX	O	there	expl	2	SENT_168	[p9l559t1608r779b1677],
2	was	VBD	O	be	_	0	SENT_168	[p9l830t1632r971b1677],
3	a	DT	O	a	det	5	SENT_168	[p9l1027t1632r1066b1677],
4	linear	JJ	O	linear	amod	5	SENT_168	[p9l1116t1608r1338b1677],
5	correlation	NN	O	correlation	nsubj	2	SENT_168	[p9l1391t1608r1813b1677],
6	of	IN	O	of	_	0	SENT_168	[p9l1866t1608r1948b1677],
7	oral	JJ	O	oral	amod	9	SENT_168	[p9l1994t1608r2142b1677],
8	risperidone	NN	O	risperidone	nn	9	SENT_168	[p9l10t1710r454b1802],
9	dose	NN	O	dose	prep_of	5	SENT_168	[p9l495t1710r667b1780],
10	and	CC	O	and	_	0	SENT_168	[p9l709t1711r851b1780],
11	plasma	NN	O	plasma	nn	12	SENT_168	[p9l889t1710r1164b1802],
12	level	NN	O	level	prep_of	5	SENT_168	[p9l1201t1710r1375b1780],
13	of	IN	O	of	_	0	SENT_168	[p9l1414t1710r1495b1780],
14	the	DT	O	the	det	18	SENT_168	[p9l1527t1710r1645b1780],
15	active	JJ	O	active	amod	18	SENT_168	[p9l1687t1713r1907b1780],
16	compound	NN	O	compound	nn	18	SENT_168	[p9l1948t1735r2139b1780, p9l9t1812r260b1903],
17	(	NN	O	(	nn	18	SENT_168	[p9l292t1813r355b1896],
18	r	NN	O	r	prep_of	9	SENT_168	[p9l292t1813r355b1896],
19	=	JJ	O	=	amod	5	SENT_168	[p9l374t1841r424b1866],
20	0.291	CD	NUMBER	0.291	tmod	19	SENT_168	[p9l446t1819r663b1892],
21	,	,	O	,	_	0	SENT_168	[p9l446t1819r663b1892],
22	p	NN	O	p	appos	5	SENT_168	[p9l688t1835r734b1903],
23	=	JJ	O	=	amod	22	SENT_168	[p9l756t1841r806b1866],
24	0.015	CD	NUMBER	0.015	tmod	23	SENT_168	[p9l827t1819r1045b1893],
25	;	:	O	;	_	0	SENT_168	[p9l827t1819r1045b1893],
26	Fig	NN	O	fig	dep	5	SENT_168	[p9l1076t1814r1212b1904],
27	.	.	O	.	_	0	SENT_168	[p9l1076t1814r1212b1904],

1	1	CD	NUMBER	1	num	2	SENT_169	[p9l1241t1813r1303b1896],
2	)	NN	O	)	nn	9	SENT_169	[p9l1241t1813r1303b1896],
3	and	CC	O	and	_	0	SENT_169	[p9l1339t1812r1481b1881],
4	between	IN	O	between	nn	9	SENT_169	[p9l1507t1812r1827b1881],
5	risperidone	NN	O	risperidone	pobj	4	SENT_169	[p9l1857t1814r2139b1903, p9l10t1914r197b1984],
6	and	CC	O	and	_	0	SENT_169	[p9l249t1914r392b1984],
7	9-OH-risperidone	NN	O	9-oh-risperidone	pobj	4	SENT_169	[p9l442t1914r1132b2006],
8	plasma	NN	O	plasma	nn	9	SENT_169	[p9l1183t1914r1458b2006],
9	levels	NNS	O	level	nsubj	10	SENT_169	[p9l1506t1914r1714b1984],
10	(	VBP	O	(	_	0	SENT_169	[p9l1769t1915r2140b1999],
11	r	NN	O	r	dobj	10	SENT_169	[p9l1769t1915r2140b1999],
12	=	JJ	O	=	amod	11	SENT_169	[p9l1769t1915r2140b1999],
13	0.262	CD	NUMBER	0.262	tmod	12	SENT_169	[p9l1769t1915r2140b1999],
14	,	,	O	,	_	0	SENT_169	[p9l1769t1915r2140b1999],
15	p	NN	O	p	appos	11	SENT_169	[p9l9t2039r54b2106],
16	=	JJ	O	=	amod	18	SENT_169	[p9l77t2045r126b2070],
17	0.016	CD	NUMBER	0.016	tmod	16	SENT_169	[p9l148t2017r398b2099],
18	)	NN	O	)	dep	15	SENT_169	[p9l148t2017r398b2099],
19	.	.	O	.	_	0	SENT_169	[p9l148t2017r398b2099],

1	Fifty-one	CD	NUMBER	fifty-one	num	2	SENT_170	[p9l125t2117r476b2210],
2	probands	NNS	O	proband	nsubj	24	SENT_170	[p9l511t2117r872b2209],
3	participating	VBG	O	participate	partmod	2	SENT_170	[p9l907t2120r1411b2210],
4	in	IN	O	in	_	0	SENT_170	[p9l1445t2120r1519b2186],
5	the	DT	O	the	det	7	SENT_170	[p9l1553t2117r1671b2187],
6	genotyping	VBG	O	genotype	amod	7	SENT_170	[p9l1706t2120r2144b2210],
7	(	NN	O	(	prep_in	3	SENT_170	[p9l13t2219r314b2303],
8	86.4	CD	PERCENT	86.4	number	9	SENT_170	[p9l13t2219r314b2303],
9	%	NN	PERCENT	%	amod	7	SENT_170	[p9l13t2219r314b2303],
10	)	CD	NUMBER	)	nsubj	11	SENT_170	[p9l13t2219r314b2303],
11	carried	VBD	O	carry	parataxis	24	SENT_170	[p9l372t2219r647b2288],
12	the	DT	O	the	det	13	SENT_170	[p9l698t2219r816b2288],
13	wildtype	JJ	O	wildtype	dobj	11	SENT_170	[p9l866t2219r1203b2311],
14	of	IN	O	of	_	0	SENT_170	[p9l1257t2219r1338b2288],
15	CYP2D6	NN	O	cyp2d6	prep_of	13	SENT_170	[p9l1386t2224r1704b2288],
16	and	CC	O	and	_	0	SENT_170	[p9l1759t2219r1901b2288],
17	eight	CD	PERCENT	eight	conj_and	13	SENT_170	[p9l1954t2219r2143b2311],
18	(	CD	PERCENT	(	number	19	SENT_170	[p9l13t2322r314b2405],
19	13.6	CD	PERCENT	13.6	num	20	SENT_170	[p9l13t2322r314b2405],
20	%	NN	PERCENT	%	dep	17	SENT_170	[p9l13t2322r314b2405],
21	)	CD	NUMBER	)	nsubj	24	SENT_170	[p9l13t2322r314b2405],
22	were	VBD	O	be	cop	24	SENT_170	[p9l371t2346r551b2391],
23	heterozygous	JJ	O	heterozygous	amod	24	SENT_170	[p9l604t2321r1112b2414],
24	carriers	NNS	O	carrier	_	0	SENT_170	[p9l1169t2324r1463b2391],
25	of	IN	O	of	_	0	SENT_170	[p9l1520t2321r1601b2391],
26	the	DT	O	the	det	28	SENT_170	[p9l1648t2321r1766b2391],
27	CYP2D6	NN	O	cyp2d6	nn	28	SENT_170	[p9l1822t2326r2141b2391],
28	allele	NN	O	allele	prep_of	24	SENT_170	[p9l11t2423r206b2492],
29	*	CD	NUMBER	*	number	30	SENT_170	[p9l251t2428r352b2492],
30	4	CD	NUMBER	4	num	28	SENT_170	[p9l251t2428r352b2492],
31	.	.	O	.	_	0	SENT_170	[p9l251t2428r352b2492],

1	Plasma	NN	O	plasma	nn	2	SENT_171	[p9l394t2423r669b2492],
2	levels	NNS	O	level	nsubj	10	SENT_171	[p9l710t2423r918b2492],
3	of	IN	O	of	_	0	SENT_171	[p9l963t2423r1044b2492],
4	the	DT	O	the	det	6	SENT_171	[p9l1080t2423r1198b2492],
5	active	JJ	O	active	amod	6	SENT_171	[p9l1243t2425r1463b2492],
6	compound	NN	O	compound	prep_of	2	SENT_171	[p9l1508t2423r1922b2513],
7	were	VBD	O	be	cop	10	SENT_171	[p9l1961t2447r2141b2492],
8	not	RB	O	not	neg	10	SENT_171	[p9l10t2537r137b2594],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_171	[p9l162t2524r637b2617],
10	different	JJ	O	different	dep	14	SENT_171	[p9l659t2524r987b2594],
11	between	IN	O	between	_	0	SENT_171	[p9l1008t2524r1328b2594],
12	extensive	JJ	O	extensive	amod	13	SENT_171	[p9l1355t2527r1704b2594],
13	metabolizers	NNS	O	metabolizer	prep_between	10	SENT_171	[p9l1730t2524r2140b2594, p9l11t2650r118b2695],
14	(	VBP	O	(	_	0	SENT_171	[p9l248t2627r423b2710],
15	42.1	CD	NUMBER	42.1	num	22	SENT_171	[p9l248t2627r423b2710],
16	i	FW	O	i	nn	22	SENT_171	[p9l450t2637r500b2694],
17	27.3	CD	NUMBER	27.3	num	19	SENT_171	[p9l521t2633r670b2695],
18	ng/ml	NN	O	ng/ml	nn	19	SENT_171	[p9l692t2626r947b2718],
19	)	NN	O	)	dep	16	SENT_171	[p9l692t2626r947b2718],
20	and	CC	O	and	_	0	SENT_171	[p9l1077t2626r1220b2695],
21	poor	JJ	O	poor	conj_and	16	SENT_171	[p9l1342t2649r1525b2717],
22	metabolizers	NNS	O	metabolizer	nsubj	23	SENT_171	[p9l1649t2626r2141b2695],
23	(	VBP	O	(	ccomp	14	SENT_171	[p9l13t2729r196b2812],
24	41.4	CD	NUMBER	41.4	dobj	23	SENT_171	[p9l13t2729r196b2812],
25	i	FW	O	i	nsubj	14	SENT_171	[p9l216t2739r266b2797],
26	24.2	CD	NUMBER	24.2	num	27	SENT_171	[p9l287t2736r437b2798],
27	ng/ml	NN	O	ng/ml	dep	25	SENT_171	[p9l457t2728r704b2821],
28	;	:	O	;	_	0	SENT_171	[p9l457t2728r704b2821],
29	p	NN	O	p	dep	25	SENT_171	[p9l753t2752r798b2820],
30	=	JJ	O	=	amod	32	SENT_171	[p9l820t2757r870b2783],
31	0.944	CD	NUMBER	0.944	tmod	30	SENT_171	[p9l891t2729r1141b2812],
32	)	NN	O	)	dep	29	SENT_171	[p9l891t2729r1141b2812],
33	.	.	O	.	_	0	SENT_171	[p9l891t2729r1141b2812],

1	Similarly	RB	O	similarly	advmod	7	SENT_172	[p9l1189t2728r1548b2821],
2	,	,	O	,	_	0	SENT_172	[p9l1189t2728r1548b2821],
3	no	DT	O	no	det	5	SENT_172	[p9l1593t2753r1688b2798],
4	significant	JJ	O	significant	amod	5	SENT_172	[p9l1740t2728r2143b2821],
5	differences	NNS	O	difference	nsubjpass	7	SENT_172	[p9l10t2830r427b2899],
6	were	VBD	O	be	auxpass	7	SENT_172	[p9l456t2854r636b2899],
7	observed	VBN	O	observe	dep	23	SENT_172	[p9l668t2830r1016b2899],
8	between	IN	O	between	_	0	SENT_172	[p9l1043t2830r1363b2899],
9	risperidone	NN	O	risperidone	nn	11	SENT_172	[p9l1393t2830r1837b2920],
10	plasma	NN	O	plasma	nn	11	SENT_172	[p9l1867t2830r2143b2920],
11	levels	NNS	O	level	prep_between	7	SENT_172	[p9l8t2931r216b3001],
12	with	IN	O	with	_	0	SENT_172	[p9l252t2931r424b3001],
13	extensive	JJ	O	extensive	amod	14	SENT_172	[p9l462t2934r812b3001],
14	(	NN	O	(	prep_with	7	SENT_172	[p9l853t2932r1035b3015],
15	11.8	CD	NUMBER	11.8	num	14	SENT_172	[p9l853t2932r1035b3015],
16	i	FW	O	i	dep	14	SENT_172	[p9l1057t2942r1107b2999],
17	16.6	CD	NUMBER	16.6	num	19	SENT_172	[p9l1134t2938r1279b3001],
18	ng/ml	NN	O	ng/ml	nn	19	SENT_172	[p9l1298t2931r1554b3024],
19	)	NN	O	)	dep	16	SENT_172	[p9l1298t2931r1554b3024],
20	and	CC	O	and	_	0	SENT_172	[p9l1597t2931r1739b3001],
21	poor	JJ	O	poor	amod	22	SENT_172	[p9l1774t2955r1958b3023],
22	metabolizers	NNS	O	metabolizer	dep	16	SENT_172	[p9l1994t2956r2139b3001, p9l9t3033r382b3102],
23	(	VBP	O	(	_	0	SENT_172	[p9l415t3034r596b3117],
24	21.9	CD	NUMBER	21.9	dobj	23	SENT_172	[p9l415t3034r596b3117],
25	i	FW	O	i	nsubj	23	SENT_172	[p9l618t3044r668b3101],
26	23.1	CD	NUMBER	23.1	num	27	SENT_172	[p9l689t3040r834b3102],
27	ng/ml	NN	O	ng/ml	dep	25	SENT_172	[p9l860t3033r1106b3125],
28	;	:	O	;	_	0	SENT_172	[p9l860t3033r1106b3125],
29	p	NN	O	p	dep	25	SENT_172	[p9l1134t3057r1179b3124],
30	=	JJ	O	=	amod	32	SENT_172	[p9l1201t3062r1251b3087],
31	0.271	CD	NUMBER	0.271	tmod	30	SENT_172	[p9l1272t3033r1522b3117],
32	)	NN	O	)	dep	29	SENT_172	[p9l1272t3033r1522b3117],
33	.	.	O	.	_	0	SENT_172	[p9l1272t3033r1522b3117],

1	Between	IN	O	between	_	0	SENT_173	[p9l1549t3039r1871b3102],
2	9OHrisperidone	NN	O	9ohrisperidone	nn	4	SENT_173	[p9l1900t3038r2138b3102, p9l10t3135r454b3227],
3	plasma	NN	O	plasma	nn	4	SENT_173	[p9l476t3135r752b3227],
4	levels	NNS	O	level	dep	9	SENT_173	[p9l772t3135r980b3204],
5	with	IN	O	with	_	0	SENT_173	[p9l1002t3135r1173b3204],
6	extensive	JJ	O	extensive	amod	7	SENT_173	[p9l1197t3138r1547b3204],
7	(	NN	O	(	prep_with	4	SENT_173	[p9l1575t3136r1756b3219],
8	35.0	CD	NUMBER	35.0	dep	9	SENT_173	[p9l1575t3136r1756b3219],
9	i	FW	O	i	dep	14	SENT_173	[p9l1778t3146r1828b3203],
10	18.0	CD	NUMBER	18.0	num	11	SENT_173	[p9l1856t3143r2000b3204],
11	ng	NN	O	ng	dep	9	SENT_173	[p9l2019t3140r2142b3228],
12	/	:	O	/	punct	14	SENT_173	[p9l2019t3140r2142b3228],
13	ml	NN	O	ml	nn	14	SENT_173	[p9l9t3237r137b3321],
14	)	NN	O	)	prep_between	18	SENT_173	[p9l9t3237r137b3321],
15	and	CC	O	and	_	0	SENT_173	[p9l265t3237r407b3306],
16	poor	JJ	O	poor	amod	17	SENT_173	[p9l527t3260r710b3328],
17	metabolizers	NNS	O	metabolizer	conj_and	14	SENT_173	[p9l830t3237r1323b3306],
18	(	VBP	O	(	_	0	SENT_173	[p9l1450t3238r1631b3321],
19	22.9	CD	NUMBER	22.9	dobj	18	SENT_173	[p9l1450t3238r1631b3321],
20	i	FW	O	i	nsubj	18	SENT_173	[p9l1652t3248r1702b3305],
21	17.2	CD	NUMBER	17.2	num	22	SENT_173	[p9l1730t3244r1873b3306],
22	ng/ml	NN	O	ng/ml	dep	20	SENT_173	[p9l1893t3237r2140b3329],
23	;	:	O	;	_	0	SENT_173	[p9l1893t3237r2140b3329],
24	p	NN	O	p	dep	20	SENT_173	[p9l9t3363r54b3431],
25	=	JJ	O	=	amod	27	SENT_173	[p9l77t3368r126b3393],
26	0.097	CD	NUMBER	0.097	tmod	25	SENT_173	[p9l148t3340r399b3423],
27	)	NN	O	)	nsubjpass	35	SENT_173	[p9l148t3340r399b3423],
28	,	,	O	,	_	0	SENT_173	[p9l148t3340r399b3423],
29	only	RB	O	only	advmod	33	SENT_173	[p9l423t3339r591b3432],
30	a	DT	O	a	det	33	SENT_173	[p9l615t3364r654b3408],
31	tendentially	RB	O	tendentially	advmod	32	SENT_173	[p9l679t3339r1141b3432],
32	significant	JJ	O	significant	amod	33	SENT_173	[p9l1165t3339r1568b3432],
33	difference	NN	O	difference	appos	27	SENT_173	[p9l1595t3339r1975b3408],
34	was	VBD	O	be	auxpass	35	SENT_173	[p9l2000t3364r2141b3408],
35	seen	VBN	O	see	rcmod	24	SENT_173	[p9l11t3465r197b3510],
36	.	.	O	.	_	0	SENT_173	[p9l11t3465r197b3510],

1	Correspondingly	RB	O	correspondingly	advmod	5	SENT_174	[p9l231t3441r894b3533],
2	,	,	O	,	_	0	SENT_174	[p9l231t3441r894b3533],
3	CYP2D6	NN	O	cyp2d6	nn	4	SENT_174	[p9l925t3446r1244b3510],
4	genotypes	NNS	O	genotype	nsubj	5	SENT_174	[p9l1279t3454r1669b3533],
5	predicted	VBD	O	predict	_	0	SENT_174	[p9l1704t3441r2069b3532],
6	a	DT	O	a	quantmod	7	SENT_174	[p9l2104t3465r2143b3510],
7	264	CD	NUMBER	264	dobj	5	SENT_174	[p9l9t3565r104b3617],

1	Table	NNP	O	Table	_	0	SENT_175	[p9l8t3715r165b3770],
2	1	CD	NUMBER	1	num	1	SENT_175	[p9l182t3719r204b3769],
3	Baseline	NN	O	baseline	dep	1	SENT_175	[p9l266t3715r478b3770],
4	and	CC	O	and	_	0	SENT_175	[p9l496t3715r590b3770],
5	endpoint	NN	O	endpoint	dep	1	SENT_175	[p9l610t3715r847b3784],
6	clinical	JJ	O	clinical	amod	7	SENT_175	[p9l864t3715r1038b3770],
7	characteristics	NNS	O	characteristic	dep	1	SENT_175	[p9l1058t3715r1426b3770],

1	Risperidone	NN	O	risperidone	_	0	SENT_176	[p10l16t3025r76b3327],
2	+	CC	O	+	_	0	SENT_176	[p10l28t2975r64b3009],
3	9-OH-Risperidone	NN	O	9-oh-risperidone	nn	6	SENT_176	[p10l16t2486r76b2947],
4	(	CD	NUMBER	(	num	6	SENT_176	[p10l17t2274r76b2464],
5	ng/ml	NN	O	ng/ml	nn	6	SENT_176	[p10l17t2274r76b2464],
6	)	NN	O	)	conj_+	1	SENT_176	[p10l17t2274r76b2464],
7	1	CD	NUMBER	1	num	8	SENT_176	[p10l7t81r9b83],
8	Medication	NN	O	medication	dep	6	SENT_176	[p10l48t82r336b136],
9	(	CD	NUMBER	(	num	11	SENT_176	[p10l358t82r477b151],
10	mg	NN	O	mg	nn	11	SENT_176	[p10l358t82r477b151],
11	)	NN	O	)	dep	1	SENT_176	[p10l358t82r477b151],
12	Rkpendone	NNP	O	Rkpendone	nn	14	SENT_176	[p10l50t241r355b310],
13	Lorazepam	NNP	O	Lorazepam	nn	14	SENT_176	[p10l50t338r332b405],
14	Biperiden	NNP	O	Biperiden	dep	11	SENT_176	[p10l50t430r295b499],

1	:	:	O	:	_	0	SENT_177	[p10l7t599r217b668],
2	PANSS	NN	O	panss	nn	4	SENT_177	[p10l7t599r217b668],
3	Positive	JJ	O	positive	amod	4	SENT_177	[p10l50t761r249b814],
4	Negaﬂve	NN	O	negaﬂve	_	0	SENT_177	[p10l50t855r278b923],
5	Global	JJ	O	global	amod	6	SENT_177	[p10l47t949r209b1003],
6	Total	JJ	O	total	dep	4	SENT_177	[p10l46t1043r173b1098],

1	1	CD	NUMBER	1	num	3	SENT_178	[p10l7t1211r9b1213],
2	Plasma	NN	O	plasma	nn	3	SENT_178	[p10l49t1212r230b1266],
3	levels	NNS	O	level	nsubj	4	SENT_178	[p10l251t1212r394b1266],
4	(	VBP	O	(	_	0	SENT_178	[p10l413t1211r606b1281],
5	ng/ml	JJ	O	ng/ml	amod	8	SENT_178	[p10l413t1211r606b1281],
6	)	NN	O	)	nn	8	SENT_178	[p10l413t1211r606b1281],
7	Rbpendone	NN	O	rbpendone	nn	8	SENT_178	[p10l50t1371r355b1440],
8	9-OH	NN	O	9-oh	nsubj	10	SENT_178	[p10l47t1466r499b1535],
9	—	CD	NUMBER	—	num	10	SENT_178	[p10l47t1466r499b1535],
10	risperidone	NN	O	risperidone	xcomp	4	SENT_178	[p10l47t1466r499b1535],
11	Active	JJ	O	active	amod	16	SENT_178	[p10l47t1562r206b1615],
12	moiety	NN	O	moiety	nn	16	SENT_178	[p10l225t1562r405b1630],
13	l	NN	O	l	nn	16	SENT_178	[p10l102t2261r119b2292],
14	\	CD	NUMBER	\	num	16	SENT_178	[p10l102t2261r119b2292],
15	J	NN	O	j	nn	16	SENT_178	[p10l102t2261r119b2292],
16	o	NN	O	o	dep	10	SENT_178	[p10l122t2261r140b2293],
17	.	.	O	.	_	0	SENT_178	[p10l143t2261r171b2293],

1	o	NN	O	o	_	0	SENT_179	[p10l143t2261r171b2293],
2	o	NN	O	o	nn	3	SENT_179	[p10l173t2261r192b2293],
3	o	NN	O	o	dep	1	SENT_179	[p10l194t2261r212b2293],

1	U1	NN	O	u1	_	0	SENT_180	[p10l121t3305r138b3337],
2	.	.	O	.	_	0	SENT_180	[p10l141t3304r168b3337],

1	o	NN	O	o	_	0	SENT_181	[p10l141t3304r168b3337],
2	o	NN	O	o	nn	3	SENT_181	[p10l170t3304r188b3337],
3	o	NN	O	o	dep	1	SENT_181	[p10l192t3304r210b3337],

1	Baseline	NN	O	baseline	_	0	SENT_182	[p10l713t82r925b136],

1	2.0	CD	NUMBER	2.0	num	2	SENT_183	[p10l711t244r927b296],
2	i0	NN	O	i0	_	0	SENT_183	[p10l711t244r927b296],
3	.4	CD	NUMBER	.4	num	4	SENT_183	[p10l711t244r927b296],
4	0.6	CD	NUMBER	0.6	dep	2	SENT_183	[p10l710t339r918b390],
5	-	:	O	-	_	0	SENT_183	[p10l710t339r918b390],
6	$	$	MONEY	$	dep	4	SENT_183	[p10l710t339r918b390],
7	1.1	CD	MONEY	1.1	number	6	SENT_183	[p10l710t339r918b390],
8	0.3	CD	MONEY	0.3	number	6	SENT_183	[p10l710t433r926b485],
9	i1	NN	O	i1	dep	6	SENT_183	[p10l710t433r926b485],
10	.0	CD	NUMBER	.0	num	9	SENT_183	[p10l710t433r926b485],

1	Baseline	NN	O	baseline	_	0	SENT_184	[p10l713t599r925b654],

1	20.5	CD	NUMBER	20.5	num	2	SENT_185	[p10l711t762r818b814],
2	:63	CD	NUMBER	:63	_	0	SENT_185	[p10l831t762r957b814],
3	22.6	CD	NUMBER	22.6	dep	2	SENT_185	[p10l711t857r871b909],
4	:	:	O	:	_	0	SENT_185	[p10l711t857r871b909],
5	7.0	CD	NUMBER	7.0	num	7	SENT_185	[p10l884t857r959b909],
6	42.3	CD	NUMBER	42.3	num	7	SENT_185	[p10l709t952r817b1003],
7	i11	NN	O	i11	dep	3	SENT_185	[p10l831t952r992b1003],
8	.0	CD	NUMBER	.0	number	9	SENT_185	[p10l831t952r992b1003],
9	85.4	CD	NUMBER	85.4	dep	7	SENT_185	[p10l710t1046r871b1098],
10	:	:	O	:	_	0	SENT_185	[p10l710t1046r871b1098],
11	19.4	CD	NUMBER	19.4	dep	3	SENT_185	[p10l886t1046r993b1098],

1	Visit	NN	O	visit	_	0	SENT_186	[p10l709t1213r821b1266],
2	1	CD	NUMBER	1	num	1	SENT_186	[p10l840t1215r857b1266],

1	5.8	CD	NUMBER	5.8	num	2	SENT_187	[p10l743t1374r959b1426],
2	i8	NN	O	i8	_	0	SENT_187	[p10l743t1374r959b1426],
3	.6	CD	NUMBER	.6	number	4	SENT_187	[p10l743t1374r959b1426],
4	18.7	CD	NUMBER	18.7	num	5	SENT_187	[p10l714t1469r992b1520],
5	i23	NN	O	i23	dep	2	SENT_187	[p10l714t1469r992b1520],
6	.9	CD	NUMBER	.9	number	7	SENT_187	[p10l714t1469r992b1520],
7	24.5	CD	NUMBER	24.5	num	9	SENT_187	[p10l711t1563r818b1615],
8	i26	NN	O	i26	nn	9	SENT_187	[p10l831t1563r983b1615],
9	.1	NN	NUMBER	.1	dep	5	SENT_187	[p10l831t1563r983b1615],

1	Endpoint	NNP	O	Endpoint	_	0	SENT_188	[p10l1134t82r1369b151],
2	5.1	CD	NUMBER	5.1	num	1	SENT_188	[p10l1131t245r1200b296],
3	i	FW	O	i	dep	1	SENT_188	[p10l1219t251r1260b295],
4	1.4	CD	NUMBER	1.4	num	6	SENT_188	[p10l1275t245r1349b296],
5	0.4	CD	NUMBER	0.4	num	6	SENT_188	[p10l1131t339r1348b390],
6	i0	NN	O	i0	dep	1	SENT_188	[p10l1131t339r1348b390],
7	.8	CD	NUMBER	.8	number	8	SENT_188	[p10l1131t339r1348b390],
8	1.3	CD	NUMBER	1.3	num	10	SENT_188	[p10l1135t433r1346b485],
9	i2	NN	O	i2	nn	10	SENT_188	[p10l1135t433r1346b485],
10	.2	NN	NUMBER	.2	dep	6	SENT_188	[p10l1135t433r1346b485],

1	Endpoint	NNP	O	Endpoint	_	0	SENT_189	[p10l1133t599r1369b668],
2	13.2:4.9	CD	NUMBER	13.2:4.9	num	1	SENT_189	[p10l1135t762r1380b814],
3	18.0	CD	NUMBER	18.0	num	4	SENT_189	[p10l1135t857r1371b909],
4	i7	NN	O	i7	dep	1	SENT_189	[p10l1135t857r1371b909],
5	.1	CD	NUMBER	.1	number	6	SENT_189	[p10l1135t857r1371b909],
6	31.9	CD	NUMBER	31.9	num	11	SENT_189	[p10l1132t952r1412b1003],
7	i11	NN	O	i11	nn	11	SENT_189	[p10l1132t952r1412b1003],
8	.2	NN	NUMBER	.2	nn	11	SENT_189	[p10l1132t952r1412b1003],
9	63.0	CD	NUMBER	63.0	num	11	SENT_189	[p10l1131t1046r1410b1098],
10	i21	NN	O	i21	nn	11	SENT_189	[p10l1131t1046r1410b1098],
11	.3	NN	NUMBER	.3	dep	4	SENT_189	[p10l1131t1046r1410b1098],

1	Endpoint	NNP	O	Endpoint	nn	3	SENT_190	[p10l1134t1212r1369b1281],
2	22.9	CD	NUMBER	22.9	num	3	SENT_190	[p10l1132t1374r1412b1426],
3	i28	NN	O	i28	_	0	SENT_190	[p10l1132t1374r1412b1426],
4	.7	CD	NUMBER	.7	number	5	SENT_190	[p10l1132t1374r1412b1426],
5	42.0	CD	NUMBER	42.0	num	9	SENT_190	[p10l1130t1469r1412b1520],
6	i25	NN	O	i25	nn	9	SENT_190	[p10l1130t1469r1412b1520],
7	.2	NN	NUMBER	.2	nn	9	SENT_190	[p10l1130t1469r1412b1520],
8	65.6	CD	NUMBER	65.6	num	9	SENT_190	[p10l1131t1563r1414b1615],
9	i38	NN	O	i38	dep	3	SENT_190	[p10l1131t1563r1414b1615],
10	.4	CD	NUMBER	.4	num	11	SENT_190	[p10l1131t1563r1414b1615],
11	Mean	NN	O	mean	dep	9	SENT_190	[p10l1515t83r1656b136],
12	1	CD	NUMBER	1	num	13	SENT_190	[p10l1675t91r1717b136],
13	SD	NN	O	sd	dep	3	SENT_190	[p10l1734t83r1801b136],

1	4.3	CD	NUMBER	4.3	_	0	SENT_191	[p10l1513t244r1588b296],
2	i	FW	O	i	dep	1	SENT_191	[p10l1602t251r1642b295],
3	0.9	CD	NUMBER	0.9	number	4	SENT_191	[p10l1653t244r1730b296],
4	0.5	CD	NUMBER	0.5	dep	2	SENT_191	[p10l1514t339r1588b390],
5	i	FW	O	i	dep	4	SENT_191	[p10l1602t345r1642b390],
6	0.8	CD	NUMBER	0.8	number	7	SENT_191	[p10l1653t339r1730b390],
7	0.9	CD	NUMBER	0.9	dep	4	SENT_191	[p10l1514t433r1591b485],
8	i	FW	O	i	dep	7	SENT_191	[p10l1602t440r1642b484],
9	1.4	CD	NUMBER	1.4	dep	1	SENT_191	[p10l1657t434r1731b485],

1	Mean	NN	O	mean	_	0	SENT_192	[p10l1515t1213r1656b1266],
2	1	CD	NUMBER	1	num	3	SENT_192	[p10l1676t1221r1717b1266],
3	SD	NN	O	sd	dep	1	SENT_192	[p10l1735t1213r1801b1266],

1	13.1	CD	NUMBER	13.1	_	0	SENT_193	[p10l1518t1374r1615b1426],
2	i	FW	O	i	dep	1	SENT_193	[p10l1635t1381r1675b1425],
3	18.6	CD	NUMBER	18.6	number	4	SENT_193	[p10l1690t1374r1796b1426],
4	32.8	CD	NUMBER	32.8	num	5	SENT_193	[p10l1515t1469r1763b1520],
5	i7	NN	O	i7	dep	2	SENT_193	[p10l1515t1469r1763b1520],
6	.6	CD	NUMBER	.6	number	7	SENT_193	[p10l1515t1469r1763b1520],
7	45.8	CD	NUMBER	45.8	num	9	SENT_193	[p10l1513t1563r1797b1615],
8	i27	NN	O	i27	nn	9	SENT_193	[p10l1513t1563r1797b1615],
9	.4	NN	NUMBER	.4	dep	2	SENT_193	[p10l1513t1563r1797b1615],

1	Dose	NN	O	dose	_	0	SENT_194	[p11l1088t90r1208b135],
2	(	CD	NUMBER	(	num	4	SENT_194	[p11l1229t88r1343b147],
3	mg	NN	O	mg	nn	4	SENT_194	[p11l1229t88r1343b147],
4	)	NN	O	)	dep	1	SENT_194	[p11l1229t88r1343b147],

1	Fig	NN	O	fig	_	0	SENT_195	[p11l11t228r151b298],
2	.1	CD	NUMBER	.1	num	4	SENT_195	[p11l11t228r151b298],
3	Positive	JJ	O	positive	amod	4	SENT_195	[p11l214t231r413b284],
4	correlation	NN	O	correlation	dep	1	SENT_195	[p11l443t229r721b284],
5	between	IN	O	between	_	0	SENT_195	[p11l755t229r980b284],
6	oral	JJ	O	oral	amod	7	SENT_195	[p11l1012t229r1107b284],
7	dose	NN	O	dose	prep_between	4	SENT_195	[p11l1139t229r1259b284],
8	and	CC	O	and	_	0	SENT_195	[p11l1289t229r1383b284],
9	plasma	NN	O	plasma	nn	10	SENT_195	[p11l1417t229r1599b298],
10	levels	NNS	O	level	prep_between	4	SENT_195	[p11l1632t229r1774b283],
11	of	IN	O	of	_	0	SENT_195	[p11l1805t229r1858b284],
12	the	DT	O	the	det	16	SENT_195	[p11l1882t229r1966b283],
13	active	JJ	O	active	amod	16	SENT_195	[p11l1996t231r2148b284],
14	moiety	NN	O	moiety	nn	16	SENT_195	[p11l11t312r190b381],
15	(	NN	O	(	nn	16	SENT_195	[p11l209t311r245b374],
16	r	NN	O	r	prep_of	7	SENT_195	[p11l209t311r245b374],
17	=	JJ	O	=	amod	16	SENT_195	[p11l264t334r304b354],
18	0.291	CD	NUMBER	0.291	tmod	17	SENT_195	[p11l325t314r482b374],
19	;	:	O	;	_	0	SENT_195	[p11l325t314r482b374],
20	p	NN	O	p	dep	4	SENT_195	[p11l502t327r531b379],
21	=	JJ	O	=	amod	23	SENT_195	[p11l552t334r593b353],
22	0.015	CD	NUMBER	0.015	tmod	21	SENT_195	[p11l614t311r773b374],
23	)	NN	O	)	dep	20	SENT_195	[p11l614t311r773b374],

1	tendential	JJ	O	tendential	amod	2	SENT_196	[p11l9t544r398b613],
2	increase	NN	O	increase	_	0	SENT_196	[p11l429t546r744b613],
3	in	IN	O	in	_	0	SENT_196	[p11l776t546r850b611],
4	the	DT	O	the	det	5	SENT_196	[p11l881t543r1000b613],
5	risperidone	NN	O	risperidone	prep_in	2	SENT_196	[p11l1032t543r1477b635],
6	to	TO	O	to	_	0	SENT_196	[p11l1509t556r1581b613],
7	9OHrisperidone	NN	O	9ohrisperidone	nn	8	SENT_196	[p11l1616t546r2146b635, p11l10t645r197b714],
8	ratio	NN	O	ratio	prep_to	5	SENT_196	[p11l231t648r410b714],
9	(	CD	NUMBER	(	num	10	SENT_196	[p11l448t646r584b729],
10	0.5	CD	NUMBER	0.5	dep	13	SENT_196	[p11l448t646r584b729],
11	i	FW	O	i	dep	10	SENT_196	[p11l606t656r656b713],
12	0.6	CD	NUMBER	0.6	dep	13	SENT_196	[p11l678t652r784b714],
13	VS.	NNP	O	VS.	dep	16	SENT_196	[p11l816t669r915b714],
14	1.9	CD	NUMBER	1.9	num	13	SENT_196	[p11l943t652r1042b715],
15	i	FW	O	i	dep	13	SENT_196	[p11l1064t656r1114b713],
16	1.8	CD	NUMBER	1.8	dep	2	SENT_196	[p11l1142t652r1264b725],
17	;	:	O	;	_	0	SENT_196	[p11l1142t652r1264b725],
18	p	NN	O	p	dep	2	SENT_196	[p11l1296t669r1342b736],
19	=	JJ	O	=	amod	21	SENT_196	[p11l1364t674r1414b699],
20	0.120	CD	NUMBER	0.120	tmod	19	SENT_196	[p11l1436t646r1686b729],
21	)	NN	O	)	dep	18	SENT_196	[p11l1436t646r1686b729],
22	.	.	O	.	_	0	SENT_196	[p11l1436t646r1686b729],

1	The	DT	O	the	det	2	SENT_197	[p11l1717t645r1861b714],
2	spread	NN	O	spread	nsubjpass	9	SENT_197	[p11l1895t645r2149b736],
3	of	IN	O	of	_	0	SENT_197	[p11l10t747r92b816],
4	poor	JJ	O	poor	amod	7	SENT_197	[p11l110t771r294b839],
5	and	CC	O	and	_	0	SENT_197	[p11l320t747r463b816],
6	extensive	JJ	O	extensive	amod	7	SENT_197	[p11l488t750r839b816],
7	metabolizers	NNS	O	metabolizer	prep_of	2	SENT_197	[p11l866t747r1360b816],
8	is	VBZ	O	be	auxpass	9	SENT_197	[p11l1387t750r1445b816],
9	depicted	VBN	O	depict	_	0	SENT_197	[p11l1473t748r1801b839],
10	in	IN	O	in	_	0	SENT_197	[p11l1827t750r1900b815],
11	Fig	NN	O	fig	nn	12	SENT_197	[p11l1928t750r2146b840],
12	.2	NN	NUMBER	.2	prep_in	9	SENT_197	[p11l1928t750r2146b840],
13	.	.	O	.	_	0	SENT_197	[p11l1928t750r2146b840],

1	Additional	JJ	O	additional	amod	2	SENT_198	[p11l9t849r421b918],
2	comparisons	NNS	O	comparison	nsubj	14	SENT_198	[p11l448t852r940b940],
3	of	IN	O	of	_	0	SENT_198	[p11l970t849r1052b918],
4	dose-corrected	JJ	O	dose-corrected	amod	7	SENT_198	[p11l1072t849r1649b918],
5	plasma	NN	O	plasma	nn	7	SENT_198	[p11l1674t849r1950b940],
6	level	NN	O	level	nn	7	SENT_198	[p11l1975t849r2148b918],
7	ratios	NNS	O	ratio	prep_of	2	SENT_198	[p11l10t954r225b1021],
8	between	IN	O	between	_	0	SENT_198	[p11l262t952r582b1020],
9	the	DT	O	the	det	11	SENT_198	[p11l619t952r737b1020],
10	two	CD	NUMBER	two	num	11	SENT_198	[p11l775t964r912b1020],
11	genotypes	NNS	O	genotype	prep_between	7	SENT_198	[p11l951t964r1342b1044],
12	did	VBD	O	do	aux	14	SENT_198	[p11l1381t952r1505b1020],
13	not	RB	O	not	neg	14	SENT_198	[p11l1542t964r1668b1020],
14	adduce	VB	O	adduce	_	0	SENT_198	[p11l1706t951r1977b1021],
15	any	DT	O	any	det	17	SENT_198	[p11l2016t976r2152b1044],
16	significant	JJ	O	significant	amod	17	SENT_198	[p11l11t1053r415b1145],
17	differences	NNS	O	difference	dobj	14	SENT_198	[p11l441t1053r858b1122],
18	to	TO	O	to	_	0	SENT_198	[p11l885t1066r957b1122],
19	these	DT	O	these	det	20	SENT_198	[p11l984t1053r1181b1122],
20	ﬁndings	NNS	O	ﬁndings	prep_to	14	SENT_198	[p11l1208t1053r1543b1145],
21	.	.	O	.	_	0	SENT_198	[p11l1208t1053r1543b1145],

1	Clinical	JJ	O	clinical	amod	2	SENT_199	[p11l137t1307r401b1380],
2	parameters	NNS	O	parameter	_	0	SENT_199	[p11l427t1317r856b1398],

1	Tablel	NNP	PERSON	Tablel	nsubj	3	SENT_200	[p11l10t1514r262b1583],
2	also	RB	O	also	advmod	3	SENT_200	[p11l325t1514r473b1583],
3	contains	VBZ	O	contain	_	0	SENT_200	[p11l531t1517r851b1583],
4	baseline	NN	O	baseline	nn	8	SENT_200	[p11l905t1514r1219b1583],
5	and	CC	O	and	_	0	SENT_200	[p11l1276t1514r1418b1583],
6	endpoint	NN	O	endpoint	nn	8	SENT_200	[p11l1474t1514r1818b1606],
7	clinical	JJ	O	clinical	amod	8	SENT_200	[p11l1874t1514r2149b1583],
8	characteristics	NNS	O	characteristic	dobj	3	SENT_200	[p11l10t1615r589b1684],
9	.	.	O	.	_	0	SENT_200	[p11l10t1615r589b1684],

1	PANSS	NNP	O	PANSS	nn	3	SENT_201	[p11l626t1620r883b1684],
2	Total	NNP	O	Total	nn	3	SENT_201	[p11l924t1615r1112b1684],
3	scores	NNS	O	score	nsubj	6	SENT_201	[p11l1152t1639r1384b1684],
4	and	CC	O	and	_	0	SENT_201	[p11l1425t1615r1568b1684],
5	subscores	NNS	O	subscore	conj_and	3	SENT_201	[p11l1606t1615r1975b1684],
6	improved	VBD	O	improve	_	0	SENT_201	[p11l2015t1618r2145b1683, p11l9t1716r275b1807],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_201	[p11l301t1716r778b1809],
8	throughout	IN	O	throughout	_	0	SENT_201	[p11l799t1716r1237b1809],
9	the	DT	O	the	det	11	SENT_201	[p11l1262t1716r1380b1785],
10	study	NN	O	study	nn	11	SENT_201	[p11l1408t1716r1620b1809],
11	sample	NN	O	sample	prep_throughout	6	SENT_201	[p11l1642t1716r1931b1807],
12	.	.	O	.	_	0	SENT_201	[p11l1642t1716r1931b1807],

1	Nonresponders	NNS	O	nonresponder	_	0	SENT_202	[p11l123t1818r714b1909],
2	to	TO	O	to	_	0	SENT_202	[p11l762t1831r834b1887],
3	pharmacotherapy	NN	O	pharmacotherapy	prep_to	1	SENT_202	[p11l883t1818r1574b1910],
4	(	CD	NUMBER	(	num	3	SENT_202	[p11l1621t1819r1910b1902],
5	PANSS	NNP	O	PANSS	nn	6	SENT_202	[p11l1621t1819r1910b1902],
6	Total	NNP	O	Total	dep	1	SENT_202	[p11l1960t1818r2149b1887],

1	5-00	CD	NUMBER	5-00	num	2	SENT_203	[p12l97t178r170b212],
2	CYPZD6	NN	O	cypzd6	_	0	SENT_203	[p12l1910t177r2074b221],
3	I	PRP	O	I	nsubj	4	SENT_203	[p12l1827t256r1879b308],
4	Wildtype	VBP	O	wildtype	rcmod	2	SENT_203	[p12l1909t265r2066b311],
5	A	DT	O	a	det	6	SENT_203	[p12l1821t325r1886b382],
6	Heterozygous	JJ	O	heterozygous	dobj	4	SENT_203	[p12l1911t346r2144b391],

1	QUOT	NNP	O	QUOT	_	0	SENT_204	[p12l10t1425r66b1573],
2	Risperidone/9-OH-Risperidone	NN	O	risperidone/9-oh-risperidone	dep	1	SENT_204	[p12l8t595r72b1401],

1	o	NN	O	o	_	0	SENT_205	[p12l295t2195r315b2230],
2	2o	SYM	O	2o	dep	3	SENT_205	[p12l478t2195r519b2230],
3	40	CD	NUMBER	40	rcmod	1	SENT_205	[p12l665t2195r709b2230],
4	so	RB	O	so	quantmod	6	SENT_205	[p12l858t2195r901b2230],
5	so	RB	O	so	quantmod	6	SENT_205	[p12l1050t2195r1092b2230],
6	100	CD	NUMBER	100	dep	1	SENT_205	[p12l1236t2195r1292b2230],
7	no	DT	O	no	det	8	SENT_205	[p12l1424t2195r1483b2230],
8	140	CD	NUMBER	140	dep	6	SENT_205	[p12l1613t2195r1675b2230],

1	Risperidone	NNP	O	Risperidone	nn	3	SENT_206	[p12l522t2269r833b2334],
2	Plasma	NN	O	plasma	nn	3	SENT_206	[p12l851t2271r1036b2321],
3	Level	NNP	O	Level	_	0	SENT_206	[p12l1054t2271r1186b2320],
4	(	CD	NUMBER	(	num	6	SENT_206	[p12l1204t2271r1394b2334],
5	ng/ml	JJ	O	ng/ml	amod	6	SENT_206	[p12l1204t2271r1394b2334],
6	)	NN	O	)	dep	3	SENT_206	[p12l1204t2271r1394b2334],

1	Fig	NN	O	fig	_	0	SENT_207	[p12l10t2404r112b2474],
2	.	.	O	.	_	0	SENT_207	[p12l10t2404r112b2474],

1	2	CD	NUMBER	2	num	2	SENT_208	[p12l127t2408r157b2459],
2	Relation	NN	O	relation	_	0	SENT_208	[p12l213t2405r420b2460],
3	between	IN	O	between	_	0	SENT_208	[p12l444t2405r667b2460],
4	poor	JJ	O	poor	amod	7	SENT_208	[p12l690t2421r809b2474],
5	and	CC	O	and	_	0	SENT_208	[p12l825t2405r920b2460],
6	extensive	JJ	O	extensive	amod	7	SENT_208	[p12l941t2407r1185b2459],
7	metabolizers	NNS	O	metabolizer	prep_between	2	SENT_208	[p12l1206t2405r1553b2460],
8	.	.	O	.	_	0	SENT_208	[p12l1206t2405r1553b2460],

1	Tendential	JJ	O	tendential	amod	2	SENT_209	[p12l1571t2405r1846b2460],
2	increase	NN	O	increase	_	0	SENT_209	[p12l1868t2407r2079b2460],
3	in	IN	O	in	_	0	SENT_209	[p12l2099t2407r2141b2459],
4	the	DT	O	the	det	5	SENT_209	[p12l7t2487r91b2541],
5	risperidone/9	NN	O	risperidone/9	prep_in	2	SENT_209	[p12l125t2487r894b2555],
6	.	.	O	.	_	0	SENT_209	[p12l125t2487r894b2555],

1	—	NN	O	—	_	0	SENT_210	[p12l125t2487r894b2555],
2	.	.	O	.	_	0	SENT_210	[p12l125t2487r894b2555],

1	OH-risperidone	JJ	O	oh-risperidone	amod	2	SENT_211	[p12l125t2487r894b2555],
2	ratio	NN	O	ratio	nsubj	8	SENT_211	[p12l928t2488r1044b2541],
3	between	IN	O	between	_	0	SENT_211	[p12l1078t2487r1302b2541],
4	the	DT	O	the	det	7	SENT_211	[p12l1335t2487r1420b2541],
5	CYPZD6	NN	O	cypzd6	nn	7	SENT_211	[p12l1452t2488r1654b2541],
6	genotype	NN	O	genotype	nn	7	SENT_211	[p12l1686t2494r1933b2556],
7	groups	NNS	O	group	prep_between	2	SENT_211	[p12l1965t2502r2143b2556],
8	(	VBP	O	(	_	0	SENT_211	[p12l10t2570r102b2633],
9	0.5	CD	NUMBER	0.5	num	11	SENT_211	[p12l10t2570r102b2633],
10	:	:	O	:	_	0	SENT_211	[p12l125t2580r166b2623],
11	0.6	CD	NUMBER	0.6	dobj	8	SENT_211	[p12l187t2572r263b2624],
12	vs.	CC	O	vs.	prep	11	SENT_211	[p12l286t2585r352b2624],
13	1.9	CD	NUMBER	1.9	dep	12	SENT_211	[p12l377t2572r449b2624],
14	i	FW	O	i	dep	8	SENT_211	[p12l471t2580r511b2623],
15	1.8	CD	NUMBER	1.8	dep	14	SENT_211	[p12l535t2572r623b2633],
16	;	:	O	;	_	0	SENT_211	[p12l535t2572r623b2633],
17	p	NN	O	p	dep	14	SENT_211	[p12l650t2585r678b2638],
18	=	JJ	O	=	amod	20	SENT_211	[p12l699t2593r740b2612],
19	0.120	CD	NUMBER	0.120	tmod	18	SENT_211	[p12l761t2570r937b2633],
20	)	NN	O	)	dep	17	SENT_211	[p12l761t2570r937b2633],
21	.	.	O	.	_	0	SENT_211	[p12l761t2570r937b2633],

1	The	DT	O	the	det	3	SENT_212	[p12l960t2570r1054b2624],
2	correlation	NN	O	correlation	nn	3	SENT_212	[p12l1079t2570r1356b2624],
3	curves	NNS	O	curve	nsubjpass	5	SENT_212	[p12l1383t2585r1547b2624],
4	are	VBP	O	be	auxpass	5	SENT_212	[p12l1571t2585r1650b2624],
5	given	VBN	O	give	_	0	SENT_212	[p12l1674t2571r1813b2639],
6	for	IN	O	for	_	0	SENT_212	[p12l1838t2569r1911b2624],
7	patients	NNS	O	patient	prep_for	5	SENT_212	[p12l1935t2571r2144b2638],
8	carrying	VBG	O	carry	xcomp	5	SENT_212	[p12l8t2653r215b2721],
9	the	DT	O	the	det	11	SENT_212	[p12l230t2651r314b2706],
10	wildtype	JJ	O	wildtype	amod	11	SENT_212	[p12l327t2651r554b2721],
11	(	NN	O	(	nsubj	12	SENT_212	[p12l570t2651r773b2715],
12	dashed	VBD	O	dash	ccomp	8	SENT_212	[p12l570t2651r773b2715],
13	line	NN	O	line	nn	14	SENT_212	[p12l791t2651r915b2715],
14	)	NN	O	)	dobj	12	SENT_212	[p12l791t2651r915b2715],
15	,	,	O	,	_	0	SENT_212	[p12l791t2651r915b2715],
16	carriers	NNS	O	carrier	dobj	12	SENT_212	[p12l930t2653r1118b2706],
17	of	IN	O	of	_	0	SENT_212	[p12l1132t2651r1185b2706],
18	allele	NN	O	allele	nn	24	SENT_212	[p12l1193t2651r1329b2706],
19	*	CD	NUMBER	*	number	20	SENT_212	[p12l1342t2653r1402b2705],
20	4	CD	NUMBER	4	num	21	SENT_212	[p12l1342t2653r1402b2705],
21	(	NN	O	(	npadvmod	22	SENT_212	[p12l1416t2652r1724b2715],
22	continuous	JJ	O	continuous	amod	24	SENT_212	[p12l1416t2652r1724b2715],
23	line	NN	O	line	nn	24	SENT_212	[p12l1740t2651r1865b2715],
24	)	NN	O	)	prep_of	16	SENT_212	[p12l1740t2651r1865b2715],
25	,	,	O	,	_	0	SENT_212	[p12l1740t2651r1865b2715],
26	and	CC	O	and	_	0	SENT_212	[p12l1879t2651r1973b2706],
27	all	DT	O	all	det	28	SENT_212	[p12l1989t2651r2044b2706],
28	patients	NNS	O	patient	conj_and	14	SENT_212	[p12l2062t2667r2144b2720, p12l7t2736r153b2789],
29	(	IN	O	(	_	0	SENT_212	[p12l172t2734r361b2797],
30	dotted	VBN	O	dot	amod	32	SENT_212	[p12l172t2734r361b2797],
31	line	NN	O	line	nn	32	SENT_212	[p12l382t2734r490b2797],
32	)	NN	O	)	prep_(	12	SENT_212	[p12l382t2734r490b2797],

1	Score	NN	NUMBER	score	nn	2	SENT_213	[p12l10t2964r214b3028],
2	improvement	NN	O	improvement	nsubj	7	SENT_213	[p12l240t2961r756b3050],
3	<	JJR	O	<	dep	2	SENT_213	[p12l782t2974r830b3026],
4	30	CD	PERCENT	30	num	5	SENT_213	[p12l853t2966r937b3028],
5	%	NN	PERCENT	%	dep	2	SENT_213	[p12l955t2960r1056b3042],
6	)	CD	NUMBER	)	dep	5	SENT_213	[p12l955t2960r1056b3042],
7	showed	VBD	O	show	dep	13	SENT_213	[p12l1086t2959r1374b3028],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_213	[p12l1398t2959r1875b3051],
9	higher	JJR	O	higher	amod	12	SENT_213	[p12l1894t2959r2145b3051],
10	plasma	NN	O	plasma	nn	12	SENT_213	[p12l8t3061r283b3152],
11	drug	NN	O	drug	nn	12	SENT_213	[p12l308t3061r489b3153],
12	concentrations	NNS	O	concentration	dobj	7	SENT_213	[p12l514t3064r1081b3130],
13	(	VBP	O	(	_	0	SENT_213	[p12l1111t3062r1293b3145],
14	49.9	CD	NUMBER	49.9	dobj	13	SENT_213	[p12l1111t3062r1293b3145],
15	i	FW	O	i	nsubj	13	SENT_213	[p12l1315t3072r1364b3129],
16	30.7	CD	NUMBER	30.7	num	17	SENT_213	[p12l1386t3068r1537b3130],
17	ng	NN	O	ng	dep	15	SENT_213	[p12l1556t3066r1679b3153],
18	/	:	O	/	punct	17	SENT_213	[p12l1556t3066r1679b3153],
19	ml	NN	O	ml	nn	20	SENT_213	[p12l1684t3061r1811b3145],
20	)	NN	O	)	nsubj	23	SENT_213	[p12l1684t3061r1811b3145],
21	than	IN	O	than	_	0	SENT_213	[p12l1840t3061r2013b3130],
22	responders	NNS	O	responder	prep_than	20	SENT_213	[p12l2038t3085r2140b3130, p12l10t3163r356b3254],
23	(	VBP	O	(	dep	17	SENT_213	[p12l398t3163r579b3247],
24	38.2	CD	NUMBER	38.2	dobj	23	SENT_213	[p12l398t3163r579b3247],
25	i	FW	O	i	dep	24	SENT_213	[p12l601t3174r651b3231],
26	17.0	CD	NUMBER	17.0	num	27	SENT_213	[p12l680t3170r824b3232],
27	ng/ml	NN	O	ng/ml	dep	24	SENT_213	[p12l843t3163r1091b3255],
28	;	:	O	;	_	0	SENT_213	[p12l843t3163r1091b3255],
29	p	NN	O	p	dep	24	SENT_213	[p12l1127t3186r1173b3254],
30	=	JJ	O	=	advmod	23	SENT_213	[p12l1195t3192r1245b3217],
31	0.045	CD	NUMBER	0.045	num	32	SENT_213	[p12l1266t3163r1493b3246],
32	)	NN	O	)	dep	30	SENT_213	[p12l1266t3163r1493b3246],
33	without	IN	O	without	_	0	SENT_213	[p12l1533t3163r1834b3232],
34	signiﬁcantly	RB	O	signiﬁcantly	advmod	35	SENT_213	[p12l1872t3163r2140b3255, p12l9t3265r241b3357],
35	higher	JJR	O	higher	prep_without	30	SENT_213	[p12l267t3265r517b3357],
36	oral	JJ	O	oral	amod	37	SENT_213	[p12l548t3265r696b3334],
37	doses	NNS	O	dose	nsubj	38	SENT_213	[p12l727t3265r936b3334],
38	(	VBP	O	(	ccomp	35	SENT_213	[p12l972t3266r1047b3356],
39	p	NN	O	p	dobj	38	SENT_213	[p12l972t3266r1047b3356],
40	=	JJ	O	=	amod	39	SENT_213	[p12l1069t3294r1119b3319],
41	0.601	CD	NUMBER	0.601	tmod	40	SENT_213	[p12l1140t3272r1358b3346],
42	;	:	O	;	_	0	SENT_213	[p12l1140t3272r1358b3346],
43	Fig	NN	O	fig	dep	15	SENT_213	[p12l1390t3268r1527b3357],
44	.	.	O	.	_	0	SENT_213	[p12l1390t3268r1527b3357],

1	3	CD	NUMBER	3	_	0	SENT_214	[p12l1549t3266r1641b3349],
2	)	NN	O	)	dep	1	SENT_214	[p12l1549t3266r1641b3349],
3	.	.	O	.	_	0	SENT_214	[p12l1549t3266r1641b3349],

1	This	DT	O	this	det	2	SENT_215	[p12l1670t3265r1834b3334],
2	ﬁnding	NN	O	ﬁnding	nsubjpass	5	SENT_215	[p12l1866t3265r2145b3357],
3	is	VBZ	O	be	auxpass	5	SENT_215	[p12l9t3369r66b3436],
4	not	RB	O	not	neg	5	SENT_215	[p12l104t3380r231b3436],
5	accounted	VBN	O	account	_	0	SENT_215	[p12l268t3367r657b3436],
6	for	IN	O	for	dep	5	SENT_215	[p12l693t3367r802b3436],
7	by	IN	O	by	_	0	SENT_215	[p12l835t3367r929b3459],
8	environmental	JJ	O	environmental	amod	9	SENT_215	[p12l963t3367r1525b3436],
9	factors	NNS	O	factor	agent	5	SENT_215	[p12l1561t3367r1819b3436],
10	such	JJ	O	such	_	0	SENT_215	[p12l1858t3367r2031b3436],
11	as	IN	O	as	_	0	SENT_215	[p12l2069t3391r2142b3436],
12	age	NN	O	age	nn	14	SENT_215	[p12l10t3493r133b3561],
13	(	CD	NUMBER	(	num	14	SENT_215	[p12l177t3470r572b3560],
14	p	NN	O	p	prep_such_as	9	SENT_215	[p12l177t3470r572b3560],
15	=	JJ	O	=	amod	14	SENT_215	[p12l177t3470r572b3560],
16	0.885	CD	NUMBER	0.885	number	17	SENT_215	[p12l177t3470r572b3560],
17	)	CD	NUMBER	)	dep	15	SENT_215	[p12l177t3470r572b3560],
18	or	CC	O	or	_	0	SENT_215	[p12l616t3493r696b3538],
19	weight	NN	O	weight	nn	21	SENT_215	[p12l733t3469r989b3561],
20	(	NN	O	(	nn	21	SENT_215	[p12l1031t3470r1451b3560],
21	p	NN	O	p	agent	5	SENT_215	[p12l1031t3470r1451b3560],
22	=	JJ	O	=	amod	24	SENT_215	[p12l1031t3470r1451b3560],
23	0.257	CD	NUMBER	0.257	tmod	22	SENT_215	[p12l1031t3470r1451b3560],
24	)	NN	O	)	dep	21	SENT_215	[p12l1031t3470r1451b3560],
25	,	,	O	,	_	0	SENT_215	[p12l1031t3470r1451b3560],
26	since	IN	O	since	mark	32	SENT_215	[p12l1488t3472r1678b3538],
27	no	DT	O	no	det	30	SENT_215	[p12l1718t3493r1813b3538],
28	statistically	RB	O	statistically	advmod	29	SENT_215	[p12l1855t3472r2140b3538, p12l9t3571r187b3664],
29	signiﬁcant	JJ	O	signiﬁcant	amod	30	SENT_215	[p12l208t3571r612b3664],
30	differences	NNS	O	difference	nsubjpass	32	SENT_215	[p12l636t3571r1052b3640],
31	were	VBD	O	be	auxpass	32	SENT_215	[p12l1074t3596r1255b3640],
32	observed	VBN	O	observe	advcl	5	SENT_215	[p12l1279t3571r1628b3640],
33	for	IN	O	for	_	0	SENT_215	[p12l1650t3571r1760b3640],
34	these	DT	O	these	det	35	SENT_215	[p12l1782t3572r1979b3641],
35	factors	NNS	O	factor	prep_for	32	SENT_215	[p12l2003t3571r2141b3640, p12l8t3686r173b3743],
36	.	.	O	.	_	0	SENT_215	[p12l2003t3571r2141b3640, p12l8t3686r173b3743],

1	Moreover	RB	O	moreover	advmod	8	SENT_216	[p12l203t3679r588b3754],
2	,	,	O	,	_	0	SENT_216	[p12l203t3679r588b3754],
3	responders	NNS	O	responder	nsubj	8	SENT_216	[p12l616t3673r1040b3764],
4	and	CC	O	and	_	0	SENT_216	[p12l1076t3673r1218b3743],
5	nonresponders	NNS	O	nonresponder	conj_and	3	SENT_216	[p12l1250t3673r1826b3764],
6	did	VBD	O	do	aux	8	SENT_216	[p12l1862t3673r1986b3743],
7	not	RB	O	not	neg	8	SENT_216	[p12l2018t3686r2145b3743],
8	differ	VB	O	differ	_	0	SENT_216	[p13l9t12r216b81],
9	regarding	VBG	O	regard	xcomp	8	SENT_216	[p13l308t12r680b105],
10	PANSS	NNP	O	PANSS	nn	12	SENT_216	[p13l771t17r1028b82],
11	total	JJ	O	total	amod	12	SENT_216	[p13l1121t12r1294b81],
12	score	NN	NUMBER	score	dobj	9	SENT_216	[p13l1385t37r1582b81],
13	at	IN	O	at	_	0	SENT_216	[p13l1674t25r1741b81],
14	baseline	NN	O	baseline	prep_at	9	SENT_216	[p13l1829t13r2142b82],
15	(	CD	NUMBER	(	num	18	SENT_216	[p13l12t115r431b205],
16	p	NN	O	p	nn	18	SENT_216	[p13l12t115r431b205],
17	=	JJ	O	=	amod	18	SENT_216	[p13l12t115r431b205],
18	O.	NNP	O	O.	tmod	9	SENT_216	[p13l12t115r431b205],
19	275	CD	NUMBER	275	num	20	SENT_216	[p13l12t115r431b205],
20	)	NN	O	)	dep	18	SENT_216	[p13l12t115r431b205],
21	.	.	O	.	_	0	SENT_216	[p13l12t115r431b205],

1	Characteristics	NNS	O	characteristic	nsubjpass	7	SENT_217	[p13l471t114r1046b184],
2	of	IN	O	of	_	0	SENT_217	[p13l1088t114r1170b184],
3	responders	NNS	O	responder	prep_of	1	SENT_217	[p13l1204t114r1627b205],
4	and	CC	O	and	_	0	SENT_217	[p13l1670t114r1812b184],
5	nonresponders	NNS	O	nonresponder	prep_of	1	SENT_217	[p13l1852t138r2140b184, p13l10t217r356b308],
6	are	VBP	O	be	auxpass	7	SENT_217	[p13l380t241r495b285],
7	depicted	VBN	O	depict	_	0	SENT_217	[p13l518t216r846b308],
8	in	IN	O	in	_	0	SENT_217	[p13l868t219r941b284],
9	Table	NNP	O	Table	prep_in	7	SENT_217	[p13l964t217r1164b285],
10	2	CD	NUMBER	2	num	9	SENT_217	[p13l1182t224r1242b285],
11	.	.	O	.	_	0	SENT_217	[p13l1182t224r1242b285],

1	CYPZD6	NN	O	cypzd6	nn	2	SENT_218	[p13l1263t221r1583b286],
2	genotypes	NNS	O	genotype	nsubj	5	SENT_218	[p13l1605t229r1996b309],
3	did	VBD	O	do	aux	5	SENT_218	[p13l2020t216r2145b285],
4	not	RB	O	not	neg	5	SENT_218	[p13l9t331r136b387],
5	predict	VB	O	predict	_	0	SENT_218	[p13l161t318r435b409],
6	clinical	JJ	O	clinical	amod	8	SENT_218	[p13l463t318r737b387],
7	response	NN	O	response	nn	8	SENT_218	[p13l765t342r1102b409],
8	(	NN	O	(	dobj	5	SENT_218	[p13l1134t318r1487b402],
9	assessed	VBN	O	assess	partmod	8	SENT_218	[p13l1134t318r1487b402],
10	by	IN	O	by	_	0	SENT_218	[p13l1511t318r1605b410],
11	improvement	NN	O	improvement	agent	9	SENT_218	[p13l1629t321r2145b409],
12	in	IN	O	in	_	0	SENT_218	[p13l9t423r82b488],
13	PANSS	NNP	O	PANSS	nn	15	SENT_218	[p13l109t425r367b490],
14	Total	NNP	O	Total	nn	15	SENT_218	[p13l395t421r583b490],
15	Scores	NNS	O	score	prep_in	11	SENT_218	[p13l610t425r851b490],
16	over	IN	O	over	_	0	SENT_218	[p13l878t445r1043b490],
17	six	CD	DURATION	six	num	18	SENT_218	[p13l1069t423r1175b490],
18	weeks	NNS	NUMBER	week	prep_over	9	SENT_218	[p13l1195t421r1448b501],
19	;	:	O	;	_	0	SENT_218	[p13l1195t421r1448b501],
20	p	NN	O	p	dep	8	SENT_218	[p13l1472t444r1518b512],
21	=	JJ	O	=	amod	23	SENT_218	[p13l1540t450r1590b475],
22	0.947	CD	NUMBER	0.947	tmod	21	SENT_218	[p13l1611t421r1862b504],
23	)	NN	O	)	dep	20	SENT_218	[p13l1611t421r1862b504],
24	.	.	O	.	_	0	SENT_218	[p13l1611t421r1862b504],

1	Patients	NNS	O	patient	nsubj	10	SENT_219	[p13l124t525r426b591],
2	with	IN	O	with	_	0	SENT_219	[p13l471t522r642b591],
3	an	DT	O	a	det	5	SENT_219	[p13l689t546r779b591],
4	illness	NN	O	illness	nn	5	SENT_219	[p13l825t522r1063b591],
5	duration	NN	O	duration	prep_with	1	SENT_219	[p13l1111t522r1442b591],
6	of	IN	O	of	_	0	SENT_219	[p13l1489t522r1570b591],
7	2	CD	NUMBER	2	number	8	SENT_219	[p13l1608t529r1656b590],
8	3	CD	DURATION	3	num	9	SENT_219	[p13l1675t529r1711b591],
9	years	NNS	NUMBER	year	prep_of	5	SENT_219	[p13l1757t546r1956b614],
10	had	VBD	O	have	dep	16	SENT_219	[p13l2001t522r2145b591],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_219	[p13l10t624r486b717],
12	higher	JJR	O	higher	amod	15	SENT_219	[p13l577t625r828b717],
13	plasma	NN	O	plasma	nn	15	SENT_219	[p13l923t625r1199b716],
14	drug	NN	O	drug	nn	15	SENT_219	[p13l1296t625r1477b717],
15	concentrations	NNS	O	concentration	dobj	10	SENT_219	[p13l1574t627r2142b693],
16	(	VBP	O	(	_	0	SENT_219	[p13l12t727r192b810],
17	48.3	CD	NUMBER	48.3	dobj	16	SENT_219	[p13l12t727r192b810],
18	i	FW	O	i	nsubj	33	SENT_219	[p13l215t737r265b794],
19	33.1	CD	NUMBER	33.1	num	21	SENT_219	[p13l287t733r432b795],
20	ng/ml	NN	O	ng/ml	nn	21	SENT_219	[p13l457t726r713b818],
21	)	NN	O	)	nsubj	31	SENT_219	[p13l457t726r713b818],
22	than	IN	O	than	_	0	SENT_219	[p13l762t726r935b795],
23	those	DT	O	those	prep_than	21	SENT_219	[p13l981t726r1185b795],
24	with	IN	O	with	_	0	SENT_219	[p13l1229t726r1401b795],
25	a	DT	O	a	det	26	SENT_219	[p13l1448t750r1487b795],
26	duration	NN	O	duration	prep_with	23	SENT_219	[p13l1532t726r1863b795],
27	of	IN	O	of	_	0	SENT_219	[p13l1910t726r1991b795],
28	<	JJR	O	<	prep_of	26	SENT_219	[p13l2033t742r2081b794],
29	3	CD	DURATION	3	num	30	SENT_219	[p13l2104t733r2140b795],
30	years	NNS	NUMBER	year	tmod	28	SENT_219	[p13l6t853r204b921],
31	(	VBP	O	(	rcmod	18	SENT_219	[p13l235t829r415b912],
32	35.5	CD	NUMBER	35.5	dobj	31	SENT_219	[p13l235t829r415b912],
33	i	FW	O	i	rcmod	17	SENT_219	[p13l438t840r488b896],
34	17.8	CD	NUMBER	17.8	num	35	SENT_219	[p13l516t836r660b897],
35	ng/ml	NN	O	ng/ml	dobj	33	SENT_219	[p13l680t829r927b921],
36	;	:	O	;	_	0	SENT_219	[p13l680t829r927b921],
37	p	NN	O	p	dep	35	SENT_219	[p13l952t852r997b920],
38	=	JJ	O	=	amod	40	SENT_219	[p13l1019t858r1069b883],
39	0.039	CD	NUMBER	0.039	tmod	38	SENT_219	[p13l1091t829r1317b912],
40	)	NN	O	)	dep	37	SENT_219	[p13l1091t829r1317b912],
41	without	IN	O	without	_	0	SENT_219	[p13l1345t829r1646b897],
42	signiﬁcantly	RB	O	signiﬁcantly	advmod	43	SENT_219	[p13l1672t828r2148b921],
43	higher	JJR	O	higher	amod	44	SENT_219	[p13l7t930r258b1022],
44	dosages	NNS	O	dosage	prep_without	33	SENT_219	[p13l288t930r586b1022],
45	(	CD	NUMBER	(	num	46	SENT_219	[p13l621t931r696b1021],
46	p	NN	O	p	npadvmod	47	SENT_219	[p13l621t931r696b1021],
47	=	JJ	O	=	amod	44	SENT_219	[p13l718t959r768b984],
48	0.316	CD	NUMBER	0.316	num	49	SENT_219	[p13l789t931r1039b1014],
49	)	NN	O	)	nsubj	16	SENT_219	[p13l789t931r1039b1014],
50	.	.	O	.	_	0	SENT_219	[p13l789t931r1039b1014],

1	This	DT	O	this	det	2	SENT_220	[p13l1067t930r1232b999],
2	subgroup	NN	O	subgroup	_	0	SENT_220	[p13l1264t930r1624b1022],
3	was	VBD	O	be	cop	6	SENT_220	[p13l1653t954r1794b999],
4	also	RB	O	also	advmod	6	SENT_220	[p13l1827t930r1974b999],
5	significantly	RB	O	significantly	advmod	6	SENT_220	[p13l2007t933r2140b1022, p13l9t1032r375b1125],
6	older	JJR	O	older	rcmod	2	SENT_220	[p13l414t1032r612b1101],
7	(	CD	NUMBER	(	number	8	SENT_220	[p13l658t1033r834b1116],
8	40.1	CD	NUMBER	40.1	dep	2	SENT_220	[p13l658t1033r834b1116],
9	i	FW	O	i	dep	8	SENT_220	[p13l861t1044r911b1100],
10	12.2	CD	DURATION	12.2	num	11	SENT_220	[p13l940t1040r1083b1101],
11	years	NNS	NUMBER	year	tmod	8	SENT_220	[p13l1125t1057r1323b1125],
12	vs.	CC	O	vs.	_	0	SENT_220	[p13l1366t1040r1708b1102],
13	31.9	CD	NUMBER	31.9	dep	2	SENT_220	[p13l1366t1040r1708b1102],
14	i	FW	O	i	dep	13	SENT_220	[p13l1366t1040r1708b1102],
15	12.3	CD	DURATION	12.3	num	16	SENT_220	[p13l1736t1040r1878b1101],
16	years	NNS	NUMBER	year	tmod	13	SENT_220	[p13l1922t1057r2142b1125],
17	;	:	O	;	_	0	SENT_220	[p13l1922t1057r2142b1125],
18	p	NN	O	p	dep	2	SENT_220	[p13l8t1158r53b1225],
19	=	JJ	O	=	amod	21	SENT_220	[p13l75t1163r125b1188],
20	0.004	CD	NUMBER	0.004	tmod	19	SENT_220	[p13l147t1135r397b1218],
21	)	NN	O	)	dep	18	SENT_220	[p13l147t1135r397b1218],
22	.	.	O	.	_	0	SENT_220	[p13l147t1135r397b1218],

1	Side-effect	JJ	O	side-effect	amod	2	SENT_221	[p13l136t1387r540b1459],
2	assessment	NN	O	assessment	_	0	SENT_221	[p13l560t1397r991b1459],

1	No	DT	O	no	det	2	SENT_222	[p13l8t1599r116b1662],
2	correlation	NN	O	correlation	nsubj	15	SENT_222	[p13l145t1593r567b1662],
3	between	IN	O	between	_	0	SENT_222	[p13l590t1593r910b1662],
4	plasma	NN	O	plasma	nn	5	SENT_222	[p13l934t1593r1211b1685],
5	levels	NNS	O	level	prep_between	2	SENT_222	[p13l1233t1593r1441b1662],
6	of	IN	O	of	_	0	SENT_222	[p13l1469t1593r1550b1662],
7	the	DT	O	the	det	9	SENT_222	[p13l1568t1593r1686b1662],
8	active	JJ	O	active	amod	9	SENT_222	[p13l1714t1596r1934b1662],
9	moiety	NN	O	moiety	prep_of	5	SENT_222	[p13l1961t1596r2139b1662, p13l9t1708r126b1787],
10	and	CC	O	and	_	0	SENT_222	[p13l152t1695r294b1764],
11	extrapyramidal	JJ	O	extrapyramidal	amod	13	SENT_222	[p13l323t1695r919b1787],
12	side	JJ	O	side	amod	13	SENT_222	[p13l948t1695r1098b1764],
13	effects	NNS	O	effect	prep_of	5	SENT_222	[p13l1128t1695r1370b1764],
14	as	IN	O	as	advmod	15	SENT_222	[p13l1402t1719r1475b1764],
15	measured	VBN	O	measure	_	0	SENT_222	[p13l1506t1695r1881b1764],
16	by	IN	O	by	_	0	SENT_222	[p13l1906t1695r2001b1787],
17	the	DT	O	the	det	20	SENT_222	[p13l2025t1695r2143b1764],
18	SAS	NNP	O	SAS	nn	20	SENT_222	[p13l10t1802r155b1867],
19	(	NN	O	(	nn	20	SENT_222	[p13l204t1798r624b1881],
20	r	NN	O	r	prep_by	15	SENT_222	[p13l204t1798r624b1881],
21	=	JJ	O	=	amod	20	SENT_222	[p13l204t1798r624b1881],
22	.	.	O	.	_	0	SENT_222	[p13l204t1798r624b1881],

1	—	NN	O	—	_	0	SENT_223	[p13l204t1798r624b1881],
2	.	.	O	.	_	0	SENT_223	[p13l204t1798r624b1881],

1	0.040	CD	NUMBER	0.040	_	0	SENT_224	[p13l204t1798r624b1881],
2	;	:	O	;	_	0	SENT_224	[p13l204t1798r624b1881],
3	p	NN	O	p	dep	1	SENT_224	[p13l667t1798r1032b1889],
4	=	JJ	O	=	amod	6	SENT_224	[p13l667t1798r1032b1889],
5	0.722	CD	NUMBER	0.722	num	6	SENT_224	[p13l667t1798r1032b1889],
6	)	NN	O	)	nsubjpass	8	SENT_224	[p13l667t1798r1032b1889],
7	was	VBD	O	be	auxpass	8	SENT_224	[p13l1078t1822r1219b1867],
8	found	VBN	O	find	rcmod	3	SENT_224	[p13l1264t1797r1509b1866],
9	.	.	O	.	_	0	SENT_224	[p13l1264t1797r1509b1866],

1	Comparison	NN	O	comparison	nsubj	10	SENT_225	[p13l1552t1800r2027b1889],
2	of	IN	O	of	_	0	SENT_225	[p13l2072t1797r2153b1866],
3	patients	NNS	O	patient	prep_of	1	SENT_225	[p13l8t1901r312b1990],
4	with	IN	O	with	_	0	SENT_225	[p13l353t1899r525b1968],
5	more	RBR	O	more	advmod	6	SENT_225	[p13l566t1923r764b1968],
6	pronounced	JJ	O	pronounced	amod	9	SENT_225	[p13l806t1899r1273b1990],
7	and	CC	O	and	_	0	SENT_225	[p13l1314t1899r1457b1968],
8	less	RBR	O	less	amod	9	SENT_225	[p13l1496t1899r1632b1968],
9	EPS	NN	O	ep	prep_with	3	SENT_225	[p13l1675t1904r1820b1968],
10	yielded	VBD	O	yield	_	0	SENT_225	[p13l1861t1899r2145b1991],
11	significant	JJ	O	significant	amod	12	SENT_225	[p13l10t2001r413b2094],
12	results	NNS	O	result	dobj	10	SENT_225	[p13l462t2001r710b2070],
13	in	IN	O	in	_	0	SENT_225	[p13l761t2004r834b2069],
14	terms	NNS	O	term	prep_in	10	SENT_225	[p13l882t2014r1101b2070],
15	of	IN	O	of	_	0	SENT_225	[p13l1152t2001r1233b2070],
16	patients	NNS	O	patient	prep_of	14	SENT_225	[p13l1275t2004r1580b2092],
17	with	IN	O	with	_	0	SENT_225	[p13l1627t2001r1799b2070],
18	initially	RB	O	initially	advmod	10	SENT_225	[p13l1849t2001r2148b2094],
19	higher	JJR	O	higher	amod	22	SENT_225	[p13l7t2103r258b2195],
20	drug	NN	O	drug	nn	22	SENT_225	[p13l288t2103r470b2195],
21	plasma	NN	O	plasma	nn	22	SENT_225	[p13l497t2103r773b2194],
22	levels	NNS	O	level	prep_with	10	SENT_225	[p13l801t2103r1008b2172],
23	being	VBG	O	be	cop	25	SENT_225	[p13l1037t2103r1253b2195],
24	more	RBR	O	more	advmod	25	SENT_225	[p13l1281t2127r1480b2172],
25	likely	JJ	O	likely	partmod	22	SENT_225	[p13l1509t2103r1718b2195],
26	to	TO	O	to	aux	27	SENT_225	[p13l1743t2116r1816b2172],
27	develop	VB	O	develop	xcomp	25	SENT_225	[p13l1848t2103r2141b2194],

1	Fig	NN	O	fig	nn	3	SENT_226	[p13l9t2330r130b2389],
2	.3	NN	NUMBER	.3	nn	3	SENT_226	[p13l9t2330r130b2389],
3	Response	NN	O	response	_	0	SENT_226	[p13l177t2332r380b2388],
4	to	TO	O	to	_	0	SENT_226	[p13l425t2338r469b2376],
5	treatment	NN	O	treatment	prep_to	3	SENT_226	[p13l515t2338r746b2384],
6	,	,	O	,	_	0	SENT_226	[p13l515t2338r746b2384],
7	oral	JJ	O	oral	appos	5	SENT_226	[p13l794t2331r872b2376],
8	.	.	O	.	_	0	SENT_226	[p13l1138t2335r1540b2403],

1	—	NN	O	—	_	0	SENT_227	[p13l1138t2335r1540b2403],
2	.	.	O	.	_	0	SENT_227	[p13l1138t2335r1540b2403],

1	Q	NNP	O	Q	_	0	SENT_228	[p13l1138t2335r1540b2403],
2	.	.	O	.	_	0	SENT_228	[p13l1138t2335r1540b2403],

1	—	NN	O	—	_	0	SENT_229	[p13l1138t2335r1540b2403],
2	.	.	O	.	_	0	SENT_229	[p13l1138t2335r1540b2403],

1	Re5ponder	NN	O	re5ponder	_	0	SENT_230	[p13l1138t2335r1540b2403],
2	.	.	O	.	_	0	SENT_230	[p13l1636t2336r2153b2402],

1	—	NN	O	—	_	0	SENT_231	[p13l1636t2336r2153b2402],
2	.	.	O	.	_	0	SENT_231	[p13l1636t2336r2153b2402],

1	|	NN	O	|	_	0	SENT_232	[p13l1636t2336r2153b2402],
2	.	.	O	.	_	0	SENT_232	[p13l1636t2336r2153b2402],

1	—	NN	O	—	_	0	SENT_233	[p13l1636t2336r2153b2402],
2	.	.	O	.	_	0	SENT_233	[p13l1636t2336r2153b2402],

1	Non-Re5ponder	JJ	O	non-re5ponder	amod	2	SENT_234	[p13l1636t2336r2153b2402],
2	dose	NN	O	dose	_	0	SENT_234	[p13l7t2400r119b2453],
3	,	,	O	,	_	0	SENT_234	[p13l7t2400r119b2453],
4	and	CC	O	and	_	0	SENT_234	[p13l134t2400r212b2445],
5	plasma	NN	O	plasma	nn	6	SENT_234	[p13l230t2400r381b2457],
6	levels	NNS	O	level	conj_and	2	SENT_234	[p13l398t2400r528b2445],
7	.	.	O	.	_	0	SENT_234	[p13l398t2400r528b2445],

1	Nonresponders	NNS	O	nonresponder	nsubj	32	SENT_235	[p13l546t2400r873b2457],
2	to	TO	O	to	_	0	SENT_235	[p13l6t2475r49b2514],
3	pharmacotherapy	JJ	O	pharmacotherapy	amod	8	SENT_235	[p13l80t2469r467b2527],
4	(	NN	O	(	nn	8	SENT_235	[p13l498t2469r874b2526, p13l8t2544r121b2583],
5	PANSS	NN	O	panss	nn	8	SENT_235	[p13l498t2469r874b2526, p13l8t2544r121b2583],
6	—	CD	NUMBER	—	num	8	SENT_235	[p13l498t2469r874b2526, p13l8t2544r121b2583],
7	|	NN	O	|	nn	8	SENT_235	[p13l498t2469r874b2526, p13l8t2544r121b2583],
8	mprovement	NN	O	mprovement	prep_to	1	SENT_235	[p13l498t2469r874b2526, p13l8t2544r121b2583],
9	<	JJR	O	<	amod	8	SENT_235	[p13l140t2549r170b2582],
10	30	CD	PERCENT	30	num	11	SENT_235	[p13l189t2540r240b2583],
11	%	NN	PERCENT	%	dep	9	SENT_235	[p13l257t2538r313b2591],
12	)	CD	NUMBER	)	nsubj	13	SENT_235	[p13l257t2538r313b2591],
13	showed	VBD	O	show	rcmod	8	SENT_235	[p13l379t2538r546b2583],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	15	SENT_235	[p13l612t2537r875b2596],
15	higher	JJR	O	higher	amod	19	SENT_235	[p13l9t2607r148b2665],
16	active	JJ	O	active	amod	19	SENT_235	[p13l162t2608r288b2652],
17	moiety	NN	O	moiety	nn	19	SENT_235	[p13l306t2608r455b2665],
18	plasma	NN	O	plasma	nn	19	SENT_235	[p13l471t2607r622b2664],
19	levels	NNS	O	level	dobj	13	SENT_235	[p13l642t2607r760b2652],
20	than	IN	O	than	_	0	SENT_235	[p13l775t2607r872b2652],
21	responders	NNS	O	responder	nn	25	SENT_235	[p13l8t2676r246b2733],
22	(	RB	O	(	advmod	23	SENT_235	[p13l264t2676r382b2733],
23	right	JJ	O	right	amod	25	SENT_235	[p13l264t2676r382b2733],
24	figure	NN	O	figure	nn	25	SENT_235	[p13l395t2675r537b2733],
25	)	NN	O	)	prep_than	13	SENT_235	[p13l395t2675r537b2733],
26	without	IN	O	without	_	0	SENT_235	[p13l553t2676r725b2721],
27	significantly	RB	O	significantly	advmod	28	SENT_235	[p13l739t2675r874b2733, p13l8t2745r149b2803],
28	higher	JJR	O	higher	amod	30	SENT_235	[p13l165t2745r304b2803],
29	oral	JJ	O	oral	amod	30	SENT_235	[p13l317t2745r395b2790],
30	doses	NNS	O	dose	prep_without	13	SENT_235	[p13l412t2745r533b2790],
31	(	RB	O	(	advmod	13	SENT_235	[p13l549t2744r634b2797],
32	left	VBD	O	leave	_	0	SENT_235	[p13l549t2744r634b2797],
33	figure	NN	O	figure	nn	34	SENT_235	[p13l646t2744r789b2803],
34	)	NN	O	)	dobj	32	SENT_235	[p13l646t2744r789b2803],

1	-	:	O	-	_	0	SENT_236	[p13l442t3680r631b3760],
2	o	NN	O	o	_	0	SENT_236	[p13l442t3680r631b3760],
3	-	:	O	-	_	0	SENT_236	[p13l442t3680r631b3760],
4	Responder	NN	O	responder	dep	2	SENT_236	[p13l651t3681r1038b3782],
5	.	.	O	.	_	0	SENT_236	[p13l1246t3681r1434b3756],

1	—	NN	O	—	_	0	SENT_237	[p13l1246t3681r1434b3756],
2	.	.	O	.	_	0	SENT_237	[p13l1246t3681r1434b3756],

1	I	PRP	O	I	nsubj	2	SENT_238	[p13l1246t3681r1434b3756],
2	Non-Responder	VBP	O	non-responder	_	0	SENT_238	[p13l1455t3681r2034b3782],

1	G	NN	O	g	nn	2	SENT_239	[p14l138t261r189b301],
2	)	NNS	O	)	_	0	SENT_239	[p14l138t261r189b301],

1	+5	CD	NUMBER	+5	num	2	SENT_240	[p14l25t308r190b399],
2	60 375250	CD	NUMBER	60 375250	nsubj	3	SENT_240	[p14l29t406r438b505],[p14l352t306r438b378],
3	OGJE	NN	O	ogje	_	0	SENT_240	[p14l29t509r297b582],
4	3.33.40	CD	NUMBER	3.33.40	num	5	SENT_240	[p14l7t556r438b666],
5	_	NN	O	_	dobj	3	SENT_240	[p14l7t663r438b817],
6	;	:	O	;	_	0	SENT_240	[p14l7t663r438b817],
7	.	.	O	.	_	0	SENT_240	[p14l7t663r438b817],
8	'	''	O	'	_	0	SENT_240	[p14l7t663r438b817],

1	_	NN	O	_	_	0	SENT_241	[p14l7t663r438b817],
2	3	CD	NUMBER	3	num	1	SENT_241	[p14l7t663r438b817],
3	=	SYM	O	=	dep	1	SENT_241	[p14l7t663r438b817],
4	-	:	O	-	_	0	SENT_241	[p14l7t663r438b817],
5	‘	NN	O	‘	dep	1	SENT_241	[p14l7t663r438b817],
6	£	CD	MONEY	£	number	7	SENT_241	[p14l7t663r438b817],
7	30	CD	MONEY	30	num	10	SENT_241	[p14l7t663r438b817],
8	=	JJ	O	=	quantmod	10	SENT_241	[p14l11t807r190b892],
9	9	CD	NUMBER	9	number	10	SENT_241	[p14l11t807r190b892],
10	20	CD	NUMBER	20	dep	5	SENT_241	[p14l352t816r438b886],

1	O5	NN	O	o5	_	0	SENT_242	[p14l121t897r190b940],

1	Mean	NN	O	mean	nn	4	SENT_243	[p14l331t1511r396b1535],
2	1	CD	NUMBER	1	num	4	SENT_243	[p14l405t1514r424b1535],
3	SD	NN	O	sd	nn	4	SENT_243	[p14l432t1510r463b1535],
4	(	NN	O	(	dep	13	SENT_243	[p14l472t1510r544b1539],
5	week	NN	DURATION	week	dep	4	SENT_243	[p14l472t1510r544b1539],
6	1-6	CD	NUMBER	1-6	num	5	SENT_243	[p14l553t1510r606b1539],
7	)	CD	NUMBER	)	dep	13	SENT_243	[p14l553t1510r606b1539],
8	Dose	NN	O	dose	nn	13	SENT_243	[p14l331t1583r388b1608],
9	(	NN	O	(	nn	13	SENT_243	[p14l397t1583r452b1615],
10	mg	NN	O	mg	nn	13	SENT_243	[p14l397t1583r452b1615],
11	)	CD	NUMBER	)	num	13	SENT_243	[p14l397t1583r452b1615],
12	Plasma	NN	O	plasma	nn	13	SENT_243	[p14l331t1634r415b1659],
13	Level	NN	O	level	_	0	SENT_243	[p14l425t1634r484b1659],
14	(	CD	NUMBER	(	num	16	SENT_243	[p14l494t1634r584b1666],
15	ng/ml	NN	O	ng/ml	nn	16	SENT_243	[p14l494t1634r584b1666],
16	)	NN	O	)	dep	13	SENT_243	[p14l494t1634r584b1666],

1	N	NN	O	n	_	0	SENT_244	[p14l762t1511r777b1535],
2	31/42	CD	NUMBER	31/42	num	3	SENT_244	[p14l761t1583r830b1609],
3	31/41	CD	NUMBER	31/41	dep	1	SENT_244	[p14l761t1634r827b1660],

1	Responder	NN	O	responder	_	0	SENT_245	[p14l987t1510r1115b1542],
2	4.3	CD	NUMBER	4.3	num	1	SENT_245	[p14l1001t1584r1035b1608],
3	10.8	CD	NUMBER	10.8	number	4	SENT_245	[p14l1042t1584r1101b1608],
4	38.2	CD	NUMBER	38.2	dep	1	SENT_245	[p14l986t1635r1116b1659],
5	i17	NN	O	i17	dep	4	SENT_245	[p14l986t1635r1116b1659],
6	.0	CD	NUMBER	.0	num	5	SENT_245	[p14l986t1635r1116b1659],

1	Week	NN	DURATION	week	_	0	SENT_246	[p14l1231t1333r1441b1405],

1	Non-Responder	JJ	O	non-responder	amod	2	SENT_247	[p14l1271t1510r1459b1542],
2	p	NN	O	p	_	0	SENT_247	[p14l1610t1517r1626b1542],
3	4.4	CD	NUMBER	4.4	dep	2	SENT_247	[p14l1284t1584r1344b1608],
4	:	:	O	:	_	0	SENT_247	[p14l1284t1584r1344b1608],
5	0.8	CD	NUMBER	0.8	dep	2	SENT_247	[p14l1349t1584r1385b1608],
6	0.601	CD	NUMBER	0.601	number	7	SENT_247	[p14l1612t1584r1674b1608],
7	49.9	CD	NUMBER	49.9	dep	5	SENT_247	[p14l1269t1635r1320b1659],
8	i	FW	O	i	dep	2	SENT_247	[p14l1325t1638r1344b1659],
9	30.7	CD	NUMBER	30.7	number	10	SENT_247	[p14l1349t1635r1400b1659],
10	0.045	CD	NUMBER	0.045	dep	8	SENT_247	[p14l1612t1635r1677b1659],

1	Table	NNP	O	Table	nn	3	SENT_248	[p14l7t1847r165b1901],
2	2	CD	NUMBER	2	num	3	SENT_248	[p14l179t1850r210b1901],
3	Characteristics	NNS	O	characteristic	_	0	SENT_248	[p14l263t1847r640b1901],
4	of	IN	O	of	_	0	SENT_248	[p14l659t1846r713b1901],
5	responders	NNS	O	responder	prep_of	3	SENT_248	[p14l728t1847r1014b1915],
6	and	CC	O	and	_	0	SENT_248	[p14l1033t1847r1128b1901],
7	non	JJ	O	non	amod	9	SENT_248	[p14l1150t1847r1562b1916],
8	—	NN	O	—	nn	9	SENT_248	[p14l1150t1847r1562b1916],
9	responders	NNS	O	responder	prep_of	3	SENT_248	[p14l1150t1847r1562b1916],
10	as	IN	O	as	mark	11	SENT_248	[p14l1581t1863r1632b1901],
11	deﬁned	VBN	O	deﬁned	dep	3	SENT_248	[p14l1651t1846r1846b1901],
12	by	IN	O	by	_	0	SENT_248	[p14l1869t1847r1929b1917],
13	a	DT	O	a	det	14	SENT_248	[p14l1946t1863r1971b1901],
14	difference	NN	O	difference	prep_by	11	SENT_248	[p14l1992t1846r2150b1901, p14l8t1945r128b1984],
15	in	IN	O	in	_	0	SENT_248	[p14l146t1931r189b1984],
16	PANSS	NNP	O	PANSS	nn	18	SENT_248	[p14l210t1931r378b1984],
17	total	JJ	O	total	amod	18	SENT_248	[p14l393t1930r511b1984],
18	scores	NNS	O	score	prep_in	14	SENT_248	[p14l530t1945r688b1984],
19	between	IN	O	between	_	0	SENT_248	[p14l707t1930r932b1984],
20	baseline	NN	O	baseline	prep_between	18	SENT_248	[p14l952t1930r1165b1984],
21	and	CC	O	and	_	0	SENT_248	[p14l1182t1930r1276b1984],
22	last	JJ	O	last	amod	23	SENT_248	[p14l1297t1930r1384b1984],
23	observation	NN	O	observation	conj_and	18	SENT_248	[p14l1400t1930r1705b1984],
24	of	IN	O	of	prep	23	SENT_248	[p14l1725t1929r1778b1984],
25	at	IN	O	at	pcomp	24	SENT_248	[p14l1789t1938r1838b1984],
26	least	JJS	O	least	pobj	25	SENT_248	[p14l1856t1930r1975b1984],
27	or	CC	O	or	_	0	SENT_248	[p14l1991t1945r2043b1984],
28	less	JJR	O	less	mwe	29	SENT_248	[p14l2060t1930r2150b1984],
29	than	IN	O	than	quantmod	30	SENT_248	[p14l7t2012r124b2066],
30	30	CD	PERCENT	30	num	31	SENT_248	[p14l144t2014r205b2066],
31	%	NN	PERCENT	%	prep_by	11	SENT_248	[p14l225t2014r290b2075],
32	,	,	O	,	_	0	SENT_248	[p14l225t2014r290b2075],
33	respectively	RB	O	respectively	advmod	11	SENT_248	[p14l309t2012r618b2081],

1	Mean	NN	O	mean	_	0	SENT_249	[p14l48t2189r189b2243],
2	i	FW	O	i	dep	1	SENT_249	[p14l208t2197r249b2242],
3	SD	NN	O	sd	dep	1	SENT_249	[p14l267t2189r334b2243],

1	Sex	NN	O	sex	dep	9	SENT_250	[p14l47t2349r135b2403],
2	(	CD	NUMBER	(	num	1	SENT_250	[p14l154t2347r520b2411],
3	male/female	NN	O	male/female	nn	5	SENT_250	[p14l154t2347r520b2411],
4	)	CD	NUMBER	)	num	5	SENT_250	[p14l154t2347r520b2411],
5	Age	NNP	O	Age	dep	1	SENT_250	[p14l46t2451r146b2518],
6	(	CD	NUMBER	(	num	7	SENT_250	[p14l166t2449r336b2519],
7	years	NNS	NUMBER	year	dep	9	SENT_250	[p14l166t2449r336b2519],
8	)	JJ	O	)	amod	9	SENT_250	[p14l166t2449r336b2519],
9	Age	NN	O	age	dep	18	SENT_250	[p14l46t2553r146b2621],
10	of	IN	O	of	_	0	SENT_250	[p14l164t2551r218b2606],
11	onset	NN	O	onset	nn	14	SENT_250	[p14l230t2559r373b2606],
12	Illness	NN	O	illness	nn	14	SENT_250	[p14l49t2653r205b2707],
13	duration	NN	O	duration	nn	14	SENT_250	[p14l223t2653r443b2707],
14	Weight	NNP	O	Weight	prep_of	9	SENT_250	[p14l46t2756r236b2825],
15	(	CD	NUMBER	(	num	14	SENT_250	[p14l255t2756r351b2825],
16	kg	NN	O	kg	nn	18	SENT_250	[p14l255t2756r351b2825],
17	)	NN	O	)	nn	18	SENT_250	[p14l255t2756r351b2825],
18	Diagnosis	NN	O	diagnosis	_	0	SENT_250	[p14l49t2861r297b2929],
19	Paranoid	JJ	O	paranoid	amod	23	SENT_250	[p14l113t2949r340b3004],
20	Disorganized	JJ	O	disorganized	amod	23	SENT_250	[p14l113t3039r448b3108],
21	Schizoaffective	JJ	O	schizoaffective	amod	23	SENT_250	[p14l111t3129r500b3184],
22	Undifferentiated	JJ	O	undifferentiated	amod	23	SENT_250	[p14l113t3219r542b3274],
23	Schizophreniform	NN	O	schizophreniform	dep	18	SENT_250	[p14l111t3307r572b3377],

1	Medication	NN	O	medication	_	0	SENT_251	[p14l48t3411r336b3466],

1	Rkpendone	NNP	O	Rkpendone	nn	3	SENT_252	[p14l113t3501r418b3570],
2	Lorazepam	NNP	O	Lorazepam	nn	3	SENT_252	[p14l113t3592r396b3659],
3	Biperiden	NNP	O	Biperiden	_	0	SENT_252	[p14l113t3681r358b3750],

1	N	NN	O	n	_	0	SENT_253	[p14l687t2189r719b2242],

1	48	CD	NUMBER	48	_	0	SENT_254	[p14l684t2952r747b3004],
2	l	NN	O	l	prep	1	SENT_254	[p14l717t3042r748b3362],
3	\	CD	NUMBER	\	dep	2	SENT_254	[p14l717t3042r748b3362],
4	)	SYM	O	)	dep	1	SENT_254	[p14l717t3042r748b3362],
5	-	:	O	-	_	0	SENT_254	[p14l717t3042r748b3362],
6	l	NN	O	l	dep	7	SENT_254	[p14l717t3042r748b3362],
7	>	JJR	O	>	dep	1	SENT_254	[p14l717t3042r748b3362],
8	\	CD	NUMBER	\	num	9	SENT_254	[p14l717t3042r748b3362],
9	l	NN	O	l	dep	1	SENT_254	[p14l717t3042r748b3362],
10	®	IN	O	®	amod	9	SENT_254	[p14l717t3042r748b3362],

1	Responder	NN	O	responder	_	0	SENT_255	[p14l943t2188r1220b2257],

1	18/13	CD	NUMBER	18/13	number	2	SENT_256	[p14l944t2349r1089b2405],
2	35.9	CD	NUMBER	35.9	_	0	SENT_256	[p14l941t2452r1102b2503],
3	:	:	O	:	_	0	SENT_256	[p14l941t2452r1102b2503],
4	12.3	CD	NUMBER	12.3	number	5	SENT_256	[p14l1117t2452r1221b2503],
5	34.3	CD	NUMBER	34.3	dep	2	SENT_256	[p14l941t2554r1048b2606],
6	i	FW	O	i	dep	5	SENT_256	[p14l1061t2561r1102b2605],
7	18.3	CD	NUMBER	18.3	number	8	SENT_256	[p14l1117t2554r1221b2606],
8	56.0	CD	NUMBER	56.0	num	9	SENT_256	[p14l941t2656r1221b2707],
9	i78	NN	O	i78	dep	2	SENT_256	[p14l941t2656r1221b2707],
10	.5	CD	NUMBER	.5	number	11	SENT_256	[p14l941t2656r1221b2707],
11	72.6	CD	NUMBER	72.6	num	13	SENT_256	[p14l942t2759r1224b2811],
12	i13	NN	O	i13	nn	13	SENT_256	[p14l942t2759r1224b2811],
13	.4	NN	NUMBER	.4	dep	9	SENT_256	[p14l942t2759r1224b2811],

1	l	NN	O	l	_	0	SENT_257	[p14l973t2953r1002b3362],
2	\	SYM	O	\	dep	3	SENT_257	[p14l973t2953r1002b3362],
3	)	CD	MONEY	)	rcmod	1	SENT_257	[p14l973t2953r1002b3362],
4	$	$	MONEY	$	amod	7	SENT_257	[p14l973t2953r1002b3362],
5	l	NN	MONEY	l	dep	4	SENT_257	[p14l973t2953r1002b3362],
6	\	NN	O	\	nn	7	SENT_257	[p14l973t2953r1002b3362],
7	Jl	NN	O	jl	dep	1	SENT_257	[p14l973t2953r1002b3362],
8	\	CD	NUMBER	\	num	9	SENT_257	[p14l973t2953r1002b3362],
9	JU'I	NN	O	ju'us	dep	7	SENT_257	[p14l973t2953r1002b3362],

1	Non-Responder	JJ	O	non-responder	_	0	SENT_258	[p14l1339t2188r1748b2257],

1	20/22	CD	NUMBER	20/22	number	2	SENT_259	[p14l1337t2349r1486b2405],
2	36.3	CD	NUMBER	36.3	num	3	SENT_259	[p14l1337t2452r1620b2503],
3	i13	NN	O	i13	_	0	SENT_259	[p14l1337t2452r1620b2503],
4	.4	CD	NUMBER	.4	number	5	SENT_259	[p14l1337t2452r1620b2503],
5	31.1	CD	NUMBER	31.1	num	3	SENT_259	[p14l1337t2554r1438b2606],
6	i	FW	O	i	dep	3	SENT_259	[p14l1457t2561r1498b2605],
7	16.8	CD	NUMBER	16.8	number	8	SENT_259	[p14l1513t2554r1619b2606],
8	94.9	CD	NUMBER	94.9	num	9	SENT_259	[p14l1337t2656r1651b2707],
9	i108	NN	O	i108	dep	3	SENT_259	[p14l1337t2656r1651b2707],
10	.6	CD	NUMBER	.6	number	11	SENT_259	[p14l1337t2656r1651b2707],
11	76.9	CD	NUMBER	76.9	num	13	SENT_259	[p14l1338t2759r1610b2811],
12	i16	NN	O	i16	nn	13	SENT_259	[p14l1338t2759r1610b2811],
13	.1	NN	NUMBER	.1	dep	9	SENT_259	[p14l1338t2759r1610b2811],

1	24	CD	NUMBER	24	_	0	SENT_260	[p14l1337t2952r1399b3003],
2	©	SYM	O	©	dep	1	SENT_260	[p14l1369t3042r1399b3362],
3	-	:	O	-	_	0	SENT_260	[p14l1369t3042r1399b3362],
4	bU'IOO	NN	O	bu'ioo	dep	1	SENT_260	[p14l1369t3042r1399b3362],

1	P	NN	O	p	_	0	SENT_261	[p14l1862t2203r1891b2257],

1	PANSS	NNS	O	panss	_	0	SENT_262	[p15l49t24r216b77],

1	Total	JJ	O	total	amod	3	SENT_263	[p15l109t113r236b169],
2	(	NN	O	(	nn	3	SENT_263	[p15l258t113r509b177],
3	baseline	NN	O	baseline	_	0	SENT_263	[p15l258t113r509b177],
4	)	CD	NUMBER	)	dep	3	SENT_263	[p15l258t113r509b177],
5	31/42	CD	NUMBER	31/42	number	6	SENT_263	[p15l685t115r835b171],
6	88.8	CD	NUMBER	88.8	num	7	SENT_263	[p15l940t116r1223b169],
7	i20	NN	O	i20	dep	4	SENT_263	[p15l940t116r1223b169],
8	.0	CD	NUMBER	.0	num	9	SENT_263	[p15l940t116r1223b169],
9	83.6	CD	NUMBER	83.6	dep	3	SENT_263	[p15l1337t116r1498b169],
10	:	:	O	:	_	0	SENT_263	[p15l1337t116r1498b169],
11	19.2	CD	NUMBER	19.2	number	12	SENT_263	[p15l1512t116r1618b169],
12	0.275	CD	NUMBER	0.275	dep	9	SENT_263	[p15l1860t116r2001b169],

1	Genotype	NN	O	genotype	_	0	SENT_264	[p15l46t217r298b286],

1	Wildtype	JJ	O	wildtype	amod	3	SENT_265	[p15l110t305r344b375],
2	45	CD	NUMBER	45	number	3	SENT_265	[p15l684t309r745b360],
3	19	CD	NUMBER	19	_	0	SENT_265	[p15l944t308r1002b360],
4	26	CD	NUMBER	26	number	5	SENT_265	[p15l1337t308r1398b360],
5	Heterozygous	JJ	O	heterozygous	amod	3	SENT_265	[p15l113t397r469b465],
6	6	CD	NUMBER	6	number	7	SENT_265	[p15l718t398r747b450],
7	2	CD	NUMBER	2	dep	3	SENT_265	[p15l974t398r1001b449],
8	4	CD	NUMBER	4	dep	7	SENT_265	[p15l1369t399r1399b449],

1	EPS	NN	O	ep	nn	3	SENT_266	[p15l9t670r154b734],
2	(	CD	NUMBER	(	num	3	SENT_266	[p15l209t666r493b757],
3	Fig	NN	O	fig	_	0	SENT_266	[p15l209t666r493b757],
4	.4	CD	NUMBER	.4	num	5	SENT_266	[p15l209t666r493b757],
5	)	NN	O	)	dep	3	SENT_266	[p15l209t666r493b757],
6	.	.	O	.	_	0	SENT_266	[p15l209t666r493b757],

1	Interestingly	RB	O	interestingly	advmod	10	SENT_267	[p15l541t665r1043b757],
2	,	,	O	,	_	0	SENT_267	[p15l541t665r1043b757],
3	high	JJ	O	high	amod	5	SENT_267	[p15l1087t665r1260b757],
4	plasma	NN	O	plasma	nn	5	SENT_267	[p15l1309t665r1585b756],
5	levels	NNS	O	level	nsubj	10	SENT_267	[p15l1633t665r1841b734],
6	during	IN	O	during	_	0	SENT_267	[p15l1893t665r2152b757],
7	treatment	NN	O	treatment	prep_during	5	SENT_267	[p15l8t779r387b836],
8	did	VBD	O	do	aux	10	SENT_267	[p15l420t766r545b836],
9	not	RB	O	not	neg	10	SENT_267	[p15l577t779r705b836],
10	correspond	VB	O	correspond	_	0	SENT_267	[p15l738t767r1177b858],
11	to	TO	O	to	_	0	SENT_267	[p15l1208t779r1280b836],
12	elevated	JJ	O	elevated	amod	13	SENT_267	[p15l1317t766r1629b836],
13	risk	NN	O	risk	prep_to	10	SENT_267	[p15l1661t767r1808b836],
14	for	IN	O	for	_	0	SENT_267	[p15l1839t766r1948b836],
15	EPS	NNP	O	EPS	prep_for	10	SENT_267	[p15l1981t771r2149b847],
16	,	,	O	,	_	0	SENT_267	[p15l1981t771r2149b847],
17	when	WRB	O	when	advmod	23	SENT_267	[p15l6t868r215b937],
18	initial	JJ	O	initial	amod	20	SENT_267	[p15l241t868r468b937],
19	plasma	NN	O	plasma	nn	20	SENT_267	[p15l493t868r769b959],
20	levels	NNS	O	level	nsubj	23	SENT_267	[p15l793t868r1001b937],
21	were	VBD	O	be	cop	23	SENT_267	[p15l1026t892r1207b937],
22	comparably	RB	O	comparably	advmod	23	SENT_267	[p15l1234t868r1691b960],
23	low	JJ	O	low	advcl	10	SENT_267	[p15l1712t868r1859b937],
24	.	.	O	.	_	0	SENT_267	[p15l1712t868r1859b937],

1	Discussion	NN	O	discussion	_	0	SENT_268	[p15l12t1122r437b1199],

1	Monitoring	NN	O	monitoring	nsubj	13	SENT_269	[p15l8t1337r451b1427],
2	of	IN	O	of	_	0	SENT_269	[p15l485t1334r566b1403],
3	drug	NN	O	drug	nn	5	SENT_269	[p15l594t1334r777b1427],
4	plasma	NN	O	plasma	nn	5	SENT_269	[p15l809t1334r1085b1425],
5	levels	NNS	O	level	prep_of	1	SENT_269	[p15l1117t1334r1326b1403],
6	to	TO	O	to	aux	7	SENT_269	[p15l1361t1347r1434b1403],
7	assess	VB	O	assess	infmod	1	SENT_269	[p15l1471t1359r1698b1403],
8	clinical	JJ	O	clinical	amod	10	SENT_269	[p15l1735t1334r2010b1403],
9	response	NN	O	response	nn	10	SENT_269	[p15l2045t1359r2148b1403, p15l10t1460r270b1527],
10	variability	NN	O	variability	dobj	7	SENT_269	[p15l295t1436r694b1528],
11	became	VBD	O	become	cop	13	SENT_269	[p15l714t1436r1010b1505],
12	a	DT	O	a	det	13	SENT_269	[p15l1038t1460r1077b1505],
13	focus	NN	O	focus	_	0	SENT_269	[p15l1103t1436r1305b1505],
14	of	IN	O	of	_	0	SENT_269	[p15l1334t1436r1415b1505],
15	interest	NN	O	interest	prep_of	13	SENT_269	[p15l1435t1439r1723b1505],
16	some	DT	O	some	det	17	SENT_269	[p15l1749t1460r1950b1505],
17	time	NN	O	time	npadvmod	18	SENT_269	[p15l1976t1438r2150b1505],
18	ago	IN	O	ago	advmod	13	SENT_269	[p15l10t1563r140b1631],
19	(	CD	NUMBER	(	num	20	SENT_269	[p15l191t1538r657b1630],
20	Ereshevsky	NNP	O	Ereshevsky	dep	13	SENT_269	[p15l191t1538r657b1630],
21	1995	CD	DATE	1995	num	20	SENT_269	[p15l705t1539r927b1622],
22	)	CD	NUMBER	)	dep	20	SENT_269	[p15l705t1539r927b1622],
23	.	.	O	.	_	0	SENT_269	[p15l705t1539r927b1622],

1	Close	JJ	O	close	amod	3	SENT_270	[p15l971t1538r1176b1607],
2	clinical	JJ	O	clinical	amod	3	SENT_270	[p15l1223t1538r1498b1607],
3	observation	NN	O	observation	nsubj	12	SENT_270	[p15l1543t1538r1998b1607],
4	together	RB	O	together	_	0	SENT_270	[p15l2042t1551r2148b1607, p15l8t1641r252b1733],
5	with	IN	O	with	_	0	SENT_270	[p15l277t1641r450b1710],
6	frequent	JJ	O	frequent	amod	10	SENT_270	[p15l479t1641r805b1732],
7	drug	NN	O	drug	nn	10	SENT_270	[p15l834t1641r1016b1733],
8	plasma	NN	O	plasma	nn	10	SENT_270	[p15l1043t1641r1319b1732],
9	level	NN	O	level	nn	10	SENT_270	[p15l1346t1641r1520b1710],
10	monitoring	NN	O	monitoring	prep_together_with	12	SENT_270	[p15l1548t1644r1991b1733],
11	can	MD	O	can	aux	12	SENT_270	[p15l2019t1665r2151b1710],
12	improve	VB	O	improve	_	0	SENT_270	[p15l9t1775r324b1864],
13	precision	NN	O	precision	dobj	12	SENT_270	[p15l388t1775r743b1863],
14	in	IN	O	in	_	0	SENT_270	[p15l806t1775r880b1840],
15	optimizing	VBG	O	optimize	prepc_in	12	SENT_270	[p15l945t1775r1368b1865],
16	individual	JJ	O	individual	amod	18	SENT_270	[p15l1429t1772r1823b1841],
17	dosage	NN	O	dosage	nn	18	SENT_270	[p15l1888t1772r2150b1865],
18	strategies	NNS	O	strategy	nsubj	19	SENT_270	[p15l10t1876r373b1966],
19	(	VBP	O	(	ccomp	15	SENT_270	[p15l411t1874r682b1966],
20	Darby	NNP	PERSON	Darby	nsubj	22	SENT_270	[p15l411t1874r682b1966],
21	et	FW	O	et	nn	22	SENT_270	[p15l712t1887r780b1943],
22	al.	FW	O	al.	xcomp	19	SENT_270	[p15l798t1874r880b1943],
23	1997	CD	DATE	1997	num	24	SENT_270	[p15l919t1875r1140b1958],
24	)	CD	NUMBER	)	dep	22	SENT_270	[p15l919t1875r1140b1958],
25	.	.	O	.	_	0	SENT_270	[p15l919t1875r1140b1958],

1	For	IN	O	for	_	0	SENT_271	[p15l1173t1880r1301b1943],
2	example	NN	O	example	prep_for	8	SENT_271	[p15l1335t1874r1676b1965],
3	,	,	O	,	_	0	SENT_271	[p15l1335t1874r1676b1965],
4	haloperidol	NN	O	haloperidol	nn	5	SENT_271	[p15l1704t1874r2151b1965],
5	levels	NNS	O	level	nsubjpass	8	SENT_271	[p15l8t1975r216b2044],
6	have	VBP	O	have	aux	8	SENT_271	[p15l248t1975r422b2044],
7	been	VBN	O	be	auxpass	8	SENT_271	[p15l452t1975r636b2044],
8	established	VBN	O	establish	_	0	SENT_271	[p15l670t1975r1097b2044],
9	in	IN	O	in	_	0	SENT_271	[p15l1128t1978r1201b2043],
10	order	NN	O	order	prep_in	8	SENT_271	[p15l1235t1975r1443b2044],
11	to	TO	O	to	aux	12	SENT_271	[p15l1474t1988r1546b2044],
12	maximize	VB	O	maximize	xcomp	8	SENT_271	[p15l1580t1978r1955b2044],
13	efficacy	NN	O	efficacy	dobj	12	SENT_271	[p15l1989t1975r2139b2044, p15l11t2101r181b2169],
14	while	IN	O	while	_	0	SENT_271	[p15l207t2077r413b2146],
15	keeping	VBG	O	keep	prepc_while	12	SENT_271	[p15l444t2077r746b2169],
16	side	JJ	O	side	amod	17	SENT_271	[p15l779t2077r928b2146],
17	effects	NNS	O	effect	dobj	15	SENT_271	[p15l962t2077r1204b2146],
18	to	TO	O	to	_	0	SENT_271	[p15l1238t2090r1310b2146],
19	a	DT	O	a	det	22	SENT_271	[p15l1345t2101r1384b2146],
20	minimum	JJ	O	minimum	amod	22	SENT_271	[p15l1416t2079r1799b2146],
21	(	JJ	O	(	amod	22	SENT_271	[p15l1836t2077r2138b2161, p15l11t2182r271b2272],
22	BalantGorgia	NN	PERSON	balantgorgium	prep_to	15	SENT_271	[p15l1836t2077r2138b2161, p15l11t2182r271b2272],
23	and	CC	O	and	_	0	SENT_271	[p15l295t2179r438b2248],
24	Balant	JJ	O	balant	amod	26	SENT_271	[p15l462t2179r704b2248],
25	1995	CD	DATE	1995	num	26	SENT_271	[p15l735t2180r955b2263],
26	)	NN	O	)	prep_to	15	SENT_271	[p15l735t2180r955b2263],
27	.	.	O	.	_	0	SENT_271	[p15l735t2180r955b2263],

1	Routine	JJ	O	routine	amod	2	SENT_272	[p15l978t2182r1278b2248],
2	monitoring	NN	O	monitoring	nsubj	6	SENT_272	[p15l1303t2182r1743b2272],
3	of	IN	O	of	_	0	SENT_272	[p15l1766t2179r1847b2248],
4	clozapine	NN	O	clozapine	nn	5	SENT_272	[p15l1865t2179r2139b2270, p15l10t2283r125b2350],
5	levels	NNS	O	level	prep_of	2	SENT_272	[p15l159t2281r367b2350],
6	improves	VBZ	O	improve	_	0	SENT_272	[p15l403t2283r753b2372],
7	treatment	NN	O	treatment	nn	8	SENT_272	[p15l789t2294r1166b2350],
8	outcome	NN	O	outcome	dobj	6	SENT_272	[p15l1201t2294r1530b2350],
9	and	CC	O	and	_	0	SENT_272	[p15l1567t2281r1709b2350],
10	safety	NN	O	safety	dobj	6	SENT_272	[p15l1745t2281r1969b2373],
11	and	CC	O	and	_	0	SENT_272	[p15l2001t2281r2143b2350],
12	may	MD	O	may	aux	14	SENT_272	[p15l9t2408r173b2475],
13	also	RB	O	also	advmod	14	SENT_272	[p15l219t2383r367b2452],
14	provide	VB	O	provide	conj_and	6	SENT_272	[p15l417t2383r711b2474],
15	important	JJ	O	important	amod	17	SENT_272	[p15l762t2386r1151b2475],
16	treatment	NN	O	treatment	nn	17	SENT_272	[p15l1199t2396r1576b2452],
17	guidelines	NNS	O	guideline	dep	22	SENT_272	[p15l1625t2383r2017b2476],
18	in	IN	O	in	_	0	SENT_272	[p15l2069t2386r2142b2451],
19	treatment-resistant	JJ	O	treatment-resistant	amod	20	SENT_272	[p15l9t2487r750b2554],
20	patients	NNS	O	patient	prep_in	17	SENT_272	[p15l803t2487r1107b2576],
21	(	CD	NUMBER	(	dep	22	SENT_272	[p15l1167t2485r1410b2576],
22	Spina	NNP	O	Spina	dep	36	SENT_272	[p15l1167t2485r1410b2576],
23	et	FW	O	et	nn	24	SENT_272	[p15l1465t2498r1531b2554],
24	al.	FW	O	al.	dep	22	SENT_272	[p15l1550t2485r1632b2554],
25	2000	CD	DATE	2000	dep	24	SENT_272	[p15l1683t2492r1879b2565],
26	;	:	O	;	_	0	SENT_272	[p15l1683t2492r1879b2565],
27	Perry	NNP	PERSON	Perry	dep	24	SENT_272	[p15l1935t2491r2147b2577],
28	et	FW	O	et	nn	29	SENT_272	[p15l11t2600r77b2656],
29	al.	FW	O	al.	dep	27	SENT_272	[p15l96t2587r177b2656],
30	1991	CD	DATE	1991	dep	27	SENT_272	[p15l207t2595r395b2668],
31	;	:	O	;	_	0	SENT_272	[p15l207t2595r395b2668],
32	Kronig	NNP	O	Kronig	dep	24	SENT_272	[p15l420t2590r686b2680],
33	et	FW	O	et	nn	34	SENT_272	[p15l709t2600r776b2656],
34	al.	FW	O	al.	dep	32	SENT_272	[p15l794t2587r876b2656],
35	1995	CD	DATE	1995	num	36	SENT_272	[p15l906t2588r1126b2671],
36	)	NN	O	)	dep	14	SENT_272	[p15l906t2588r1126b2671],
37	.	.	O	.	_	0	SENT_272	[p15l906t2588r1126b2671],

1	On	IN	O	on	_	0	SENT_273	[p15l1150t2592r1262b2656],
2	the	DT	O	the	det	3	SENT_273	[p15l1286t2587r1404b2656],
3	contrary	NN	O	contrary	prep_on	8	SENT_273	[p15l1430t2600r1771b2679],
4	,	,	O	,	_	0	SENT_273	[p15l1430t2600r1771b2679],
5	Olanzapine	JJ	MISC	olanzapine	amod	6	SENT_273	[p15l1793t2587r2139b2678, p15l10t2691r125b2758],
6	monitoring	NN	O	monitoring	nsubj	8	SENT_273	[p15l152t2691r592b2781],
7	has	VBZ	O	have	aux	8	SENT_273	[p15l617t2689r744b2758],
8	yielded	VBN	O	yield	dep	17	SENT_273	[p15l770t2689r1054b2781],
9	mixed	JJ	O	mixed	amod	10	SENT_273	[p15l1079t2689r1318b2758],
10	results	NNS	O	result	dobj	8	SENT_273	[p15l1344t2689r1592b2758],
11	in	IN	O	in	_	0	SENT_273	[p15l1622t2691r1695b2757],
12	the	DT	O	the	det	13	SENT_273	[p15l1722t2689r1840b2758],
13	prediction	NN	O	prediction	prep_in	8	SENT_273	[p15l1867t2689r2139b2780, p15l9t2794r162b2860],
14	of	IN	O	of	_	0	SENT_273	[p15l202t2791r283b2860],
15	clinical	JJ	O	clinical	amod	16	SENT_273	[p15l316t2791r590b2860],
16	responses	NNS	O	response	prep_of	13	SENT_273	[p15l627t2815r1000b2882],
17	(	VBP	O	(	_	0	SENT_273	[p15l1044t2791r1458b2883],
18	Callaghan	NNP	PERSON	Callaghan	dobj	17	SENT_273	[p15l1044t2791r1458b2883],
19	et	FW	O	et	nn	20	SENT_273	[p15l1497t2804r1564b2860],
20	al.	FW	O	al.	nsubj	17	SENT_273	[p15l1582t2791r1664b2860],
21	1999	CD	DATE	1999	dep	20	SENT_273	[p15l1707t2798r1895b2871],
22	;	:	O	;	_	0	SENT_273	[p15l1707t2798r1895b2871],
23	Perry	NNP	PERSON	Perry	dep	20	SENT_273	[p15l1934t2797r2146b2883],
24	et	FW	O	et	nn	25	SENT_273	[p15l11t2905r77b2961],
25	al.	FW	O	al.	dep	23	SENT_273	[p15l96t2892r177b2961],
26	1997	CD	DATE	1997	num	27	SENT_273	[p15l208t2892r429b2975],
27	)	CD	NUMBER	)	dep	23	SENT_273	[p15l208t2892r429b2975],
28	.	.	O	.	_	0	SENT_273	[p15l208t2892r429b2975],

1	Our	PRP$	O	we	poss	2	SENT_274	[p15l126t2999r274b3063],
2	study	NN	O	study	nsubj	3	SENT_274	[p15l328t2994r539b3086],
3	results	VBZ	O	result	_	0	SENT_274	[p15l589t2994r836b3063],
4	suggest	VBP	O	suggest	ccomp	3	SENT_274	[p15l893t3007r1175b3086],
5	that	IN	O	that	complm	12	SENT_274	[p15l1227t2994r1376b3063],
6	the	DT	O	the	det	11	SENT_274	[p15l1428t2994r1546b3063],
7	active	JJ	O	active	amod	11	SENT_274	[p15l1602t2997r1822b3063],
8	moiety	NN	O	moiety	nn	11	SENT_274	[p15l1876t2997r2146b3086],
9	blood	NN	O	blood	nn	11	SENT_274	[p15l7t3096r232b3165],
10	plasma	NN	O	plasma	nn	11	SENT_274	[p15l260t3096r535b3187],
11	levels	NNS	O	level	nsubj	12	SENT_274	[p15l561t3096r769b3165],
12	consisting	VBG	O	consist	ccomp	4	SENT_274	[p15l800t3098r1191b3188],
13	of	IN	O	of	_	0	SENT_274	[p15l1219t3096r1300b3165],
14	both	DT	O	both	det	15	SENT_274	[p15l1320t3096r1498b3165],
15	risperidone	NN	O	risperidone	prep_of	12	SENT_274	[p15l1527t3096r1970b3187],
16	and	CC	O	and	_	0	SENT_274	[p15l2001t3096r2143b3165],
17	9	CD	NUMBER	9	prep_of	12	SENT_274	[p15l10t3198r701b3288],
18	.	.	O	.	_	0	SENT_274	[p15l10t3198r701b3288],

1	—	NN	O	—	_	0	SENT_275	[p15l10t3198r701b3288],
2	.	.	O	.	_	0	SENT_275	[p15l10t3198r701b3288],

1	OH	NN	O	oh	_	0	SENT_276	[p15l10t3198r701b3288],
2	.	.	O	.	_	0	SENT_276	[p15l10t3198r701b3288],

1	—	NN	O	—	_	0	SENT_277	[p15l10t3198r701b3288],
2	.	.	O	.	_	0	SENT_277	[p15l10t3198r701b3288],

1	risperidone	NN	O	risperidone	nsubjpass	3	SENT_278	[p15l10t3198r701b3288],
2	are	VBP	O	be	auxpass	3	SENT_278	[p15l729t3222r843b3267],
3	correlated	VBN	O	correlate	_	0	SENT_278	[p15l871t3198r1258b3267],
4	with	IN	O	with	_	0	SENT_278	[p15l1282t3198r1453b3267],
5	clinical	JJ	O	clinical	amod	6	SENT_278	[p15l1482t3198r1756b3267],
6	response	NN	O	response	prep_with	3	SENT_278	[p15l1782t3221r2140b3288],
7	,	,	O	,	_	0	SENT_278	[p15l1782t3221r2140b3288],
8	albeit	IN	O	albeit	mark	11	SENT_278	[p15l11t3298r223b3367],
9	their	PRP$	O	they	poss	10	SENT_278	[p15l269t3298r451b3367],
10	ratios	NNS	O	ratio	nsubj	11	SENT_278	[p15l498t3300r714b3367],
11	show	VBP	O	show	advcl	3	SENT_278	[p15l764t3298r959b3367],
12	considerable	JJ	O	considerable	amod	16	SENT_278	[p15l1004t3298r1488b3367],
13	inter-individual	JJ	O	inter-individual	amod	16	SENT_278	[p15l1536t3298r2143b3367],
14	variation	NN	O	variation	nn	16	SENT_278	[p16l7t26r355b92],
15	(	NN	O	(	nn	16	SENT_278	[p16l427t23r813b115],
16	Heykants	NNS	O	heykant	iobj	11	SENT_278	[p16l427t23r813b115],
17	et	FW	O	et	nn	18	SENT_278	[p16l882t36r949b92],
18	al.	FW	O	al.	dep	16	SENT_278	[p16l967t23r1050b92],
19	1994	CD	DATE	1994	num	20	SENT_278	[p16l1121t24r1342b107],
20	)	CD	NUMBER	)	dobj	11	SENT_278	[p16l1121t24r1342b107],
21	.	.	O	.	_	0	SENT_278	[p16l1121t24r1342b107],

1	While	IN	O	while	mark	7	SENT_279	[p16l1403t23r1630b92],
2	risperidone	NN	O	risperidone	nn	4	SENT_279	[p16l1697t23r2141b114],
3	plasma	NN	O	plasma	nn	4	SENT_279	[p16l9t125r284b215],
4	levels	NNS	O	level	nsubjpass	7	SENT_279	[p16l313t125r520b193],
5	alone	RB	O	alone	advmod	7	SENT_279	[p16l553t125r757b193],
6	were	VBD	O	be	auxpass	7	SENT_279	[p16l785t148r965b193],
7	correlated	VBN	O	correlate	advcl	15	SENT_279	[p16l997t125r1384b193],
8	to	TO	O	to	_	0	SENT_279	[p16l1413t138r1486b193],
9	oral	JJ	O	oral	amod	11	SENT_279	[p16l1519t125r1668b193],
10	risperidone	NN	O	risperidone	nn	11	SENT_279	[p16l1697t125r2141b215],
11	intake	NN	O	intake	prep_to	7	SENT_279	[p16l10t226r263b307],
12	,	,	O	,	_	0	SENT_279	[p16l10t226r263b307],
13	9-OH-risperidone	NN	O	9-oh-risperidone	nn	14	SENT_279	[p16l282t226r973b317],
14	levels	NNS	O	level	nsubjpass	20	SENT_279	[p16l994t226r1202b295],
15	were	VBD	O	be	_	0	SENT_279	[p16l1223t250r1403b295],
16	not	RB	O	not	neg	15	SENT_279	[p16l1426t239r1552b295],
17	and	CC	O	and	_	0	SENT_279	[p16l1575t226r1717b295],
18	were	VBD	O	be	auxpass	20	SENT_279	[p16l1736t250r1915b295],
19	likely	JJ	O	likely	advmod	20	SENT_279	[p16l1937t226r2146b318],
20	determined	VBN	O	determine	conj_and	15	SENT_279	[p16l10t328r457b397],
21	by	IN	O	by	_	0	SENT_279	[p16l489t328r583b420],
22	CYP2D6	NN	O	cyp2d6	nn	23	SENT_279	[p16l617t333r935b397],
23	polymorphisms	NNS	O	polymorphism	agent	20	SENT_279	[p16l972t328r1603b420],
24	.	.	O	.	_	0	SENT_279	[p16l972t328r1603b420],

1	For	IN	O	for	_	0	SENT_280	[p16l1637t334r1765b397],
2	example	NN	O	example	prep_for	22	SENT_280	[p16l1801t328r2141b419],
3	,	,	O	,	_	0	SENT_280	[p16l1801t328r2141b419],
4	some	DT	O	some	det	5	SENT_280	[p16l11t454r211b499],
5	alleles	NNS	O	allele	nsubjpass	22	SENT_280	[p16l233t430r465b499],
6	of	IN	O	of	_	0	SENT_280	[p16l488t430r569b499],
7	the	DT	O	the	det	8	SENT_280	[p16l582t430r700b499],
8	CYP2D6-isoenzyme	NN	O	cyp2d6-isoenzyme	prep_of	5	SENT_280	[p16l723t433r1492b522],
9	such	JJ	O	such	_	0	SENT_280	[p16l1515t430r1688b499],
10	as	IN	O	as	_	0	SENT_280	[p16l1710t454r1783b499],
11	the	DT	O	the	det	12	SENT_280	[p16l1805t430r1923b499],
12	allele	NN	O	allele	prep_such_as	8	SENT_280	[p16l1945t430r2141b499],
13	4	CD	NUMBER	4	num	12	SENT_280	[p16l9t540r49b600],
14	found	VBN	O	find	partmod	5	SENT_280	[p16l80t532r307b601],
15	in	IN	O	in	_	0	SENT_280	[p16l336t535r410b600],
16	several	JJ	O	several	prep_in	14	SENT_280	[p16l442t533r705b601],
17	of	IN	O	of	_	0	SENT_280	[p16l736t532r817b601],
18	our	PRP$	O	we	poss	19	SENT_280	[p16l841t557r972b601],
19	subjects	NNS	O	subject	prep_of	16	SENT_280	[p16l1002t532r1306b625],
20	are	VBP	O	be	auxpass	22	SENT_280	[p16l1339t557r1453b601],
21	highly	RB	O	highly	advmod	22	SENT_280	[p16l1482t532r1728b625],
22	correlated	VBN	O	correlate	_	0	SENT_280	[p16l1755t532r2143b601],
23	with	IN	O	with	_	0	SENT_280	[p16l7t634r179b703],
24	a	DT	O	a	det	27	SENT_280	[p16l215t658r254b703],
25	poor	JJ	O	poor	amod	27	SENT_280	[p16l286t658r469b725],
26	metabolizer	NN	O	metabolizer	nn	27	SENT_280	[p16l502t634r961b703],
27	status	NN	O	status	prep_with	22	SENT_280	[p16l995t647r1215b703],
28	with	IN	O	with	_	0	SENT_280	[p16l1248t634r1420b703],
29	respect	NN	O	respect	prep_with	27	SENT_280	[p16l1454t647r1728b725],
30	to	TO	O	to	_	0	SENT_280	[p16l1760t647r1832b703],
31	the	DT	O	the	det	32	SENT_280	[p16l1868t634r1986b703],
32	hydroxylation	NN	O	hydroxylation	prep_to	22	SENT_280	[p16l2019t634r2139b726, p16l10t737r453b829],
33	of	IN	O	of	_	0	SENT_280	[p16l498t736r580b805],
34	risperidone	NN	O	risperidone	prep_of	32	SENT_280	[p16l616t737r1060b828],
35	to	TO	O	to	_	0	SENT_280	[p16l1104t749r1176b805],
36	9-OH-risperidone	NN	O	9-oh-risperidone	prep_to	22	SENT_280	[p16l1223t737r1933b828],
37	.	.	O	.	_	0	SENT_280	[p16l1223t737r1933b828],

1	Heterozygote	NN	O	heterozygote	nn	2	SENT_281	[p16l1975t743r2139b805, p16l11t851r378b930],
2	carriers	NNS	O	carrier	nsubj	9	SENT_281	[p16l407t841r702b907],
3	of	IN	O	of	_	0	SENT_281	[p16l732t838r813b907],
4	such	PDT	O	such	predet	7	SENT_281	[p16l836t838r1009b907],
5	a	DT	O	a	det	7	SENT_281	[p16l1037t862r1077b907],
6	mutant	JJ	O	mutant	amod	7	SENT_281	[p16l1104t851r1380b907],
7	allele	NN	O	allele	prep_of	2	SENT_281	[p16l1408t838r1604b907],
8	4	CD	NUMBER	4	dep	7	SENT_281	[p16l1632t846r1673b906],
9	show	VBP	O	show	_	0	SENT_281	[p16l1703t838r1898b907],
10	a	DT	O	a	det	12	SENT_281	[p16l1924t862r1963b907],
11	tendential	JJ	O	tendential	amod	12	SENT_281	[p16l1989t851r2139b907, p16l10t941r274b1010],
12	increase	NN	O	increase	dobj	9	SENT_281	[p16l300t943r612b1010],
13	in	IN	O	in	_	0	SENT_281	[p16l639t943r712b1008],
14	the	DT	O	the	det	15	SENT_281	[p16l737t940r855b1010],
15	risperidone	NN	O	risperidone	prep_in	12	SENT_281	[p16l881t941r1325b1032],
16	to	TO	O	to	_	0	SENT_281	[p16l1351t953r1423b1010],
17	9-OH-risperidone	NN	O	9-oh-risperidone	prep_to	15	SENT_281	[p16l1451t941r2141b1032],
18	ratio	NN	O	ratio	dep	27	SENT_281	[p16l10t1045r188b1111],
19	without	IN	O	without	_	0	SENT_281	[p16l210t1042r511b1111],
20	an	DT	O	a	det	22	SENT_281	[p16l534t1066r624b1111],
21	additional	JJ	O	additional	amod	22	SENT_281	[p16l649t1042r1041b1111],
22	change	NN	O	change	prep_without	18	SENT_281	[p16l1065t1042r1333b1134],
23	in	IN	O	in	_	0	SENT_281	[p16l1356t1045r1430b1110],
24	active	JJ	O	active	amod	25	SENT_281	[p16l1455t1045r1675b1111],
25	moiety	NN	O	moiety	prep_in	22	SENT_281	[p16l1698t1045r1969b1134],
26	(	CD	NUMBER	(	dep	27	SENT_281	[p16l1991t1043r2139b1126, p16l11t1144r498b1213],
27	Yasui-Furukori	NNP	O	Yasui-Furukori	dep	31	SENT_281	[p16l1991t1043r2139b1126, p16l11t1144r498b1213],
28	et	FW	O	et	nn	29	SENT_281	[p16l536t1157r603b1213],
29	al.	FW	O	al.	dep	27	SENT_281	[p16l621t1144r703b1213],
30	2003	CD	DATE	2003	num	31	SENT_281	[p16l737t1145r965b1228],
31	)	CD	NUMBER	)	dep	9	SENT_281	[p16l737t1145r965b1228],
32	.	.	O	.	_	0	SENT_281	[p16l737t1145r965b1228],

1	Consequently	RB	O	consequently	advmod	8	SENT_282	[p16l1001t1145r1537b1237],
2	,	,	O	,	_	0	SENT_282	[p16l1001t1145r1537b1237],
3	the	DT	O	the	det	5	SENT_282	[p16l1569t1145r1688b1213],
4	clinical	JJ	O	clinical	amod	5	SENT_282	[p16l1726t1145r2000b1213],
5	response	NN	O	response	nsubjpass	8	SENT_282	[p16l2037t1169r2139b1213, p16l11t1269r270b1336],
6	is	VBZ	O	be	auxpass	8	SENT_282	[p16l298t1249r355b1315],
7	not	RB	O	not	neg	8	SENT_282	[p16l384t1259r511b1315],
8	altered	VBN	O	alter	_	0	SENT_282	[p16l538t1246r818b1315],
9	.	.	O	.	_	0	SENT_282	[p16l538t1246r818b1315],

1	Yet	RB	O	yet	advmod	10	SENT_283	[p16l838t1252r972b1326],
2	,	,	O	,	_	0	SENT_283	[p16l838t1252r972b1326],
3	for	IN	O	for	_	0	SENT_283	[p16l995t1246r1104b1315],
4	the	DT	O	the	det	6	SENT_283	[p16l1130t1246r1248b1315],
5	same	JJ	O	same	amod	6	SENT_283	[p16l1277t1270r1471b1315],
6	reasons	NNS	O	reason	prep_for	10	SENT_283	[p16l1499t1270r1810b1326],
7	,	,	O	,	_	0	SENT_283	[p16l1499t1270r1810b1326],
8	it	PRP	O	it	nsubj	10	SENT_283	[p16l1833t1249r1885b1315],
9	seems	VBZ	O	seem	cop	10	SENT_283	[p16l1913t1270r2140b1315],
10	important	JJ	O	important	_	0	SENT_283	[p16l10t1350r399b1439],
11	to	TO	O	to	aux	12	SENT_283	[p16l439t1360r511b1417],
12	measure	VB	O	measure	xcomp	10	SENT_283	[p16l554t1372r876b1417],
13	both	CC	O	both	prep	12	SENT_283	[p16l915t1347r1093b1417],
14	compounds	NNS	O	compound	dep	13	SENT_283	[p16l1135t1348r1583b1439],
15	and	CC	O	and	_	0	SENT_283	[p16l1626t1347r1769b1417],
16	calculate	VB	O	calculate	xcomp	10	SENT_283	[p16l1809t1348r2141b1417],
17	the	DT	O	the	det	19	SENT_283	[p16l9t1449r127b1518],
18	active	JJ	O	active	amod	19	SENT_283	[p16l166t1452r386b1518],
19	moiety	NN	O	moiety	dobj	16	SENT_283	[p16l425t1452r695b1541],
20	to	TO	O	to	aux	22	SENT_283	[p16l728t1462r800b1518],
21	effectively	RB	O	effectively	advmod	22	SENT_283	[p16l841t1449r1231b1541],
22	relate	VB	O	relate	xcomp	16	SENT_283	[p16l1265t1449r1474b1518],
23	plasma	NN	O	plasma	nn	24	SENT_283	[p16l1511t1449r1786b1540],
24	levels	NNS	O	level	dobj	22	SENT_283	[p16l1821t1449r2029b1518],
25	to	TO	O	to	_	0	SENT_283	[p16l2068t1462r2139b1518],
26	clinical	JJ	O	clinical	amod	27	SENT_283	[p16l11t1551r285b1621],
27	response	NN	O	response	prep_to	22	SENT_283	[p16l310t1575r666b1643],
28	.	.	O	.	_	0	SENT_283	[p16l310t1575r666b1643],

1	Animal	NN	O	animal	nn	2	SENT_284	[p16l123t1652r408b1721],
2	models	NNS	O	model	nsubj	4	SENT_284	[p16l450t1652r727b1721],
3	have	VBP	O	have	aux	4	SENT_284	[p16l769t1652r943b1721],
4	shown	VBN	O	show	_	0	SENT_284	[p16l988t1652r1235b1721],
5	a	DT	O	a	det	6	SENT_284	[p16l1279t1676r1318b1721],
6	correlation	NN	O	correlation	dobj	4	SENT_284	[p16l1360t1652r1782b1721],
7	between	IN	O	between	_	0	SENT_284	[p16l1823t1652r2142b1721],
8	dopamine	NN	O	dopamine	nn	11	SENT_284	[p16l10t1755r396b1846],
9	D2	NN	O	d2	nn	11	SENT_284	[p16l434t1761r538b1822],
10	receptor	NN	O	receptor	nn	11	SENT_284	[p16l576t1767r895b1846],
11	occupancy	NN	O	occupancy	prep_between	6	SENT_284	[p16l932t1778r1346b1847],
12	in	IN	O	in	_	0	SENT_284	[p16l1378t1757r1451b1822],
13	the	DT	O	the	det	14	SENT_284	[p16l1487t1755r1605b1823],
14	CNS	NN	O	cn	prep_in	4	SENT_284	[p16l1644t1759r1807b1824],
15	and	CC	O	and	_	0	SENT_284	[p16l1846t1755r1989b1823],
16	the	DT	O	the	det	18	SENT_284	[p16l2024t1755r2141b1823],
17	serum	NN	O	serum	nn	18	SENT_284	[p16l11t1880r251b1925],
18	level	NN	O	level	prep_in	4	SENT_284	[p16l323t1856r497b1925],
19	of	IN	O	of	_	0	SENT_284	[p16l572t1856r653b1925],
20	the	DT	O	the	det	22	SENT_284	[p16l719t1856r837b1925],
21	active	JJ	O	active	amod	22	SENT_284	[p16l913t1859r1133b1925],
22	moiety	NN	O	moiety	prep_of	18	SENT_284	[p16l1208t1859r1478b1948],
23	of	IN	O	of	_	0	SENT_284	[p16l1549t1856r1630b1925],
24	risperidone	NN	O	risperidone	nn	26	SENT_284	[p16l1697t1856r2141b1947],
25	(	CD	NUMBER	(	num	26	SENT_284	[p16l13t1958r444b2051],
26	Sumiyoshi	NNP	O	Sumiyoshi	prep_of	22	SENT_284	[p16l13t1958r444b2051],
27	et	FW	O	et	nn	28	SENT_284	[p16l482t1971r548b2027],
28	al.	FW	O	al.	dep	26	SENT_284	[p16l566t1959r648b2027],
29	1994	CD	DATE	1994	num	30	SENT_284	[p16l689t1959r910b2042],
30	)	CD	NUMBER	)	dep	28	SENT_284	[p16l689t1959r910b2042],
31	.	.	O	.	_	0	SENT_284	[p16l689t1959r910b2042],

1	Undoubtedly	NNP	O	Undoubtedly	amod	3	SENT_285	[p16l944t1958r1460b2051],
2	,	,	O	,	_	0	SENT_285	[p16l944t1958r1460b2051],
3	antipsychotic	JJ	O	antipsychotic	amod	4	SENT_285	[p16l1493t1959r2007b2051],
4	effects	NNS	O	effect	nsubj	9	SENT_285	[p16l2044t1958r2139b2027, p16l10t2060r182b2129],
5	of	IN	O	of	_	0	SENT_285	[p16l207t2060r288b2129],
6	neuroleptics	NNS	O	neuroleptic	prep_of	4	SENT_285	[p16l304t2060r778b2151],
7	are	VBP	O	be	cop	9	SENT_285	[p16l804t2084r918b2129],
8	mainly	RB	O	mainly	advmod	9	SENT_285	[p16l940t2060r1209b2152],
9	due	JJ	O	due	_	0	SENT_285	[p16l1228t2060r1364b2129],
10	to	TO	O	to	_	0	SENT_285	[p16l1387t2073r1459b2129],
11	dopamine	NN	O	dopamine	nn	13	SENT_285	[p16l1484t2060r1870b2151],
12	D2	NN	O	d2	nn	13	SENT_285	[p16l1893t2066r1998b2128],
13	occupancy	NN	O	occupancy	prep_to	9	SENT_285	[p16l2023t2084r2139b2129, p16l11t2186r356b2255],
14	;	:	O	;	_	0	SENT_285	[p16l2023t2084r2139b2129, p16l11t2186r356b2255],
15	the	DT	O	the	det	17	SENT_285	[p16l393t2163r511b2231],
16	observed	VBN	O	observe	amod	17	SENT_285	[p16l550t2162r898b2231],
17	differences	NNS	O	difference	nsubj	27	SENT_285	[p16l935t2162r1351b2231],
18	between	IN	O	between	_	0	SENT_285	[p16l1387t2163r1707b2232],
19	oral	JJ	O	oral	amod	20	SENT_285	[p16l1745t2162r1894b2231],
20	doses	NNS	O	dose	prep_between	17	SENT_285	[p16l1931t2162r2140b2231],
21	and	CC	O	and	_	0	SENT_285	[p16l11t2264r153b2333],
22	plasma	NN	O	plasma	nn	23	SENT_285	[p16l177t2264r453b2355],
23	levels	NNS	O	level	prep_between	17	SENT_285	[p16l476t2264r684b2333],
24	in	IN	O	in	_	0	SENT_285	[p16l712t2266r786b2332],
25	our	PRP$	O	we	poss	26	SENT_285	[p16l813t2288r944b2333],
26	study	NN	O	study	prep_in	20	SENT_285	[p16l971t2264r1182b2356],
27	predict	VBP	O	predict	parataxis	9	SENT_285	[p16l1203t2264r1476b2355],
28	a	DT	O	a	det	30	SENT_285	[p16l1502t2288r1541b2333],
29	large	JJ	O	large	amod	30	SENT_285	[p16l1565t2264r1753b2356],
30	variety	NN	O	variety	dobj	27	SENT_285	[p16l1777t2266r2048b2356],
31	of	IN	O	of	_	0	SENT_285	[p16l2071t2264r2152b2333],
32	clinical	JJ	O	clinical	amod	33	SENT_285	[p16l11t2366r285b2435],
33	responses	NNS	O	response	prep_of	30	SENT_285	[p16l323t2390r695b2458],
34	within	IN	O	within	_	0	SENT_285	[p16l733t2367r982b2435],
35	a	DT	O	a	det	40	SENT_285	[p16l1022t2391r1060b2435],
36	given	VBN	O	give	amod	40	SENT_285	[p16l1098t2369r1303b2459],
37	24	CD	DURATION	24	num	40	SENT_285	[p16l1341t2374r1425b2434],
38	hour	NN	NUMBER	hour	nn	40	SENT_285	[p16l1463t2366r1647b2435],
39	time	NN	O	time	nn	40	SENT_285	[p16l1683t2369r1856b2435],
40	frame	NN	O	frame	prep_within	27	SENT_285	[p16l1895t2366r2140b2447],
41	,	,	O	,	_	0	SENT_285	[p16l1895t2366r2140b2447],
42	provided	VBD	O	provide	prep	27	SENT_285	[p16l9t2468r355b2558],
43	similar	JJ	O	similar	amod	45	SENT_285	[p16l402t2468r668b2537],
44	oral	JJ	O	oral	amod	45	SENT_285	[p16l715t2468r863b2537],
45	doses	NNS	O	dose	nsubjpass	47	SENT_285	[p16l909t2468r1118b2537],
46	are	VBP	O	be	auxpass	47	SENT_285	[p16l1168t2491r1282b2537],
47	administered	VBN	O	administer	dep	42	SENT_285	[p16l1330t2468r1856b2537],
48	.	.	O	.	_	0	SENT_285	[p16l1330t2468r1856b2537],

1	9OHFig	NN	O	9ohfig	_	0	SENT_286	[p16l1900t2473r2139b2537, p16l8t2667r131b2725],
2	.4	CD	NUMBER	.4	num	1	SENT_286	[p16l1900t2473r2139b2537, p16l8t2667r131b2725],

1	Comparison	NN	O	comparison	_	0	SENT_287	[p16l173t2669r427b2725],
2	between	IN	O	between	_	0	SENT_287	[p16l453t2668r638b2713],
3	oral	JJ	O	oral	amod	4	SENT_287	[p16l663t2668r740b2713],
4	dose	NN	O	dose	prep_between	1	SENT_287	[p16l765t2668r864b2713],
5	.	.	O	.	_	0	SENT_287	[p16l1118t2667r1354b2722],

1	—	NN	O	—	_	0	SENT_288	[p16l1118t2667r1354b2722],
2	.	.	O	.	_	0	SENT_288	[p16l1118t2667r1354b2722],

1	Q	NNP	O	Q	_	0	SENT_289	[p16l1118t2667r1354b2722],
2	.	.	O	.	_	0	SENT_289	[p16l1118t2667r1354b2722],

1	—	NN	O	—	_	0	SENT_290	[p16l1118t2667r1354b2722],
2	.	.	O	.	_	0	SENT_290	[p16l1118t2667r1354b2722],

1	SA5	NN	O	sa5	_	0	SENT_291	[p16l1118t2667r1354b2722],
2	>	JJR	O	>	amod	4	SENT_291	[p16l1371t2682r1458b2721],
3	=	JJ	O	=	amod	4	SENT_291	[p16l1371t2682r1458b2721],
4	Mean	NN	O	mean	dep	1	SENT_291	[p16l1479t2671r1612b2722],
5	.	.	O	.	_	0	SENT_291	[p16l1695t2667r1936b2722],

1	—	NN	O	—	_	0	SENT_292	[p16l1695t2667r1936b2722],
2	.	.	O	.	_	0	SENT_292	[p16l1695t2667r1936b2722],

1	I	PRP	O	I	_	0	SENT_293	[p16l1695t2667r1936b2722],
2	.	.	O	.	_	0	SENT_293	[p16l1695t2667r1936b2722],

1	—	NN	O	—	_	0	SENT_294	[p16l1695t2667r1936b2722],
2	.	.	O	.	_	0	SENT_294	[p16l1695t2667r1936b2722],

1	5A5	NN	O	5a5	_	0	SENT_295	[p16l1695t2667r1936b2722],
2	<	JJR	O	<	amod	3	SENT_295	[p16l1952t2681r1987b2721],
3	Mean	NN	O	mean	dep	1	SENT_295	[p16l2009t2670r2141b2722],
4	and	CC	O	and	_	0	SENT_295	[p16l7t2737r84b2782],
5	active	JJ	O	active	amod	6	SENT_295	[p16l107t2738r232b2782],
6	moiety	NN	O	moiety	dep	1	SENT_295	[p16l255t2738r402b2795],
7	plasma	NN	O	plasma	nn	8	SENT_295	[p16l424t2737r573b2793],
8	levels	NNS	O	level	dep	1	SENT_295	[p16l598t2737r714b2782],
9	in	IN	O	in	_	0	SENT_295	[p16l737t2738r772b2782],
10	patients	NNS	O	patient	prep_in	8	SENT_295	[p16l796t2750r864b2794, p16l6t2806r126b2850],
11	with	IN	O	with	_	0	SENT_295	[p16l153t2805r247b2850],
12	more	JJR	O	more	prep_with	10	SENT_295	[p16l279t2818r388b2850],
13	vs.	CC	O	vs.	prep	12	SENT_295	[p16l416t2818r470b2850],
14	less	RBR	O	less	advmod	15	SENT_295	[p16l501t2805r576b2850],
15	pronounced	JJ	O	pronounced	amod	16	SENT_295	[p16l605t2805r862b2862],
16	EPMS	NNP	O	EPMS	dep	13	SENT_295	[p16l9t2875r123b2918],
17	(	CD	NUMBER	(	dep	1	SENT_295	[p16l258t2874r611b2931],
18	Simpson	NNP	PERSON	Simpson	dep	17	SENT_295	[p16l258t2874r611b2931],
19	.	.	O	.	_	0	SENT_295	[p16l258t2874r611b2931],

1	—	NN	O	—	_	0	SENT_296	[p16l258t2874r611b2931],
2	.	.	O	.	_	0	SENT_296	[p16l258t2874r611b2931],

1	Angus	NNP	PERSON	Angus	nn	2	SENT_297	[p16l258t2874r611b2931],
2	Scale	NNP	PERSON	Scale	_	0	SENT_297	[p16l743t2873r863b2926],
3	,	,	O	,	_	0	SENT_297	[p16l743t2873r863b2926],
4	mean	NN	O	mean	appos	2	SENT_297	[p16l8t2955r125b2987],
5	=	JJ	O	=	amod	4	SENT_297	[p16l144t2961r177b2977],
6	0.9	CD	NUMBER	0.9	tmod	5	SENT_297	[p16l194t2944r257b2987],
7	i	FW	O	i	dep	2	SENT_297	[p16l274t2950r308b2986],
8	2.0	CD	NUMBER	2.0	num	9	SENT_297	[p16l325t2942r416b2994],
9	)	NN	O	)	dep	7	SENT_297	[p16l325t2942r416b2994],
10	.	.	O	.	_	0	SENT_297	[p16l325t2942r416b2994],

1	Plasma	NN	O	plasma	nn	2	SENT_298	[p16l465t2941r613b2987],
2	levels	NNS	O	level	nsubj	6	SENT_298	[p16l662t2941r778b2987],
3	at	IN	O	at	_	0	SENT_298	[p16l824t2948r864b2987],
4	week	NN	DURATION	week	prep_at	2	SENT_298	[p16l6t3010r120b3055],
5	2	CD	NUMBER	2	num	4	SENT_298	[p16l141t3012r163b3054],
6	predicted	VBD	O	predict	_	0	SENT_298	[p16l188t3010r388b3067],
7	an	DT	O	a	det	8	SENT_298	[p16l411t3023r460b3055],
8	incidence	NN	O	incidence	dobj	6	SENT_298	[p16l485t3010r687b3055],
9	for	IN	O	for	_	0	SENT_298	[p16l708t3009r768b3055],
10	EPS	NNP	O	EPS	nn	14	SENT_298	[p16l791t3011r863b3055],
11	(	RB	O	(	advmod	12	SENT_298	[p16l8t3078r125b3135],
12	right	JJ	O	right	amod	14	SENT_298	[p16l8t3078r125b3135],
13	ﬁgure	NN	O	ﬁgure	nn	14	SENT_298	[p16l143t3077r297b3135],
14	)	NN	O	)	prep_for	6	SENT_298	[p16l143t3077r297b3135],
15	.	.	O	.	_	0	SENT_298	[p16l143t3077r297b3135],

1	Accordingly	RB	O	accordingly	advmod	14	SENT_299	[p16l317t3078r582b3136],
2	,	,	O	,	_	0	SENT_299	[p16l317t3078r582b3136],
3	patients	NNS	O	patient	nsubj	14	SENT_299	[p16l603t3079r775b3135],
4	initially	RB	O	initially	advmod	5	SENT_299	[p16l796t3079r864b3123, p16l6t3146r110b3204],
5	receiving	VBG	O	receive	partmod	3	SENT_299	[p16l147t3147r338b3203],
6	higher	JJR	O	higher	amod	8	SENT_299	[p16l378t3146r516b3203],
7	oral	JJ	O	oral	amod	8	SENT_299	[p16l551t3146r629b3191],
8	doses	NNS	O	dose	dobj	5	SENT_299	[p16l668t3146r787b3191],
9	of	IN	O	of	_	0	SENT_299	[p16l824t3146r868b3191],
10	risperidone	NN	O	risperidone	prep_of	8	SENT_299	[p16l8t3214r248b3271],
11	were	VBD	O	be	cop	14	SENT_299	[p16l295t3227r400b3259],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_299	[p16l447t3214r707b3272],
13	more	RBR	O	more	advmod	14	SENT_299	[p16l754t3227r864b3260],
14	likely	JJ	O	likely	_	0	SENT_299	[p16l8t3282r117b3340],
15	to	TO	O	to	aux	16	SENT_299	[p16l140t3289r182b3328],
16	respond	VB	O	respond	xcomp	14	SENT_299	[p16l209t3282r379b3339],
17	with	IN	O	with	_	0	SENT_299	[p16l405t3282r499b3328],
18	EPS	NN	O	ep	prep_with	16	SENT_299	[p16l527t3284r600b3327],
19	in	IN	O	in	_	0	SENT_299	[p16l627t3284r662b3327],
20	the	DT	O	the	det	22	SENT_299	[p16l687t3282r757b3328],
21	trial	NN	O	trial	nn	22	SENT_299	[p16l780t3282r862b3328],
22	course	NN	O	course	prep_in	18	SENT_299	[p16l7t3364r145b3396],
23	(	CD	NUMBER	(	dobj	16	SENT_299	[p16l161t3350r245b3403],
24	left	VBD	O	leave	rcmod	23	SENT_299	[p16l161t3350r245b3403],
25	figure	NN	O	figure	nn	26	SENT_299	[p16l257t3350r436b3408],
26	)	NN	O	)	dobj	24	SENT_299	[p16l257t3350r436b3408],
27	.	.	O	.	_	0	SENT_299	[p16l257t3350r436b3408],

1	*	NN	O	*	nn	2	SENT_300	[p16l257t3350r436b3408],
2	p	NN	O	p	_	0	SENT_300	[p16l452t3364r475b3408],
3	<	JJR	O	<	dep	2	SENT_300	[p16l492t3362r522b3395],
4	0.05	CD	NUMBER	0.05	dep	2	SENT_300	[p16l539t3353r627b3396],

1	-	:	O	-	_	0	SENT_301	[p17l472t165r862b255],
2	O-SAS	NN	O	o-sa	_	0	SENT_301	[p17l472t165r862b255],
3	>	JJR	O	>	amod	5	SENT_301	[p17l889t189r945b252],
4	=	JJ	O	=	amod	5	SENT_301	[p17l966t204r1028b235],
5	Mean	NN	O	mean	dep	2	SENT_301	[p17l1058t172r1270b254],
6	-	:	O	-	_	0	SENT_301	[p17l1414t165r1640b251],
7	I	PRP	O	I	dep	5	SENT_301	[p17l1414t165r1640b251],
8	-	:	O	-	_	0	SENT_301	[p17l1414t165r1640b251],
9	SAS	NNP	O	SAS	dep	5	SENT_301	[p17l1660t169r1808b252],
10	<	JJR	O	<	amod	11	SENT_301	[p17l1840t188r1897b251],
11	Mean	NN	O	mean	dep	9	SENT_301	[p17l1926t170r2136b253],

1	+	CC	O	+	cc	3	SENT_302	[p17l28t513r222b677],
2	§	CD	NUMBER	§	num	3	SENT_302	[p17l28t513r222b677],
3	50	CD	NUMBER	50	_	0	SENT_302	[p17l390t528r502b619],
4	2-3	CD	TIME	2-3	num	5	SENT_302	[p17l33t685r502b803],
5	:40	CD	TIME	:40	dobj	3	SENT_302	[p17l33t685r502b803],
6	.	.	O	.	_	0	SENT_302	[p17l7t810r502b962],
7	'	''	O	'	_	0	SENT_302	[p17l7t810r502b962],

1	§	NN	O	§	_	0	SENT_303	[p17l7t810r502b962],
2	a	DT	O	a	det	5	SENT_303	[p17l7t810r502b962],
3	§	NN	O	§	nn	5	SENT_303	[p17l7t810r502b962],
4	3	CD	NUMBER	3	num	5	SENT_303	[p17l7t810r502b962],
5	(	NN	O	(	dep	1	SENT_303	[p17l7t810r502b962],
6	)	CD	PERCENT	)	number	7	SENT_303	[p17l7t810r502b962],
7	32	CD	PERCENT	32	num	8	SENT_303	[p17l32t925r372b1056],
8	%	NN	PERCENT	%	dep	5	SENT_303	[p17l32t925r372b1056],
9	?	.	O	?	_	0	SENT_303	[p17l32t925r372b1056],

1	.	.	O	.	_	0	SENT_304	[p17l7t1043r502b1176],

1	%	NN	O	%	nsubj	2	SENT_305	[p17l7t1043r502b1176],
2	:	:	O	:	_	0	SENT_305	[p17l7t1043r502b1176],
3	.	.	O	.	_	0	SENT_305	[p17l7t1043r502b1176],
4	'	''	O	'	_	0	SENT_305	[p17l7t1043r502b1176],

1	:	:	O	:	_	0	SENT_306	[p17l7t1043r502b1176],
2	"	``	O	"	punct	4	SENT_306	[p17l7t1043r502b1176],
3	20	CD	NUMBER	20	num	4	SENT_306	[p17l7t1043r502b1176],
4	“	CD	NUMBER	“	_	0	SENT_306	[p17l11t1173r222b1325],
5	ii	LS	O	ii	dep	4	SENT_306	[p17l11t1173r222b1325],
6	10	CD	NUMBER	10	dep	4	SENT_306	[p17l396t1214r502b1303],

1	Week	NN	DURATION	week	nn	3	SENT_307	[p17l1270t1767r1518b1853],
2	risperidone	NN	O	risperidone	nn	3	SENT_307	[p17l10t2015r453b2106],
3	levels	NNS	O	level	nsubj	6	SENT_307	[p17l493t2015r702b2084],
4	were	VBD	O	be	cop	6	SENT_307	[p17l741t2039r921b2084],
5	generally	RB	O	generally	advmod	6	SENT_307	[p17l962t2015r1317b2107],
6	higher	JJR	O	higher	_	0	SENT_307	[p17l1353t2015r1603b2107],
7	than	IN	O	than	_	0	SENT_307	[p17l1642t2015r1815b2084],
8	risperidone	NN	O	risperidone	nn	9	SENT_307	[p17l1857t2017r2138b2106, p17l10t2116r197b2185],
9	levels	NNS	O	level	prep_than	6	SENT_307	[p17l229t2116r459b2197],
10	,	,	O	,	_	0	SENT_307	[p17l229t2116r459b2197],
11	which	WDT	O	which	nsubj	13	SENT_307	[p17l485t2116r717b2185],
12	is	VBZ	O	be	cop	13	SENT_307	[p17l750t2119r806b2185],
13	concordant	JJ	O	concordant	rcmod	9	SENT_307	[p17l841t2116r1275b2186],
14	with	IN	O	with	mark	17	SENT_307	[p17l1304t2116r1476b2185],
15	previous	JJ	O	previous	amod	16	SENT_307	[p17l1508t2119r1838b2208],
16	studies	NNS	O	study	nsubj	17	SENT_307	[p17l1874t2116r2140b2185],
17	(	VBP	O	(	advcl	13	SENT_307	[p17l13t2217r404b2309],
18	Aravagiri	NNP	PERSON	Aravagiri	nsubj	20	SENT_307	[p17l13t2217r404b2309],
19	et	FW	O	et	nn	20	SENT_307	[p17l458t2229r525b2286],
20	al.	FW	O	al.	xcomp	17	SENT_307	[p17l543t2217r625b2286],
21	2003	CD	DATE	2003	num	22	SENT_307	[p17l677t2217r904b2301],
22	)	CD	NUMBER	)	dep	20	SENT_307	[p17l677t2217r904b2301],
23	.	.	O	.	_	0	SENT_307	[p17l677t2217r904b2301],

1	Aravagiri	NNP	PERSON	Aravagiri	nsubj	7	SENT_308	[p17l952t2219r1313b2309],
2	and	CC	O	and	_	0	SENT_308	[p17l1368t2217r1510b2286],
3	Marder	NNP	PERSON	Marder	conj_and	1	SENT_308	[p17l1563t2217r1846b2286],
4	(	CD	NUMBER	(	num	3	SENT_308	[p17l1903t2217r2137b2300],
5	2002	CD	DATE	2002	num	6	SENT_308	[p17l1903t2217r2137b2300],
6	)	NN	O	)	dep	3	SENT_308	[p17l1903t2217r2137b2300],
7	found	VBD	O	find	_	0	SENT_308	[p17l9t2318r236b2387],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_308	[p17l291t2318r950b2410],
9	differences	NNS	O	difference	dobj	7	SENT_308	[p17l1007t2318r1424b2387],
10	between	IN	O	between	_	0	SENT_308	[p17l1480t2318r1799b2387],
11	risperidone	NN	O	risperidone	prep_between	9	SENT_308	[p17l1857t2321r2138b2410, p17l10t2419r197b2487],
12	and	CC	O	and	_	0	SENT_308	[p17l229t2419r371b2487],
13	9-OH	NN	O	9-oh	nn	15	SENT_308	[p17l401t2419r1090b2509],
14	—	CD	NUMBER	—	num	15	SENT_308	[p17l401t2419r1090b2509],
15	risperidone	NN	O	risperidone	dobj	7	SENT_308	[p17l401t2419r1090b2509],
16	in	IN	O	in	_	0	SENT_308	[p17l1121t2421r1195b2486],
17	rat	NN	O	rat	nn	20	SENT_308	[p17l1225t2431r1329b2487],
18	brain	NN	O	brain	nn	20	SENT_308	[p17l1356t2419r1561b2487],
19	tissue	NN	O	tissue	nn	20	SENT_308	[p17l1590t2421r1809b2487],
20	concentration	NN	O	concentration	prep_in	15	SENT_308	[p17l1840t2442r2138b2487, p17l9t2522r271b2588],
21	after	IN	O	after	_	0	SENT_308	[p17l302t2519r478b2588],
22	oral	JJ	O	oral	amod	23	SENT_308	[p17l507t2519r655b2588],
23	administration	NN	O	administration	prep_after	7	SENT_308	[p17l685t2519r1281b2600],
24	,	,	O	,	_	0	SENT_308	[p17l685t2519r1281b2600],
25	but	CC	O	but	_	0	SENT_308	[p17l1304t2519r1432b2588],
26	the	DT	O	the	det	27	SENT_308	[p17l1460t2519r1578b2588],
27	difference	NN	O	difference	nsubj	33	SENT_308	[p17l1608t2519r1988b2588],
28	did	VBD	O	do	aux	33	SENT_308	[p17l2019t2519r2143b2588],
29	not	RB	O	not	neg	33	SENT_308	[p17l9t2633r136b2689],
30	signiﬁcantly	JJ	O	signiﬁcantly	amod	33	SENT_308	[p17l160t2620r635b2712],
31	inﬂuence	NN	O	inﬂuence	nn	33	SENT_308	[p17l655t2620r1005b2689],
32	overall	JJ	O	overall	amod	33	SENT_308	[p17l1031t2620r1288b2689],
33	exposure	NN	O	exposure	conj_but	7	SENT_308	[p17l1312t2643r1657b2711],
34	to	TO	O	to	_	0	SENT_308	[p17l1680t2633r1753b2689],
35	the	DT	O	the	det	37	SENT_308	[p17l1777t2620r1896b2689],
36	active	JJ	O	active	amod	37	SENT_308	[p17l1920t2622r2141b2689],
37	compound	NN	O	compound	prep_to	33	SENT_308	[p17l10t2722r442b2814],
38	.	.	O	.	_	0	SENT_308	[p17l10t2722r442b2814],

1	In	IN	O	in	_	0	SENT_309	[p17l462t2728r541b2790],
2	this	DT	O	this	det	3	SENT_309	[p17l562t2722r701b2791],
3	respect	NN	O	respect	prep_in	6	SENT_309	[p17l724t2735r1017b2814],
4	,	,	O	,	_	0	SENT_309	[p17l724t2735r1017b2814],
5	risperidone	NN	O	risperidone	nsubj	6	SENT_309	[p17l1036t2722r1480b2814],
6	seems	VBZ	O	seem	_	0	SENT_309	[p17l1504t2747r1731b2791],
7	rather	RB	O	rather	advmod	8	SENT_309	[p17l1755t2722r1988b2791],
8	unusual	JJ	O	unusual	acomp	6	SENT_309	[p17l2010t2747r2138b2791, p17l9t2823r212b2892],
9	in	IN	O	in	_	0	SENT_309	[p17l271t2825r344b2891],
10	terms	NNS	O	term	prep_in	8	SENT_309	[p17l403t2836r621b2892],
11	of	IN	O	of	_	0	SENT_309	[p17l682t2823r764b2892],
12	a	DT	O	a	det	14	SENT_309	[p17l817t2847r856b2892],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_309	[p17l915t2823r1318b2915],
14	contribution	NN	O	contribution	prep_of	10	SENT_309	[p17l1377t2823r1860b2892],
15	of	IN	O	of	_	0	SENT_309	[p17l1920t2823r2001b2892],
16	its	PRP$	O	its	poss	18	SENT_309	[p17l2054t2825r2140b2892],
17	metabolite	NN	O	metabolite	nn	18	SENT_309	[p17l9t2924r417b2993],
18	9-OH	NN	O	9-oh	prep_of	14	SENT_309	[p17l455t2924r1145b3016],
19	—	CD	NUMBER	—	num	20	SENT_309	[p17l455t2924r1145b3016],
20	risperidone	NN	O	risperidone	dep	8	SENT_309	[p17l455t2924r1145b3016],
21	to	TO	O	to	_	0	SENT_309	[p17l1182t2937r1254b2993],
22	clinical	JJ	O	clinical	amod	23	SENT_309	[p17l1294t2924r1567b2993],
23	efficacy	NN	O	efficacy	prep_to	20	SENT_309	[p17l1605t2924r1910b3017],
24	,	,	O	,	_	0	SENT_309	[p17l1605t2924r1910b3017],
25	especially	RB	O	especially	advmod	45	SENT_309	[p17l1943t2948r2138b3016, p17l10t3025r214b3117],
26	as	IN	O	as	dep	45	SENT_309	[p17l233t3049r306b3094],
27	the	DT	O	the	det	29	SENT_309	[p17l329t3025r447b3094],
28	plasma	NN	O	plasma	nn	29	SENT_309	[p17l469t3025r744b3116],
29	concentrations	NNS	O	concentration	nsubj	45	SENT_309	[p17l766t3027r1334b3094],
30	of	IN	O	of	_	0	SENT_309	[p17l1358t3025r1439b3094],
31	the	DT	O	the	det	32	SENT_309	[p17l1454t3025r1572b3094],
32	metabolite	NN	O	metabolite	prep_of	29	SENT_309	[p17l1594t3025r2003b3094],
33	are	VBP	O	be	cop	45	SENT_309	[p17l2027t3049r2141b3094],
34	consistently	RB	O	consistently	advmod	35	SENT_309	[p17l10t3126r468b3219],
35	higher	JJR	O	higher	advmod	45	SENT_309	[p17l498t3126r749b3219],
36	than	IN	O	than	_	0	SENT_309	[p17l782t3126r955b3195],
37	concentration	NN	O	concentration	prep_than	35	SENT_309	[p17l991t3129r1523b3195],
38	of	IN	O	of	_	0	SENT_309	[p17l1560t3126r1641b3195],
39	the	DT	O	the	det	44	SENT_309	[p17l1668t3126r1786b3195],
40	“	JJ	O	“	amod	44	SENT_309	[p17l1816t3127r2140b3218],
41	parent	NN	O	parent	nn	44	SENT_309	[p17l1816t3127r2140b3218],
42	”	NN	O	”	nn	44	SENT_309	[p17l1816t3127r2140b3218],
43	compound	NN	O	compound	nn	44	SENT_309	[p17l10t3227r424b3318],
44	risperidone	NN	O	risperidone	prep_of	37	SENT_309	[p17l464t3227r908b3318],
45	itself	PRP	O	itself	ccomp	6	SENT_309	[p17l949t3227r1153b3296],
46	.	.	O	.	_	0	SENT_309	[p17l949t3227r1153b3296],

1	The	DT	O	the	det	2	SENT_310	[p17l1191t3227r1335b3296],
2	contribution	NN	O	contribution	nsubjpass	24	SENT_310	[p17l1377t3227r1860b3296],
3	of	IN	O	of	_	0	SENT_310	[p17l1902t3227r1983b3296],
4	antipsychotic	JJ	O	antipsychotic	amod	5	SENT_310	[p17l2018t3251r2139b3296, p17l9t3328r431b3420],
5	metabolites	NNS	O	metabolite	prep_of	2	SENT_310	[p17l463t3328r907b3397],
6	to	TO	O	to	_	0	SENT_310	[p17l941t3341r1013b3397],
7	the	DT	O	the	det	9	SENT_310	[p17l1047t3328r1165b3397],
8	clinical	JJ	O	clinical	amod	9	SENT_310	[p17l1200t3328r1474b3397],
9	efﬁcacy	NN	O	efﬁcacy	prep_to	5	SENT_310	[p17l1507t3328r1802b3420],
10	of	IN	O	of	_	0	SENT_310	[p17l1832t3328r1913b3397],
11	other	JJ	O	other	amod	13	SENT_310	[p17l1940t3328r2143b3397],
12	antipsychotic	JJ	O	antipsychotic	amod	13	SENT_310	[p17l10t3429r524b3521],
13	drugs	NNS	O	drug	prep_of	9	SENT_310	[p17l557t3429r773b3521],
14	such	JJ	O	such	_	0	SENT_310	[p17l808t3429r981b3498],
15	as	IN	O	as	_	0	SENT_310	[p17l1013t3453r1087b3498],
16	clozapine	NN	O	clozapine	nn	18	SENT_310	[p17l1121t3429r1505b3520],
17	,	,	O	,	_	0	SENT_310	[p17l1121t3429r1505b3520],
18	ﬂuphenazine	NN	O	ﬂuphenazine	nn	22	SENT_310	[p17l1533t3429r2029b3520],
19	or	CC	O	or	_	0	SENT_310	[p17l2062t3453r2143b3498],
20	other	JJ	O	other	nn	22	SENT_310	[p17l10t3530r213b3599],
21	classical	JJ	O	classical	amod	22	SENT_310	[p17l244t3530r557b3599],
22	antipsychotics	NNS	O	antipsychotic	prep_such_as	13	SENT_310	[p17l588t3530r1138b3622],
23	is	VBZ	O	be	auxpass	24	SENT_310	[p17l1170t3533r1227b3599],
24	thought	VBN	O	think	_	0	SENT_310	[p17l1258t3530r1561b3622],
25	to	TO	O	to	aux	28	SENT_310	[p17l1590t3543r1662b3599],
26	be	VB	O	be	cop	28	SENT_310	[p17l1692t3530r1782b3599],
27	only	RB	O	only	advmod	28	SENT_310	[p17l1815t3530r1982b3622],
28	minor	JJ	O	minor	xcomp	24	SENT_310	[p17l2009t3533r2139b3598, p17l10t3655r157b3711],
29	,	,	O	,	_	0	SENT_310	[p17l2009t3533r2139b3598, p17l10t3655r157b3711],
30	if	IN	O	if	mark	39	SENT_310	[p17l179t3630r239b3699],
31	at	IN	O	at	dep	34	SENT_310	[p17l259t3643r326b3700],
32	all	DT	O	all	det	34	SENT_310	[p17l352t3631r441b3700],
33	present	JJ	DATE	present	amod	34	SENT_310	[p17l465t3643r748b3722],
34	(	CD	NUMBER	(	dep	35	SENT_310	[p17l776t3631r1278b3715],
35	Baldessarini	NNP	O	Baldessarini	dep	39	SENT_310	[p17l776t3631r1278b3715],
36	et	FW	O	et	nn	37	SENT_310	[p17l1304t3644r1371b3700],
37	al.	FW	O	al.	dep	35	SENT_310	[p17l1389t3631r1471b3700],
38	1993	CD	DATE	1993	num	39	SENT_310	[p17l1501t3631r1722b3715],
39	)	CD	NUMBER	)	dep	24	SENT_310	[p17l1501t3631r1722b3715],
40	.	.	O	.	_	0	SENT_310	[p17l1501t3631r1722b3715],

1	Risperidone	NN	O	risperidone	nsubj	3	SENT_311	[p17l124t3732r590b3823],
2	signiﬁcantly	RB	O	signiﬁcantly	advmod	3	SENT_311	[p17l648t3732r1123b3824],
3	improved	VBD	O	improve	_	0	SENT_311	[p17l1175t3732r1541b3823],
4	psychopathology	NN	O	psychopathology	dobj	3	SENT_311	[p17l1595t3732r2139b3824, p18l10t36r151b104],

1	in	IN	O	in	_	0	SENT_312	[p18l172t14r246b80],
2	the	DT	O	the	det	4	SENT_312	[p18l271t12r388b81],
3	vast	JJ	O	vast	amod	4	SENT_312	[p18l412t24r565b81],
4	majority	NN	O	majority	pobj	1	SENT_312	[p18l588t14r923b104],
5	of	IN	O	of	_	0	SENT_312	[p18l945t12r1026b81],
6	study	NN	O	study	nn	7	SENT_312	[p18l1045t12r1256b104],
7	participants	NNS	O	participant	prep_of	4	SENT_312	[p18l1277t14r1742b103],
8	over	IN	O	over	_	0	SENT_312	[p18l1770t36r1934b81],
9	the	DT	DURATION	the	det	13	SENT_312	[p18l1957t12r2076b81],
10	6	CD	DURATION	6	num	13	SENT_312	[p18l2102t18r2140b81],
11	week	NN	NUMBER	week	nn	13	SENT_312	[p18l7t113r202b182],
12	treatment	NN	O	treatment	nn	13	SENT_312	[p18l226t126r604b182],
13	period	NN	O	period	prep_over	7	SENT_312	[p18l629t113r903b203],
14	.	.	O	.	_	0	SENT_312	[p18l629t113r903b203],

1	We	PRP	O	we	nsubj	2	SENT_313	[p18l923t119r1039b182],
2	found	VBD	O	find	_	0	SENT_313	[p18l1066t113r1294b182],
3	increased	VBN	O	increase	amod	7	SENT_313	[p18l1319t113r1685b182],
4	active	JJ	O	active	amod	7	SENT_313	[p18l1712t116r1932b182],
5	moiety	NN	O	moiety	nn	7	SENT_313	[p18l1960t116r2138b182, p18l10t225r127b305],
6	plasma	NN	O	plasma	nn	7	SENT_313	[p18l156t213r431b304],
7	levels	NNS	O	level	dobj	2	SENT_313	[p18l462t213r670b282],
8	in	IN	O	in	_	0	SENT_313	[p18l705t215r779b281],
9	patients	NNS	O	patient	prep_in	7	SENT_313	[p18l812t215r1116b304],
10	with	IN	O	with	_	0	SENT_313	[p18l1149t213r1321b282],
11	a	DT	O	a	det	13	SENT_313	[p18l1355t237r1394b282],
12	longer	RBR	O	longer	amod	13	SENT_313	[p18l1426t213r1671b305],
13	duration	NN	O	duration	prep_with	9	SENT_313	[p18l1705t213r2036b282],
14	of	IN	O	of	_	0	SENT_313	[p18l2070t213r2151b282],
15	illness	NN	O	illness	prep_of	13	SENT_313	[p18l10t314r270b395],
16	,	,	O	,	_	0	SENT_313	[p18l10t314r270b395],
17	without	IN	O	without	_	0	SENT_313	[p18l284t314r585b383],
18	receiving	VBG	O	receive	prepc_without	2	SENT_313	[p18l605t317r957b406],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_313	[p18l977t314r1452b406],
20	higher	JJR	O	higher	amod	22	SENT_313	[p18l1468t314r1719b406],
21	oral	JJ	O	oral	amod	22	SENT_313	[p18l1740t314r1888b383],
22	doses	NNS	O	dose	dobj	18	SENT_313	[p18l1909t314r2139b383],
23	.	.	O	.	_	0	SENT_313	[p18l1909t314r2139b383],

1	This	DT	O	this	nsubj	2	SENT_314	[p18l10t415r174b484],
2	confirms	VBZ	O	confirm	dep	26	SENT_314	[p18l199t415r539b484],
3	previous	JJ	O	previous	amod	4	SENT_314	[p18l562t417r893b506],
4	observations	NNS	O	observation	nsubj	13	SENT_314	[p18l918t415r1406b484],
5	(	VBP	O	(	ccomp	2	SENT_314	[p18l1434t415r1722b499],
6	Olesen	NNP	PERSON	Olesen	nsubj	8	SENT_314	[p18l1434t415r1722b499],
7	et	FW	O	et	nn	8	SENT_314	[p18l1746t428r1813b484],
8	al.	FW	O	al.	xcomp	5	SENT_314	[p18l1831t415r1913b484],
9	1998	CD	DATE	1998	num	10	SENT_314	[p18l1940t415r2137b499],
10	)	NN	O	)	dep	8	SENT_314	[p18l1940t415r2137b499],
11	and	CC	O	and	_	0	SENT_314	[p18l10t516r153b585],
12	may	MD	O	may	aux	13	SENT_314	[p18l176t540r339b608],
13	represent	VB	O	represent	conj_and	5	SENT_314	[p18l359t529r717b607],
14	a	DT	O	a	det	17	SENT_314	[p18l741t540r780b585],
15	general	JJ	O	general	amod	17	SENT_314	[p18l804t516r1085b608],
16	aging	NN	O	aging	nn	17	SENT_314	[p18l1109t519r1320b608],
17	effect	NN	O	effect	dobj	13	SENT_314	[p18l1343t516r1550b585],
18	rather	RB	O	rather	_	0	SENT_314	[p18l1574t516r1807b585],
19	than	IN	O	than	_	0	SENT_314	[p18l1829t516r2002b585],
20	genetic	JJ	O	genetic	amod	25	SENT_314	[p18l2026t540r2139b608, p18l9t620r197b687],
21	or	CC	O	or	_	0	SENT_314	[p18l227t642r307b687],
22	direct	JJ	O	direct	amod	25	SENT_314	[p18l335t617r557b687],
23	cumulative	JJ	O	cumulative	amod	25	SENT_314	[p18l586t617r1007b687],
24	pharmacotherapeutic	JJ	O	pharmacotherapeutic	amod	25	SENT_314	[p18l1036t617r1869b709],
25	effects	NNS	O	effect	conj_negcc	17	SENT_314	[p18l1899t617r2140b687],
26	(	VBP	O	(	_	0	SENT_314	[p18l13t718r381b802],
27	Zubenko	NNP	PERSON	Zubenko	dobj	26	SENT_314	[p18l13t718r381b802],
28	and	CC	O	and	_	0	SENT_314	[p18l425t718r567b787],
29	Sunderland	NNP	O	Sunderland	dobj	26	SENT_314	[p18l609t718r1052b787],
30	2000	CD	DATE	2000	num	29	SENT_314	[p18l1092t719r1320b802],
31	)	CD	NUMBER	)	nsubj	26	SENT_314	[p18l1092t719r1320b802],
32	.	.	O	.	_	0	SENT_314	[p18l1092t719r1320b802],

1	Surprisingly	RB	O	surprisingly	advmod	6	SENT_315	[p18l1360t718r1846b810],
2	,	,	O	,	_	0	SENT_315	[p18l1360t718r1846b810],
3	nonresponders	NNS	O	nonresponder	nsubj	6	SENT_315	[p18l1884t742r2138b787, p18l11t821r356b912],
4	to	TO	O	to	_	0	SENT_315	[p18l387t833r459b890],
5	pharmacotherapy	NN	O	pharmacotherapy	prep_to	3	SENT_315	[p18l490t820r1181b913],
6	had	VBD	O	have	_	0	SENT_315	[p18l1206t820r1349b890],
7	higher	JJR	O	higher	amod	10	SENT_315	[p18l1377t820r1628b913],
8	drug	NN	O	drug	nn	10	SENT_315	[p18l1658t820r1839b913],
9	plasma	NN	O	plasma	nn	10	SENT_315	[p18l1867t821r2142b912],
10	levels	NNS	O	level	dobj	6	SENT_315	[p18l8t921r216b990],
11	than	IN	O	than	_	0	SENT_315	[p18l239t921r412b990],
12	responders	NNS	O	responder	prep_than	10	SENT_315	[p18l435t921r858b1011],
13	despite	IN	O	despite	_	0	SENT_315	[p18l883t921r1153b1011],
14	administration	NN	O	administration	prep_despite	6	SENT_315	[p18l1178t921r1753b990],
15	of	IN	O	of	_	0	SENT_315	[p18l1777t921r1858b990],
16	similar	JJ	O	similar	amod	18	SENT_315	[p18l1875t921r2142b990],
17	oral	JJ	O	oral	amod	18	SENT_315	[p18l10t1021r159b1091],
18	doses	NNS	O	dose	prep_of	14	SENT_315	[p18l183t1021r412b1091],
19	.	.	O	.	_	0	SENT_315	[p18l183t1021r412b1091],

1	This	DT	O	this	det	2	SENT_316	[p18l434t1021r598b1091],
2	finding	NN	O	finding	nsubjpass	5	SENT_316	[p18l624t1021r903b1114],
3	is	VBZ	O	be	auxpass	5	SENT_316	[p18l925t1024r982b1091],
4	not	RB	O	not	neg	5	SENT_316	[p18l1008t1034r1135b1091],
5	accounted	VBN	O	account	_	0	SENT_316	[p18l1159t1021r1548b1091],
6	for	IN	O	for	dep	5	SENT_316	[p18l1570t1021r1679b1091],
7	by	IN	O	by	_	0	SENT_316	[p18l1700t1021r1795b1114],
8	environmental	JJ	O	environmental	amod	9	SENT_316	[p18l1816t1024r2139b1091, p18l9t1122r273b1191],
9	factors	NNS	O	factor	agent	5	SENT_316	[p18l306t1122r564b1191],
10	such	JJ	O	such	_	0	SENT_316	[p18l601t1122r774b1191],
11	as	IN	O	as	_	0	SENT_316	[p18l808t1146r882b1191],
12	age	NN	O	age	prep_such_as	9	SENT_316	[p18l919t1146r1043b1214],
13	or	CC	O	or	_	0	SENT_316	[p18l1078t1146r1158b1191],
14	weight	NN	O	weight	conj_or	12	SENT_316	[p18l1189t1122r1465b1214],
15	,	,	O	,	_	0	SENT_316	[p18l1189t1122r1465b1214],
16	since	IN	O	since	mark	22	SENT_316	[p18l1496t1125r1687b1191],
17	no	DT	O	no	det	20	SENT_316	[p18l1722t1146r1816b1191],
18	statistically	RB	O	statistically	advmod	19	SENT_316	[p18l1854t1125r2138b1191, p18l10t1223r188b1316],
19	significant	JJ	O	significant	amod	20	SENT_316	[p18l208t1223r612b1316],
20	differences	NNS	O	difference	nsubjpass	22	SENT_316	[p18l636t1223r1052b1293],
21	were	VBD	O	be	auxpass	22	SENT_316	[p18l1074t1248r1254b1293],
22	observed	VBN	O	observe	advcl	5	SENT_316	[p18l1279t1223r1627b1293],
23	for	IN	O	for	_	0	SENT_316	[p18l1649t1223r1758b1293],
24	these	DT	O	these	det	25	SENT_316	[p18l1780t1223r1977b1293],
25	factors	NNS	O	factor	prep_for	22	SENT_316	[p18l2001t1223r2139b1293, p18l9t1337r174b1393],
26	.	.	O	.	_	0	SENT_316	[p18l2001t1223r2139b1293, p18l9t1337r174b1393],

1	Similarly	RB	O	similarly	advmod	8	SENT_317	[p18l195t1324r553b1416],
2	,	,	O	,	_	0	SENT_317	[p18l195t1324r553b1416],
3	our	PRP$	O	we	poss	5	SENT_317	[p18l572t1348r703b1393],
4	trial	NN	O	trial	nn	5	SENT_317	[p18l724t1324r884b1393],
5	results	NNS	O	result	nsubj	8	SENT_317	[p18l906t1324r1154b1393],
6	do	VBP	O	do	aux	8	SENT_317	[p18l1178t1324r1271b1393],
7	not	RB	O	not	neg	8	SENT_317	[p18l1296t1337r1422b1393],
8	indicate	VB	O	indicate	_	0	SENT_317	[p18l1444t1324r1747b1393],
9	disturbed	JJ	O	disturbed	amod	12	SENT_317	[p18l1771t1324r2142b1393],
10	CYP450	NN	O	cyp450	nn	12	SENT_317	[p18l11t1430r308b1495],
11	drug	NN	O	drug	nn	12	SENT_317	[p18l342t1425r524b1518],
12	metabolism	NN	O	metabolism	dobj	8	SENT_317	[p18l555t1425r1029b1506],
13	,	,	O	,	_	0	SENT_317	[p18l555t1425r1029b1506],
14	as	IN	O	as	mark	21	SENT_317	[p18l1058t1450r1132b1495],
15	the	DT	O	the	det	19	SENT_317	[p18l1165t1425r1282b1495],
16	active	JJ	O	active	amod	19	SENT_317	[p18l1317t1428r1537b1495],
17	moiety	NN	O	moiety	nn	19	SENT_317	[p18l1570t1428r1840b1518],
18	plasma	NN	O	plasma	nn	19	SENT_317	[p18l1867t1426r2142b1517],
19	concentrations	NNS	O	concentration	nsubj	21	SENT_317	[p18l10t1529r578b1595],
20	were	VBD	O	be	cop	21	SENT_317	[p18l608t1550r788b1595],
21	similar	JJ	O	similar	dep	12	SENT_317	[p18l821t1526r1088b1595],
22	in	IN	O	in	_	0	SENT_317	[p18l1119t1529r1193b1594],
23	poor	JJ	O	poor	amod	26	SENT_317	[p18l1223t1549r1407b1616],
24	and	CC	O	and	_	0	SENT_317	[p18l1438t1526r1580b1595],
25	extensive	JJ	O	extensive	conj_and	23	SENT_317	[p18l1611t1529r1962b1595],
26	metabolizers	NNS	O	metabolizer	prep_in	21	SENT_317	[p18l1993t1550r2139b1595, p18l9t1626r402b1696],
27	.	.	O	.	_	0	SENT_317	[p18l1993t1550r2139b1595, p18l9t1626r402b1696],

1	Absorption	NN	O	absorption	nn	2	SENT_318	[p18l422t1626r861b1718],
2	differences	NNS	O	difference	nsubj	5	SENT_318	[p18l888t1626r1304b1696],
3	do	VBP	O	do	aux	5	SENT_318	[p18l1331t1626r1424b1696],
4	not	RB	O	not	neg	5	SENT_318	[p18l1452t1639r1579b1696],
5	seem	VB	O	seem	_	0	SENT_318	[p18l1605t1651r1797b1696],
6	to	TO	O	to	aux	8	SENT_318	[p18l1822t1639r1895b1696],
7	be	VB	O	be	cop	8	SENT_318	[p18l1920t1626r2009b1696],
8	responsible	JJ	O	responsible	xcomp	5	SENT_318	[p18l2036t1651r2138b1696, p18l11t1727r369b1817],
9	either	CC	O	either	advmod	8	SENT_318	[p18l400t1727r645b1807],
10	;	:	O	;	_	0	SENT_318	[p18l400t1727r645b1807],
11	in	IN	O	in	_	0	SENT_318	[p18l674t1729r747b1795],
12	such	PDT	O	such	predet	14	SENT_318	[p18l778t1727r950b1796],
13	an	DT	O	a	det	14	SENT_318	[p18l980t1751r1070b1796],
14	instance	NN	O	instance	prep_in	21	SENT_318	[p18l1099t1729r1437b1807],
15	,	,	O	,	_	0	SENT_318	[p18l1099t1729r1437b1807],
16	lower	JJR	O	lower	amod	18	SENT_318	[p18l1460t1727r1672b1796],
17	plasma	NN	O	plasma	nn	18	SENT_318	[p18l1698t1727r1974b1817],
18	levels	NNS	O	level	nsubj	21	SENT_318	[p18l2000t1727r2138b1796, p18l10t1827r106b1897],
19	in	IN	O	in	_	0	SENT_318	[p18l185t1830r258b1896],
20	nonresponders	NNS	O	nonresponder	prep_in	18	SENT_318	[p18l335t1827r911b1919],
21	are	VBP	O	be	parataxis	5	SENT_318	[p18l990t1852r1104b1897],
22	to	TO	O	to	aux	24	SENT_318	[p18l1181t1840r1253b1897],
23	be	VB	O	be	auxpass	24	SENT_318	[p18l1329t1827r1419b1897],
24	expected	VBN	O	expect	xcomp	21	SENT_318	[p18l1498t1827r1856b1919],
25	.	.	O	.	_	0	SENT_318	[p18l1498t1827r1856b1919],

1	Thus	RB	O	thus	advmod	17	SENT_319	[p18l1930t1827r2140b1908],
2	,	,	O	,	_	0	SENT_319	[p18l1930t1827r2140b1908],
3	hypothetically	RB	O	hypothetically	advmod	6	SENT_319	[p18l8t1928r562b2020],
4	a	DT	O	a	det	6	SENT_319	[p18l587t1952r626b1997],
5	genetic	JJ	O	genetic	amod	6	SENT_319	[p18l653t1930r928b2020],
6	component	NN	O	component	nsubjpass	17	SENT_319	[p18l957t1941r1390b2019],
7	such	JJ	O	such	_	0	SENT_319	[p18l1418t1928r1591b1997],
8	as	IN	O	as	_	0	SENT_319	[p18l1620t1952r1694b1997],
9	differences	NNS	O	difference	prep_such_as	6	SENT_319	[p18l1724t1928r2140b1997],
10	in	IN	O	in	_	0	SENT_319	[p18l10t2032r83b2098],
11	P-glycoprotein	NN	O	p-glycoprotein	nn	12	SENT_319	[p18l129t2029r688b2122],
12	afﬁnity	NN	O	afﬁnity	prep_in	9	SENT_319	[p18l734t2029r1015b2122],
13	for	IN	O	for	_	0	SENT_319	[p18l1056t2029r1164b2099],
14	risperidone	NN	O	risperidone	prep_for	12	SENT_319	[p18l1209t2029r1652b2121],
15	may	MD	O	may	aux	17	SENT_319	[p18l1697t2054r1861b2122],
16	be	VB	O	be	auxpass	17	SENT_319	[p18l1899t2029r1989b2099],
17	involved	VBN	O	involve	_	0	SENT_319	[p18l2035t2032r2138b2098, p18l7t2130r257b2199],
18	(	NNP	O	(	nn	19	SENT_319	[p18l317t2130r649b2214],
19	Boulton	NNP	PERSON	Boulton	nsubj	21	SENT_319	[p18l317t2130r649b2214],
20	et	FW	O	et	nn	21	SENT_319	[p18l707t2143r774b2199],
21	al.	FW	O	al.	xcomp	17	SENT_319	[p18l792t2130r874b2199],
22	2002	CD	DATE	2002	num	23	SENT_319	[p18l929t2131r1156b2214],
23	)	CD	NUMBER	)	dep	21	SENT_319	[p18l929t2131r1156b2214],
24	.	.	O	.	_	0	SENT_319	[p18l929t2131r1156b2214],

1	Alternatively	RB	O	alternatively	advmod	10	SENT_320	[p18l1207t2130r1717b2222],
2	,	,	O	,	_	0	SENT_320	[p18l1207t2130r1717b2222],
3	disturbed	JJ	O	disturbed	amod	7	SENT_320	[p18l1771t2130r2142b2199],
4	Phase	NN	O	phase	nn	7	SENT_320	[p18l10t2231r230b2301],
5	II	CD	NUMBER	ii	num	7	SENT_320	[p18l251t2238r309b2300],
6	drug	NN	O	drug	nn	7	SENT_320	[p18l332t2231r513b2324],
7	metabolism	NN	O	metabolism	nsubj	10	SENT_320	[p18l531t2231r985b2301],
8	may	MD	O	may	aux	10	SENT_320	[p18l1005t2256r1168b2324],
9	be	VB	O	be	cop	10	SENT_320	[p18l1182t2231r1271b2301],
10	responsible	JJ	O	responsible	_	0	SENT_320	[p18l1292t2231r1729b2323],
11	for	IN	O	for	_	0	SENT_320	[p18l1749t2231r1858b2301],
12	the	DT	O	the	prep_for	10	SENT_320	[p18l1876t2231r1994b2301],
13	observed	VBN	O	observe	partmod	12	SENT_320	[p18l2015t2232r2138b2301, p18l11t2332r260b2401],
14	higher	JJR	O	higher	amod	17	SENT_320	[p18l283t2332r534b2424],
15	plasma	NN	O	plasma	nn	17	SENT_320	[p18l558t2332r833b2423],
16	drug	NN	O	drug	nn	17	SENT_320	[p18l859t2332r1041b2424],
17	levels	NNS	O	level	dobj	13	SENT_320	[p18l1063t2332r1271b2401],
18	of	IN	O	of	_	0	SENT_320	[p18l1299t2332r1380b2401],
19	nonresponders	NNS	O	nonresponder	prep_of	17	SENT_320	[p18l1399t2332r1996b2423],
20	.	.	O	.	_	0	SENT_320	[p18l1399t2332r1996b2423],

1	Aside	RB	O	aside	_	0	SENT_321	[p18l123t2433r335b2503],
2	from	IN	O	from	_	0	SENT_321	[p18l395t2433r581b2503],
3	this	DT	O	this	prep_aside_from	19	SENT_321	[p18l640t2433r801b2514],
4	,	,	O	,	_	0	SENT_321	[p18l640t2433r801b2514],
5	both	CC	O	both	prep	3	SENT_321	[p18l853t2433r1031b2503],
6	the	DT	O	the	det	7	SENT_321	[p18l1090t2433r1209b2503],
7	ﬁndings	NNS	O	ﬁndings	dep	5	SENT_321	[p18l1269t2433r1582b2526],
8	of	IN	O	of	_	0	SENT_321	[p18l1644t2433r1725b2503],
9	increased	VBN	O	increase	amod	12	SENT_321	[p18l1777t2433r2143b2503],
10	plasma	NN	O	plasma	nn	12	SENT_321	[p18l9t2536r284b2627],
11	drug	NN	O	drug	nn	12	SENT_321	[p18l347t2536r528b2628],
12	concentrations	NNS	O	concentration	prep_of	7	SENT_321	[p18l591t2538r1158b2605],
13	in	IN	O	in	_	0	SENT_321	[p18l1223t2538r1296b2604],
14	nonresponders	NNS	O	nonresponder	prep_in	12	SENT_321	[p18l1359t2536r1935b2627],
15	and	CC	O	and	_	0	SENT_321	[p18l2001t2536r2143b2605],
16	more	JJR	O	more	amod	18	SENT_321	[p18l9t2661r207b2706],
17	chronic	JJ	O	chronic	amod	18	SENT_321	[p18l230t2637r518b2706],
18	patients	NNS	O	patient	conj_and	14	SENT_321	[p18l539t2639r843b2727],
19	raise	VBP	O	raise	_	0	SENT_321	[p18l865t2639r1044b2706],
20	the	DT	O	the	det	21	SENT_321	[p18l1065t2637r1183b2706],
21	question	NN	O	question	nsubj	19	SENT_321	[p18l1206t2639r1536b2727],
22	which	WDT	O	which	dobj	25	SENT_321	[p18l1555t2637r1787b2706],
23	pharmacotherapeutic	JJ	O	pharmacotherapeutic	amod	24	SENT_321	[p18l1807t2637r2139b2727, p18l10t2738r537b2830],
24	approach	NN	O	approach	nsubj	25	SENT_321	[p18l569t2738r926b2830],
25	constitutes	VBZ	O	constitute	ccomp	21	SENT_321	[p18l958t2741r1371b2808],
26	the	DT	O	the	det	28	SENT_321	[p18l1403t2738r1521b2808],
27	most	RBS	O	most	advmod	28	SENT_321	[p18l1553t2751r1744b2808],
28	appropriate	JJ	O	appropriate	dobj	25	SENT_321	[p18l1775t2741r2138b2830, p18l10t2881r117b2937],

1	approach	NN	O	approach	_	0	SENT_322	[p18l158t2868r515b2959],
2	in	IN	O	in	_	0	SENT_322	[p18l555t2870r628b2936],
3	such	JJ	O	such	amod	4	SENT_322	[p18l669t2868r842b2937],
4	cases	NNS	O	case	prep_in	1	SENT_322	[p18l883t2892r1097b2937],
5	.	.	O	.	_	0	SENT_322	[p18l883t2892r1097b2937],

1	Considering	VBG	O	consider	_	0	SENT_323	[p18l1135t2868r1607b2960],
2	current	JJ	DATE	current	amod	4	SENT_323	[p18l1647t2881r1929b2937],
3	dose	NN	O	dose	nn	4	SENT_323	[p18l1969t2868r2141b2937],
4	suggestions	NNS	O	suggestion	prep_considering	14	SENT_323	[p18l11t2972r454b3062],
5	for	IN	O	for	_	0	SENT_323	[p18l483t2969r591b3039],
6	the	DT	O	the	det	7	SENT_323	[p18l616t2969r734b3039],
7	treatment	NN	O	treatment	prep_for	4	SENT_323	[p18l761t2982r1138b3039],
8	of	IN	O	of	_	0	SENT_323	[p18l1165t2969r1246b3039],
9	chronic	JJ	O	chronic	amod	10	SENT_323	[p18l1267t2969r1554b3039],
10	schizophrenia	NN	O	schizophrenia	prep_of	7	SENT_323	[p18l1582t2969r2140b3061],
11	,	,	O	,	_	0	SENT_323	[p18l1582t2969r2140b3061],
12	most	JJS	O	most	amod	13	SENT_323	[p18l9t3083r200b3139],
13	clinicians	NNS	O	clinician	nsubj	14	SENT_323	[p18l246t3070r608b3139],
14	agree	VBP	O	agree	dep	39	SENT_323	[p18l656t3094r859b3162],
15	that	IN	O	that	complm	23	SENT_323	[p18l905t3070r1054b3139],
16	dose	NN	O	dose	nn	17	SENT_323	[p18l1100t3070r1273b3139],
17	escalation	NN	O	escalation	nsubj	23	SENT_323	[p18l1321t3070r1701b3139],
18	is	VBZ	O	be	cop	23	SENT_323	[p18l1748t3072r1805b3139],
19	not	RB	O	not	neg	23	SENT_323	[p18l1852t3083r1979b3139],
20	the	DT	O	the	det	23	SENT_323	[p18l2023t3070r2141b3139],
21	number	NN	O	number	nn	23	SENT_323	[p18l9t3171r313b3240],
22	one	CD	NUMBER	one	num	23	SENT_323	[p18l345t3196r480b3240],
23	choice	NN	O	choice	ccomp	14	SENT_323	[p18l513t3171r776b3252],
24	,	,	O	,	_	0	SENT_323	[p18l513t3171r776b3252],
25	but	CC	O	but	_	0	SENT_323	[p18l801t3171r929b3240],
26	rather	RB	O	rather	_	0	SENT_323	[p18l959t3171r1192b3240],
27	a	DT	O	a	det	30	SENT_323	[p18l1224t3196r1263b3240],
28	longer	JJR	O	longer	amod	30	SENT_323	[p18l1292t3171r1537b3264],
29	term	NN	O	term	nn	30	SENT_323	[p18l1567t3184r1750b3240],
30	trial	NN	O	trial	ccomp	14	SENT_323	[p18l1781t3171r1941b3240],
31	with	IN	O	with	_	0	SENT_323	[p18l1970t3171r2141b3240],
32	low	JJ	O	low	amod	34	SENT_323	[p18l8t3272r144b3341],
33	to	TO	O	to	dep	34	SENT_323	[p18l179t3285r251b3341],
34	moderate	JJ	O	moderate	amod	35	SENT_323	[p18l292t3272r656b3341],
35	doses	NNS	O	dose	prep_with	30	SENT_323	[p18l697t3272r906b3341],
36	of	IN	O	of	_	0	SENT_323	[p18l947t3272r1028b3341],
37	antipsychotics	NNS	O	antipsychotic	prep_of	35	SENT_323	[p18l1061t3272r1611b3364],
38	is	VBZ	O	be	auxpass	39	SENT_323	[p18l1651t3274r1709b3341],
39	warranted	VBN	O	warrant	_	0	SENT_323	[p18l1746t3272r2143b3341],
40	(	RB	O	(	advmod	41	SENT_323	[p18l13t3373r332b3457],
41	Meltzer	NNP	PERSON	Meltzer	dobj	39	SENT_323	[p18l13t3373r332b3457],
42	1992	CD	DATE	1992	num	41	SENT_323	[p18l373t3381r561b3454],
43	;	:	O	;	_	0	SENT_323	[p18l373t3381r561b3454],
44	Kane	NNP	PERSON	Kane	dep	41	SENT_323	[p18l597t3379r790b3442],
45	and	CC	O	and	_	0	SENT_323	[p18l826t3373r969b3442],
46	Marder	NNP	PERSON	Marder	dep	41	SENT_323	[p18l1002t3373r1285b3442],
47	1993	CD	DATE	1993	num	46	SENT_323	[p18l1327t3381r1515b3454],
48	;	:	O	;	_	0	SENT_323	[p18l1327t3381r1515b3454],
49	Carpenter	NNP	PERSON	Carpenter	dep	41	SENT_323	[p18l1552t3378r1937b3465],
50	et	FW	O	et	nn	51	SENT_323	[p18l1971t3386r2038b3442],
51	al.	FW	O	al.	dep	49	SENT_323	[p18l2056t3373r2138b3442],
52	1995	CD	DATE	1995	num	53	SENT_323	[p18l17t3475r238b3558],
53	)	NN	O	)	nsubjpass	39	SENT_323	[p18l17t3475r238b3558],
54	.	.	O	.	_	0	SENT_323	[p18l17t3475r238b3558],

1	This	DT	O	this	nsubj	5	SENT_324	[p18l261t3474r426b3543],
2	is	VBZ	O	be	cop	5	SENT_324	[p18l454t3477r511b3543],
3	even	RB	O	even	advmod	5	SENT_324	[p18l540t3498r713b3543],
4	more	RBR	O	more	advmod	5	SENT_324	[p18l739t3498r938b3543],
5	important	JJ	O	important	_	0	SENT_324	[p18l964t3476r1374b3565],
6	,	,	O	,	_	0	SENT_324	[p18l964t3476r1374b3565],
7	as	RB	O	as	advmod	16	SENT_324	[p18l1398t3498r1471b3543],
8	long	JJ	O	long	amod	10	SENT_324	[p18l1498t3474r1666b3566],
9	term	NN	O	term	nn	10	SENT_324	[p18l1690t3487r1873b3543],
10	observations	NNS	O	observation	nsubj	16	SENT_324	[p18l1901t3474r2138b3543, p18l7t3578r283b3644],
11	of	IN	O	of	_	0	SENT_324	[p18l342t3575r423b3644],
12	risperidone	NN	O	risperidone	nn	14	SENT_324	[p18l473t3575r916b3667],
13	plasma	NN	O	plasma	nn	14	SENT_324	[p18l973t3575r1248b3667],
14	levels	NNS	O	level	prep_of	10	SENT_324	[p18l1302t3575r1510b3645],
15	have	VBP	O	have	aux	16	SENT_324	[p18l1567t3575r1740b3644],
16	shown	VBN	O	show	ccomp	5	SENT_324	[p18l1799t3575r2046b3644],
17	a	DT	O	a	det	18	SENT_324	[p18l2104t3600r2143b3644],
18	propensity	NN	O	propensity	dobj	16	SENT_324	[p18l9t3680r425b3770],
19	for	IN	O	for	_	0	SENT_324	[p18l453t3678r562b3747],
20	the	DT	O	the	det	22	SENT_324	[p18l593t3678r711b3747],
21	active	JJ	O	active	amod	22	SENT_324	[p18l746t3680r966b3747],
22	compound	NN	O	compound	prep_for	16	SENT_324	[p18l1001t3678r1414b3769],
23	to	TO	O	to	aux	24	SENT_324	[p18l1445t3691r1518b3747],
24	accumulate	VB	O	accumulate	xcomp	16	SENT_324	[p18l1553t3678r1987b3747],
25	before	IN	O	before	prep	24	SENT_324	[p18l2018t3678r2138b3747, p19l9t11r157b80],

1	leveling	VBG	O	level	_	0	SENT_325	[p19l188t11r486b104],
2	out	RP	O	out	prt	1	SENT_325	[p19l517t24r641b80],
3	at	IN	O	at	prep	1	SENT_325	[p19l673t24r740b80],
4	a	DT	O	a	det	5	SENT_325	[p19l772t36r811b80],
5	higher	JJR	O	higher	dep	10	SENT_325	[p19l840t11r1091b104],
6	than	IN	O	than	_	0	SENT_325	[p19l1121t11r1294b80],
7	baseline	NN	O	baseline	prep_than	5	SENT_325	[p19l1324t11r1636b80],
8	level	NN	O	level	dep	10	SENT_325	[p19l1667t11r1841b80],
9	(	CD	NUMBER	(	num	8	SENT_325	[p19l1876t11r2146b104],
10	Darby	NNP	PERSON	Darby	dep	14	SENT_325	[p19l1876t11r2146b104],
11	et	FW	O	et	nn	12	SENT_325	[p19l10t125r77b181],
12	al.	FW	O	al.	dep	10	SENT_325	[p19l95t112r177b181],
13	1997	CD	DATE	1997	num	14	SENT_325	[p19l240t113r461b196],
14	)	CD	NUMBER	)	dep	3	SENT_325	[p19l240t113r461b196],
15	.	.	O	.	_	0	SENT_325	[p19l240t113r461b196],

1	Yet	RB	O	yet	advmod	9	SENT_326	[p19l512t118r646b192],
2	,	,	O	,	_	0	SENT_326	[p19l512t118r646b192],
3	today	NN	DATE	today	nsubj	16	SENT_326	[p19l700t112r964b204],
4	’s	POS	O	’s	nsubj	5	SENT_326	[p19l700t112r964b204],
5	managed	VBD	O	manage	rcmod	3	SENT_326	[p19l1024t112r1376b204],
6	care	NN	O	care	nn	7	SENT_326	[p19l1434t136r1589b181],
7	environment	NN	O	environment	dobj	5	SENT_326	[p19l1649t114r2143b181],
8	might	MD	O	might	aux	9	SENT_326	[p19l9t213r236b306],
9	pressure	VB	O	pressure	_	0	SENT_326	[p19l260t237r583b305],
10	clinicians	NNS	O	clinician	dobj	9	SENT_326	[p19l610t213r972b282],
11	into	IN	O	into	_	0	SENT_326	[p19l999t216r1147b282],
12	“	JJ	O	“	amod	14	SENT_326	[p19l1168t214r1476b282],
13	action	NN	O	action	nn	14	SENT_326	[p19l1168t214r1476b282],
14	”	NN	O	”	prep_into	9	SENT_326	[p19l1168t214r1476b282],
15	and	CC	O	and	_	0	SENT_326	[p19l1498t213r1640b282],
16	lead	VB	O	lead	conj_and	9	SENT_326	[p19l1663t213r1822b282],
17	them	PRP	O	they	dobj	16	SENT_326	[p19l1846t213r2042b282],
18	to	TO	O	to	_	0	SENT_326	[p19l2067t226r2139b282],
19	premature	JJ	O	premature	amod	21	SENT_326	[p19l9t327r409b404],
20	dose	NN	O	dose	nn	21	SENT_326	[p19l445t314r618b383],
21	escalations	NNS	O	escalation	prep_to	16	SENT_326	[p19l655t314r1092b383],
22	.	.	O	.	_	0	SENT_326	[p19l655t314r1092b383],

1	Given	VBN	O	give	prep	7	SENT_327	[p19l1126t316r1345b383],
2	our	PRP$	O	we	poss	3	SENT_327	[p19l1381t337r1511b383],
3	trial	NN	O	trial	dep	1	SENT_327	[p19l1545t314r1705b383],
4	results	VBZ	O	result	dep	3	SENT_327	[p19l1740t314r2010b394],
5	,	,	O	,	_	0	SENT_327	[p19l1740t314r2010b394],
6	we	PRP	O	we	nsubj	7	SENT_327	[p19l2038t338r2141b383],
7	found	VBD	O	find	_	0	SENT_327	[p19l9t414r236b484],
8	that	IN	O	that	complm	14	SENT_327	[p19l269t414r419b483],
9	such	JJ	O	such	amod	11	SENT_327	[p19l454t414r626b483],
10	an	DT	O	a	det	11	SENT_327	[p19l662t439r752b483],
11	approach	NN	O	approach	nsubj	14	SENT_327	[p19l788t414r1144b506],
12	is	VBZ	O	be	cop	14	SENT_327	[p19l1179t417r1236b483],
13	rather	RB	O	rather	advmod	14	SENT_327	[p19l1272t414r1505b483],
14	counterproductive	JJ	O	counterproductive	ccomp	7	SENT_327	[p19l1540t414r2138b506, p19l9t517r145b584],
15	in	IN	O	in	_	0	SENT_327	[p19l182t517r256b583],
16	the	DT	O	the	det	18	SENT_327	[p19l292t515r410b584],
17	long	JJ	O	long	amod	18	SENT_327	[p19l446t515r615b607],
18	term	NN	O	term	prep_in	14	SENT_327	[p19l649t528r853b595],
19	,	,	O	,	_	0	SENT_327	[p19l649t528r853b595],
20	especially	RB	O	especially	advmod	21	SENT_327	[p19l887t515r1261b607],
21	when	WRB	O	when	advmod	22	SENT_327	[p19l1291t515r1498b584],
22	considering	VBG	O	consider	dep	18	SENT_327	[p19l1536t515r1989b607],
23	the	DT	O	the	det	24	SENT_327	[p19l2023t515r2141b584],
24	disparity	NN	O	disparity	dobj	22	SENT_327	[p19l10t616r358b709],
25	between	IN	O	between	_	0	SENT_327	[p19l373t616r692b685],
26	a	DT	O	a	det	30	SENT_327	[p19l715t641r754b685],
27	probable	JJ	O	probable	amod	28	SENT_327	[p19l773t616r1110b708],
28	minor	JJ	O	minor	amod	30	SENT_327	[p19l1132t619r1369b685],
29	additional	JJ	O	additional	amod	30	SENT_327	[p19l1391t616r1783b685],
30	response	NN	O	response	prep_between	24	SENT_327	[p19l1804t640r2141b708],
31	and	CC	O	and	_	0	SENT_327	[p19l10t717r153b786],
32	increased	VBD	O	increase	conj_and	22	SENT_327	[p19l191t717r556b786],
33	likelihood	NN	O	likelihood	dobj	32	SENT_327	[p19l594t717r984b786],
34	for	IN	O	for	_	0	SENT_327	[p19l1022t716r1131b786],
35	developing	VBG	O	develop	amod	36	SENT_327	[p19l1171t717r1590b809],
36	EPS	NNS	O	ep	prep_for	33	SENT_327	[p19l1628t722r1794b786],
37	.	.	O	.	_	0	SENT_327	[p19l1628t722r1794b786],

1	Medication	NN	O	medication	nn	2	SENT_328	[p19l1830t717r2138b786, p19l9t821r162b887],
2	switch	NN	O	switch	nsubjpass	9	SENT_328	[p19l188t818r432b887],
3	or	CC	O	or	_	0	SENT_328	[p19l457t843r538b887],
4	augmentation	NN	O	augmentation	nn	5	SENT_328	[p19l562t821r1096b911],
5	treatment	NN	O	treatment	conj_or	2	SENT_328	[p19l1119t831r1497b887],
6	should	MD	O	should	aux	9	SENT_328	[p19l1522t818r1780b887],
7	probably	RB	O	probably	advmod	9	SENT_328	[p19l1802t818r2146b911],
8	be	VB	O	be	auxpass	9	SENT_328	[p19l7t919r97b987],
9	pursued	VBN	O	pursue	_	0	SENT_328	[p19l124t919r439b1009],
10	instead	RB	O	instead	prep	9	SENT_328	[p19l466t919r742b987],
11	(	CD	NUMBER	(	num	13	SENT_328	[p19l772t919r993b1002],
12	Stahl	NNP	PERSON	Stahl	nn	13	SENT_328	[p19l772t919r993b1002],
13	1999a	NN	DATE	1999a	pobj	10	SENT_328	[p19l1027t926r1259b998],
14	,	,	O	,	_	0	SENT_328	[p19l1027t926r1259b998],
15	b	NN	O	b	nn	16	SENT_328	[p19l1280t919r1381b1002],
16	)	NN	O	)	appos	13	SENT_328	[p19l1280t919r1381b1002],
17	.	.	O	.	_	0	SENT_328	[p19l1280t919r1381b1002],

1	At	IN	O	at	_	0	SENT_329	[p19l1402t924r1488b987],
2	times	NNS	O	time	prep_at	12	SENT_329	[p19l1513t921r1745b999],
3	,	,	O	,	_	0	SENT_329	[p19l1513t921r1745b999],
4	even	RB	O	even	advmod	6	SENT_329	[p19l1769t942r1942b987],
5	a	DT	O	a	det	6	SENT_329	[p19l1971t942r2009b987],
6	reduction	NN	O	reduction	nsubj	12	SENT_329	[p19l2036t942r2138b987, p19l10t1019r304b1088],
7	in	IN	O	in	_	0	SENT_329	[p19l331t1022r404b1087],
8	oral	JJ	O	oral	amod	9	SENT_329	[p19l431t1019r580b1088],
9	dose	NN	O	dose	prep_in	6	SENT_329	[p19l605t1019r778b1088],
10	may	MD	O	may	aux	12	SENT_329	[p19l804t1044r968b1112],
11	be	VB	O	be	cop	12	SENT_329	[p19l987t1019r1076b1088],
12	adequate	JJ	O	adequate	_	0	SENT_329	[p19l1104t1019r1466b1111],
13	.	.	O	.	_	0	SENT_329	[p19l1104t1019r1466b1111],

1	Extrapyramidal	JJ	O	extrapyramidal	amod	3	SENT_330	[p19l124t1120r732b1212],
2	side	JJ	O	side	amod	3	SENT_330	[p19l787t1120r936b1189],
3	effects	NNS	O	effect	nsubj	4	SENT_330	[p19l992t1119r1234b1189],
4	(	VBP	O	(	_	0	SENT_330	[p19l1294t1120r1500b1204],
5	EPS	NN	O	ep	nn	6	SENT_330	[p19l1294t1120r1500b1204],
6	)	NN	O	)	nsubj	9	SENT_330	[p19l1294t1120r1500b1204],
7	were	VBD	O	be	cop	9	SENT_330	[p19l1556t1144r1736b1189],
8	generally	RB	O	generally	advmod	9	SENT_330	[p19l1791t1120r2146b1212],
9	mild	JJ	O	mild	ccomp	4	SENT_330	[p19l9t1221r204b1290],
10	.	.	O	.	_	0	SENT_330	[p19l9t1221r204b1290],

1	Interestingly	RB	O	interestingly	advmod	3	SENT_331	[p19l280t1221r780b1314],
2	,	,	O	,	_	0	SENT_331	[p19l280t1221r780b1314],
3	accelerated	VBD	O	accelerate	_	0	SENT_331	[p19l855t1221r1281b1290],
4	dose	NN	O	dose	nn	5	SENT_331	[p19l1358t1221r1531b1290],
5	escalation	NN	O	escalation	nsubjpass	20	SENT_331	[p19l1610t1221r1992b1290],
6	of	IN	O	of	_	0	SENT_331	[p19l2070t1221r2152b1290],
7	risperidone	NN	O	risperidone	prep_of	5	SENT_331	[p19l10t1322r453b1413],
8	depicted	VBN	O	depict	partmod	7	SENT_331	[p19l474t1322r803b1413],
9	by	IN	O	by	_	0	SENT_331	[p19l819t1322r914b1414],
10	both	CC	O	both	preconj	13	SENT_331	[p19l927t1322r1105b1391],
11	higher	JJR	O	higher	amod	13	SENT_331	[p19l1124t1322r1375b1414],
12	oral	JJ	O	oral	amod	13	SENT_331	[p19l1395t1322r1543b1391],
13	dose	NN	O	dose	agent	8	SENT_331	[p19l1563t1322r1736b1391],
14	and	CC	O	and	_	0	SENT_331	[p19l1758t1322r1900b1391],
15	active	JJ	O	active	amod	18	SENT_331	[p19l1920t1324r2141b1391],
16	moiety	NN	O	moiety	nn	18	SENT_331	[p19l9t1426r280b1516],
17	plasma	NN	O	plasma	nn	18	SENT_331	[p19l303t1423r578b1515],
18	levels	NNS	O	level	agent	8	SENT_331	[p19l603t1423r812b1492],
19	was	VBD	O	be	auxpass	20	SENT_331	[p19l838t1448r980b1492],
20	associated	VBN	O	associate	ccomp	3	SENT_331	[p19l1010t1423r1405b1492],
21	with	IN	O	with	_	0	SENT_331	[p19l1430t1423r1602b1492],
22	a	DT	O	a	det	24	SENT_331	[p19l1631t1448r1670b1492],
23	higher	JJR	O	higher	amod	24	SENT_331	[p19l1696t1423r1946b1516],
24	likelihood	NN	O	likelihood	prep_with	20	SENT_331	[p19l1972t1423r2138b1492, p19l8t1524r260b1593],
25	to	TO	O	to	_	0	SENT_331	[p19l291t1537r363b1593],
26	developing	VBG	O	develop	amod	27	SENT_331	[p19l399t1524r818b1616],
27	EPS	NNS	O	ep	prep_to	20	SENT_331	[p19l849t1529r994b1593],
28	in	IN	O	in	_	0	SENT_331	[p19l1029t1526r1102b1592],
29	the	DT	O	the	det	31	SENT_331	[p19l1134t1524r1252b1593],
30	initial	JJ	O	initial	amod	31	SENT_331	[p19l1286t1524r1512b1593],
31	course	NN	O	course	prep_in	27	SENT_331	[p19l1545t1548r1792b1593],
32	of	IN	O	of	_	0	SENT_331	[p19l1826t1524r1908b1593],
33	treatment	NN	O	treatment	prep_of	31	SENT_331	[p19l1932t1537r2138b1593, p19l9t1638r224b1694],
34	.	.	O	.	_	0	SENT_331	[p19l1932t1537r2138b1593, p19l9t1638r224b1694],

1	Looking	VBG	O	look	partmod	22	SENT_332	[p19l252t1625r571b1717],
2	at	IN	O	at	_	0	SENT_332	[p19l601t1638r667b1694],
3	the	DT	O	the	det	6	SENT_332	[p19l696t1625r815b1694],
4	main	JJ	O	main	amod	6	SENT_332	[p19l846t1628r1041b1694],
5	analysis	NN	O	analysis	nn	6	SENT_332	[p19l1073t1625r1374b1717],
6	point	NN	O	point	prep_at	1	SENT_332	[p19l1406t1628r1608b1716],
7	at	IN	O	at	_	0	SENT_332	[p19l1639t1638r1706b1694],
8	week	NN	DURATION	week	prep_at	6	SENT_332	[p19l1733t1625r1928b1694],
9	5	CD	NUMBER	5	num	8	SENT_332	[p19l1958t1634r2018b1706],
10	,	,	O	,	_	0	SENT_332	[p19l1958t1634r2018b1706],
11	no	DT	O	no	det	13	SENT_332	[p19l2045t1649r2140b1694],
12	significant	JJ	O	significant	amod	13	SENT_332	[p19l11t1726r414b1818],
13	differences	NNS	O	difference	nsubjpass	22	SENT_332	[p19l435t1726r851b1795],
14	in	IN	O	in	_	0	SENT_332	[p19l874t1728r947b1794],
15	either	CC	O	either	preconj	17	SENT_332	[p19l970t1726r1192b1795],
16	oral	JJ	O	oral	amod	17	SENT_332	[p19l1213t1726r1361b1795],
17	dose	NN	O	dose	prep_in	13	SENT_332	[p19l1383t1726r1555b1795],
18	or	CC	O	or	_	0	SENT_332	[p19l1578t1750r1658b1795],
19	plasma	NN	O	plasma	nn	20	SENT_332	[p19l1678t1726r1953b1817],
20	concentrations	NNS	O	concentration	prep_in	13	SENT_332	[p19l1974t1750r2139b1795, p19l10t1831r439b1897],
21	were	VBD	O	be	auxpass	22	SENT_332	[p19l461t1852r641b1897],
22	seen	VBN	O	see	_	0	SENT_332	[p19l666t1852r833b1897],
23	between	IN	O	between	_	0	SENT_332	[p19l854t1828r1174b1897],
24	the	DT	O	the	det	25	SENT_332	[p19l1197t1828r1315b1897],
25	groups	NNS	O	group	prep_between	22	SENT_332	[p19l1339t1852r1601b1920],
26	with	IN	O	with	_	0	SENT_332	[p19l1623t1828r1796b1897],
27	more	JJR	O	more	prep_with	22	SENT_332	[p19l1819t1852r2017b1897],
28	vs.	CC	O	vs.	prep	27	SENT_332	[p19l2039t1852r2138b1897],
29	less	RBR	O	less	advmod	30	SENT_332	[p19l8t1929r144b1998],
30	pronounced	JJ	O	pronounced	amod	31	SENT_332	[p19l187t1929r653b2020],
31	EPS	NNP	O	EPS	dep	28	SENT_332	[p19l695t1934r860b1998],
32	.	.	O	.	_	0	SENT_332	[p19l695t1934r860b1998],

1	These	DT	O	these	det	2	SENT_333	[p19l901t1929r1123b1998],
2	findings	NNS	O	finding	nsubj	3	SENT_333	[p19l1166t1929r1479b2021],
3	replicate	VBP	O	replicate	_	0	SENT_333	[p19l1523t1929r1849b2020],
4	results	NNS	O	result	nsubj	8	SENT_333	[p19l1892t1929r2140b1998],
5	from	IN	O	from	_	0	SENT_333	[p19l9t2030r196b2099],
6	previous	JJ	O	previous	amod	7	SENT_333	[p19l234t2033r565b2120],
7	studies	NNS	O	study	prep_from	4	SENT_333	[p19l608t2030r874b2099],
8	(	VBP	O	(	ccomp	3	SENT_333	[p19l919t2030r1207b2113],
9	Olesen	NNP	PERSON	Olesen	nsubj	11	SENT_333	[p19l919t2030r1207b2113],
10	et	FW	O	et	nn	11	SENT_333	[p19l1248t2043r1314b2099],
11	al.	FW	O	al.	xcomp	8	SENT_333	[p19l1333t2030r1415b2099],
12	1998	CD	DATE	1998	num	13	SENT_333	[p19l1459t2031r1681b2113],
13	)	CD	NUMBER	)	dep	11	SENT_333	[p19l1459t2031r1681b2113],
14	,	,	O	,	_	0	SENT_333	[p19l1459t2031r1681b2113],
15	but	CC	O	but	_	0	SENT_333	[p19l1714t2030r1842b2099],
16	do	VBP	O	do	aux	18	SENT_333	[p19l1881t2030r1975b2099],
17	not	RB	O	not	neg	18	SENT_333	[p19l2016t2043r2143b2099],
18	confirm	VB	O	confirm	ccomp	3	SENT_333	[p19l10t2129r315b2199],
19	results	NNS	O	result	dobj	18	SENT_333	[p19l363t2130r610b2199],
20	by	IN	O	by	_	0	SENT_333	[p19l657t2130r751b2222],
21	others	NNS	O	other	prep_by	18	SENT_333	[p19l796t2130r1032b2199],
22	(	CD	NUMBER	(	num	21	SENT_333	[p19l1085t2130r1219b2213],
23	He	PRP	O	he	dep	21	SENT_333	[p19l1085t2130r1219b2213],
24	and	CC	O	and	_	0	SENT_333	[p19l1268t2130r1410b2199],
25	Richardson	NNP	PERSON	Richardson	conj_and	21	SENT_333	[p19l1457t2130r1897b2199],
26	1995	CD	DATE	1995	num	25	SENT_333	[p19l1952t2137r2140b2210],
27	;	:	O	;	_	0	SENT_333	[p19l1952t2137r2140b2210],
28	Yoshimura	NNP	PERSON	Yoshimura	dep	25	SENT_333	[p19l9t2231r422b2300],
29	et	FW	O	et	nn	30	SENT_333	[p19l455t2244r522b2300],
30	al.	FW	O	al.	dep	28	SENT_333	[p19l540t2231r622b2300],
31	2001	CD	DATE	2001	num	32	SENT_333	[p19l654t2232r882b2315],
32	)	CD	NUMBER	)	dep	28	SENT_333	[p19l654t2232r882b2315],
33	.	.	O	.	_	0	SENT_333	[p19l654t2232r882b2315],

1	Most	RBS	O	most	advmod	2	SENT_334	[p19l913t2237r1104b2300],
2	likely	RB	O	likely	advmod	14	SENT_334	[p19l1136t2231r1355b2323],
3	,	,	O	,	_	0	SENT_334	[p19l1136t2231r1355b2323],
4	however	RB	O	however	advmod	14	SENT_334	[p19l1384t2231r1720b2312],
5	,	,	O	,	_	0	SENT_334	[p19l1384t2231r1720b2312],
6	individual	JJ	O	individual	amod	7	SENT_334	[p19l1750t2231r2143b2300],
7	susceptibility	NN	O	susceptibility	nsubjpass	14	SENT_334	[p19l11t2332r524b2424],
8	to	TO	O	to	_	0	SENT_334	[p19l576t2345r648b2401],
9	neuroleptic-induced	JJ	O	neuroleptic-induced	amod	11	SENT_334	[p19l707t2332r1492b2423],
10	extrapyramidal	JJ	O	extrapyramidal	amod	11	SENT_334	[p19l1549t2332r2142b2424],
11	syndromes	NNS	O	syndrome	prep_to	7	SENT_334	[p19l11t2433r430b2525],
12	may	MD	O	may	aux	14	SENT_334	[p19l453t2457r616b2525],
13	be	VB	O	be	auxpass	14	SENT_334	[p19l631t2433r721b2502],
14	implicated	VBN	O	implicate	_	0	SENT_334	[p19l743t2433r1148b2524],
15	(	CD	NUMBER	(	num	16	SENT_334	[p19l1172t2434r1504b2524],
16	Keepers	NNS	O	keeper	dobj	14	SENT_334	[p19l1172t2434r1504b2524],
17	and	CC	O	and	_	0	SENT_334	[p19l1527t2433r1670b2502],
18	Casey	NNP	PERSON	Casey	conj_and	16	SENT_334	[p19l1692t2438r1916b2525],
19	1991	CD	DATE	1991	num	18	SENT_334	[p19l1940t2434r2137b2517],
20	)	CD	NUMBER	)	dep	18	SENT_334	[p19l1940t2434r2137b2517],
21	when	WRB	O	when	advmod	22	SENT_334	[p19l7t2534r215b2603],
22	accounting	VBG	O	account	advcl	14	SENT_334	[p19l243t2536r665b2626],
23	for	IN	O	for	_	0	SENT_334	[p19l690t2534r799b2603],
24	the	DT	O	the	det	25	SENT_334	[p19l824t2534r942b2603],
25	development	NN	O	development	prep_for	22	SENT_334	[p19l970t2534r1464b2625],
26	of	IN	O	of	_	0	SENT_334	[p19l1491t2533r1572b2603],
27	EPS	NN	O	ep	prep_of	25	SENT_334	[p19l1592t2539r1737b2603],
28	after	IN	O	after	_	0	SENT_334	[p19l1766t2534r1942b2603],
29	neuroleptic	JJ	O	neuroleptic	amod	30	SENT_334	[p19l1968t2558r2138b2603, p19l10t2635r303b2726],
30	medication	NN	O	medication	prep_after	22	SENT_334	[p19l346t2635r797b2704],
31	.	.	O	.	_	0	SENT_334	[p19l346t2635r797b2704],

1	Our	PRP$	O	we	poss	2	SENT_335	[p19l839t2640r987b2704],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_335	[p19l1029t2635r1342b2727],
3	are	VBP	O	be	cop	4	SENT_335	[p19l1387t2659r1501b2704],
4	consistent	JJ	O	consistent	_	0	SENT_335	[p19l1545t2638r1931b2704],
5	with	IN	O	with	_	0	SENT_335	[p19l1970t2635r2142b2704],
6	this	DT	O	this	det	7	SENT_335	[p19l9t2736r147b2806],
7	notion	NN	O	notion	prep_with	4	SENT_335	[p19l172t2739r444b2806],
8	.	.	O	.	_	0	SENT_335	[p19l172t2739r444b2806],

1	Aside	RB	O	aside	advmod	2	SENT_336	[p19l460t2736r672b2806],
2	from	IN	O	from	advcl	18	SENT_336	[p19l696t2736r882b2805],
3	this	DT	O	this	pobj	2	SENT_336	[p19l904t2736r1065b2817],
4	,	,	O	,	_	0	SENT_336	[p19l904t2736r1065b2817],
5	careful	JJ	O	careful	amod	7	SENT_336	[p19l1085t2736r1346b2805],
6	medication	NN	O	medication	nn	7	SENT_336	[p19l1368t2736r1800b2806],
7	titration	NN	O	titration	nsubjpass	18	SENT_336	[p19l1822t2739r2142b2806],
8	in	IN	O	in	_	0	SENT_336	[p19l10t2840r83b2905],
9	the	DT	O	the	det	12	SENT_336	[p19l103t2837r220b2906],
10	initial	JJ	O	initial	amod	12	SENT_336	[p19l242t2837r468b2906],
11	few	JJ	DURATION	few	amod	12	SENT_336	[p19l487t2837r619b2906],
12	weeks	NNS	DURATION	week	prep_in	7	SENT_336	[p19l633t2837r862b2906],
13	upon	IN	O	upon	_	0	SENT_336	[p19l884t2861r1081b2928],
14	treatment	NN	O	treatment	nn	15	SENT_336	[p19l1101t2850r1478b2906],
15	initiation	NN	O	initiation	prep_upon	12	SENT_336	[p19l1497t2840r1854b2906],
16	may	MD	O	may	aux	18	SENT_336	[p19l1874t2861r2037b2929],
17	be	VB	O	be	auxpass	18	SENT_336	[p19l2051t2837r2141b2906],
18	warranted	VBN	O	warrant	_	0	SENT_336	[p19l7t2938r404b3008],
19	to	TO	O	to	aux	20	SENT_336	[p19l432t2951r505b3008],
20	avoid	VB	O	avoid	xcomp	18	SENT_336	[p19l539t2938r744b3008],
21	peak	JJ	O	peak	amod	25	SENT_336	[p19l773t2939r957b3030],
22	active	JJ	O	active	amod	25	SENT_336	[p19l987t2941r1207b3008],
23	moiety	NN	O	moiety	nn	25	SENT_336	[p19l1238t2941r1508b3031],
24	plasma	NN	O	plasma	nn	25	SENT_336	[p19l1534t2938r1809b3030],
25	concentrations	NNS	O	concentration	dobj	20	SENT_336	[p19l1840t2963r2138b3008, p19l9t3042r306b3108],
26	and	CC	O	and	_	0	SENT_336	[p19l335t3039r477b3108],
27	thus	RB	O	thus	advmod	25	SENT_336	[p19l501t3039r663b3108],
28	unnecessary	JJ	O	unnecessary	amod	30	SENT_336	[p19l690t3063r1168b3131],
29	EPS	NN	O	ep	nn	30	SENT_336	[p19l1190t3044r1335b3108],
30	responses	NNS	O	response	conj_and	25	SENT_336	[p19l1363t3063r1756b3130],
31	.	.	O	.	_	0	SENT_336	[p19l1363t3063r1756b3130],

1	The	DT	O	the	det	2	SENT_337	[p19l124t3140r268b3210],
2	usefulness	NN	O	usefulness	nsubjpass	13	SENT_337	[p19l300t3140r696b3210],
3	of	IN	O	of	_	0	SENT_337	[p19l730t3140r811b3210],
4	plasma	NN	O	plasma	nn	5	SENT_337	[p19l834t3140r1109b3232],
5	concentration	NN	O	concentration	prep_of	2	SENT_337	[p19l1140t3143r1672b3210],
6	monitoring	VBG	O	monitor	partmod	5	SENT_337	[p19l1703t3143r2143b3233],
7	to	TO	O	to	aux	8	SENT_337	[p19l9t3254r81b3310],
8	predict	VB	O	predict	xcomp	6	SENT_337	[p19l123t3241r397b3331],
9	clinical	JJ	O	clinical	amod	10	SENT_337	[p19l438t3241r712b3310],
10	response	NN	O	response	dobj	8	SENT_337	[p19l753t3264r1089b3331],
11	has	VBZ	O	have	aux	13	SENT_337	[p19l1130t3241r1256b3310],
12	been	VBN	O	be	auxpass	13	SENT_337	[p19l1297t3241r1481b3310],
13	disputed	VBN	O	dispute	_	0	SENT_337	[p19l1523t3241r1856b3331],
14	(	CD	NUMBER	(	num	15	SENT_337	[p19l1899t3242r2143b3331],
15	Spina	NNP	O	Spina	dobj	13	SENT_337	[p19l1899t3242r2143b3331],
16	et	FW	O	et	nn	17	SENT_337	[p19l11t3355r77b3412],
17	al.	FW	O	al.	tmod	13	SENT_337	[p19l96t3343r178b3412],
18	2001	CD	DATE	2001	num	19	SENT_337	[p19l197t3343r575b3426],
19	)	CD	NUMBER	)	dep	17	SENT_337	[p19l197t3343r575b3426],
20	.	.	O	.	_	0	SENT_337	[p19l197t3343r575b3426],

1	Yet	RB	O	yet	advmod	18	SENT_338	[p19l197t3343r575b3426],
2	,	,	O	,	_	0	SENT_338	[p19l197t3343r575b3426],
3	plasma	NN	O	plasma	nn	5	SENT_338	[p19l592t3343r867b3434],
4	level	NN	O	level	nn	5	SENT_338	[p19l887t3342r1061b3412],
5	monitoring	NN	O	monitoring	nsubj	18	SENT_338	[p19l1083t3345r1522b3435],
6	is	VBZ	O	be	cop	18	SENT_338	[p19l1543t3345r1601b3412],
7	certainly	RB	O	certainly	advmod	18	SENT_338	[p19l1625t3342r1965b3435],
8	useful	JJ	O	useful	acomp	18	SENT_338	[p19l1984t3367r2139b3412, p19l10t3445r112b3514],
9	in	IN	O	in	_	0	SENT_338	[p19l131t3447r204b3513],
10	clinical	JJ	O	clinical	amod	11	SENT_338	[p19l225t3445r500b3514],
11	practice	NN	O	practice	prep_in	8	SENT_338	[p19l518t3447r847b3536],
12	,	,	O	,	_	0	SENT_338	[p19l518t3447r847b3536],
13	especially	RB	O	especially	advmod	18	SENT_338	[p19l863t3445r1237b3537],
14	in	IN	O	in	_	0	SENT_338	[p19l1253t3447r1326b3513],
15	patients	NNS	O	patient	prep_in	13	SENT_338	[p19l1345t3447r1650b3536],
16	not	RB	O	not	neg	18	SENT_338	[p19l1671t3458r1798b3514],
17	properly	RB	O	properly	advmod	18	SENT_338	[p19l1816t3445r2146b3537],
18	responding	VBG	O	respond	_	0	SENT_338	[p20l10t26r445b119],
19	to	TO	O	to	_	0	SENT_338	[p20l470t39r542b96],
20	pharmacological	JJ	O	pharmacological	amod	21	SENT_338	[p20l570t26r1216b119],
21	interventions	NNS	O	intervention	prep_to	18	SENT_338	[p20l1243t29r1772b96],
22	.	.	O	.	_	0	SENT_338	[p20l1243t29r1772b96],

1	In	IN	O	in	_	0	SENT_339	[p20l1797t33r1875b95],
2	such	PDT	O	such	predet	4	SENT_339	[p20l1903t26r2077b96],
3	a	DT	O	a	det	4	SENT_339	[p20l2104t51r2143b96],
4	population	NN	O	population	prep_in	14	SENT_339	[p20l9t128r451b219],
5	,	,	O	,	_	0	SENT_339	[p20l9t128r451b219],
6	further	RB	O	further	advmod	14	SENT_339	[p20l481t128r756b197],
7	dose	NN	O	dose	nn	8	SENT_339	[p20l791t128r963b197],
8	escalation	NN	O	escalation	nsubj	14	SENT_339	[p20l1000t128r1381b197],
9	may	MD	O	may	aux	14	SENT_339	[p20l1416t152r1579b220],
10	not	RB	O	not	neg	14	SENT_339	[p20l1610t141r1737b197],
11	always	RB	O	always	advmod	14	SENT_339	[p20l1772t128r2018b220],
12	be	VB	O	be	cop	14	SENT_339	[p20l2052t128r2141b197],
13	the	DT	O	the	det	14	SENT_339	[p20l9t230r127b300],
14	treatment	NN	O	treatment	_	0	SENT_339	[p20l156t243r534b300],
15	of	IN	O	of	_	0	SENT_339	[p20l562t230r644b300],
16	choice	NN	O	choice	prep_of	14	SENT_339	[p20l667t230r930b311],
17	,	,	O	,	_	0	SENT_339	[p20l667t230r930b311],
18	as	IN	O	as	mark	25	SENT_339	[p20l956t255r1029b300],
19	drug	NN	O	drug	nn	21	SENT_339	[p20l1060t230r1242b323],
20	plasma	NN	O	plasma	nn	21	SENT_339	[p20l1269t230r1544b322],
21	concentrations	NNS	O	concentration	nsubj	25	SENT_339	[p20l1573t233r2140b300],
22	may	MD	O	may	aux	25	SENT_339	[p20l9t356r173b424],
23	already	RB	O	already	advmod	25	SENT_339	[p20l194t332r476b424],
24	be	VB	O	be	cop	25	SENT_339	[p20l493t332r583b401],
25	high	JJ	O	high	advcl	14	SENT_339	[p20l607t332r798b424],
26	.	.	O	.	_	0	SENT_339	[p20l607t332r798b424],

1	Rather	RB	O	rather	advmod	9	SENT_340	[p20l820t332r1090b412],
2	,	,	O	,	_	0	SENT_340	[p20l820t332r1090b412],
3	sometimes	RB	O	sometimes	advmod	4	SENT_340	[p20l1112t335r1524b401],
4	modiﬁcation	NN	O	modiﬁcation	nsubj	9	SENT_340	[p20l1549t332r2045b401],
5	of	IN	O	of	_	0	SENT_340	[p20l2070t332r2151b401],
6	pharmacotherapeutic	JJ	O	pharmacotherapeutic	amod	7	SENT_340	[p20l9t434r841b526],
7	measures	NNS	O	measure	prep_of	4	SENT_340	[p20l878t459r1236b504],
8	may	MD	O	may	aux	9	SENT_340	[p20l1275t459r1438b527],
9	yield	VB	O	yield	_	0	SENT_340	[p20l1469t434r1660b527],
10	results	NNS	O	result	dobj	9	SENT_340	[p20l1696t434r1966b515],
11	,	,	O	,	_	0	SENT_340	[p20l1696t434r1966b515],
12	and	CC	O	and	cc	10	SENT_340	[p20l2001t434r2143b504],
13	sometimes	RB	O	sometimes	advmod	10	SENT_340	[p20l11t538r424b605],
14	even	RB	O	even	advmod	10	SENT_340	[p20l462t560r635b605],
15	simple	JJ	O	simple	amod	16	SENT_340	[p20l672t536r922b626],
16	patience	NN	O	patience	dep	10	SENT_340	[p20l957t538r1299b626],
17	.	.	O	.	_	0	SENT_340	[p20l957t538r1299b626],

1	Furthermore	RB	O	furthermore	advmod	15	SENT_341	[p20l1333t536r1850b616],
2	,	,	O	,	_	0	SENT_341	[p20l1333t536r1850b616],
3	the	DT	O	the	det	4	SENT_341	[p20l1880t536r1999b605],
4	inﬂuence	NN	O	inﬂuence	nsubjpass	15	SENT_341	[p20l2035t538r2139b604, p20l10t637r283b707],
5	of	IN	O	of	_	0	SENT_341	[p20l315t637r396b707],
6	the	DT	O	the	det	10	SENT_341	[p20l419t637r537b707],
7	genetically	RB	O	genetically	advmod	8	SENT_341	[p20l569t637r985b730],
8	determined	VBN	O	determine	amod	10	SENT_341	[p20l1012t637r1459b707],
9	CYP	NN	O	cyp	nn	10	SENT_341	[p20l1490t642r1652b707],
10	metabolizer	NN	O	metabolizer	prep_of	4	SENT_341	[p20l1685t637r2142b707],
11	status	NN	O	status	dep	4	SENT_341	[p20l11t752r230b808],
12	has	VBZ	O	have	aux	15	SENT_341	[p20l252t739r380b808],
13	not	RB	O	not	neg	15	SENT_341	[p20l403t752r530b808],
14	been	VBN	O	be	auxpass	15	SENT_341	[p20l549t739r733b808],
15	paid	VBN	O	pay	_	0	SENT_341	[p20l754t739r925b830],
16	adequate	JJ	O	adequate	amod	17	SENT_341	[p20l947t739r1289b830],
17	attention	NN	O	attention	dobj	15	SENT_341	[p20l1313t741r1676b808],
18	.	.	O	.	_	0	SENT_341	[p20l1313t741r1676b808],

1	Although	IN	O	although	mark	9	SENT_342	[p20l1692t739r2053b831],
2	at	IN	O	at	_	0	SENT_342	[p20l2076t752r2143b808],
3	this	DT	O	this	det	4	SENT_342	[p20l9t841r147b910],
4	point	NN	O	point	prep_at	9	SENT_342	[p20l174t844r396b933],
5	,	,	O	,	_	0	SENT_342	[p20l174t844r396b933],
6	metabolizer	NN	O	metabolizer	nn	7	SENT_342	[p20l417t841r875b910],
7	status	NN	O	status	nsubj	9	SENT_342	[p20l902t854r1121b910],
8	may	MD	O	may	aux	9	SENT_342	[p20l1147t866r1311b934],
9	be	VB	O	be	advcl	35	SENT_342	[p20l1329t841r1419b910],
10	of	IN	O	of	_	0	SENT_342	[p20l1446t841r1528b910],
11	limited	JJ	O	limited	amod	12	SENT_342	[p20l1545t841r1820b910],
12	value	NN	O	value	prep_of	9	SENT_342	[p20l1842t841r2042b910],
13	in	IN	O	in	_	0	SENT_342	[p20l2068t844r2141b909],
14	a	DT	O	a	det	16	SENT_342	[p20l11t967r50b1012],
15	treatment	NN	O	treatment	nn	16	SENT_342	[p20l94t956r471b1012],
16	approach	NN	O	approach	prep_in	12	SENT_342	[p20l517t943r875b1033],
17	with	IN	O	with	_	0	SENT_342	[p20l918t943r1089b1012],
18	risperidone	NN	O	risperidone	nn	20	SENT_342	[p20l1135t943r1579b1033],
19	(	CD	NUMBER	(	num	20	SENT_342	[p20l1630t943r1923b1026],
20	Scordo	NNP	O	Scordo	prep_with	9	SENT_342	[p20l1630t943r1923b1026],
21	et	FW	O	et	nn	22	SENT_342	[p20l1972t956r2038b1012],
22	al.	FW	O	al.	dep	20	SENT_342	[p20l2056t943r2139b1012],
23	1999	CD	DATE	1999	dep	22	SENT_342	[p20l17t1052r205b1125],
24	;	:	O	;	_	0	SENT_342	[p20l17t1052r205b1125],
25	Roh	NNP	PERSON	Roh	dep	22	SENT_342	[p20l264t1044r415b1113],
26	et	FW	O	et	nn	27	SENT_342	[p20l474t1057r541b1113],
27	al.	FW	O	al.	dep	25	SENT_342	[p20l559t1044r641b1113],
28	2001	CD	DATE	2001	num	29	SENT_342	[p20l697t1045r926b1128],
29	)	CD	NUMBER	)	dep	25	SENT_342	[p20l697t1045r926b1128],
30	,	,	O	,	_	0	SENT_342	[p20l697t1045r926b1128],
31	future	JJ	DATE	future	amod	32	SENT_342	[p20l980t1044r1213b1113],
32	prospects	NNS	O	prospects	nsubj	35	SENT_342	[p20l1271t1057r1638b1136],
33	seem	VBP	O	seem	cop	35	SENT_342	[p20l1699t1069r1891b1113],
34	quite	RB	O	quite	advmod	35	SENT_342	[p20l1950t1047r2141b1136],
35	promising	JJ	O	promising	_	0	SENT_342	[p20l9t1148r423b1238],
36	.	.	O	.	_	0	SENT_342	[p20l9t1148r423b1238],

1	Customized	JJ	MISC	customized	amod	2	SENT_343	[p20l452t1146r908b1215],
2	pharmacotherapy	NN	O	pharmacotherapy	nsubj	25	SENT_343	[p20l936t1146r1636b1238],
3	,	,	O	,	_	0	SENT_343	[p20l936t1146r1636b1238],
4	according	VBG	O	accord	_	0	SENT_343	[p20l1663t1146r2040b1238],
5	to	TO	O	to	prepc_according_to	25	SENT_343	[p20l2068t1159r2140b1215],
6	the	DT	O	the	det	7	SENT_343	[p20l9t1248r127b1317],
7	patient	NN	O	patient	poss	10	SENT_343	[p20l161t1249r481b1340],
8	’s	POS	O	’s	_	0	SENT_343	[p20l161t1249r481b1340],
9	genetic	JJ	O	genetic	amod	10	SENT_343	[p20l516t1251r791b1341],
10	capability	NN	O	capability	pobj	25	SENT_343	[p20l826t1248r1207b1341],
11	to	TO	O	to	aux	12	SENT_343	[p20l1237t1261r1309b1317],
12	metabolize	VBZ	O	metabolize	infmod	10	SENT_343	[p20l1345t1248r1766b1317],
13	a	DT	O	a	det	15	SENT_343	[p20l1802t1273r1841b1317],
14	certain	JJ	O	certain	amod	15	SENT_343	[p20l1876t1251r2142b1317],
15	drug	NN	O	drug	dobj	12	SENT_343	[p20l10t1350r213b1442],
16	,	,	O	,	_	0	SENT_343	[p20l10t1350r213b1442],
17	with	IN	O	with	amod	19	SENT_343	[p20l245t1350r417b1419],
18	concomitant	JJ	O	concomitant	amod	19	SENT_343	[p20l457t1352r937b1419],
19	measurement	NN	O	measurement	nsubj	25	SENT_343	[p20l975t1363r1498b1419],
20	of	IN	O	of	_	0	SENT_343	[p20l1537t1350r1618b1419],
21	drug	NN	O	drug	nn	23	SENT_343	[p20l1650t1350r1832b1442],
22	plasma	NN	O	plasma	nn	23	SENT_343	[p20l1868t1350r2143b1441],
23	levels	NNS	O	level	prep_of	19	SENT_343	[p20l8t1452r216b1521],
24	may	MD	O	may	aux	25	SENT_343	[p20l241t1477r404b1545],
25	yield	VB	O	yield	_	0	SENT_343	[p20l421t1452r611b1545],
26	the	DT	O	the	det	37	SENT_343	[p20l633t1452r751b1521],
27	most	RBS	O	most	advmod	28	SENT_343	[p20l775t1465r966b1521],
28	effective	JJ	O	effective	amod	37	SENT_343	[p20l989t1452r1306b1521],
29	and	CC	O	and	_	0	SENT_343	[p20l1331t1452r1474b1521],
30	at	IN	O	at	conj_and	28	SENT_343	[p20l1497t1465r1564b1521],
31	the	DT	O	the	det	33	SENT_343	[p20l1586t1452r1704b1521],
32	same	JJ	O	same	amod	33	SENT_343	[p20l1729t1477r1923b1521],
33	time	NN	O	time	pobj	30	SENT_343	[p20l1946t1455r2140b1533],
34	,	,	O	,	_	0	SENT_343	[p20l1946t1455r2140b1533],
35	the	DT	O	the	appos	33	SENT_343	[p20l9t1554r127b1623],
36	most	RBS	O	most	advmod	35	SENT_343	[p20l164t1567r354b1623],
37	time	NN	O	time	dobj	25	SENT_343	[p20l389t1556r562b1623],
38	saving	VBG	O	save	xcomp	25	SENT_343	[p20l600t1556r844b1646],
39	approach	NN	O	approach	dobj	38	SENT_343	[p20l880t1554r1237b1645],
40	to	TO	O	to	_	0	SENT_343	[p20l1272t1567r1345b1623],
41	rational	JJ	O	rational	amod	43	SENT_343	[p20l1384t1554r1683b1623],
42	pharmacological	JJ	O	pharmacological	amod	43	SENT_343	[p20l1718t1554r2139b1645, p20l8t1656r262b1749],
43	treatment	NN	O	treatment	prep_to	38	SENT_343	[p20l288t1669r684b1725],
44	.	.	O	.	_	0	SENT_343	[p20l288t1669r684b1725],

1	Certainly	RB	O	certainly	advmod	7	SENT_344	[p20l710t1656r1079b1749],
2	,	,	O	,	_	0	SENT_344	[p20l710t1656r1079b1749],
3	optimal	JJ	O	optimal	amod	6	SENT_344	[p20l1102t1656r1400b1748],
4	plasma	NN	O	plasma	nn	6	SENT_344	[p20l1425t1656r1701b1748],
5	drug	NN	O	drug	nn	6	SENT_344	[p20l1727t1656r1909b1749],
6	levels	NNS	O	level	nsubj	7	SENT_344	[p20l1933t1656r2141b1725],
7	need	VBP	O	need	_	0	SENT_344	[p20l10t1758r192b1827],
8	to	TO	O	to	aux	10	SENT_344	[p20l219t1771r292b1827],
9	be	VB	O	be	auxpass	10	SENT_344	[p20l320t1758r410b1827],
10	established	VBN	O	establish	xcomp	7	SENT_344	[p20l440t1758r887b1839],
11	;	:	O	;	_	0	SENT_344	[p20l440t1758r887b1839],
12	our	PRP$	O	we	poss	13	SENT_344	[p20l917t1782r1047b1827],
13	study	NN	O	study	nsubj	17	SENT_344	[p20l1076t1758r1287b1850],
14	is	VBZ	O	be	cop	17	SENT_344	[p20l1312t1760r1369b1827],
15	but	CC	O	but	advmod	17	SENT_344	[p20l1397t1758r1524b1827],
16	one	CD	NUMBER	one	num	17	SENT_344	[p20l1553t1782r1689b1827],
17	step	NN	O	step	parataxis	7	SENT_344	[p20l1719t1771r1869b1849],
18	in	IN	O	in	_	0	SENT_344	[p20l1900t1760r1973b1826],
19	this	DT	O	this	det	20	SENT_344	[p20l2001t1758r2140b1827],
20	direction	NN	O	direction	prep_in	17	SENT_344	[p20l10t1859r379b1928],
21	.	.	O	.	_	0	SENT_344	[p20l10t1859r379b1928],

1	References	NNS	O	reference	_	0	SENT_345	[p20l13t2146r462b2221],

1	1	LS	NUMBER	1	_	0	SENT_346	[p20l51t2356r94b2406],
2	.	.	O	.	_	0	SENT_346	[p20l51t2356r94b2406],

1	Alvan	NNP	PERSON	Alvan	nn	2	SENT_347	[p20l161t2350r341b2406],
2	G	NNP	PERSON	G	_	0	SENT_347	[p20l360t2354r424b2415],
3	,	,	O	,	_	0	SENT_347	[p20l360t2354r424b2415],
4	Bechtel	NNP	ORGANIZATION	Bechtel	nn	5	SENT_347	[p20l439t2350r665b2406],
5	P	NN	ORGANIZATION	p	appos	2	SENT_347	[p20l683t2355r729b2415],
6	,	,	O	,	_	0	SENT_347	[p20l683t2355r729b2415],
7	Iselius	NNP	O	Iselius	nn	8	SENT_347	[p20l744t2350r939b2406],
8	L	NNP	O	L	appos	2	SENT_347	[p20l959t2355r1013b2415],
9	,	,	O	,	_	0	SENT_347	[p20l959t2355r1013b2415],
10	Gundert-Remy	NNP	O	Gundert-Remy	nn	12	SENT_347	[p20l1029t2350r1495b2424],
11	U	NNP	O	U	nn	12	SENT_347	[p20l1510t2355r1561b2406],
12	(	NNP	O	(	appos	2	SENT_347	[p20l1582t2350r1772b2417],
13	1990	CD	DATE	1990	dep	12	SENT_347	[p20l1582t2350r1772b2417],
14	)	CD	NUMBER	)	num	16	SENT_347	[p20l1582t2350r1772b2417],
15	Hydroxylation	NN	O	hydroxylation	nn	16	SENT_347	[p20l1794t2350r2140b2424, p20l161t2435r285b2488],
16	polymorphisms	NNS	O	polymorphism	dep	2	SENT_347	[p20l303t2433r797b2507],
17	of	IN	O	of	_	0	SENT_347	[p20l817t2432r883b2488],
18	debrisoquine	NN	O	debrisoquine	prep_of	16	SENT_347	[p20l896t2433r1306b2506],
19	and	CC	O	and	_	0	SENT_347	[p20l1326t2433r1441b2488],
20	mephenytoin	NN	O	mephenytoin	conj_and	18	SENT_347	[p20l1458t2433r1872b2507],
21	in	IN	O	in	_	0	SENT_347	[p20l1890t2435r1950b2488],
22	European	JJ	LOCATION	european	amod	23	SENT_347	[p20l1969t2438r2140b2488, p20l161t2534r310b2589],
23	populations	NNS	O	population	prep_in	16	SENT_347	[p20l331t2515r717b2589],
24	.	.	O	.	_	0	SENT_347	[p20l331t2515r717b2589],

1	Eur	NNP	O	Eur	nn	4	SENT_348	[p20l735t2520r845b2571],
2	J	NNP	O	J	nn	4	SENT_348	[p20l864t2520r886b2583],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_348	[p20l909t2515r1036b2571],
4	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_348	[p20l1057t2515r1394b2571],
5	39	CD	NUMBER	39	num	4	SENT_348	[p20l1415t2516r1848b2583],
6	(	CD	NUMBER	(	number	7	SENT_348	[p20l1415t2516r1848b2583],
7	6	CD	NUMBER	6	num	8	SENT_348	[p20l1415t2516r1848b2583],
8	)	NN	O	)	dep	4	SENT_348	[p20l1415t2516r1848b2583],
9	:533	CD	NUMBER	:533	num	10	SENT_348	[p20l1415t2516r1848b2583],
10	—	NN	O	—	dep	8	SENT_348	[p20l1415t2516r1848b2583],
11	537	CD	NUMBER	537	dep	4	SENT_348	[p20l1415t2516r1848b2583],

1	2	LS	NUMBER	2	_	0	SENT_349	[p20l45t2603r94b2653],
2	.	.	O	.	_	0	SENT_349	[p20l45t2603r94b2653],

1	American	JJ	ORGANIZATION	american	amod	3	SENT_350	[p20l161t2599r468b2653],
2	Psychiatric	NNP	ORGANIZATION	Psychiatric	nn	3	SENT_350	[p20l491t2597r831b2671],
3	Association	NNP	ORGANIZATION	Association	_	0	SENT_350	[p20l849t2599r1212b2653],
4	(	CD	NUMBER	(	num	7	SENT_350	[p20l1237t2598r1426b2665],
5	1994	CD	DATE	1994	num	7	SENT_350	[p20l1237t2598r1426b2665],
6	)	NNP	O	)	nn	7	SENT_350	[p20l1237t2598r1426b2665],
7	Diagnostic	NNP	O	Diagnostic	dep	3	SENT_350	[p20l1453t2599r1789b2671],
8	and	CC	O	and	_	0	SENT_350	[p20l1812t2597r1927b2653],
9	Statistical	NNP	O	Statistical	nn	10	SENT_350	[p20l1949t2599r2140b2653, p20l161t2679r294b2735],
10	Manual	NNP	O	Manual	dep	3	SENT_350	[p20l318t2679r553b2735],
11	of	IN	O	of	_	0	SENT_350	[p20l579t2679r645b2735],
12	Mental	JJ	O	mental	amod	13	SENT_350	[p20l665t2679r879b2735],
13	Disorders	NNS	O	disorder	prep_of	3	SENT_350	[p20l905t2679r1225b2744],
14	,	,	O	,	_	0	SENT_350	[p20l905t2679r1225b2744],
15	Fourth	JJ	ORDINAL	fourth	amod	16	SENT_350	[p20l1248t2679r1460b2735],
16	Edition	NN	O	edition	appos	13	SENT_350	[p20l1485t2679r1731b2735],
17	.	.	O	.	_	0	SENT_350	[p20l1485t2679r1731b2735],

1	Washington	NNP	LOCATION	Washington	nn	3	SENT_351	[p20l1751t2679r2141b2753],
2	,	,	O	,	_	0	SENT_351	[p20l1751t2679r2141b2753],
3	D.C.	NNP	LOCATION	D.C.	_	0	SENT_351	[p20l162t2765r309b2826],
4	,	,	O	,	_	0	SENT_351	[p20l162t2765r309b2826],
5	American	NNP	ORGANIZATION	American	nn	7	SENT_351	[p20l323t2763r630b2817],
6	Psychiatric	NNP	ORGANIZATION	Psychiatric	nn	7	SENT_351	[p20l652t2761r992b2835],
7	Association	NNP	ORGANIZATION	Association	appos	3	SENT_351	[p20l1009t2763r1371b2817],

1	3	LS	NUMBER	3	_	0	SENT_352	[p20l46t2849r94b2899],
2	.	.	O	.	_	0	SENT_352	[p20l46t2849r94b2899],

1	Aravagiri	NNP	MISC	Aravagiri	nn	4	SENT_353	[p20l161t2845r454b2917],
2	M	NNP	O	M	nn	4	SENT_353	[p20l480t2848r559b2908],
3	,	,	O	,	_	0	SENT_353	[p20l480t2848r559b2908],
4	Marder	NNP	PERSON	Marder	nsubj	6	SENT_353	[p20l582t2843r812b2899],
5	SR	JJ	O	sr	amod	6	SENT_353	[p20l839t2847r920b2899],
6	(	NN	O	(	_	0	SENT_353	[p20l949t2844r1139b2911],
7	2002	CD	DATE	2002	num	14	SENT_353	[p20l949t2844r1139b2911],
8	)	CD	NUMBER	)	num	14	SENT_353	[p20l949t2844r1139b2911],
9	Brain	NN	O	brain	nn	14	SENT_353	[p20l1170t2845r1354b2908],
10	,	,	O	,	_	0	SENT_353	[p20l1170t2845r1354b2908],
11	plasma	NN	O	plasma	nn	14	SENT_353	[p20l1377t2843r1600b2917],
12	and	CC	O	and	_	0	SENT_353	[p20l1627t2843r1742b2899],
13	tissue	NN	O	tissue	conj_and	9	SENT_353	[p20l1767t2845r1944b2899],
14	pharmacokinetics	NNS	O	pharmacokinetic	dobj	6	SENT_353	[p20l1971t2843r2140b2917, p20l162t2925r574b2981],
15	of	IN	O	of	_	0	SENT_353	[p20l617t2925r683b2981],
16	risperidone	NN	O	risperidone	prep_of	14	SENT_353	[p20l720t2925r1079b2999],
17	and	CC	O	and	_	0	SENT_353	[p20l1121t2925r1237b2981],
18	9-hydroxyrisperidone	NN	O	9-hydroxyrisperidone	prep_of	14	SENT_353	[p20l1278t2925r1958b2999],
19	after	IN	O	after	_	0	SENT_353	[p20l2001t2925r2143b2981],
20	separate	JJ	O	separate	amod	22	SENT_353	[p20l163t3017r418b3080],
21	oral	JJ	O	oral	amod	22	SENT_353	[p20l465t3007r585b3063],
22	administration	NN	O	administration	prep_after	6	SENT_353	[p20l631t3007r1097b3063],
23	to	TO	O	to	_	0	SENT_353	[p20l1143t3017r1201b3063],
24	rats	NNS	O	rat	prep_to	22	SENT_353	[p20l1249t3017r1378b3063],
25	.	.	O	.	_	0	SENT_353	[p20l1249t3017r1378b3063],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_354	[p20l1423t3007r1974b3081],
2	159	CD	NUMBER	159	num	1	SENT_354	[p20l2025t3013r2140b3063],
3	:	:	O	:	_	0	SENT_354	[p20l2025t3013r2140b3063],
4	424-431	CD	NUMBER	424-431	dep	1	SENT_354	[p20l161t3095r409b3146],

1	Aravagiri	NNP	MISC	Aravagiri	nn	2	SENT_355	[p21l161t22r454b94],
2	M	NNP	O	M	nsubj	12	SENT_355	[p21l470t24r550b84],
3	,	,	O	,	_	0	SENT_355	[p21l470t24r550b84],
4	Marder	NNP	PERSON	Marder	nn	5	SENT_355	[p21l563t20r793b75],
5	SR	NN	O	sr	appos	2	SENT_355	[p21l811t24r909b84],
6	,	,	O	,	_	0	SENT_355	[p21l811t24r909b84],
7	Nuechterlein	NNP	O	Nuechterlein	nn	8	SENT_355	[p21l922t20r1323b75],
8	KH	NNP	O	KH	appos	2	SENT_355	[p21l1341t24r1461b84],
9	,	,	O	,	_	0	SENT_355	[p21l1341t24r1461b84],
10	Gitlin	NNP	PERSON	Gitlin	nn	11	SENT_355	[p21l1477t20r1651b75],
11	M	NNP	O	M	appos	2	SENT_355	[p21l1669t25r1730b75],
12	(	VBD	O	(	_	0	SENT_355	[p21l1751t20r1941b87],
13	2003	CD	DATE	2003	num	17	SENT_355	[p21l1751t20r1941b87],
14	)	CD	NUMBER	)	num	17	SENT_355	[p21l1751t20r1941b87],
15	Intraand	NN	O	intraand	nn	17	SENT_355	[p21l1963t25r2139b75, p21l163t102r278b158],
16	interindividual	JJ	O	interindividual	amod	17	SENT_355	[p21l295t102r762b158],
17	variations	NNS	O	variation	dobj	12	SENT_355	[p21l778t104r1088b158],
18	in	IN	O	in	_	0	SENT_355	[p21l1107t105r1167b157],
19	steady-state	JJ	O	steady-state	amod	21	SENT_355	[p21l1186t102r1551b176],
20	plasma	NN	O	plasma	nn	21	SENT_355	[p21l1569t102r1792b176],
21	concentrations	NNS	O	concentration	prep_in	17	SENT_355	[p21l1810t113r2140b158, p21l161t186r314b240],
22	of	IN	O	of	_	0	SENT_355	[p21l335t184r401b240],
23	risperidone	NN	O	risperidone	prep_of	21	SENT_355	[p21l415t184r775b258],
24	and	CC	O	and	_	0	SENT_355	[p21l795t184r911b240],
25	9-hydroxyrisperidone	NN	O	9-hydroxyrisperidone	prep_of	21	SENT_355	[p21l930t184r1609b258],
26	in	IN	O	in	_	0	SENT_355	[p21l1629t186r1689b239],
27	schizophrenic	JJ	O	schizophrenic	amod	28	SENT_355	[p21l1709t184r2143b258],
28	patients	NNS	O	patient	prep_in	12	SENT_355	[p21l161t268r408b339],
29	treated	VBN	O	treat	partmod	28	SENT_355	[p21l436t266r654b322],
30	chronically	RB	O	chronically	dep	29	SENT_355	[p21l682t266r1030b340],
31	with	IN	O	with	_	0	SENT_355	[p21l1053t266r1192b322],
32	various	JJ	O	various	amod	33	SENT_355	[p21l1218t268r1448b322],
33	doses	NNS	O	dose	prep_with	30	SENT_355	[p21l1478t266r1647b322],
34	of	IN	O	of	_	0	SENT_355	[p21l1677t266r1743b322],
35	risperidone	NN	O	risperidone	prep_of	33	SENT_355	[p21l1765t266r2140b339],
36	.	.	O	.	_	0	SENT_355	[p21l1765t266r2140b339],

1	Ther	NNP	O	Ther	nn	2	SENT_356	[p21l162t348r309b403],
2	Drug	NNP	O	Drug	_	0	SENT_356	[p21l329t353r489b422],
3	Monitoring	VBG	O	monitor	partmod	2	SENT_356	[p21l508t350r865b422],
4	25	CD	NUMBER	25	number	5	SENT_356	[p21l884t348r1320b415],
5	(	CD	NUMBER	(	dobj	3	SENT_356	[p21l884t348r1320b415],
6	6	CD	NUMBER	6	num	7	SENT_356	[p21l884t348r1320b415],
7	)	NN	O	)	dep	5	SENT_356	[p21l884t348r1320b415],
8	:657	CD	NUMBER	:657	num	9	SENT_356	[p21l884t348r1320b415],
9	—	NN	O	—	dep	21	SENT_356	[p21l884t348r1320b415],
10	664	CD	NUMBER	664	num	15	SENT_356	[p21l884t348r1320b415],
11	Balant-Gorgia	NNP	O	Balant-Gorgia	nn	15	SENT_356	[p21l162t430r600b504],
12	AE	NNP	O	AE	nn	15	SENT_356	[p21l620t435r728b495],
13	,	,	O	,	_	0	SENT_356	[p21l620t435r728b495],
14	Balant	NNP	ORGANIZATION	Balant	appos	15	SENT_356	[p21l749t430r945b486],
15	LP	NN	ORGANIZATION	lp	dep	9	SENT_356	[p21l968t435r1046b485],
16	(	CD	NUMBER	(	num	15	SENT_356	[p21l1074t431r1264b498],
17	1995	CD	DATE	1995	dep	21	SENT_356	[p21l1074t431r1264b498],
18	)	CD	NUMBER	)	num	21	SENT_356	[p21l1074t431r1264b498],
19	Therapeutic	JJ	O	therapeutic	amod	21	SENT_356	[p21l1291t430r1668b504],
20	drug	NN	O	drug	nn	21	SENT_356	[p21l1692t430r1839b504],
21	monitoring	NN	O	monitoring	dep	5	SENT_356	[p21l1861t432r2139b486, p21l162t515r259b587],
22	in	IN	O	in	_	0	SENT_356	[p21l286t515r345b568],
23	psychiatry	NN	O	psychiatry	prep_in	21	SENT_356	[p21l372t513r715b587],
24	:	:	O	:	_	0	SENT_356	[p21l372t513r715b587],
25	relevance	NN	O	relevance	dep	2	SENT_356	[p21l743t513r1034b569],
26	during	IN	O	during	_	0	SENT_356	[p21l1062t513r1271b587],
27	the	DT	O	the	det	29	SENT_356	[p21l1297t513r1392b569],
28	drug	NN	O	drug	nn	29	SENT_356	[p21l1420t513r1567b587],
29	treatment	NN	O	treatment	prep_during	25	SENT_356	[p21l1593t523r1898b569],
30	of	IN	O	of	_	0	SENT_356	[p21l1926t513r1991b569],
31	psychiatric	JJ	O	psychiatric	amod	32	SENT_356	[p21l2012t532r2140b587, p21l163t595r397b651],
32	disorders	NNS	O	disorder	prep_of	29	SENT_356	[p21l418t595r724b651],
33	.	.	O	.	_	0	SENT_356	[p21l418t595r724b651],

1	CNS	NNS	O	cn	dep	5	SENT_357	[p21l744t599r877b651],
2	Drugs	NNS	O	drug	dep	1	SENT_357	[p21l900t600r1087b669],
3	4:432	CD	NUMBER	4:432	num	4	SENT_357	[p21l1108t601r1414b651],
4	—	NN	O	—	dep	5	SENT_357	[p21l1108t601r1414b651],
5	453	CD	NUMBER	453	dep	22	SENT_357	[p21l1108t601r1414b651],
6	Balant-Gorgia	NNP	O	Balant-Gorgia	nn	7	SENT_357	[p21l162t677r600b751],
7	AE	NNP	O	AE	dep	5	SENT_357	[p21l614t681r722b742],
8	,	,	O	,	_	0	SENT_357	[p21l614t681r722b742],
9	Gex-Fabry	NNP	O	Gex-Fabry	nn	10	SENT_357	[p21l737t677r1064b751],
10	M	NNP	O	M	dep	18	SENT_357	[p21l1078t682r1157b742],
11	,	,	O	,	_	0	SENT_357	[p21l1078t682r1157b742],
12	Genet	NNP	PERSON	Genet	nn	13	SENT_357	[p21l1172t681r1353b733],
13	C	NNP	O	C	appos	10	SENT_357	[p21l1370t681r1430b742],
14	,	,	O	,	_	0	SENT_357	[p21l1370t681r1430b742],
15	Balant	NNP	O	Balant	appos	10	SENT_357	[p21l1445t677r1641b733],
16	LP	NN	O	lp	dep	18	SENT_357	[p21l1658t682r1736b732],
17	(	CD	NUMBER	(	num	16	SENT_357	[p21l1758t677r1948b744],
18	1999	CD	DATE	1999	dep	22	SENT_357	[p21l1758t677r1948b744],
19	)	CD	NUMBER	)	dep	18	SENT_357	[p21l1758t677r1948b744],
20	Therapeutic	JJ	O	therapeutic	amod	22	SENT_357	[p21l1969t677r2139b733, p21l163t762r389b833],
21	drug	NN	O	drug	nn	22	SENT_357	[p21l406t759r553b833],
22	monitoring	NN	O	monitoring	_	0	SENT_357	[p21l569t761r925b834],
23	of	IN	O	of	_	0	SENT_357	[p21l941t759r1007b815],
24	risperidone	NN	O	risperidone	prep_of	22	SENT_357	[p21l1019t759r1378b833],
25	using	VBG	O	use	partmod	22	SENT_357	[p21l1396t762r1564b833],
26	a	DT	O	a	det	31	SENT_357	[p21l1581t779r1613b815],
27	new	JJ	O	new	amod	31	SENT_357	[p21l1629t779r1765b824],
28	,	,	O	,	_	0	SENT_357	[p21l1629t779r1765b824],
29	rapid	JJ	O	rapid	amod	31	SENT_357	[p21l1779t759r1944b833],
30	HPLC	NN	O	hplc	nn	31	SENT_357	[p21l1960t763r2142b815],
31	method	NN	O	method	dobj	25	SENT_357	[p21l162t841r418b897],
32	:	:	O	:	_	0	SENT_357	[p21l162t841r418b897],
33	reappraisal	NN	O	reappraisal	dep	22	SENT_357	[p21l447t841r792b915],
34	of	IN	O	of	_	0	SENT_357	[p21l820t841r886b897],
35	interindividual	JJ	O	interindividual	amod	37	SENT_357	[p21l907t841r1375b897],
36	variability	NN	O	variability	nn	37	SENT_357	[p21l1399t841r1721b915],
37	factors	NNS	O	factor	prep_of	33	SENT_357	[p21l1746t841r1971b897],
38	.	.	O	.	_	0	SENT_357	[p21l1746t841r1971b897],

1	Ther	NNP	O	Ther	nn	2	SENT_358	[p21l1996t841r2143b897],
2	Drug	NNP	O	Drug	nsubj	3	SENT_358	[p21l162t928r322b997],
3	Monitoring	VBG	O	monitor	_	0	SENT_358	[p21l341t925r698b997],
4	21	CD	NUMBER	21	num	5	SENT_358	[p21l717t924r1074b990],
5	(	NN	O	(	dobj	3	SENT_358	[p21l717t924r1074b990],
6	1	CD	NUMBER	1	dep	14	SENT_358	[p21l717t924r1074b990],
7	)	CD	NUMBER	)	num	8	SENT_358	[p21l717t924r1074b990],
8	:105	CD	NUMBER	:105	dep	6	SENT_358	[p21l717t924r1074b990],
9	—	NN	O	—	dep	14	SENT_358	[p21l717t924r1074b990],
10	1	CD	NUMBER	1	num	9	SENT_358	[p21l717t924r1074b990],
11	15	CD	NUMBER	15	num	14	SENT_358	[p21l1089t929r1150b979],
12	Baldessarini	NNP	O	Baldessarini	nn	14	SENT_358	[p21l162t1005r543b1061],
13	R	NN	O	r	nn	14	SENT_358	[p21l572t1010r657b1072],
14	]	NN	O	]	dep	29	SENT_358	[p21l572t1010r657b1072],
15	,	,	O	,	_	0	SENT_358	[p21l572t1010r657b1072],
16	Centorrino	NN	O	centorrino	nn	17	SENT_358	[p21l683t1007r1026b1061],
17	F	NN	O	f	appos	14	SENT_358	[p21l1057t1010r1102b1070],
18	,	,	O	,	_	0	SENT_358	[p21l1057t1010r1102b1070],
19	Flood	NNP	O	Flood	nn	20	SENT_358	[p21l1128t1005r1307b1061],
20	IG	NNP	O	IG	appos	14	SENT_358	[p21l1335t1009r1425b1072],
21	,	,	O	,	_	0	SENT_358	[p21l1335t1009r1425b1072],
22	Volpicelli	NNP	ORGANIZATION	Volpicelli	nn	23	SENT_358	[p21l1446t1005r1735b1078],
23	SA	NNP	ORGANIZATION	SA	appos	14	SENT_358	[p21l1765t1009r1865b1070],
24	,	,	O	,	_	0	SENT_358	[p21l1765t1009r1865b1070],
25	HustonLyons	NNP	O	HustonLyons	nn	26	SENT_358	[p21l1891t1010r2140b1061, p21l162t1092r338b1161],
26	D	NNP	O	D	appos	14	SENT_358	[p21l368t1092r431b1151],
27	,	,	O	,	_	0	SENT_358	[p21l368t1092r431b1151],
28	Cohen	NNP	PERSON	Cohen	appos	14	SENT_358	[p21l457t1087r657b1142],
29	BM	NN	O	bm	dep	31	SENT_358	[p21l686t1092r791b1142],
30	(	CD	NUMBER	(	num	29	SENT_358	[p21l823t1087r1013b1154],
31	1993	CD	DATE	1993	dep	34	SENT_358	[p21l823t1087r1013b1154],
32	)	CD	NUMBER	)	num	34	SENT_358	[p21l823t1087r1013b1154],
33	Tissue	NN	O	tissue	nn	34	SENT_358	[p21l1045t1089r1240b1142],
34	concentrations	NNS	O	concentration	dep	3	SENT_358	[p21l1270t1089r1729b1142],
35	of	IN	O	of	_	0	SENT_358	[p21l1759t1086r1825b1142],
36	clozapine	NN	O	clozapine	prep_of	34	SENT_358	[p21l1848t1087r2142b1160],
37	and	CC	O	and	_	0	SENT_358	[p21l163t1169r278b1225],
38	its	PRP$	O	its	poss	39	SENT_358	[p21l295t1171r366b1225],
39	metabolites	NNS	O	metabolite	dep	3	SENT_358	[p21l385t1169r745b1225],
40	in	IN	O	in	_	0	SENT_358	[p21l764t1172r823b1224],
41	the	DT	O	the	det	42	SENT_358	[p21l841t1169r937b1225],
42	rat	NN	O	rat	prep_in	39	SENT_358	[p21l955t1180r1055b1225],
43	.	.	O	.	_	0	SENT_358	[p21l955t1180r1055b1225],

1	Neuropsychopharmacol	NNP	O	Neuropsychopharmacol	_	0	SENT_359	[p21l1070t1169r1817b1243],
2	9:1	CD	NUMBER	9:1	num	1	SENT_359	[p21l1836t1175r1916b1225],
3	17-124	CD	NUMBER	17-124	num	5	SENT_359	[p21l1931t1175r2142b1225],
4	Barnes	NNP	ORGANIZATION	Barnes	nn	5	SENT_359	[p21l162t1256r374b1307],
5	TR	NN	ORGANIZATION	tr	dep	1	SENT_359	[p21l396t1254r487b1307],
6	(	CD	NUMBER	(	num	9	SENT_359	[p21l510t1252r699b1319],
7	1989	CD	DATE	1989	num	9	SENT_359	[p21l510t1252r699b1319],
8	)	NNP	O	)	nn	9	SENT_359	[p21l510t1252r699b1319],
9	A	NNP	O	A	dep	5	SENT_359	[p21l721t1255r769b1306],
10	rating	NN	O	rating	nn	11	SENT_359	[p21l790t1253r975b1325],
11	scale	NN	O	scale	dep	1	SENT_359	[p21l996t1251r1143b1307],
12	for	IN	O	for	_	0	SENT_359	[p21l1164t1251r1252b1307],
13	drug-induced	JJ	O	drug-induced	amod	14	SENT_359	[p21l1273t1251r1699b1325],
14	akathisia	NN	O	akathisium	prep_for	11	SENT_359	[p21l1720t1251r2011b1307],
15	.	.	O	.	_	0	SENT_359	[p21l1720t1251r2011b1307],

1	Br	NN	O	br	dep	8	SENT_360	[p21l2031t1256r2100b1306],
2	I	CD	NUMBER	i	num	1	SENT_360	[p21l2120t1256r2141b1319],
3	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_360	[p21l163t1333r488b1407],
4	154:672	CD	NUMBER	154:672	num	3	SENT_360	[p21l511t1338r884b1389],
5	—	CD	NUMBER	—	dep	8	SENT_360	[p21l511t1338r884b1389],
6	676	CD	NUMBER	676	num	8	SENT_360	[p21l511t1338r884b1389],
7	Berecz	NNP	PERSON	Berecz	nn	8	SENT_360	[p21l162t1420r368b1471],
8	R	NN	PERSON	r	dep	16	SENT_360	[p21l385t1419r448b1480],
9	,	,	O	,	_	0	SENT_360	[p21l385t1419r448b1480],
10	LLerena	NNP	O	LLerena	nn	11	SENT_360	[p21l462t1420r713b1471],
11	A	NNP	O	A	appos	8	SENT_360	[p21l726t1419r792b1480],
12	,	,	O	,	_	0	SENT_360	[p21l726t1419r792b1480],
13	de	FW	O	de	appos	8	SENT_360	[p21l807t1415r877b1471],
14	la	FW	O	la	nn	16	SENT_360	[p21l894t1415r948b1471],
15	Ruvia	FW	MISC	ruvia	nn	16	SENT_360	[p21l966t1417r1143b1471],
16	A	NN	MISC	a	dep	29	SENT_360	[p21l1157t1419r1222b1480],
17	,	,	O	,	_	0	SENT_360	[p21l1157t1419r1222b1480],
18	Gomez	NNP	PERSON	Gomez	nn	19	SENT_360	[p21l1238t1419r1455b1471],
19	A	NNP	O	A	appos	16	SENT_360	[p21l1469t1419r1534b1480],
20	,	,	O	,	_	0	SENT_360	[p21l1469t1419r1534b1480],
21	Kellermann	NNP	PERSON	Kellermann	nn	22	SENT_360	[p21l1549t1415r1914b1471],
22	M	NNP	O	M	appos	16	SENT_360	[p21l1932t1420r2011b1480],
23	,	,	O	,	_	0	SENT_360	[p21l1932t1420r2011b1480],
24	Dorado	NNP	ORGANIZATION	Dorado	nn	25	SENT_360	[p21l2026t1420r2140b1471, p21l162t1497r302b1553],
25	P	NN	ORGANIZATION	p	appos	16	SENT_360	[p21l323t1502r369b1562],
26	,	,	O	,	_	0	SENT_360	[p21l323t1502r369b1562],
27	Degrell	NN	O	degrell	appos	16	SENT_360	[p21l385t1497r609b1571],
28	I	PRP	O	I	nsubj	29	SENT_360	[p21l628t1502r649b1552],
29	(	VBP	O	(	_	0	SENT_360	[p21l673t1498r862b1565],
30	2002	CD	DATE	2002	num	32	SENT_360	[p21l673t1498r862b1565],
31	)	CD	NUMBER	)	num	32	SENT_360	[p21l673t1498r862b1565],
32	Relationship	NN	O	relationship	dobj	29	SENT_360	[p21l885t1497r1274b1571],
33	between	IN	O	between	_	0	SENT_360	[p21l1292t1497r1551b1553],
34	risperidone	NN	O	risperidone	nn	38	SENT_360	[p21l1570t1497r1929b1571],
35	and	CC	O	and	_	0	SENT_360	[p21l1949t1497r2065b1553],
36	9hydroxy-risperidone	JJ	O	9hydroxy-risperidone	conj_and	34	SENT_360	[p21l2083t1503r2140b1553, p21l161t1579r803b1653],
37	plasma	NN	O	plasma	nn	38	SENT_360	[p21l839t1579r1062b1653],
38	concentrations	NNS	O	concentration	prep_between	32	SENT_360	[p21l1098t1581r1558b1635],
39	and	CC	O	and	_	0	SENT_360	[p21l1596t1579r1711b1635],
40	CYP2D6	NN	O	cyp2d6	nn	42	SENT_360	[p21l1748t1583r2006b1635],
41	enzyme	NN	O	enzyme	nn	42	SENT_360	[p21l2043t1598r2139b1635, p21l162t1679r327b1735],
42	activity	NN	O	activity	conj_and	29	SENT_360	[p21l360t1663r594b1735],
43	in	IN	O	in	dep	42	SENT_360	[p21l623t1663r683b1716],
44	psychiatric	JJ	O	psychiatric	amod	45	SENT_360	[p21l714t1661r1056b1735],
45	patients	NNS	O	patient	pobj	43	SENT_360	[p21l1087t1663r1351b1734],
46	.	.	O	.	_	0	SENT_360	[p21l1087t1663r1351b1734],

1	Pharmacopsychiatry	NNP	O	Pharmacopsychiatry	_	0	SENT_361	[p21l1381t1661r2027b1735],
2	35	CD	NUMBER	35	num	1	SENT_361	[p21l2056t1667r2140b1717],
3	:	:	O	:	_	0	SENT_361	[p21l2056t1667r2140b1717],
4	231-234	CD	NUMBER	231-234	num	6	SENT_361	[p21l162t1749r414b1800],
5	Boulton	NNP	PERSON	Boulton	nn	6	SENT_361	[p21l162t1826r406b1882],
6	DW	NNP	O	DW	dep	1	SENT_361	[p21l424t1831r551b1892],
7	,	,	O	,	_	0	SENT_361	[p21l424t1831r551b1892],
8	DeVane	NNP	ORGANIZATION	DeVane	nn	9	SENT_361	[p21l566t1831r804b1882],
9	CL	NN	ORGANIZATION	cl	appos	1	SENT_361	[p21l822t1830r923b1892],
10	,	,	O	,	_	0	SENT_361	[p21l822t1830r923b1892],
11	Liston	NNP	PERSON	Liston	nn	12	SENT_361	[p21l938t1828r1128b1882],
12	HL	NNS	O	hl	appos	1	SENT_361	[p21l1146t1831r1256b1892],
13	,	,	O	,	_	0	SENT_361	[p21l1146t1831r1256b1892],
14	Markowitz	NNP	PERSON	Markowitz	nsubj	17	SENT_361	[p21l1270t1826r1605b1882],
15	IS	VBZ	O	be	cop	17	SENT_361	[p21l1621t1830r1679b1894],
16	(	CD	NUMBER	(	num	17	SENT_361	[p21l1702t1827r1891b1894],
17	2002	CD	DATE	2002	dep	1	SENT_361	[p21l1702t1827r1891b1894],
18	)	CD	NUMBER	)	dep	20	SENT_361	[p21l1702t1827r1891b1894],
19	In	FW	O	in	nn	20	SENT_361	[p21l1913t1831r1977b1881],
20	vitro	FW	O	vitro	advmod	17	SENT_361	[p21l1992t1828r2141b1882],
21	P-glycoprotein	NN	MISC	p-glycoprotein	nn	22	SENT_361	[p21l163t1909r615b1983],
22	affinity	NN	O	affinity	attr	17	SENT_361	[p21l650t1909r877b1983],
23	for	IN	O	for	_	0	SENT_361	[p21l908t1909r996b1965],
24	atypical	JJ	O	atypical	amod	27	SENT_361	[p21l1030t1909r1274b1983],
25	and	CC	O	and	_	0	SENT_361	[p21l1309t1909r1424b1965],
26	conventional	JJ	O	conventional	conj_and	24	SENT_361	[p21l1458t1909r1857b1965],
27	antipsychotics	NNS	O	antipsychotic	prep_for	22	SENT_361	[p21l1891t1911r2140b1983, p21l163t1991r396b2047],
28	.	.	O	.	_	0	SENT_361	[p21l1891t1911r2140b1983, p21l163t1991r396b2047],

1	Live	NNP	O	Live	nn	2	SENT_362	[p21l415t1993r539b2047],
2	Sci	NNP	O	Sci	_	0	SENT_362	[p21l561t1993r649b2047],
3	71	CD	NUMBER	71	num	4	SENT_362	[p21l670t1992r1102b2059],
4	(	NN	O	(	dep	2	SENT_362	[p21l670t1992r1102b2059],
5	2	CD	NUMBER	2	dep	4	SENT_362	[p21l670t1992r1102b2059],
6	)	CD	NUMBER	)	number	7	SENT_362	[p21l670t1992r1102b2059],
7	:163	CD	NUMBER	:163	dep	2	SENT_362	[p21l670t1992r1102b2059],
8	—	NN	O	—	nn	11	SENT_362	[p21l670t1992r1102b2059],
9	169	CD	NUMBER	169	num	11	SENT_362	[p21l670t1992r1102b2059],
10	Broly	NN	O	broly	nn	11	SENT_362	[p21l162t2073r329b2147],
11	F	NN	O	f	dep	7	SENT_362	[p21l345t2078r389b2138],
12	,	,	O	,	_	0	SENT_362	[p21l345t2078r389b2138],
13	Gaedigk	NNP	O	Gaedigk	nn	14	SENT_362	[p21l405t2073r663b2147],
14	A	NNP	O	A	appos	2	SENT_362	[p21l676t2077r741b2138],
15	,	,	O	,	_	0	SENT_362	[p21l676t2077r741b2138],
16	Heim	NNP	PERSON	Heim	nn	17	SENT_362	[p21l757t2075r926b2129],
17	M	NNP	O	M	appos	2	SENT_362	[p21l944t2078r1023b2138],
18	,	,	O	,	_	0	SENT_362	[p21l944t2078r1023b2138],
19	Eichelbaum	NNP	PERSON	Eichelbaum	nn	20	SENT_362	[p21l1038t2073r1404b2129],
20	M	NNP	O	M	appos	2	SENT_362	[p21l1423t2078r1502b2138],
21	,	,	O	,	_	0	SENT_362	[p21l1423t2078r1502b2138],
22	Morike	NNP	PERSON	Morike	nn	23	SENT_362	[p21l1516t2073r1738b2129],
23	K	NNP	PERSON	K	appos	2	SENT_362	[p21l1758t2078r1821b2138],
24	,	,	O	,	_	0	SENT_362	[p21l1758t2078r1821b2138],
25	Meyer	NNP	ORGANIZATION	Meyer	nn	26	SENT_362	[p21l1836t2078r2029b2147],
26	UA	NNP	ORGANIZATION	UA	appos	2	SENT_362	[p21l2047t2077r2142b2129],
27	(	CD	NUMBER	(	num	28	SENT_362	[p21l165t2155r354b2222],
28	1991	CD	DATE	1991	dep	26	SENT_362	[p21l165t2155r354b2222],
29	)	CD	NUMBER	)	num	32	SENT_362	[p21l165t2155r354b2222],
30	Debrisoquine/sparteine	NN	O	debrisoquine/sparteine	nn	32	SENT_362	[p21l411t2155r1150b2228],
31	hydroxylation	NN	O	hydroxylation	nn	32	SENT_362	[p21l1201t2155r1635b2229],
32	genotype	NN	O	genotype	dep	2	SENT_362	[p21l1688t2165r1974b2229],
33	and	CC	O	and	_	0	SENT_362	[p21l2027t2155r2142b2210],
34	phenotype	NN	O	phenotype	conj_and	32	SENT_362	[p21l161t2237r510b2311],
35	:	:	O	:	_	0	SENT_362	[p21l161t2237r510b2311],
36	analysis	NN	O	analysis	dep	32	SENT_362	[p21l566t2237r809b2311],
37	of	IN	O	of	_	0	SENT_362	[p21l864t2237r930b2293],
38	common	JJ	O	common	amod	39	SENT_362	[p21l978t2257r1253b2293],
39	mutations	NNS	O	mutation	prep_of	36	SENT_362	[p21l1306t2240r1618b2293],
40	and	CC	O	and	_	0	SENT_362	[p21l1674t2237r1789b2293],
41	alleles	NNS	O	allele	conj_and	39	SENT_362	[p21l1842t2237r2029b2293],
42	of	IN	O	of	_	0	SENT_362	[p21l2084t2237r2150b2293],
43	CYPZD6	NN	O	cypzd6	prep_of	39	SENT_362	[p21l163t2323r421b2375],
44	in	IN	O	in	_	0	SENT_362	[p21l441t2321r500b2374],
45	a	DT	O	a	det	47	SENT_362	[p21l520t2338r552b2375],
46	European	JJ	MISC	european	amod	47	SENT_362	[p21l570t2324r868b2393],
47	population	NN	O	population	prep_in	43	SENT_362	[p21l886t2319r1242b2393],
48	.	.	O	.	_	0	SENT_362	[p21l886t2319r1242b2393],

1	DNA	NN	O	dna	nn	2	SENT_363	[p21l1259t2323r1411b2375],
2	Cell	NN	O	cell	_	0	SENT_363	[p21l1431t2319r1549b2375],
3	Biol	NNP	O	Biol	dep	2	SENT_363	[p21l1568t2319r1689b2375],
4	10	CD	NUMBER	10	num	3	SENT_363	[p21l1713t2320r2141b2387],
5	(	CD	NUMBER	(	number	6	SENT_363	[p21l1713t2320r2141b2387],
6	8	CD	NUMBER	8	num	7	SENT_363	[p21l1713t2320r2141b2387],
7	)	NN	O	)	dep	3	SENT_363	[p21l1713t2320r2141b2387],
8	:545	CD	NUMBER	:545	num	9	SENT_363	[p21l1713t2320r2141b2387],
9	—	NN	O	—	dep	2	SENT_363	[p21l1713t2320r2141b2387],
10	558	CD	NUMBER	558	num	12	SENT_363	[p21l1713t2320r2141b2387],
11	Callaghan	NNP	O	Callaghan	nn	12	SENT_363	[p21l163t2401r473b2475],
12	IT	NNP	O	IT	dep	9	SENT_363	[p21l498t2404r576b2468],
13	,	,	O	,	_	0	SENT_363	[p21l498t2404r576b2468],
14	Bergstrom	NNP	PERSON	Bergstrom	nn	15	SENT_363	[p21l598t2406r926b2475],
15	RF	NNP	O	RF	appos	2	SENT_363	[p21l952t2406r1045b2466],
16	,	,	O	,	_	0	SENT_363	[p21l952t2406r1045b2466],
17	Ptak	NNP	PERSON	Ptak	nn	18	SENT_363	[p21l1067t2401r1207b2457],
18	LR	NNP	O	LR	appos	2	SENT_363	[p21l1231t2406r1335b2466],
19	,	,	O	,	_	0	SENT_363	[p21l1231t2406r1335b2466],
20	Beasley	NNP	PERSON	Beasley	appos	18	SENT_363	[p21l1357t2401r1590b2475],
21	CM	NN	O	cm	nn	25	SENT_363	[p21l1613t2405r1720b2457],
22	(	CD	NUMBER	(	num	25	SENT_363	[p21l1749t2401r1939b2468],
23	1999	CD	DATE	1999	num	25	SENT_363	[p21l1749t2401r1939b2468],
24	)	NNP	O	)	nn	25	SENT_363	[p21l1749t2401r1939b2468],
25	Olanzapine	NNP	MISC	Olanzapine	dep	2	SENT_363	[p21l1969t2401r2140b2457, p21l162t2486r380b2557],
26	:	:	O	:	_	0	SENT_363	[p21l1969t2401r2140b2457, p21l162t2486r380b2557],
27	pharmacokinetic	JJ	O	pharmacokinetic	amod	30	SENT_363	[p21l417t2484r949b2557],
28	and	CC	O	and	_	0	SENT_363	[p21l986t2484r1101b2539],
29	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	27	SENT_363	[p21l1135t2484r1727b2558],
30	proﬁle	NN	O	proﬁle	dep	25	SENT_363	[p21l1762t2483r1980b2557],
31	.	.	O	.	_	0	SENT_363	[p21l1762t2483r1980b2557],

1	Clin	NNP	O	Clin	nn	2	SENT_364	[p21l2015t2484r2142b2539],
2	Pharmacocinet	NNP	O	Pharmacocinet	_	0	SENT_364	[p21l162t2566r635b2622],
3	C37	NN	O	c37	dep	2	SENT_364	[p21l656t2570r1043b2622],
4	:177	CD	NUMBER	:177	num	3	SENT_364	[p21l656t2570r1043b2622],
5	—	NN	O	—	dep	2	SENT_364	[p21l656t2570r1043b2622],
6	193	CD	NUMBER	193	num	5	SENT_364	[p21l656t2570r1043b2622],

1	Carman	NNP	PERSON	Carman	nn	2	SENT_365	[p21l160t2811r411b2864],
2	I	NNP	O	I	_	0	SENT_365	[p21l427t2812r464b2876],
3	,	,	O	,	_	0	SENT_365	[p21l427t2812r464b2876],
4	Peuskens	NNP	O	Peuskens	nn	5	SENT_365	[p21l478t2807r761b2864],
5	]	NNP	O	]	appos	2	SENT_365	[p21l778t2807r1285b2882],
6	,	,	O	,	_	0	SENT_365	[p21l778t2807r1285b2882],
7	Vangeneugden	NNP	O	Vangeneugden	nn	8	SENT_365	[p21l778t2807r1285b2882],
8	A	NNP	O	A	nsubj	9	SENT_365	[p21l1299t2812r1347b2863],
9	(	VBD	O	(	rcmod	2	SENT_365	[p21l1367t2808r1557b2876],
10	1995	CD	DATE	1995	num	11	SENT_365	[p21l1367t2808r1557b2876],
11	)	CD	NUMBER	)	dobj	9	SENT_365	[p21l1367t2808r1557b2876],
12	Risperidone	NNP	O	Risperidone	dep	2	SENT_365	[p21l1578t2807r1956b2882],
13	in	IN	O	in	_	0	SENT_365	[p21l1973t2810r2033b2863],
14	the	DT	O	the	det	15	SENT_365	[p21l2049t2807r2145b2864],
15	treatment	NN	O	treatment	prep_in	12	SENT_365	[p21l158t2901r465b2948],
16	of	IN	O	of	_	0	SENT_365	[p21l482t2891r547b2948],
17	negative	JJ	O	negative	amod	18	SENT_365	[p21l559t2893r816b2966],
18	symptoms	NNS	O	symptom	prep_of	15	SENT_365	[p21l834t2902r1155b2966],
19	of	IN	O	of	_	0	SENT_365	[p21l1173t2891r1239b2948],
20	schizophrenia	NN	O	schizophrenia	prep_of	18	SENT_365	[p21l1251t2891r1704b2965],
21	:	:	O	:	_	0	SENT_365	[p21l1251t2891r1704b2965],
22	a	DT	O	a	det	24	SENT_365	[p21l1722t2910r1754b2948],
23	meta	NN	O	meta	nn	24	SENT_365	[p21l1770t2891r2143b2966],
24	—	NN	O	—	dep	2	SENT_365	[p21l1770t2891r2143b2966],
25	analy	RB	O	analy	advmod	27	SENT_365	[p21l1770t2891r2143b2966],
26	—	CD	NUMBER	—	num	27	SENT_365	[p21l1770t2891r2143b2966],
27	sis	NN	O	si	rcmod	24	SENT_365	[p21l160t2976r252b3030],
28	.	.	O	.	_	0	SENT_365	[p21l160t2976r252b3030],

1	Int	NNP	O	Int	nn	3	SENT_366	[p21l272t2979r359b3030],
2	Clin	NNP	O	Clin	nn	3	SENT_366	[p21l380t2974r507b3031],
3	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_366	[p21l529t2974r1082b3049],
4	10:207	CD	NUMBER	10:207	num	3	SENT_366	[p21l1108t2980r1445b3030],
5	—	NN	O	—	nn	9	SENT_366	[p21l1108t2980r1445b3030],
6	213	CD	NUMBER	213	num	9	SENT_366	[p21l1108t2980r1445b3030],
7	Carpenter	NNP	O	Carpenter	nn	9	SENT_366	[p21l160t3061r473b3131],
8	WT	NNP	O	WT	nn	9	SENT_366	[p21l488t3060r603b3113],
9	Ir	NNP	O	Ir	dep	3	SENT_366	[p21l622t3062r686b3125],
10	,	,	O	,	_	0	SENT_366	[p21l622t3062r686b3125],
11	Conley	NNP	ORGANIZATION	Conley	nn	12	SENT_366	[p21l703t3057r922b3132],
12	RR	NNP	ORGANIZATION	RR	conj_and	9	SENT_366	[p21l938t3062r1048b3122],
13	,	,	O	,	_	0	SENT_366	[p21l938t3062r1048b3122],
14	Buchanan	NNP	PERSON	Buchanan	nn	15	SENT_366	[p21l1065t3057r1375b3113],
15	RW	NNP	O	RW	conj_and	9	SENT_366	[p21l1395t3062r1514b3122],
16	,	,	O	,	_	0	SENT_366	[p21l1395t3062r1514b3122],
17	Breier	NNP	PERSON	Breier	nn	18	SENT_366	[p21l1530t3059r1718b3113],
18	A	NNP	O	A	conj_and	9	SENT_366	[p21l1733t3061r1798b3122],
19	,	,	O	,	_	0	SENT_366	[p21l1733t3061r1798b3122],
20	Tamminga	NNP	ORGANIZATION	Tamminga	nn	22	SENT_366	[p21l1814t3059r2147b3132],
21	CA	NNP	ORGANIZATION	CA	nn	22	SENT_366	[p21l160t3144r255b3197],
22	(	NNP	O	(	conj_and	9	SENT_366	[p21l278t3141r468b3209],
23	1995	CD	DATE	1995	num	22	SENT_366	[p21l278t3141r468b3209],
24	)	CD	NUMBER	)	num	26	SENT_366	[p21l278t3141r468b3209],
25	Patient	NN	O	patient	nn	26	SENT_366	[p21l494t3143r710b3197],
26	response	NN	O	response	dep	22	SENT_366	[p21l731t3159r1004b3215],
27	and	CC	O	and	_	0	SENT_366	[p21l1026t3140r1142b3197],
28	resource	NN	O	resource	nn	29	SENT_366	[p21l1161t3160r1425b3197],
29	management	NN	O	management	dep	3	SENT_366	[p21l1447t3151r1868b3215],
30	:	:	O	:	_	0	SENT_366	[p21l1447t3151r1868b3215],
31	Another	DT	O	another	det	32	SENT_366	[p21l1887t3140r2147b3197],
32	view	NN	O	view	dep	3	SENT_366	[p21l157t3225r303b3280],
33	of	IN	O	of	_	0	SENT_366	[p21l328t3223r394b3280],
34	clozapine	NN	O	clozapine	nn	35	SENT_366	[p21l416t3223r710b3297],
35	treatment	NN	O	treatment	prep_of	32	SENT_366	[p21l737t3234r1044b3280],
36	of	IN	O	of	_	0	SENT_366	[p21l1071t3223r1137b3280],
37	schizophrenia	NN	O	schizophrenia	prep_of	35	SENT_366	[p21l1160t3223r1612b3298],
38	.	.	O	.	_	0	SENT_366	[p21l1160t3223r1612b3298],

1	Am	VBP	O	be	dep	2	SENT_367	[p21l1634t3227r1745b3279],
2	J	NN	O	j	_	0	SENT_367	[p21l1772t3228r1794b3292],
3	Psychiatry	NNP	O	Psychiatry	dep	2	SENT_367	[p21l1823t3223r2149b3298],
4	152:827	CD	NUMBER	152:827	num	3	SENT_367	[p21l165t3312r538b3362],
5	—	CD	NUMBER	—	number	6	SENT_367	[p21l165t3312r538b3362],
6	832	CD	NUMBER	832	dep	3	SENT_367	[p21l165t3312r538b3362],

1	Dahl	NNP	PERSON	Dahl	nn	2	SENT_368	[p22l159t20r306b76],
2	ML	NNP	O	ML	_	0	SENT_368	[p22l328t25r448b85],
3	,	,	O	,	_	0	SENT_368	[p22l328t25r448b85],
4	Iohansson	NNP	O	Iohansson	nn	5	SENT_368	[p22l467t20r787b88],
5	I	NNP	O	I	appos	2	SENT_368	[p22l810t25r850b85],
6	,	,	O	,	_	0	SENT_368	[p22l810t25r850b85],
7	Bertilsson	NNP	O	Bertilsson	nn	8	SENT_368	[p22l869t20r1184b76],
8	L	NNP	O	L	appos	2	SENT_368	[p22l1207t25r1261b85],
9	,	,	O	,	_	0	SENT_368	[p22l1207t25r1261b85],
10	Ingelman	NNP	O	Ingelman	appos	2	SENT_368	[p22l1280t20r1906b95],
11	.	.	O	.	_	0	SENT_368	[p22l1280t20r1906b95],

1	—	NN	O	—	_	0	SENT_369	[p22l1280t20r1906b95],
2	.	.	O	.	_	0	SENT_369	[p22l1280t20r1906b95],

1	Sundberg	NNP	PERSON	Sundberg	nn	2	SENT_370	[p22l1280t20r1906b95],
2	M	NNP	O	M	nsubj	9	SENT_370	[p22l1927t25r2006b85],
3	,	,	O	,	_	0	SENT_370	[p22l1927t25r2006b85],
4	Sjo	NNP	O	Sjo	appos	2	SENT_370	[p22l2026t22r2143b95],
5	—	CD	NUMBER	—	num	7	SENT_370	[p22l2026t22r2143b95],
6	qvist	NN	O	qvist	nn	7	SENT_370	[p22l160t105r310b178],
7	F	NN	O	f	dep	4	SENT_370	[p22l344t108r379b159],
8	(	CD	NUMBER	(	num	9	SENT_370	[p22l417t104r608b171],
9	1995	CD	DATE	1995	_	0	SENT_370	[p22l417t104r608b171],
10	)	NN	O	)	nn	12	SENT_370	[p22l417t104r608b171],
11	Ultrarapid	NN	O	ultrarapid	nn	12	SENT_370	[p22l645t103r974b178],
12	hydroxylation	NN	O	hydroxylation	dobj	9	SENT_370	[p22l1007t103r1442b178],
13	of	IN	O	of	_	0	SENT_370	[p22l1477t103r1543b160],
14	debrisoquine	NN	O	debrisoquine	prep_of	12	SENT_370	[p22l1573t103r1985b178],
15	in	IN	O	in	_	0	SENT_370	[p22l2019t105r2079b159],
16	a	DT	O	a	det	18	SENT_370	[p22l2115t123r2146b160],
17	Swedish	JJ	MISC	swedish	amod	18	SENT_370	[p22l160t186r410b243],
18	population	NN	O	population	prep_in	9	SENT_370	[p22l446t186r803b261],
19	.	.	O	.	_	0	SENT_370	[p22l446t186r803b261],

1	Analysis	NN	O	analysis	_	0	SENT_371	[p22l835t186r1097b261],
2	of	IN	O	of	_	0	SENT_371	[p22l1135t186r1202b243],
3	the	DT	O	the	det	6	SENT_371	[p22l1232t186r1328b243],
4	molecular	JJ	O	molecular	amod	6	SENT_371	[p22l1364t186r1679b243],
5	genetic	JJ	O	genetic	amod	6	SENT_371	[p22l1714t188r1938b261],
6	basis	NN	O	basis	prep_of	1	SENT_371	[p22l1972t186r2143b243],
7	.	.	O	.	_	0	SENT_371	[p22l1972t186r2143b243],

1	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_372	[p22l160t268r497b324],
2	Exp	NNP	O	Exp	nn	3	SENT_372	[p22l518t273r635b341],
3	Ther	NNP	O	Ther	_	0	SENT_372	[p22l657t268r805b324],
4	274	CD	NUMBER	274	num	5	SENT_372	[p22l825t269r1297b335],
5	(	NN	O	(	dep	3	SENT_372	[p22l825t269r1297b335],
6	1	CD	NUMBER	1	number	7	SENT_372	[p22l825t269r1297b335],
7	)	CD	NUMBER	)	dep	5	SENT_372	[p22l825t269r1297b335],
8	:516	CD	NUMBER	:516	num	10	SENT_372	[p22l825t269r1297b335],
9	—	NN	O	—	nn	10	SENT_372	[p22l825t269r1297b335],
10	52O	NN	O	52o	dep	7	SENT_372	[p22l825t269r1297b335],
11	Darby	NNP	PERSON	Darby	nn	12	SENT_372	[p22l159t351r353b426],
12	IK	NNP	O	IK	dep	3	SENT_372	[p22l372t356r463b419],
13	,	,	O	,	_	0	SENT_372	[p22l372t356r463b419],
14	Pasta	NNP	O	Pasta	nn	15	SENT_372	[p22l483t356r645b407],
15	DI	NNP	O	DI	dep	3	SENT_372	[p22l667t356r757b419],
16	,	,	O	,	_	0	SENT_372	[p22l667t356r757b419],
17	Elfand	NNP	ORGANIZATION	Elfand	nn	18	SENT_372	[p22l776t351r979b407],
18	L	NNP	ORGANIZATION	L	dep	3	SENT_372	[p22l1001t356r1055b416],
19	,	,	O	,	_	0	SENT_372	[p22l1001t356r1055b416],
20	Dabiri	NNP	PERSON	Dabiri	nn	21	SENT_372	[p22l1075t351r1273b407],
21	L	NNP	PERSON	L	conj_and	12	SENT_372	[p22l1295t356r1350b416],
22	,	,	O	,	_	0	SENT_372	[p22l1295t356r1350b416],
23	Lincoln	NNP	PERSON	Lincoln	nn	24	SENT_372	[p22l1369t351r1603b407],
24	C	NNP	O	C	conj_and	12	SENT_372	[p22l1627t355r1687b416],
25	,	,	O	,	_	0	SENT_372	[p22l1627t355r1687b416],
26	Iohn	NNP	O	Iohn	nn	27	SENT_372	[p22l1706t351r1850b419],
27	H	NNP	O	H	conj_and	12	SENT_372	[p22l1873t356r1924b407],
28	(	CD	NUMBER	(	num	27	SENT_372	[p22l1952t351r2141b419],
29	1997	CD	DATE	1997	num	32	SENT_372	[p22l1952t351r2141b419],
30	)	NNP	O	)	nn	32	SENT_372	[p22l1952t351r2141b419],
31	Risperidone	NNP	O	Risperidone	nn	32	SENT_372	[p22l160t434r537b508],
32	dose	NN	O	dose	dep	27	SENT_372	[p22l565t434r706b490],
33	and	CC	O	and	_	0	SENT_372	[p22l734t434r850b490],
34	blood	NN	O	blood	nn	36	SENT_372	[p22l874t434r1057b490],
35	level	NN	O	level	nn	36	SENT_372	[p22l1082t434r1222b490],
36	variability	NN	O	variability	conj_and	32	SENT_372	[p22l1247t434r1586b509],
37	:	:	O	:	_	0	SENT_372	[p22l1247t434r1586b509],
38	accumulation	NN	O	accumulation	nn	39	SENT_372	[p22l1615t434r2038b490],
39	effects	NNS	O	effect	dep	3	SENT_372	[p22l2065t433r2143b490, p22l159t517r299b574],
40	and	CC	O	and	_	0	SENT_372	[p22l330t517r446b574],
41	interindividual	JJ	O	interindividual	amod	44	SENT_372	[p22l474t517r942b574],
42	and	CC	O	and	_	0	SENT_372	[p22l971t517r1087b574],
43	intraindividual	JJ	O	intraindividual	conj_and	41	SENT_372	[p22l1115t517r1585b574],
44	variability	NN	O	variability	dep	3	SENT_372	[p22l1612t517r1935b592],
45	in	IN	O	in	_	0	SENT_372	[p22l1961t520r2020b573],
46	the	DT	O	the	det	48	SENT_372	[p22l2049t517r2145b574],
47	nonresponder	JJ	O	nonresponder	amod	48	SENT_372	[p22l159t600r599b674],
48	patient	NN	O	patient	prep_in	44	SENT_372	[p22l619t602r839b674],
49	in	IN	O	in	_	0	SENT_372	[p22l859t602r919b656],
50	the	DT	O	the	det	53	SENT_372	[p22l941t600r1036b657],
51	clinical	JJ	O	clinical	amod	53	SENT_372	[p22l1060t600r1283b657],
52	practice	NN	O	practice	nn	53	SENT_372	[p22l1303t602r1553b674],
53	setting	NN	O	setting	prep_in	48	SENT_372	[p22l1576t602r1801b675],
54	.	.	O	.	_	0	SENT_372	[p22l1576t602r1801b675],

1	I	PRP	O	I	nsubj	2	SENT_373	[p22l1821t605r1843b668],
2	Clin	VBP	O	clin	_	0	SENT_373	[p22l1867t600r1994b657],
3	Psychopharm	NN	O	psychopharm	nn	5	SENT_373	[p22l2017t605r2143b675, p22l160t682r480b755],
4	17	CD	NUMBER	17	num	5	SENT_373	[p22l507t682r935b749],
5	(	NN	O	(	dep	10	SENT_373	[p22l507t682r935b749],
6	6	CD	NUMBER	6	num	7	SENT_373	[p22l507t682r935b749],
7	)	NN	O	)	dep	5	SENT_373	[p22l507t682r935b749],
8	:478	CD	NUMBER	:478	num	9	SENT_373	[p22l507t682r935b749],
9	—	NN	O	—	dep	10	SENT_373	[p22l507t682r935b749],
10	488	CD	NUMBER	488	dep	13	SENT_373	[p22l507t682r935b749],
11	de	IN	O	de	_	0	SENT_373	[p22l160t765r230b821],
12	Leon	NNP	O	Leon	prep_de	10	SENT_373	[p22l255t770r405b821],
13	I	PRP	O	I	dep	17	SENT_373	[p22l428t770r466b833],
14	,	,	O	,	_	0	SENT_373	[p22l428t770r466b833],
15	Bork	NNP	PERSON	Bork	nsubj	17	SENT_373	[p22l487t765r638b821],
16	I	PRP	O	I	dep	15	SENT_373	[p22l659t769r681b833],
17	(	VBP	O	(	ccomp	2	SENT_373	[p22l709t765r899b833],
18	1997	CD	DATE	1997	num	20	SENT_373	[p22l709t765r899b833],
19	)	CD	NUMBER	)	num	20	SENT_373	[p22l709t765r899b833],
20	Risperidone	NN	O	risperidone	dobj	17	SENT_373	[p22l927t765r1305b839],
21	and	CC	O	and	_	0	SENT_373	[p22l1330t765r1446b821],
22	cytochrome	NN	O	cytochrome	nn	29	SENT_373	[p22l1469t765r1841b840],
23	P450	NN	O	p450	nn	29	SENT_373	[p22l1866t770r2013b821],
24	3AI	NN	O	3aus	nn	29	SENT_373	[p22l2038t769r2145b833],
25	Clin	NNP	O	Clin	nn	29	SENT_373	[p22l160t848r287b905],
26	Psychiatry	NNP	O	Psychiatry	nn	29	SENT_373	[p22l309t848r636b923],
27	58:450	CD	NUMBER	58:450	num	29	SENT_373	[p22l654t854r848b905],
28	Ereshevsky	NNP	O	Ereshevsky	nn	29	SENT_373	[p22l159t931r512b1006],
29	L	NN	O	l	conj_and	20	SENT_373	[p22l525t936r563b987],
30	(	CD	NUMBER	(	num	34	SENT_373	[p22l583t932r773b1000],
31	1995	CD	DATE	1995	num	34	SENT_373	[p22l583t932r773b1000],
32	)	NNP	O	)	nn	34	SENT_373	[p22l583t932r773b1000],
33	Treatment	NN	O	treatment	nn	34	SENT_373	[p22l794t934r1113b988],
34	strategies	NNS	O	strategy	tmod	17	SENT_373	[p22l1131t933r1424b1006],
35	for	IN	O	for	_	0	SENT_373	[p22l1442t931r1531b988],
36	schizophrenia	NN	O	schizophrenia	prep_for	34	SENT_373	[p22l1548t931r2001b1006],
37	.	.	O	.	_	0	SENT_373	[p22l1548t931r2001b1006],

1	Psychiatr	NNP	O	Psychiatr	nn	2	SENT_374	[p22l2017t936r2143b1006, p22l160t1013r340b1069],
2	Ann	NNP	O	Ann	_	0	SENT_374	[p22l357t1017r490b1068],
3	25:285	CD	NUMBER	25:285	number	4	SENT_374	[p22l511t1018r855b1069],
4	—	CD	NUMBER	—	dep	2	SENT_374	[p22l511t1018r855b1069],
5	296	CD	NUMBER	296	dep	4	SENT_374	[p22l511t1018r855b1069],
6	Fang	NNP	O	Fang	nn	10	SENT_374	[p22l160t1101r310b1171],
7	I	PRP	O	I	dep	10	SENT_374	[p22l333t1101r371b1164],
8	,	,	O	,	_	0	SENT_374	[p22l333t1101r371b1164],
9	Borurin	NNP	O	Borurin	dep	10	SENT_374	[p22l393t1098r639b1152],
10	M	NNP	O	M	dep	2	SENT_374	[p22l664t1101r743b1161],
11	,	,	O	,	_	0	SENT_374	[p22l664t1101r743b1161],
12	Baker	NNP	PERSON	Baker	nn	14	SENT_374	[p22l765t1096r943b1152],
13	GB	NNP	O	GB	nn	14	SENT_374	[p22l968t1100r1058b1152],
14	(	NNP	O	(	appos	10	SENT_374	[p22l1087t1096r1277b1164],
15	1999	CD	DATE	1999	num	17	SENT_374	[p22l1087t1096r1277b1164],
16	)	CD	NUMBER	)	num	17	SENT_374	[p22l1087t1096r1277b1164],
17	Metabolism	NN	O	metabolism	dep	2	SENT_374	[p22l1305t1096r1674b1152],
18	of	IN	O	of	_	0	SENT_374	[p22l1699t1096r1766b1152],
19	risperidone	NN	O	risperidone	prep_of	17	SENT_374	[p22l1785t1096r2145b1170],
20	to	TO	O	to	_	0	SENT_374	[p22l158t1190r217b1236],
21	9-hydroxyrisperidone	NN	O	9-hydroxyrisperidone	prep_to	19	SENT_374	[p22l243t1179r924b1254],
22	by	IN	O	by	_	0	SENT_374	[p22l946t1179r1023b1254],
23	human	JJ	O	human	amod	24	SENT_374	[p22l1042t1179r1262b1236],
24	cytochromes	NNS	O	cytochrome	prep_by	21	SENT_374	[p22l1286t1179r1688b1254],
25	P450	NN	O	p450	nn	26	SENT_374	[p22l1713t1184r1859b1236],
26	2D6	NN	O	2d6	dep	2	SENT_374	[p22l1884t1184r2005b1236],
27	and	CC	O	and	_	0	SENT_374	[p22l2031t1179r2147b1236],
28	3A4	NN	O	3a4	conj_and	26	SENT_374	[p22l160t1265r295b1317],
29	.	.	O	.	_	0	SENT_374	[p22l160t1265r295b1317],

1	Arch	NNP	O	Arch	nn	2	SENT_375	[p22l310t1261r462b1317],
2	Pharmacol	NNP	O	Pharmacol	dep	17	SENT_375	[p22l483t1261r821b1317],
3	359:147	CD	NUMBER	359:147	num	2	SENT_375	[p22l842t1267r1216b1317],
4	—	CD	NUMBER	—	number	5	SENT_375	[p22l842t1267r1216b1317],
5	151	CD	NUMBER	151	num	7	SENT_375	[p22l842t1267r1216b1317],
6	Fenton	NN	PERSON	fenton	nn	7	SENT_375	[p22l160t1349r373b1401],
7	WS	NN	O	w	dep	2	SENT_375	[p22l409t1348r529b1410],
8	,	,	O	,	_	0	SENT_375	[p22l409t1348r529b1410],
9	Blyler	NNP	O	Blyler	appos	7	SENT_375	[p22l564t1344r745b1419],
10	CR	NN	O	cr	nn	13	SENT_375	[p22l783t1348r893b1410],
11	,	,	O	,	_	0	SENT_375	[p22l783t1348r893b1410],
12	Heinssen	JJ	O	heinssen	amod	13	SENT_375	[p22l928t1346r1211b1401],
13	RK	NN	O	rk	dep	17	SENT_375	[p22l1250t1349r1346b1400],
14	(	CD	NUMBER	(	num	17	SENT_375	[p22l1387t1345r1553b1412],
15	1997	CD	DATE	1997	num	17	SENT_375	[p22l1387t1345r1553b1412],
16	)	CD	NUMBER	)	num	17	SENT_375	[p22l1559t1345r1577b1412],
17	Determinants	NNS	O	determinant	dep	27	SENT_375	[p22l1619t1346r2047b1401],
18	of	IN	O	of	_	0	SENT_375	[p22l2087t1344r2153b1401],
19	medication	NN	O	medication	nn	20	SENT_375	[p22l159t1426r509b1482],
20	compliance	NN	O	compliance	prep_of	17	SENT_375	[p22l533t1426r887b1499],
21	in	IN	O	in	_	0	SENT_375	[p22l910t1428r970b1481],
22	schizophrenia	NN	O	schizophrenia	prep_in	20	SENT_375	[p22l993t1426r1445b1499],
23	:	:	O	:	_	0	SENT_375	[p22l993t1426r1445b1499],
24	empirical	JJ	O	empirical	amod	27	SENT_375	[p22l1469t1426r1763b1499],
25	and	CC	O	and	_	0	SENT_375	[p22l1786t1426r1901b1482],
26	clinical	JJ	O	clinical	conj_and	24	SENT_375	[p22l1924t1426r2146b1482],
27	ﬁndings	NNS	O	ﬁndings	_	0	SENT_375	[p22l159t1508r430b1584],
28	.	.	O	.	_	0	SENT_375	[p22l159t1508r430b1584],

1	Schiz	NNP	O	Schiz	nn	2	SENT_376	[p22l450t1509r612b1565],
2	Bull	NNP	O	Bull	_	0	SENT_376	[p22l633t1509r754b1565],
3	23:637	CD	NUMBER	23:637	number	4	SENT_376	[p22l775t1514r1113b1565],
4	—	CD	NUMBER	—	dep	2	SENT_376	[p22l775t1514r1113b1565],
5	651	CD	NUMBER	651	num	7	SENT_376	[p22l775t1514r1113b1565],
6	Grant	NNP	O	Grant	nn	7	SENT_376	[p22l160t1596r336b1649],
7	S	NN	O	s	dep	4	SENT_376	[p22l357t1596r406b1658],
8	,	,	O	,	_	0	SENT_376	[p22l357t1596r406b1658],
9	Fitton	NNP	PERSON	Fitton	nn	10	SENT_376	[p22l423t1595r609b1649],
10	A	NNP	O	A	appos	4	SENT_376	[p22l626t1597r674b1648],
11	(	CD	NUMBER	(	num	14	SENT_376	[p22l697t1593r886b1661],
12	1994	CD	DATE	1994	num	14	SENT_376	[p22l697t1593r886b1661],
13	)	NNP	O	)	nn	14	SENT_376	[p22l697t1593r886b1661],
14	Risperidone	NNP	O	Risperidone	dep	10	SENT_376	[p22l911t1592r1304b1667],
15	.	.	O	.	_	0	SENT_376	[p22l911t1592r1304b1667],

1	A	DT	O	a	det	2	SENT_377	[p22l1319t1596r1367b1648],
2	review	NN	O	review	_	0	SENT_377	[p22l1387t1595r1594b1649],
3	of	IN	O	of	_	0	SENT_377	[p22l1611t1592r1677b1649],
4	its	PRP$	O	its	poss	5	SENT_377	[p22l1691t1595r1762b1649],
5	pharmacology	NN	O	pharmacology	prep_of	2	SENT_377	[p22l1782t1592r2144b1667, p22l160t1694r274b1750],
6	and	CC	O	and	_	0	SENT_377	[p22l290t1675r406b1732],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_377	[p22l423t1675r780b1749],
8	potential	NN	O	potential	conj_and	5	SENT_377	[p22l797t1675r1076b1749],
9	in	IN	O	in	_	0	SENT_377	[p22l1094t1677r1154b1731],
10	the	DT	O	the	det	11	SENT_377	[p22l1171t1675r1268b1732],
11	treatment	NN	O	treatment	prep_in	2	SENT_377	[p22l1286t1685r1593b1732],
12	of	IN	O	of	_	0	SENT_377	[p22l1611t1675r1677b1732],
13	schizophrenia	NN	O	schizophrenia	prep_of	11	SENT_377	[p22l1691t1675r2143b1749],
14	.	.	O	.	_	0	SENT_377	[p22l1691t1675r2143b1749],

1	Drugs	NNS	O	drug	nsubj	10	SENT_378	[p22l159t1762r348b1831],
2	48:253	CD	NUMBER	48:253	num	3	SENT_378	[p22l369t1762r712b1812],
3	—	NN	O	—	dep	1	SENT_378	[p22l369t1762r712b1812],
4	273	CD	NUMBER	273	num	6	SENT_378	[p22l369t1762r712b1812],
5	Guy	NNP	O	Guy	nn	6	SENT_378	[p22l160t1844r286b1915],
6	W	NNP	O	W	dep	1	SENT_378	[p22l302t1845r379b1905],
7	,	,	O	,	_	0	SENT_378	[p22l302t1845r379b1905],
8	Bunate	NNP	ORGANIZATION	Bunate	nn	9	SENT_378	[p22l399t1845r612b1896],
9	RR	NNP	ORGANIZATION	RR	appos	6	SENT_378	[p22l635t1845r729b1896],
10	(	VBD	O	(	_	0	SENT_378	[p22l752t1840r943b1908],
11	1970	CD	DATE	1970	num	12	SENT_378	[p22l752t1840r943b1908],
12	)	CD	NUMBER	)	dobj	10	SENT_378	[p22l752t1840r943b1908],
13	Clinical	JJ	O	clinical	amod	15	SENT_378	[p22l970t1840r1207b1896],
14	global	JJ	O	global	amod	15	SENT_378	[p22l1228t1840r1418b1915],
15	impression	NN	O	impression	dep	12	SENT_378	[p22l1440t1842r1800b1914],
16	.	.	O	.	_	0	SENT_378	[p22l1440t1842r1800b1914],

1	In	IN	O	in	dep	4	SENT_379	[p22l1821t1845r1900b1896],
2	:	:	O	:	_	0	SENT_379	[p22l1821t1845r1900b1896],
3	Guy	NNP	O	Guy	nn	4	SENT_379	[p22l1925t1844r2051b1915],
4	W	NNP	O	W	_	0	SENT_379	[p22l2066t1845r2144b1905],
5	,	,	O	,	_	0	SENT_379	[p22l2066t1845r2144b1905],
6	Bonate	NNP	ORGANIZATION	Bonate	nn	8	SENT_379	[p22l160t1928r372b1980],
7	RR	NNP	ORGANIZATION	RR	nn	8	SENT_379	[p22l407t1928r501b1980],
8	(	NNP	O	(	appos	4	SENT_379	[p22l536t1923r687b1992],
9	eds	VBZ	O	ed	rcmod	8	SENT_379	[p22l536t1923r687b1992],
10	)	CD	NUMBER	)	num	11	SENT_379	[p22l536t1923r687b1992],
11	Manual	NNP	O	Manual	dobj	9	SENT_379	[p22l724t1923r959b1980],
12	for	IN	O	for	_	0	SENT_379	[p22l993t1923r1081b1980],
13	the	DT	O	the	det	16	SENT_379	[p22l1114t1923r1209b1980],
14	ECDEU	NNP	O	ECDEU	nn	16	SENT_379	[p22l1244t1927r1482b1980],
15	Assessment	NNP	O	Assessment	nn	16	SENT_379	[p22l1513t1928r1875b1980],
16	Battery	NNP	O	Battery	prep_for	11	SENT_379	[p22l1909t1928r2143b1998],
17	.	.	O	.	_	0	SENT_379	[p22l1909t1928r2143b1998],

1	Chevy	NNP	LOCATION	Chevy	nn	2	SENT_380	[p22l160t2006r355b2081],
2	Chase	NNP	LOCATION	Chase	_	0	SENT_380	[p22l375t2006r575b2072],
3	,	,	O	,	_	0	SENT_380	[p22l375t2006r575b2072],
4	MD	NNP	O	MD	appos	2	SENT_380	[p22l595t2011r727b2063],
5	:	:	O	:	_	0	SENT_380	[p22l595t2011r727b2063],
6	National	NNP	ORGANIZATION	National	nn	7	SENT_380	[p22l750t2006r1017b2063],
7	Institute	NNP	ORGANIZATION	Institute	dep	2	SENT_380	[p22l1040t2008r1302b2063],
8	of	IN	ORGANIZATION	of	_	0	SENT_380	[p22l1326t2006r1392b2063],
9	Mental	NNP	ORGANIZATION	Mental	nn	10	SENT_380	[p22l1409t2006r1624b2063],
10	Health	NNP	ORGANIZATION	Health	prep_of	7	SENT_380	[p22l1646t2006r1851b2063],
11	121126	CD	NUMBER	121126	num	10	SENT_380	[p22l1879t2012r2143b2062, p22l159t2095r191b2146],
12	He	PRP	O	he	dep	13	SENT_380	[p22l159t2177r244b2228],
13	H	NN	O	h	dep	7	SENT_380	[p22l278t2177r347b2237],
14	,	,	O	,	_	0	SENT_380	[p22l278t2177r347b2237],
15	Richardson	NNP	PERSON	Richardson	nsubj	19	SENT_380	[p22l378t2172r735b2228],
16	IS	VBZ	O	be	cop	19	SENT_380	[p22l768t2176r826b2240],
17	(	CD	NUMBER	(	num	19	SENT_380	[p22l864t2172r1055b2240],
18	1995	CD	DATE	1995	num	19	SENT_380	[p22l864t2172r1055b2240],
19	)	NN	O	)	dep	2	SENT_380	[p22l864t2172r1055b2240],
20	A	DT	O	a	det	24	SENT_380	[p22l1088t2176r1137b2228],
21	pharmacological	JJ	O	pharmacological	amod	24	SENT_380	[p22l1169t2172r1711b2247],
22	,	,	O	,	_	0	SENT_380	[p22l1169t2172r1711b2247],
23	pharmacoki	JJ	O	pharmacoki	amod	24	SENT_380	[p22l1740t2172r2143b2246],
24	—	NN	O	—	dep	19	SENT_380	[p22l1740t2172r2143b2246],
25	netic	JJ	O	netic	amod	24	SENT_380	[p22l159t2258r312b2312],
26	and	CC	O	and	_	0	SENT_380	[p22l338t2255r453b2312],
27	clinical	JJ	O	clinical	amod	28	SENT_380	[p22l479t2255r702b2312],
28	overview	NN	O	overview	conj_and	19	SENT_380	[p22l728t2258r1011b2312],
29	of	IN	O	of	_	0	SENT_380	[p22l1034t2255r1100b2312],
30	risperidone	NN	O	risperidone	prep_of	28	SENT_380	[p22l1120t2255r1498b2330],
31	,	,	O	,	_	0	SENT_380	[p22l1120t2255r1498b2330],
32	a	DT	O	a	det	34	SENT_380	[p22l1521t2275r1553b2312],
33	new	JJ	O	new	amod	34	SENT_380	[p22l1578t2275r1705b2312],
34	antipsychotic	JJ	O	antipsychotic	appos	2	SENT_380	[p22l1729t2255r2146b2330],
35	that	IN	O	that	nsubj	36	SENT_380	[p22l158t2338r280b2395],
36	blocks	VBZ	O	block	rcmod	34	SENT_380	[p22l310t2338r512b2395],
37	serotonin	NN	O	serotonin	dobj	36	SENT_380	[p22l547t2340r842b2395],
38	5	CD	NUMBER	5	num	37	SENT_380	[p22l876t2341r1072b2395],
39	.	.	O	.	_	0	SENT_380	[p22l876t2341r1072b2395],

1	—	NN	O	—	_	0	SENT_381	[p22l876t2341r1072b2395],
2	.	.	O	.	_	0	SENT_381	[p22l876t2341r1072b2395],

1	HT2	NN	O	ht2	_	0	SENT_382	[p22l876t2341r1072b2395],
2	and	CC	O	and	_	0	SENT_382	[p22l1108t2338r1223b2395],
3	dopamine	NN	O	dopamine	conj_and	1	SENT_382	[p22l1257t2338r1570b2413],
4	D2	NN	O	d2	nn	5	SENT_382	[p22l1604t2343r1689b2394],
5	receptors	NNS	O	receptor	dep	1	SENT_382	[p22l1724t2349r2027b2413],
6	.	.	O	.	_	0	SENT_382	[p22l1724t2349r2027b2413],

1	Int	NNP	O	Int	nn	6	SENT_383	[p22l2059t2343r2146b2395],
2	Clin	NNP	O	Clin	nn	6	SENT_383	[p22l160t2421r287b2478],
3	Psychopharmacol	NNP	O	Psychopharmacol	nn	6	SENT_383	[p22l309t2421r862b2496],
4	10:19	CD	TIME	10:19	num	6	SENT_383	[p22l888t2427r1153b2478],
5	-30	CD	NUMBER	-30	num	6	SENT_383	[p22l888t2427r1153b2478],
6	Heykants	NNS	O	heykant	_	0	SENT_383	[p22l159t2504r448b2579],
7	I	PRP	O	I	dep	6	SENT_383	[p22l472t2509r510b2572],
8	,	,	O	,	_	0	SENT_383	[p22l472t2509r510b2572],
9	Huang	NNP	PERSON	Huang	nn	10	SENT_383	[p22l530t2509r737b2579],
10	ML	NNP	O	ML	appos	7	SENT_383	[p22l759t2509r879b2569],
11	,	,	O	,	_	0	SENT_383	[p22l759t2509r879b2569],
12	Mannens	NNP	O	Mannens	nn	13	SENT_383	[p22l899t2509r1185b2560],
13	G	NNP	O	G	appos	7	SENT_383	[p22l1210t2508r1274b2569],
14	,	,	O	,	_	0	SENT_383	[p22l1210t2508r1274b2569],
15	etal	NN	O	etal	appos	7	SENT_383	[p22l1295t2504r1420b2560],
16	.	.	O	.	_	0	SENT_383	[p22l1295t2504r1420b2560],

1	(	RB	O	(	dep	2	SENT_384	[p22l1444t2504r1634b2572],
2	1994	CD	DATE	1994	dep	3	SENT_384	[p22l1444t2504r1634b2572],
3	)	CD	NUMBER	)	dep	5	SENT_384	[p22l1444t2504r1634b2572],
4	The	DT	O	the	det	5	SENT_384	[p22l1661t2504r1778b2560],
5	pharmacokinetics	NNS	O	pharmacokinetic	dep	12	SENT_384	[p22l1801t2504r2143b2578, p22l157t2587r402b2643],
6	of	IN	O	of	_	0	SENT_384	[p22l424t2586r490b2643],
7	risperidone	NN	O	risperidone	prep_of	5	SENT_384	[p22l505t2587r865b2661],
8	in	IN	O	in	_	0	SENT_384	[p22l886t2589r946b2642],
9	humans	NNS	O	human	prep_in	7	SENT_384	[p22l966t2586r1231b2643],
10	:	:	O	:	_	0	SENT_384	[p22l966t2586r1231b2643],
11	a	DT	O	a	det	12	SENT_384	[p22l1253t2606r1285b2643],
12	summary	NN	O	summary	_	0	SENT_384	[p22l1305t2606r1612b2662],
13	.	.	O	.	_	0	SENT_384	[p22l1305t2606r1612b2662],

1	I	PRP	O	I	nsubj	2	SENT_385	[p22l1630t2592r1652b2655],
2	Clin	VBP	O	clin	ccomp	36	SENT_385	[p22l1674t2587r1801b2643],
3	Psychiatry	NNP	O	Psychiatry	dobj	2	SENT_385	[p22l1822t2587r2149b2662],
4	55	CD	NUMBER	55	number	5	SENT_385	[p22l160t2670r663b2745],
5	(	CD	NUMBER	(	dep	3	SENT_385	[p22l160t2670r663b2745],
6	Suppl	NN	O	suppl	nn	7	SENT_385	[p22l160t2670r663b2745],
7	)	NN	O	)	dep	12	SENT_385	[p22l160t2670r663b2745],
8	:13	CD	NUMBER	:13	num	9	SENT_385	[p22l160t2670r663b2745],
9	—	CD	NUMBER	—	dep	7	SENT_385	[p22l160t2670r663b2745],
10	17	CD	NUMBER	17	num	11	SENT_385	[p22l160t2670r663b2745],
11	Heykants	NNS	O	heykant	dep	12	SENT_385	[p22l159t2753r448b2828],
12	I	PRP	O	I	dep	3	SENT_385	[p22l472t2758r510b2821],
13	,	,	O	,	_	0	SENT_385	[p22l472t2758r510b2821],
14	Huang	NNP	PERSON	Huang	nn	15	SENT_385	[p22l530t2758r736b2828],
15	ML	NNP	O	ML	appos	12	SENT_385	[p22l758t2758r879b2819],
16	,	,	O	,	_	0	SENT_385	[p22l758t2758r879b2819],
17	Mannens	NNP	O	Mannens	nn	18	SENT_385	[p22l898t2758r1184b2810],
18	G	NNP	O	G	appos	12	SENT_385	[p22l1209t2757r1273b2819],
19	,	,	O	,	_	0	SENT_385	[p22l1209t2757r1273b2819],
20	Meuldermans	NNP	MISC	Meuldermans	nn	21	SENT_385	[p22l1292t2753r1723b2810],
21	W	NNP	O	W	appos	12	SENT_385	[p22l1744t2758r1822b2818],
22	,	,	O	,	_	0	SENT_385	[p22l1744t2758r1822b2818],
23	Snoeck	NNP	O	Snoeck	nn	24	SENT_385	[p22l1843t2753r2066b2810],
24	E	NNP	O	E	appos	12	SENT_385	[p22l2088t2758r2144b2819],
25	,	,	O	,	_	0	SENT_385	[p22l2088t2758r2144b2819],
26	Van	NNP	PERSON	Van	nn	28	SENT_385	[p22l158t2841r277b2892],
27	Beijsterveldt	NNP	PERSON	Beijsterveldt	nn	28	SENT_385	[p22l309t2836r700b2911],
28	L	NNP	PERSON	L	appos	12	SENT_385	[p22l731t2841r785b2901],
29	,	,	O	,	_	0	SENT_385	[p22l731t2841r785b2901],
30	Van	NNP	O	Van	nn	32	SENT_385	[p22l808t2841r926b2892],
31	Peer	NNP	O	Peer	nn	32	SENT_385	[p22l958t2841r1093b2892],
32	A	NNP	O	A	appos	12	SENT_385	[p22l1120t2840r1185b2901],
33	,	,	O	,	_	0	SENT_385	[p22l1120t2840r1185b2901],
34	Woestenborghs	NNP	O	Woestenborghs	nn	35	SENT_385	[p22l1210t2836r1692b2911],
35	R	NNP	O	R	nsubj	36	SENT_385	[p22l1724t2841r1770b2892],
36	(	VBD	O	(	_	0	SENT_385	[p22l1803t2836r1993b2904],
37	1994	CD	DATE	1994	num	38	SENT_385	[p22l1803t2836r1993b2904],
38	)	CD	NUMBER	)	dobj	36	SENT_385	[p22l1803t2836r1993b2904],
39	The	DT	O	the	det	40	SENT_385	[p22l2028t2836r2145b2892],
40	pharmacokinetics	NNS	O	pharmacokinetic	tmod	36	SENT_385	[p22l158t2919r721b2993],
41	of	IN	O	of	_	0	SENT_385	[p22l747t2918r813b2975],
42	risperidone	NN	O	risperidone	prep_of	40	SENT_385	[p22l831t2919r1191b2993],
43	in	IN	O	in	_	0	SENT_385	[p22l1215t2921r1275b2974],
44	humans	NNS	O	human	prep_in	42	SENT_385	[p22l1297t2919r1562b2975],
45	:	:	O	:	_	0	SENT_385	[p22l1297t2919r1562b2975],
46	a	DT	O	a	det	47	SENT_385	[p22l1588t2938r1620b2975],
47	summary	NN	O	summary	dep	40	SENT_385	[p22l1643t2924r1993b2994],
48	.	.	O	.	_	0	SENT_385	[p22l1643t2924r1993b2994],

1	I	PRP	O	I	nsubj	2	SENT_386	[p22l1643t2924r1993b2994],
2	Clin	VBP	O	clin	_	0	SENT_386	[p22l2018t2919r2146b2975],
3	Psychiatry	NNP	O	Psychiatry	nsubj	20	SENT_386	[p22l160t3002r486b3077],
4	55	CD	NUMBER	55	num	3	SENT_386	[p22l505t3002r1008b3077],
5	(	CD	NUMBER	(	num	6	SENT_386	[p22l505t3002r1008b3077],
6	Supp1	NN	O	supp1	dep	3	SENT_386	[p22l505t3002r1008b3077],
7	)	CD	NUMBER	)	number	8	SENT_386	[p22l505t3002r1008b3077],
8	:13	CD	NUMBER	:13	dep	3	SENT_386	[p22l505t3002r1008b3077],
9	—	NN	O	—	dep	8	SENT_386	[p22l505t3002r1008b3077],
10	17	CD	NUMBER	17	num	20	SENT_386	[p22l505t3002r1008b3077],
11	Kane	NNP	O	Kane	nn	20	SENT_386	[p22l160t3090r316b3142],
12	IM	NNP	O	IM	nn	20	SENT_386	[p22l341t3090r446b3154],
13	,	,	O	,	_	0	SENT_386	[p22l341t3090r446b3154],
14	Marder	NNP	PERSON	Marder	appos	20	SENT_386	[p22l466t3085r697b3142],
15	SR	JJ	O	sr	amod	20	SENT_386	[p22l722t3089r802b3142],
16	(	NN	O	(	nn	20	SENT_386	[p22l829t3086r1019b3154],
17	1993	CD	DATE	1993	num	20	SENT_386	[p22l829t3086r1019b3154],
18	)	CD	NUMBER	)	num	20	SENT_386	[p22l829t3086r1019b3154],
19	Psychopharmacologic	JJ	O	psychopharmacologic	amod	20	SENT_386	[p22l1047t3085r1733b3160],
20	treatment	NN	O	treatment	xcomp	2	SENT_386	[p22l1756t3096r2063b3142],
21	of	IN	O	of	_	0	SENT_386	[p22l2087t3085r2153b3142],
22	schizophrenia	NN	O	schizophrenia	prep_of	2	SENT_386	[p22l160t3167r612b3240],
23	.	.	O	.	_	0	SENT_386	[p22l160t3167r612b3240],

1	Schiz	NNP	O	Schiz	nn	2	SENT_387	[p22l632t3167r794b3223],
2	Bull	NNP	O	Bull	nsubj	18	SENT_387	[p22l815t3167r936b3223],
3	19:287	CD	NUMBER	19:287	num	4	SENT_387	[p22l962t3173r1299b3223],
4	—	NN	O	—	dep	2	SENT_387	[p22l962t3173r1299b3223],
5	302	CD	NUMBER	302	num	10	SENT_387	[p22l962t3173r1299b3223],
6	Keepers	NNP	O	Keepers	nn	10	SENT_387	[p22l159t3255r404b3324],
7	GA	NNP	O	GA	nn	10	SENT_387	[p22l438t3254r553b3315],
8	,	,	O	,	_	0	SENT_387	[p22l438t3254r553b3315],
9	Casey	NNP	PERSON	Casey	appos	10	SENT_387	[p22l583t3254r764b3325],
10	DE	NN	PERSON	de	dep	2	SENT_387	[p22l793t3255r886b3306],
11	(	CD	NUMBER	(	num	10	SENT_387	[p22l921t3250r1111b3318],
12	1991	CD	DATE	1991	num	14	SENT_387	[p22l921t3250r1111b3318],
13	)	CD	NUMBER	)	num	14	SENT_387	[p22l921t3250r1111b3318],
14	Use	NN	O	use	dep	10	SENT_387	[p22l1147t3255r1258b3307],
15	of	IN	O	of	_	0	SENT_387	[p22l1291t3250r1357b3306],
16	neuroleptic	JJ	O	neuroleptic	amod	17	SENT_387	[p22l1383t3250r2020b3324],
17	—	NN	O	—	prep_of	14	SENT_387	[p22l1383t3250r2020b3324],
18	induced	VBD	O	induce	_	0	SENT_387	[p22l1383t3250r2020b3324],
19	extrapyramidal	JJ	O	extrapyramidal	amod	20	SENT_387	[p22l2052t3269r2143b3306, p22l158t3333r572b3408],
20	symptoms	NNS	O	symptom	dobj	18	SENT_387	[p22l600t3344r922b3408],
21	to	TO	O	to	aux	22	SENT_387	[p22l950t3344r1009b3390],
22	predict	VB	O	predict	xcomp	18	SENT_387	[p22l1038t3333r1260b3408],
23	future	JJ	DATE	future	amod	24	SENT_387	[p22l1287t3333r1476b3390],
24	vulnerability	NN	O	vulnerability	dobj	22	SENT_387	[p22l1503t3333r1909b3408],
25	to	TO	O	to	_	0	SENT_387	[p22l1934t3344r1992b3390],
26	side	JJ	O	side	amod	27	SENT_387	[p22l2023t3333r2144b3390],
27	effects	NNS	O	effect	prep_to	22	SENT_387	[p22l160t3416r373b3473],
28	.	.	O	.	_	0	SENT_387	[p22l160t3416r373b3473],

1	Am	VBP	O	be	dep	2	SENT_388	[p22l389t3420r500b3472],
2	I	PRP	O	I	dep	34	SENT_388	[p22l521t3421r543b3485],
3	Psychiatry	NNP	O	Psychiatry	nn	5	SENT_388	[p22l565t3416r892b3491],
4	148	CD	NUMBER	148	num	5	SENT_388	[p22l914t3417r1307b3485],
5	(	NN	O	(	dep	2	SENT_388	[p22l914t3417r1307b3485],
6	1	CD	NUMBER	1	number	7	SENT_388	[p22l914t3417r1307b3485],
7	)	CD	NUMBER	)	num	8	SENT_388	[p22l914t3417r1307b3485],
8	:85	CD	NUMBER	:85	dep	5	SENT_388	[p22l914t3417r1307b3485],
9	—	NN	O	—	nn	12	SENT_388	[p22l914t3417r1307b3485],
10	89	CD	NUMBER	89	num	12	SENT_388	[p22l914t3417r1307b3485],
11	Kronig	NNP	O	Kronig	nn	12	SENT_388	[p22l160t3501r375b3574],
12	MH	NNP	O	MH	dep	5	SENT_388	[p22l398t3504r534b3565],
13	,	,	O	,	_	0	SENT_388	[p22l398t3504r534b3565],
14	Munne	NNP	O	Munne	nn	15	SENT_388	[p22l555t3504r774b3556],
15	RA	NN	O	ra	appos	12	SENT_388	[p22l800t3503r913b3564],
16	,	,	O	,	_	0	SENT_388	[p22l800t3503r913b3564],
17	Szymanski	NNP	PERSON	Szymanski	nn	18	SENT_388	[p22l936t3499r1273b3574],
18	S	NNP	O	S	appos	12	SENT_388	[p22l1298t3503r1348b3564],
19	,	,	O	,	_	0	SENT_388	[p22l1298t3503r1348b3564],
20	Safferman	NNP	LOCATION	Safferman	nn	21	SENT_388	[p22l1370t3499r1690b3556],
21	AZ	NNP	LOCATION	AZ	appos	12	SENT_388	[p22l1711t3502r1822b3565],
22	,	,	O	,	_	0	SENT_388	[p22l1711t3502r1822b3565],
23	Pollack	NNP	PERSON	Pollack	nn	24	SENT_388	[p22l1844t3499r2070b3556],
24	S	NNP	O	S	appos	12	SENT_388	[p22l2095t3503r2144b3565],
25	,	,	O	,	_	0	SENT_388	[p22l2095t3503r2144b3565],
26	Cooper	NNP	ORGANIZATION	Cooper	nn	27	SENT_388	[p22l160t3585r388b3654],
27	T	NN	ORGANIZATION	t	appos	12	SENT_388	[p22l411t3584r463b3646],
28	,	,	O	,	_	0	SENT_388	[p22l411t3584r463b3646],
29	Kane	NNP	PERSON	Kane	nn	30	SENT_388	[p22l484t3586r640b3637],
30	IM	NNP	O	IM	appos	12	SENT_388	[p22l664t3586r769b3648],
31	,	,	O	,	_	0	SENT_388	[p22l664t3586r769b3648],
32	Lieberman	NNP	ORGANIZATION	Lieberman	nn	33	SENT_388	[p22l790t3581r1127b3637],
33	IA	NNP	ORGANIZATION	IA	nsubj	34	SENT_388	[p22l1151t3585r1222b3648],
34	(	VBD	O	(	_	0	SENT_388	[p22l1248t3581r1438b3648],
35	1995	CD	DATE	1995	num	39	SENT_388	[p22l1248t3581r1438b3648],
36	)	CD	NUMBER	)	num	39	SENT_388	[p22l1248t3581r1438b3648],
37	Plasma	NN	O	plasma	nn	39	SENT_388	[p22l1466t3581r1690b3637],
38	clozapine	NN	O	clozapine	nn	39	SENT_388	[p22l1713t3581r2007b3654],
39	levels	NNS	O	level	dobj	34	SENT_388	[p22l2030t3581r2143b3637, p22l160t3664r238b3720],
40	and	CC	O	and	_	0	SENT_388	[p22l261t3664r376b3720],
41	clinical	JJ	O	clinical	amod	42	SENT_388	[p22l397t3664r619b3720],
42	response	NN	O	response	dobj	34	SENT_388	[p22l640t3683r913b3738],
43	for	IN	O	for	_	0	SENT_388	[p22l934t3663r1022b3720],
44	treatment	NN	O	treatment	prep_for	34	SENT_388	[p22l1042t3663r1693b3739],
45	—	CD	NUMBER	—	num	48	SENT_388	[p22l1042t3663r1693b3739],
46	refractory	JJ	O	refractory	amod	48	SENT_388	[p22l1042t3663r1693b3739],
47	schizophrenic	JJ	O	schizophrenic	amod	48	SENT_388	[p22l1712t3664r2146b3738],
48	patients	NNS	O	patient	dep	44	SENT_388	[p22l158t3750r422b3822],
49	.	.	O	.	_	0	SENT_388	[p22l158t3750r422b3822],

1	Am	VBP	O	be	dep	2	SENT_389	[p22l438t3752r549b3803],
2	I	PRP	O	I	_	0	SENT_389	[p22l570t3752r592b3816],
3	Psychiatry	NNP	O	Psychiatry	dep	2	SENT_389	[p22l614t3747r941b3822],
4	152:179	CD	NUMBER	152:179	num	3	SENT_389	[p22l964t3753r1338b3804],
5	—	NN	O	—	dep	3	SENT_389	[p22l964t3753r1338b3804],
6	182	CD	NUMBER	182	num	5	SENT_389	[p22l964t3753r1338b3804],

1	Marder	NNP	PERSON	Marder	nn	5	SENT_390	[p23l159t10r389b66],
2	SR	JJ	O	sr	amod	5	SENT_390	[p23l413t14r512b75],
3	,	,	O	,	_	0	SENT_390	[p23l413t14r512b75],
4	Meibach	NNP	ORGANIZATION	Meibach	dep	5	SENT_390	[p23l531t10r795b66],
5	RC	NNP	ORGANIZATION	RC	_	0	SENT_390	[p23l819t14r908b66],
6	(	CD	NUMBER	(	num	9	SENT_390	[p23l935t11r1125b78],
7	1994	CD	DATE	1994	num	9	SENT_390	[p23l935t11r1125b78],
8	)	NNP	O	)	nn	9	SENT_390	[p23l935t11r1125b78],
9	Risperidone	NNP	O	Risperidone	dep	5	SENT_390	[p23l1153t10r1531b83],
10	in	IN	O	in	_	0	SENT_390	[p23l1555t12r1615b65],
11	the	DT	O	the	det	12	SENT_390	[p23l1638t10r1734b66],
12	treatment	NN	O	treatment	prep_in	9	SENT_390	[p23l1757t20r2064b66],
13	of	IN	O	of	_	0	SENT_390	[p23l2088t10r2153b66],
14	schizophrenia	NN	O	schizophrenia	prep_of	12	SENT_390	[p23l160t93r612b167],
15	.	.	O	.	_	0	SENT_390	[p23l160t93r612b167],

1	Am	VBP	O	be	cop	3	SENT_391	[p23l628t97r739b149],
2	I	PRP	O	I	dep	3	SENT_391	[p23l760t98r782b161],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_391	[p23l804t93r1130b168],
4	151	CD	NUMBER	151	number	5	SENT_391	[p23l1153t93r1617b161],
5	(	CD	NUMBER	(	dep	3	SENT_391	[p23l1153t93r1617b161],
6	6	CD	NUMBER	6	num	7	SENT_391	[p23l1153t93r1617b161],
7	)	NN	O	)	dep	16	SENT_391	[p23l1153t93r1617b161],
8	:825	CD	NUMBER	:825	dep	7	SENT_391	[p23l1153t93r1617b161],
9	—	NN	O	—	dep	16	SENT_391	[p23l1153t93r1617b161],
10	835	CD	NUMBER	835	num	9	SENT_391	[p23l1153t93r1617b161],
11	Meltzer	NNP	PERSON	Meltzer	nn	16	SENT_391	[p23l159t176r393b232],
12	HY	NNP	PERSON	HY	nn	16	SENT_391	[p23l416t181r517b231],
13	(	NNP	O	(	nn	16	SENT_391	[p23l543t176r733b244],
14	1992	CD	DATE	1992	num	16	SENT_391	[p23l543t176r733b244],
15	)	NNP	O	)	nn	16	SENT_391	[p23l543t176r733b244],
16	Treatment	NN	O	treatment	dep	23	SENT_391	[p23l761t179r1079b232],
17	of	IN	O	of	_	0	SENT_391	[p23l1103t175r1169b232],
18	the	DT	O	the	det	20	SENT_391	[p23l1186t176r1282b232],
19	neuroleptic	JJ	O	neuroleptic	amod	20	SENT_391	[p23l1305t176r2145b250],
20	—	NN	O	—	prep_of	16	SENT_391	[p23l1305t176r2145b250],
21	nonresponsive	JJ	O	nonresponsive	amod	23	SENT_391	[p23l1305t176r2145b250],
22	schizophrenic	JJ	O	schizophrenic	amod	23	SENT_391	[p23l160t259r594b334],
23	patient	NN	O	patient	dep	3	SENT_391	[p23l614t262r848b334],
24	.	.	O	.	_	0	SENT_391	[p23l614t262r848b334],

1	Schiz	NNP	O	Schiz	nn	2	SENT_392	[p23l868t259r1030b316],
2	Bull	NNP	O	Bull	dep	9	SENT_392	[p23l1051t259r1173b316],
3	18	CD	NUMBER	18	number	4	SENT_392	[p23l1198t260r1627b328],
4	(	CD	NUMBER	(	dep	2	SENT_392	[p23l1198t260r1627b328],
5	3	CD	NUMBER	3	num	6	SENT_392	[p23l1198t260r1627b328],
6	)	NN	O	)	dep	4	SENT_392	[p23l1198t260r1627b328],
7	:515	CD	NUMBER	:515	num	8	SENT_392	[p23l1198t260r1627b328],
8	—	NN	O	—	dep	9	SENT_392	[p23l1198t260r1627b328],
9	542	CD	NUMBER	542	dep	12	SENT_392	[p23l1198t260r1627b328],
10	Moller	NNP	PERSON	Moller	nn	11	SENT_392	[p23l159t342r366b399],
11	HI	NNP	PERSON	HI	dep	9	SENT_392	[p23l392t347r470b411],
12	(	VBD	O	(	_	0	SENT_392	[p23l501t343r691b411],
13	1999	CD	DATE	1999	num	16	SENT_392	[p23l501t343r691b411],
14	)	CD	NUMBER	)	num	16	SENT_392	[p23l501t343r691b411],
15	Atypical	JJ	O	atypical	amod	16	SENT_392	[p23l719t342r978b417],
16	neuroleptics	NNS	O	neuroleptic	dobj	12	SENT_392	[p23l1005t342r1407b417],
17	:	:	O	:	_	0	SENT_392	[p23l1005t342r1407b417],
18	a	DT	O	a	det	20	SENT_392	[p23l1436t362r1468b399],
19	new	JJ	O	new	amod	20	SENT_392	[p23l1494t362r1621b399],
20	approach	NN	O	approach	dep	16	SENT_392	[p23l1646t342r1936b417],
21	in	IN	O	in	_	0	SENT_392	[p23l1963t344r2023b398],
22	the	DT	O	the	det	23	SENT_392	[p23l2049t342r2145b399],
23	treatment	NN	O	treatment	prep_in	20	SENT_392	[p23l158t435r465b482],
24	of	IN	O	of	_	0	SENT_392	[p23l486t425r552b482],
25	negative	JJ	O	negative	amod	26	SENT_392	[p23l567t427r824b500],
26	symptoms	NNS	O	symptom	prep_of	23	SENT_392	[p23l846t436r1184b500],
27	.	.	O	.	_	0	SENT_392	[p23l846t436r1184b500],

1	Eur	NNP	O	Eur	nn	5	SENT_393	[p23l1203t430r1313b482],
2	Arch	NNP	O	Arch	nn	5	SENT_393	[p23l1330t425r1480b482],
3	Psychiatry	NNP	O	Psychiatry	nn	5	SENT_393	[p23l1502t425r1828b500],
4	Clin	NNP	O	Clin	nn	5	SENT_393	[p23l1847t425r1974b482],
5	Neurosci	NNP	O	Neurosci	_	0	SENT_393	[p23l1994t430r2143b482, p23l159t509r308b563],
6	249	CD	NUMBER	249	number	7	SENT_393	[p23l329t507r640b580],
7	(	CD	NUMBER	(	num	8	SENT_393	[p23l329t507r640b580],
8	Suppl	NN	O	suppl	dep	5	SENT_393	[p23l329t507r640b580],
9	4	CD	NUMBER	4	num	10	SENT_393	[p23l660t508r1167b574],
10	)	NN	O	)	dep	5	SENT_393	[p23l660t508r1167b574],
11	:	:	O	:	_	0	SENT_393	[p23l660t508r1167b574],
12	IV/99	NN	O	iv/99	dep	5	SENT_393	[p23l660t508r1167b574],
13	.	.	O	.	_	0	SENT_393	[p23l660t508r1167b574],

1	—	NN	O	—	_	0	SENT_394	[p23l660t508r1167b574],
2	.	.	O	.	_	0	SENT_394	[p23l660t508r1167b574],

1	IV/107	NNP	O	IV/107	nn	3	SENT_395	[p23l660t508r1167b574],
2	Moller	NNP	PERSON	Moller	nn	3	SENT_395	[p23l159t590r366b647],
3	HI	NNP	PERSON	HI	_	0	SENT_395	[p23l417t595r495b659],
4	(	CD	NUMBER	(	num	7	SENT_395	[p23l550t591r740b659],
5	2003	CD	DATE	2003	num	7	SENT_395	[p23l550t591r740b659],
6	)	NNP	O	)	nn	7	SENT_395	[p23l550t591r740b659],
7	Management	NNP	O	Management	dep	3	SENT_395	[p23l795t595r1203b665],
8	of	IN	O	of	_	0	SENT_395	[p23l1254t590r1320b647],
9	the	DT	O	the	det	11	SENT_395	[p23l1365t590r1461b647],
10	negative	JJ	O	negative	amod	11	SENT_395	[p23l1513t593r1770b665],
11	symptoms	NNS	O	symptom	prep_of	7	SENT_395	[p23l1823t601r2144b665],
12	of	IN	O	of	_	0	SENT_395	[p23l160t673r226b730],
13	schizophrenia	NN	O	schizophrenia	prep_of	11	SENT_395	[p23l257t673r709b748],
14	:	:	O	:	_	0	SENT_395	[p23l257t673r709b748],
15	new	JJ	O	new	amod	17	SENT_395	[p23l747t693r874b730],
16	treatment	NN	O	treatment	nn	17	SENT_395	[p23l907t684r1214b730],
17	options	NNS	O	option	dep	3	SENT_395	[p23l1250t675r1499b748],
18	.	.	O	.	_	0	SENT_395	[p23l1250t675r1499b748],

1	CNS	NNS	O	cn	nn	2	SENT_396	[p23l1534t677r1667b730],
2	Drugs	NNS	O	drug	_	0	SENT_396	[p23l1705t678r1893b748],
3	17	CD	NUMBER	17	number	4	SENT_396	[p23l1936t674r2143b742],
4	(	CD	NUMBER	(	dep	2	SENT_396	[p23l1936t674r2143b742],
5	11	CD	NUMBER	11	num	6	SENT_396	[p23l1936t674r2143b742],
6	)	NN	O	)	dep	4	SENT_396	[p23l1936t674r2143b742],
7	:	:	O	:	_	0	SENT_396	[p23l1936t674r2143b742],
8	793-823	CD	NUMBER	793-823	num	10	SENT_396	[p23l160t762r410b812],
9	Nasrallah	NNP	ORGANIZATION	Nasrallah	nn	10	SENT_396	[p23l158t839r455b895],
10	HA	NNP	ORGANIZATION	HA	dep	2	SENT_396	[p23l473t843r594b904],
11	,	,	O	,	_	0	SENT_396	[p23l473t843r594b904],
12	Mulvihil1T	NN	O	mulvihil1t	appos	10	SENT_396	[p23l608t839r950b895],
13	(	CD	NUMBER	(	num	17	SENT_396	[p23l971t839r1161b907],
14	2001	CD	DATE	2001	num	17	SENT_396	[p23l971t839r1161b907],
15	)	CD	NUMBER	)	num	17	SENT_396	[p23l971t839r1161b907],
16	Iatrogenic	JJ	MISC	iatrogenic	amod	17	SENT_396	[p23l1183t841r1499b914],
17	disorders	NNS	O	disorder	dep	12	SENT_396	[p23l1517t839r1806b895],
18	associated	VBN	O	associate	partmod	10	SENT_396	[p23l1826t839r2146b895],
19	with	IN	O	with	_	0	SENT_396	[p23l157t922r297b978],
20	conventional	JJ	O	conventional	prep_with	18	SENT_396	[p23l320t922r720b978],
21	vs	CC	O	vs	_	0	SENT_396	[p23l741t941r805b978],
22	atypical	JJ	O	atypical	amod	23	SENT_396	[p23l830t922r1074b997],
23	antipsychotics	NNS	O	antipsychotic	conj_vs	20	SENT_396	[p23l1098t922r1561b997],
24	.	.	O	.	_	0	SENT_396	[p23l1098t922r1561b997],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_397	[p23l1579t926r1712b977],
2	Clin	NNP	O	Clin	nn	3	SENT_397	[p23l1736t922r1863b978],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_397	[p23l1887t922r2144b997, p23l158t1015r251b1079],
4	13:215	CD	NUMBER	13:215	dep	3	SENT_397	[p23l275t1011r613b1061],
5	—	CD	NUMBER	—	number	6	SENT_397	[p23l275t1011r613b1061],
6	227	CD	NUMBER	227	dep	4	SENT_397	[p23l275t1011r613b1061],
7	Odou	NN	O	odou	nn	8	SENT_397	[p23l160t1087r332b1144],
8	P	NN	O	p	dep	3	SENT_397	[p23l368t1092r413b1153],
9	,	,	O	,	_	0	SENT_397	[p23l368t1092r413b1153],
10	Levron	NNP	PERSON	Levron	nn	11	SENT_397	[p23l445t1092r661b1144],
11	IC	NN	PERSON	ic	appos	8	SENT_397	[p23l696t1091r784b1155],
12	,	,	O	,	_	0	SENT_397	[p23l696t1091r784b1155],
13	Luyckx	NN	O	luyckx	nn	14	SENT_397	[p23l816t1087r1039b1162],
14	M	NN	O	m	appos	8	SENT_397	[p23l1072t1092r1151b1153],
15	,	,	O	,	_	0	SENT_397	[p23l1072t1092r1151b1153],
16	et	FW	O	et	dep	8	SENT_397	[p23l1184t1098r1238b1144],
17	al.	FW	O	al.	nn	18	SENT_397	[p23l1252t1087r1319b1144],
18	(	FW	O	(	dep	8	SENT_397	[p23l1356t1088r1546b1155],
19	2000	CD	DATE	2000	num	20	SENT_397	[p23l1356t1088r1546b1155],
20	)	CD	NUMBER	)	dep	3	SENT_397	[p23l1356t1088r1546b1155],
21	Risperidone	NN	O	risperidone	nn	23	SENT_397	[p23l1585t1087r1963b1161],
22	drug	NN	O	drug	nn	23	SENT_397	[p23l1999t1087r2147b1162],
23	monitoring	NN	O	monitoring	dep	20	SENT_397	[p23l159t1172r532b1245],
24	.	.	O	.	_	0	SENT_397	[p23l159t1172r532b1245],

1	A	DT	O	a	det	4	SENT_398	[p23l547t1174r595b1225],
2	useful	JJ	O	useful	amod	4	SENT_398	[p23l616t1170r804b1226],
3	clinical	JJ	O	clinical	amod	4	SENT_398	[p23l825t1170r1048b1226],
4	tool	NN	O	tool	_	0	SENT_398	[p23l1068t1170r1214b1226],
5	?	.	O	?	_	0	SENT_398	[p23l1068t1170r1214b1226],

1	Clin	NNP	O	Clin	nn	3	SENT_399	[p23l1237t1170r1364b1227],
2	Drug	NNP	O	Drug	nn	3	SENT_399	[p23l1385t1175r1545b1245],
3	Invest	NNP	O	Invest	dep	8	SENT_399	[p23l1566t1175r1751b1226],
4	19:283	CD	NUMBER	19:283	dep	3	SENT_399	[p23l1777t1176r2114b1226],
5	—	NN	O	—	dep	8	SENT_399	[p23l1777t1176r2114b1226],
6	292	CD	NUMBER	292	num	5	SENT_399	[p23l1777t1176r2114b1226],
7	Olesen	NNP	O	Olesen	nn	8	SENT_399	[p23l160t1253r369b1309],
8	OV	NNP	O	OV	dep	24	SENT_399	[p23l394t1257r498b1318],
9	,	,	O	,	_	0	SENT_399	[p23l394t1257r498b1318],
10	Licht	NNP	O	Licht	nn	11	SENT_399	[p23l519t1253r673b1309],
11	RW	NNP	O	RW	appos	8	SENT_399	[p23l697t1258r816b1318],
12	,	,	O	,	_	0	SENT_399	[p23l697t1258r816b1318],
13	Thomsen	NNP	PERSON	Thomsen	nn	14	SENT_399	[p23l837t1253r1128b1309],
14	E	NNP	O	E	appos	8	SENT_399	[p23l1153t1258r1209b1318],
15	,	,	O	,	_	0	SENT_399	[p23l1153t1258r1209b1318],
16	Bruun	NNP	ORGANIZATION	Bruun	nn	17	SENT_399	[p23l1230t1258r1425b1309],
17	T	NN	ORGANIZATION	t	appos	8	SENT_399	[p23l1450t1256r1501b1318],
18	,	,	O	,	_	0	SENT_399	[p23l1450t1256r1501b1318],
19	Viftrup	NNP	O	Viftrup	nn	20	SENT_399	[p23l1517t1252r1747b1327],
20	IE	NN	O	ie	appos	8	SENT_399	[p23l1772t1258r1854b1321],
21	,	,	O	,	_	0	SENT_399	[p23l1772t1258r1854b1321],
22	Linnet	NNP	PERSON	Linnet	nn	23	SENT_399	[p23l1875t1255r2075b1309],
23	K	NNP	PERSON	K	appos	8	SENT_399	[p23l2099t1258r2146b1308],
24	(	VBD	O	(	_	0	SENT_399	[p23l162t1337r353b1405],
25	1998	CD	DATE	1998	dobj	24	SENT_399	[p23l162t1337r353b1405],
26	)	CD	NUMBER	)	num	28	SENT_399	[p23l162t1337r353b1405],
27	Serum	NN	O	serum	nn	28	SENT_399	[p23l380t1340r583b1393],
28	concentrations	NNS	O	concentration	dep	25	SENT_399	[p23l606t1338r1067b1393],
29	and	CC	O	and	_	0	SENT_399	[p23l1092t1336r1208b1393],
30	side	JJ	O	side	amod	31	SENT_399	[p23l1231t1336r1352b1393],
31	effects	NNS	O	effect	conj_and	25	SENT_399	[p23l1376t1336r1573b1393],
32	in	IN	O	in	_	0	SENT_399	[p23l1597t1339r1656b1392],
33	psychiatric	JJ	O	psychiatric	amod	34	SENT_399	[p23l1679t1336r2022b1411],
34	patients	NNS	O	patient	prep_in	31	SENT_399	[p23l2044t1355r2143b1411, p23l158t1421r329b1476],
35	during	IN	O	during	_	0	SENT_399	[p23l354t1419r563b1494],
36	risperidone	NN	O	risperidone	nn	37	SENT_399	[p23l585t1419r945b1494],
37	therapy	NN	O	therapy	prep_during	24	SENT_399	[p23l967t1419r1216b1494],
38	.	.	O	.	_	0	SENT_399	[p23l967t1419r1216b1494],

1	T	NN	O	t	nn	3	SENT_400	[p23l1236t1422r1278b1475],
2	her	PRP$	O	she	poss	3	SENT_400	[p23l1281t1419r1384b1476],
3	Drug	NN	O	drug	_	0	SENT_400	[p23l1406t1424r1566b1494],
4	Monitoring	VBG	O	monitor	partmod	3	SENT_400	[p23l1587t1421r1945b1494],
5	20	CD	NUMBER	20	number	6	SENT_400	[p23l1966t1420r2143b1488],
6	(	CD	NUMBER	(	dobj	4	SENT_400	[p23l1966t1420r2143b1488],
7	4	CD	NUMBER	4	num	8	SENT_400	[p23l1966t1420r2143b1488],
8	)	NN	O	)	dep	6	SENT_400	[p23l1966t1420r2143b1488],
9	:	:	O	:	_	0	SENT_400	[p23l1966t1420r2143b1488],
10	380-384	CD	NUMBER	380-384	dep	6	SENT_400	[p23l160t1508r412b1558],

1	Perry	NNP	PERSON	Perry	nn	2	SENT_401	[p23l162t1747r334b1817],
2	PI	NN	O	pi	_	0	SENT_401	[p23l356t1747r436b1811],
3	,	,	O	,	_	0	SENT_401	[p23l356t1747r436b1811],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_401	[p23l457t1742r646b1799],
5	DD	NNP	O	DD	appos	2	SENT_401	[p23l671t1747r788b1808],
6	,	,	O	,	_	0	SENT_401	[p23l671t1747r788b1808],
7	Arndt	NNP	PERSON	Arndt	nn	8	SENT_401	[p23l807t1742r994b1799],
8	SV	NNP	O	SV	appos	2	SENT_401	[p23l1019t1746r1111b1808],
9	,	,	O	,	_	0	SENT_401	[p23l1019t1746r1111b1808],
10	Cadoret	NNP	PERSON	Cadoret	nn	11	SENT_401	[p23l1134t1742r1381b1799],
11	R	NNP	PERSON	R	appos	2	SENT_401	[p23l1406t1747r1451b1799],
12	(	CD	NUMBER	(	num	15	SENT_401	[p23l1479t1743r1669b1811],
13	1991	CD	DATE	1991	num	15	SENT_401	[p23l1479t1743r1669b1811],
14	)	NNP	O	)	nn	15	SENT_401	[p23l1479t1743r1669b1811],
15	Clozapine	NNP	O	Clozapine	dep	11	SENT_401	[p23l1700t1742r2009b1817],
16	and	CC	O	and	_	0	SENT_401	[p23l2036t1742r2151b1799],
17	norclozapine	JJ	O	norclozapine	amod	19	SENT_401	[p23l161t1826r567b1901],
18	plasma	NN	O	plasma	nn	19	SENT_401	[p23l604t1826r828b1901],
19	concentrations	NNS	O	concentration	dep	11	SENT_401	[p23l865t1828r1327b1883],
20	and	CC	O	and	_	0	SENT_401	[p23l1366t1826r1482b1883],
21	clinical	JJ	O	clinical	amod	22	SENT_401	[p23l1519t1826r1742b1883],
22	response	NN	O	response	conj_and	11	SENT_401	[p23l1779t1845r2053b1901],
23	in	IN	O	in	_	0	SENT_401	[p23l2091t1828r2151b1882],
24	treatment	NN	O	treatment	prep_in	22	SENT_401	[p23l160t1909r813b1984],
25	—	CD	NUMBER	—	num	27	SENT_401	[p23l160t1909r813b1984],
26	refractory	JJ	O	refractory	amod	27	SENT_401	[p23l160t1909r813b1984],
27	schizophrenics	NNS	O	schizophrenic	dep	22	SENT_401	[p23l867t1909r1348b1983],
28	.	.	O	.	_	0	SENT_401	[p23l867t1909r1348b1983],

1	Am	VBP	O	be	cop	2	SENT_402	[p23l1399t1913r1511b1965],
2	I	PRP	O	I	dep	8	SENT_402	[p23l1567t1914r1589b1978],
3	Psychiatry	NNP	O	Psychiatry	tmod	2	SENT_402	[p23l1647t1909r1974b1984],
4	148	CD	NUMBER	148	num	3	SENT_402	[p23l2033t1915r2148b1966],
5	:	:	O	:	_	0	SENT_402	[p23l2033t1915r2148b1966],
6	231-235	CD	NUMBER	231-235	num	8	SENT_402	[p23l161t1997r413b2048],
7	Perry	NNP	O	Perry	nn	8	SENT_402	[p23l162t2080r334b2150],
8	PI	NN	O	pi	_	0	SENT_402	[p23l352t2080r431b2144],
9	,	,	O	,	_	0	SENT_402	[p23l352t2080r431b2144],
10	Sanger	NNP	ORGANIZATION	Sanger	nn	11	SENT_402	[p23l450t2079r661b2151],
11	T	NN	ORGANIZATION	t	appos	8	SENT_402	[p23l681t2079r733b2141],
12	,	,	O	,	_	0	SENT_402	[p23l681t2079r733b2141],
13	Beasley	NN	PERSON	beasley	nn	14	SENT_402	[p23l751t2075r986b2150],
14	C	NN	O	c	appos	8	SENT_402	[p23l1004t2079r1047b2132],
15	(	CD	NUMBER	(	num	20	SENT_402	[p23l1071t2076r1261b2143],
16	1997	CD	DATE	1997	num	20	SENT_402	[p23l1071t2076r1261b2143],
17	)	NNP	O	)	nn	20	SENT_402	[p23l1071t2076r1261b2143],
18	Olanzapine	NNP	MISC	Olanzapine	nn	20	SENT_402	[p23l1287t2075r1640b2150],
19	plasma	NN	O	plasma	nn	20	SENT_402	[p23l1661t2075r1885b2150],
20	concentrations	NNS	O	concentration	dep	14	SENT_402	[p23l1905t2095r2148b2132, p23l160t2160r403b2215],
21	and	CC	O	and	_	0	SENT_402	[p23l437t2158r553b2215],
22	clinical	JJ	O	clinical	amod	23	SENT_402	[p23l585t2158r808b2215],
23	response	NN	O	response	conj_and	14	SENT_402	[p23l840t2177r1114b2233],
24	in	IN	O	in	_	0	SENT_402	[p23l1147t2160r1207b2214],
25	acutely	RB	O	acutely	advmod	26	SENT_402	[p23l1240t2158r1462b2233],
26	ill	JJ	O	ill	amod	28	SENT_402	[p23l1491t2158r1550b2214],
27	schizophrenic	JJ	O	schizophrenic	amod	28	SENT_402	[p23l1583t2158r2018b2233],
28	patients	NNS	O	patient	prep_in	23	SENT_402	[p23l2049t2177r2148b2233, p23l160t2243r389b2309],
29	.	.	O	.	_	0	SENT_402	[p23l2049t2177r2148b2233, p23l160t2243r389b2309],

1	I	PRP	O	I	nsubj	2	SENT_403	[p23l2049t2177r2148b2233, p23l160t2243r389b2309],
2	Clin	VBP	O	clin	_	0	SENT_403	[p23l412t2241r539b2298],
3	Psychopharm	NN	O	psychopharm	nn	5	SENT_403	[p23l561t2241r987b2316],
4	17	CD	NUMBER	17	num	5	SENT_403	[p23l1014t2242r1445b2309],
5	(	NN	O	(	dobj	2	SENT_403	[p23l1014t2242r1445b2309],
6	6	CD	NUMBER	6	num	7	SENT_403	[p23l1014t2242r1445b2309],
7	)	NN	O	)	rcmod	5	SENT_403	[p23l1014t2242r1445b2309],
8	:472	CD	NUMBER	:472	num	9	SENT_403	[p23l1014t2242r1445b2309],
9	—	NN	O	—	dep	7	SENT_403	[p23l1014t2242r1445b2309],
10	477	CD	NUMBER	477	num	12	SENT_403	[p23l1014t2242r1445b2309],
11	Prior	JJ	O	prior	amod	12	SENT_403	[p23l162t2326r321b2380],
12	T	NN	O	t	dep	20	SENT_403	[p23l346t2327r388b2380],
13	1	CD	NUMBER	1	dep	12	SENT_403	[p23l393t2329r432b2389],
14	,	,	O	,	_	0	SENT_403	[p23l393t2329r432b2389],
15	Baker	NNP	PERSON	Baker	nn	17	SENT_403	[p23l455t2324r632b2380],
16	GB	NNP	O	GB	nn	17	SENT_403	[p23l659t2328r748b2381],
17	(	NNP	O	(	appos	13	SENT_403	[p23l778t2325r969b2392],
18	2003	CD	DATE	2003	num	20	SENT_403	[p23l778t2325r969b2392],
19	)	CD	NUMBER	)	num	20	SENT_403	[p23l778t2325r969b2392],
20	Interaction	NN	O	interaction	dep	7	SENT_403	[p23l999t2326r1346b2380],
21	between	IN	O	between	_	0	SENT_403	[p23l1370t2324r1629b2380],
22	the	DT	O	the	det	25	SENT_403	[p23l1654t2324r1750b2380],
23	cytochrome	NN	O	cytochrome	nn	25	SENT_403	[p23l1777t2324r2150b2399],
24	P450	NN	O	p450	nn	25	SENT_403	[p23l162t2412r309b2463],
25	system	NN	O	system	prep_between	20	SENT_403	[p23l329t2417r540b2482],
26	and	CC	O	and	_	0	SENT_403	[p23l559t2407r675b2463],
27	the	DT	O	the	det	31	SENT_403	[p23l691t2407r787b2463],
28	second	JJ	ORDINAL	second	amod	31	SENT_403	[p23l807t2407r1387b2482],
29	—	NN	O	—	nn	31	SENT_403	[p23l807t2407r1387b2482],
30	generation	NN	O	generation	nn	31	SENT_403	[p23l807t2407r1387b2482],
31	antipsychotics	NNS	O	antipsychotic	conj_and	25	SENT_403	[p23l1406t2407r1907b2482],
32	.	.	O	.	_	0	SENT_403	[p23l1406t2407r1907b2482],
33	]	SYM	O	]	dep	5	SENT_403	[p23l1406t2407r1907b2482],

1	Psychiatry	NNP	O	Psychiatry	nn	2	SENT_404	[p23l1927t2407r2148b2482, p23l162t2501r288b2565],
2	Neurosci	NNP	O	Neurosci	dep	7	SENT_404	[p23l305t2492r583b2547],
3	28	CD	NUMBER	28	dep	2	SENT_404	[p23l603t2491r925b2559],
4	(	NN	O	(	dep	7	SENT_404	[p23l603t2491r925b2559],
5	2	CD	NUMBER	2	num	4	SENT_404	[p23l603t2491r925b2559],
6	)	CD	NUMBER	)	num	7	SENT_404	[p23l603t2491r925b2559],
7	:99	CD	NUMBER	:99	_	0	SENT_404	[p23l603t2491r925b2559],
8	—	NN	O	—	dep	7	SENT_404	[p23l603t2491r925b2559],
9	1	CD	NUMBER	1	num	8	SENT_404	[p23l603t2491r925b2559],
10	12	CD	NUMBER	12	num	19	SENT_404	[p23l939t2496r1001b2546],
11	Prior	JJ	O	prior	amod	19	SENT_404	[p23l162t2575r321b2630],
12	TI	NNP	O	TI	nn	19	SENT_404	[p23l343t2576r428b2639],
13	,	,	O	,	_	0	SENT_404	[p23l343t2576r428b2639],
14	Baker	NNP	PERSON	Baker	appos	19	SENT_404	[p23l447t2573r625b2630],
15	GB	NNP	O	GB	nn	19	SENT_404	[p23l648t2577r737b2630],
16	(	NNP	O	(	nn	19	SENT_404	[p23l764t2574r954b2641],
17	2003	CD	DATE	2003	num	19	SENT_404	[p23l764t2574r954b2641],
18	)	CD	NUMBER	)	num	19	SENT_404	[p23l764t2574r954b2641],
19	Interactions	NNS	O	interaction	dep	8	SENT_404	[p23l980t2575r1356b2630],
20	between	IN	O	between	prep	19	SENT_404	[p23l1377t2573r1636b2630],
21	the	DT	O	the	det	24	SENT_404	[p23l1658t2573r1754b2630],
22	cytochrome	NN	O	cytochrome	nn	24	SENT_404	[p23l1777t2573r2150b2648],
23	P450	NN	O	p450	nn	24	SENT_404	[p23l162t2661r309b2712],
24	system	NN	O	system	dep	29	SENT_404	[p23l329t2666r540b2731],
25	and	CC	O	and	_	0	SENT_404	[p23l559t2656r675b2712],
26	the	DT	O	the	det	28	SENT_404	[p23l691t2656r787b2712],
27	second	JJ	ORDINAL	second	amod	28	SENT_404	[p23l807t2656r1387b2731],
28	—	NN	O	—	dep	29	SENT_404	[p23l807t2656r1387b2731],
29	generation	NN	O	generation	dep	20	SENT_404	[p23l807t2656r1387b2731],
30	antipsychotics	NNS	O	antipsychotic	dep	29	SENT_404	[p23l1406t2656r1908b2731],
31	.	.	O	.	_	0	SENT_404	[p23l1406t2656r1908b2731],
32	]	SYM	O	]	dep	19	SENT_404	[p23l1406t2656r1908b2731],

1	Psychiatr	NNP	MISC	Psychiatr	nn	2	SENT_405	[p23l1927t2656r2148b2731, p23l162t2747r247b2793],
2	Neurosci	NNP	MISC	Neurosci	_	0	SENT_405	[p23l266t2740r545b2793],
3	28:99	CD	NUMBER	28:99	num	8	SENT_405	[p23l565t2743r795b2794],
4	—	CD	NUMBER	—	num	8	SENT_405	[p23l565t2743r795b2794],
5	1	CD	NUMBER	1	num	8	SENT_405	[p23l565t2743r795b2794],
6	12	CD	NUMBER	12	num	8	SENT_405	[p23l810t2743r872b2793],
7	Roh	NNP	O	Roh	nn	8	SENT_405	[p23l162t2821r285b2878],
8	H-K	NNP	O	H-K	dep	2	SENT_405	[p23l306t2826r454b2887],
9	,	,	O	,	_	0	SENT_405	[p23l306t2826r454b2887],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_405	[p23l472t2824r603b2877],
11	C-E	NNP	O	C-E	appos	8	SENT_405	[p23l625t2825r755b2887],
12	,	,	O	,	_	0	SENT_405	[p23l625t2825r755b2887],
13	Chung	NNP	PERSON	Chung	nn	14	SENT_405	[p23l774t2821r979b2896],
14	W-G	NNP	O	W-G	appos	8	SENT_405	[p23l995t2825r1157b2887],
15	,	,	O	,	_	0	SENT_405	[p23l995t2825r1157b2887],
16	Park	NNP	O	Park	nn	17	SENT_405	[p23l1175t2821r1318b2878],
17	C-S	NNP	O	C-S	appos	8	SENT_405	[p23l1338t2825r1463b2887],
18	,	,	O	,	_	0	SENT_405	[p23l1338t2825r1463b2887],
19	Svensson	NNP	PERSON	Svensson	nn	20	SENT_405	[p23l1481t2825r1765b2878],
20	I-O	NNP	O	I-O	appos	8	SENT_405	[p23l1785t2825r1902b2890],
21	,	,	O	,	_	0	SENT_405	[p23l1785t2825r1902b2890],
22	Bertilsson	NNP	PERSON	Bertilsson	nn	23	SENT_405	[p23l1920t2821r2148b2878, p23l162t2924r269b2961],
23	L	NNP	PERSON	L	appos	8	SENT_405	[p23l291t2909r328b2960],
24	(	CD	NUMBER	(	num	27	SENT_405	[p23l353t2905r543b2973],
25	2001	CD	DATE	2001	num	27	SENT_405	[p23l353t2905r543b2973],
26	)	NNP	O	)	nn	27	SENT_405	[p23l353t2905r543b2973],
27	Risperidone	NNP	O	Risperidone	dep	23	SENT_405	[p23l568t2904r947b2979],
28	metabolism	NN	O	metabolism	dep	2	SENT_405	[p23l968t2904r1337b2961],
29	in	IN	O	in	_	0	SENT_405	[p23l1358t2906r1418b2960],
30	relation	NN	O	relation	prep_in	28	SENT_405	[p23l1440t2904r1680b2961],
31	to	TO	O	to	_	0	SENT_405	[p23l1701t2915r1760b2961],
32	CYP2D6	NN	O	cyp2d6	prep_to	30	SENT_405	[p23l1784t2908r2150b2961],
33	*	CD	NUMBER	*	number	34	SENT_405	[p23l1784t2908r2150b2961],
34	10	CD	NUMBER	10	num	35	SENT_405	[p23l1784t2908r2150b2961],
35	allele	NN	O	allele	dep	2	SENT_405	[p23l162t2987r321b3044],
36	in	IN	O	in	_	0	SENT_405	[p23l353t2989r413b3043],
37	Korean	JJ	MISC	korean	amod	39	SENT_405	[p23l445t2992r668b3044],
38	schizophrenic	JJ	O	schizophrenic	amod	39	SENT_405	[p23l700t2987r1135b3061],
39	patients	NNS	O	patient	prep_in	35	SENT_405	[p23l1165t2989r1430b3061],
40	.	.	O	.	_	0	SENT_405	[p23l1165t2989r1430b3061],

1	Eur	NNP	MISC	Eur	nsubj	3	SENT_406	[p23l1459t2992r1569b3044],
2	I	PRP	O	I	dep	1	SENT_406	[p23l1599t2992r1621b3055],
3	Clin	VBP	O	clin	_	0	SENT_406	[p23l1654t2987r1781b3044],
4	Pharmacol	NNP	O	Pharmacol	dobj	3	SENT_406	[p23l1813t2987r2151b3044],
5	57	CD	NUMBER	57	num	4	SENT_406	[p23l162t3069r596b3136],
6	(	CD	NUMBER	(	number	7	SENT_406	[p23l162t3069r596b3136],
7	9	CD	NUMBER	9	num	8	SENT_406	[p23l162t3069r596b3136],
8	)	NN	O	)	dep	4	SENT_406	[p23l162t3069r596b3136],
9	:671	CD	NUMBER	:671	num	10	SENT_406	[p23l162t3069r596b3136],
10	—	NN	O	—	dep	22	SENT_406	[p23l162t3069r596b3136],
11	675	CD	NUMBER	675	num	13	SENT_406	[p23l162t3069r596b3136],
12	Ross-Chouinard	NN	O	ross-chouinard	nn	13	SENT_406	[p23l161t3152r670b3209],
13	A	NN	O	a	dep	10	SENT_406	[p23l690t3157r756b3218],
14	,	,	O	,	_	0	SENT_406	[p23l690t3157r756b3218],
15	Annable	JJ	PERSON	annable	amod	16	SENT_406	[p23l774t3152r1035b3209],
16	L	NN	PERSON	l	appos	13	SENT_406	[p23l1060t3157r1115b3218],
17	,	,	O	,	_	0	SENT_406	[p23l1060t3157r1115b3218],
18	et	FW	O	et	dep	13	SENT_406	[p23l1136t3163r1191b3209],
19	al.	FW	O	al.	nn	20	SENT_406	[p23l1205t3152r1272b3209],
20	(	FW	O	(	dep	13	SENT_406	[p23l1297t3153r1487b3221],
21	1980	CD	DATE	1980	dep	22	SENT_406	[p23l1297t3153r1487b3221],
22	)	CD	NUMBER	)	dep	4	SENT_406	[p23l1297t3153r1487b3221],
23	The	DT	O	the	det	27	SENT_406	[p23l1516t3152r1632b3209],
24	Extrapyramidal	NNP	O	Extrapyramidal	nn	27	SENT_406	[p23l1657t3152r2151b3227],
25	Symptom	NNP	O	Symptom	nn	27	SENT_406	[p23l162t3239r461b3310],
26	Rating	NNP	O	Rating	nn	27	SENT_406	[p23l483t3237r688b3310],
27	Scale	NNP	O	Scale	dep	22	SENT_406	[p23l709t3235r879b3292],
28	.	.	O	.	_	0	SENT_406	[p23l709t3235r879b3292],

1	Can	MD	O	can	aux	3	SENT_407	[p23l899t3239r1020b3292],
2	I	PRP	O	I	nsubj	3	SENT_407	[p23l1041t3240r1063b3304],
3	Neurol	VB	O	neurol	_	0	SENT_407	[p23l1084t3235r1297b3292],
4	Sci	NNP	O	Sci	nn	7	SENT_407	[p23l1319t3237r1406b3292],
5	7:233	CD	NUMBER	7:233	num	7	SENT_407	[p23l1427t3241r1584b3292],
6	Sachse	NNP	PERSON	Sachse	nn	7	SENT_407	[p23l162t3318r367b3375],
7	C	NNP	O	C	dobj	3	SENT_407	[p23l401t3322r461b3383],
8	,	,	O	,	_	0	SENT_407	[p23l401t3322r461b3383],
9	Brockmoller	NNP	O	Brockmoller	appos	7	SENT_407	[p23l491t3318r881b3375],
10	I	PRP	O	I	dep	9	SENT_407	[p23l912t3323r950b3386],
11	,	,	O	,	_	0	SENT_407	[p23l912t3323r950b3386],
12	Bauer	NNP	PERSON	Bauer	nn	13	SENT_407	[p23l979t3323r1160b3375],
13	S	NN	O	s	appos	7	SENT_407	[p23l1192t3322r1242b3383],
14	,	,	O	,	_	0	SENT_407	[p23l1192t3322r1242b3383],
15	Roots	NNS	O	root	appos	7	SENT_407	[p23l1271t3323r1447b3375],
16	I	PRP	O	I	nsubj	17	SENT_407	[p23l1481t3323r1501b3374],
17	(	VBP	O	(	rcmod	15	SENT_407	[p23l1538t3319r1728b3386],
18	1997	CD	DATE	1997	num	19	SENT_407	[p23l1538t3319r1728b3386],
19	)	CD	NUMBER	)	dobj	17	SENT_407	[p23l1538t3319r1728b3386],
20	Cytochrome	NN	O	cytochrome	nn	23	SENT_407	[p23l1766t3318r2150b3393],
21	P450	NN	O	p450	nn	23	SENT_407	[p23l162t3406r309b3457],
22	2D6	NN	O	2d6	nn	23	SENT_407	[p23l332t3406r454b3457],
23	variants	NNS	O	variant	npadvmod	17	SENT_407	[p23l475t3403r726b3457],
24	in	IN	O	in	_	0	SENT_407	[p23l750t3403r810b3457],
25	a	DT	O	a	det	27	SENT_407	[p23l833t3420r865b3457],
26	Caucasian	JJ	LOCATION	caucasian	amod	27	SENT_407	[p23l888t3403r1205b3458],
27	population	NN	O	population	prep_in	17	SENT_407	[p23l1227t3401r1585b3475],
28	:	:	O	:	_	0	SENT_407	[p23l1227t3401r1585b3475],
29	allele	NN	O	allele	nn	30	SENT_407	[p23l1610t3401r1769b3457],
30	frequencies	NNS	O	frequency	dep	15	SENT_407	[p23l1792t3401r2150b3475],
31	and	CC	O	and	_	0	SENT_407	[p23l162t3484r278b3540],
32	phenotypic	JJ	O	phenotypic	amod	33	SENT_407	[p23l297t3484r652b3559],
33	consequences	NNS	O	consequence	dep	15	SENT_407	[p23l674t3503r1117b3558],
34	.	.	O	.	_	0	SENT_407	[p23l674t3503r1117b3558],

1	Am	VBP	O	be	_	0	SENT_408	[p23l1132t3488r1244b3539],
2	I	PRP	O	I	nsubj	4	SENT_408	[p23l1264t3489r1286b3552],
3	Hum	NNP	O	Hum	nn	4	SENT_408	[p23l1308t3489r1463b3540],
4	Genet	NNP	O	Genet	xcomp	1	SENT_408	[p23l1485t3488r1666b3540],
5	60	CD	NUMBER	60	num	6	SENT_408	[p23l1687t3484r2122b3552],
6	(	NN	O	(	dep	4	SENT_408	[p23l1687t3484r2122b3552],
7	2	CD	NUMBER	2	number	8	SENT_408	[p23l1687t3484r2122b3552],
8	)	CD	NUMBER	)	dep	4	SENT_408	[p23l1687t3484r2122b3552],
9	:284	CD	NUMBER	:284	num	10	SENT_408	[p23l1687t3484r2122b3552],
10	—	NN	O	—	dep	8	SENT_408	[p23l1687t3484r2122b3552],
11	295	CD	NUMBER	295	num	13	SENT_408	[p23l1687t3484r2122b3552],
12	Scordo	NNP	O	Scordo	nn	13	SENT_408	[p23l162t3567r375b3624],
13	MG	NN	O	mg	dep	8	SENT_408	[p23l401t3571r532b3633],
14	,	,	O	,	_	0	SENT_408	[p23l401t3571r532b3633],
15	Spina	NNP	LOCATION	Spina	nn	16	SENT_408	[p23l554t3570r726b3642],
16	E	NNP	LOCATION	E	dep	8	SENT_408	[p23l750t3572r806b3633],
17	,	,	O	,	_	0	SENT_408	[p23l750t3572r806b3633],
18	Facciola	NNP	PERSON	Facciola	nn	19	SENT_408	[p23l828t3567r1081b3624],
19	G	NNP	O	G	appos	16	SENT_408	[p23l1106t3571r1169b3633],
20	,	,	O	,	_	0	SENT_408	[p23l1106t3571r1169b3633],
21	et	FW	O	et	dep	16	SENT_408	[p23l1191t3578r1246b3624],
22	al.	FW	O	al.	nn	23	SENT_408	[p23l1260t3567r1327b3624],
23	(	FW	O	(	dep	16	SENT_408	[p23l1353t3568r1543b3636],
24	1999	CD	DATE	1999	number	25	SENT_408	[p23l1353t3568r1543b3636],
25	)	CD	NUMBER	)	num	30	SENT_408	[p23l1353t3568r1543b3636],
26	Cytochrome	NN	O	cytochrome	nn	30	SENT_408	[p23l1572t3567r1956b3642],
27	P	NN	O	p	nn	30	SENT_408	[p23l1982t3572r2019b3623],
28	450	CD	NUMBER	450	num	30	SENT_408	[p23l2044t3573r2150b3624],
29	2D6	NN	O	2d6	nn	30	SENT_408	[p23l161t3655r283b3707],
30	genotype	NN	O	genotype	dep	23	SENT_408	[p23l306t3661r593b3725],
31	and	CC	O	and	_	0	SENT_408	[p23l616t3650r732b3707],
32	steady	JJ	O	steady	amod	35	SENT_408	[p23l754t3650r953b3725],
33	state	NN	O	state	nn	35	SENT_408	[p23l972t3661r1112b3707],
34	plasma	NN	O	plasma	nn	35	SENT_408	[p23l1134t3650r1357b3725],
35	levels	NNS	O	level	conj_and	16	SENT_408	[p23l1377t3650r1546b3707],
36	of	IN	O	of	_	0	SENT_408	[p23l1570t3650r1636b3707],
37	risperidone	NN	O	risperidone	prep_of	35	SENT_408	[p23l1652t3650r2013b3725],
38	and	CC	O	and	_	0	SENT_408	[p23l2036t3650r2152b3707],
39	9	CD	NUMBER	9	num	41	SENT_408	[p23l162t3733r861b3808],
40	—	NN	O	—	nn	41	SENT_408	[p23l162t3733r861b3808],
41	hydroXyrisperidone	NN	O	hydroxyrisperidone	dep	8	SENT_408	[p23l162t3733r861b3808],
42	.	.	O	.	_	0	SENT_408	[p23l162t3733r861b3808],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_409	[p23l880t3733r1434b3808],
2	147:300	CD	NUMBER	147:300	num	3	SENT_409	[p23l1461t3739r1834b3789],
3	—	NN	O	—	dep	1	SENT_409	[p23l1461t3739r1834b3789],
4	305	CD	NUMBER	305	dep	1	SENT_409	[p23l1461t3739r1834b3789],

1	Scordo	NNP	O	Scordo	nn	2	SENT_410	[p24l163t11r375b67],
2	MG	NN	O	mg	nsubj	18	SENT_410	[p24l400t15r531b76],
3	,	,	O	,	_	0	SENT_410	[p24l400t15r531b76],
4	Spina	NNP	PERSON	Spina	nn	5	SENT_410	[p24l553t13r725b85],
5	E	NNP	PERSON	E	appos	2	SENT_410	[p24l749t16r805b76],
6	,	,	O	,	_	0	SENT_410	[p24l749t16r805b76],
7	Facciola	NNP	PERSON	Facciola	nn	8	SENT_410	[p24l827t11r1079b67],
8	G	NNP	PERSON	G	appos	2	SENT_410	[p24l1104t15r1167b76],
9	,	,	O	,	_	0	SENT_410	[p24l1104t15r1167b76],
10	Avenoso	NNP	PERSON	Avenoso	nn	11	SENT_410	[p24l1185t15r1447b67],
11	A	NNP	O	A	appos	2	SENT_410	[p24l1469t15r1535b76],
12	,	,	O	,	_	0	SENT_410	[p24l1469t15r1535b76],
13	Iohannsson	NNP	O	Iohannsson	nn	17	SENT_410	[p24l1555t11r1919b79],
14	I	PRP	O	I	dep	17	SENT_410	[p24l1943t16r1982b76],
15	,	,	O	,	_	0	SENT_410	[p24l1943t16r1982b76],
16	Dahl	NNP	PERSON	Dahl	dep	17	SENT_410	[p24l2004t11r2151b67],
17	M-L	NNP	O	M-L	appos	2	SENT_410	[p24l160t99r292b150],
18	(	VBD	O	(	_	0	SENT_410	[p24l318t95r509b163],
19	1999	CD	DATE	1999	num	20	SENT_410	[p24l318t95r509b163],
20	)	CD	NUMBER	)	dobj	18	SENT_410	[p24l318t95r509b163],
21	Cytochcorome	NNP	O	Cytochcorome	nn	24	SENT_410	[p24l538t94r994b169],
22	P450	NN	O	p450	nn	24	SENT_410	[p24l1018t99r1165b151],
23	2D6	NN	O	2d6	nn	24	SENT_410	[p24l1190t99r1312b151],
24	genotype	NN	O	genotype	dep	20	SENT_410	[p24l1337t105r1624b169],
25	and	CC	O	and	_	0	SENT_410	[p24l1650t94r1766b151],
26	steady	JJ	O	steady	amod	29	SENT_410	[p24l1790t94r1988b169],
27	state	NN	O	state	nn	29	SENT_410	[p24l2010t105r2150b151],
28	plasma	NN	O	plasma	nn	29	SENT_410	[p24l160t177r385b252],
29	levels	NNS	O	level	conj_and	20	SENT_410	[p24l421t177r590b234],
30	of	IN	O	of	_	0	SENT_410	[p24l631t177r697b234],
31	risperidone	NN	O	risperidone	prep_of	29	SENT_410	[p24l730t177r1091b252],
32	and	CC	O	and	_	0	SENT_410	[p24l1131t177r1247b234],
33	9-hydroxyrisperidone	NN	O	9-hydroxyrisperidone	prep_of	29	SENT_410	[p24l1285t177r1984b252],
34	.	.	O	.	_	0	SENT_410	[p24l1285t177r1984b252],

1	Psychopharmacology	NN	O	psychopharmacology	tmod	11	SENT_411	[p24l2021t182r2148b252, p24l162t260r729b335],
2	147:300	CD	NUMBER	147:300	num	1	SENT_411	[p24l752t266r1126b317],
3	—	NN	O	—	nn	6	SENT_411	[p24l752t266r1126b317],
4	305	CD	NUMBER	305	num	6	SENT_411	[p24l752t266r1126b317],
5	Simpson	NNP	ORGANIZATION	Simpson	nn	6	SENT_411	[p24l162t345r431b417],
6	GM	NNP	ORGANIZATION	GM	dep	1	SENT_411	[p24l450t347r788b418],
7	,	,	O	,	_	0	SENT_411	[p24l450t347r788b418],
8	Angus	NNP	PERSON	Angus	nn	10	SENT_411	[p24l450t347r788b418],
9	]	NNP	O	]	nn	10	SENT_411	[p24l805t348r901b411],
10	W	NNP	O	W	nsubj	11	SENT_411	[p24l805t348r901b411],
11	(	VBD	O	(	_	0	SENT_411	[p24l921t343r1111b411],
12	1970	CD	DATE	1970	num	13	SENT_411	[p24l921t343r1111b411],
13	)	CD	NUMBER	)	dobj	11	SENT_411	[p24l921t343r1111b411],
14	A	DT	O	a	det	16	SENT_411	[p24l1129t347r1177b399],
15	rating	NN	O	rating	nn	16	SENT_411	[p24l1194t345r1381b418],
16	scale	NN	O	scale	npadvmod	11	SENT_411	[p24l1397t343r1545b399],
17	for	IN	O	for	_	0	SENT_411	[p24l1562t343r1651b399],
18	extrapyramidal	JJ	O	extrapyramidal	amod	20	SENT_411	[p24l1668t343r2151b418],
19	side	JJ	O	side	amod	20	SENT_411	[p24l162t426r284b483],
20	effects	NNS	O	effect	prep_for	11	SENT_411	[p24l306t426r519b483],
21	.	.	O	.	_	0	SENT_411	[p24l306t426r519b483],

1	Acta	NNP	PERSON	Acta	nn	5	SENT_412	[p24l535t431r675b483],
2	Psychiatr	NNP	PERSON	Psychiatr	nn	5	SENT_412	[p24l696t426r982b501],
3	Scand	NNP	PERSON	Scand	nn	5	SENT_412	[p24l1003t426r1189b483],
4	(	NNP	O	(	nn	5	SENT_412	[p24l1212t426r1411b501],
5	Suppl	NNP	O	Suppl	_	0	SENT_412	[p24l1212t426r1411b501],
6	212	CD	NUMBER	212	number	7	SENT_412	[p24l1432t427r1614b495],
7	)	CD	NUMBER	)	dep	5	SENT_412	[p24l1432t427r1614b495],
8	:1	CD	NUMBER	:1	dep	7	SENT_412	[p24l1432t427r1614b495],
9	1-19	CD	NUMBER	1-19	num	11	SENT_412	[p24l1629t432r1767b483],
10	Snoeck	NN	O	snoeck	nn	11	SENT_412	[p24l162t509r386b566],
11	E	NN	O	e	dep	5	SENT_412	[p24l404t514r460b575],
12	,	,	O	,	_	0	SENT_412	[p24l404t514r460b575],
13	Van	NNP	O	Van	nn	15	SENT_412	[p24l472t514r590b566],
14	Peer	NNP	O	Peer	nn	15	SENT_412	[p24l610t514r745b566],
15	A	NNP	O	A	appos	11	SENT_412	[p24l760t513r825b575],
16	,	,	O	,	_	0	SENT_412	[p24l760t513r825b575],
17	Sack	NNP	O	Sack	nn	18	SENT_412	[p24l843t509r985b566],
18	M	NNP	O	M	appos	11	SENT_412	[p24l1002t514r1082b575],
19	,	,	O	,	_	0	SENT_412	[p24l1002t514r1082b575],
20	et	FW	O	et	dep	11	SENT_412	[p24l1098t520r1153b566],
21	al.	FW	O	al.	nn	22	SENT_412	[p24l1167t509r1234b566],
22	(	FW	O	(	dep	11	SENT_412	[p24l1255t510r1445b577],
23	1995	CD	DATE	1995	num	25	SENT_412	[p24l1255t510r1445b577],
24	)	CD	NUMBER	)	num	25	SENT_412	[p24l1255t510r1445b577],
25	Inﬂuence	NN	O	inﬂuence	dep	5	SENT_412	[p24l1469t509r1758b566],
26	of	IN	O	of	_	0	SENT_412	[p24l1778t509r1845b566],
27	age	NN	O	age	prep_of	25	SENT_412	[p24l1859t529r1977b584],
28	,	,	O	,	_	0	SENT_412	[p24l1859t529r1977b584],
29	renal	JJ	O	renal	amod	32	SENT_412	[p24l1993t509r2151b566],
30	and	CC	O	and	_	0	SENT_412	[p24l162t592r278b649],
31	liver	NN	O	liver	conj_and	29	SENT_412	[p24l294t592r431b649],
32	impairment	NN	O	impairment	appos	5	SENT_412	[p24l449t594r821b666],
33	on	IN	O	on	_	0	SENT_412	[p24l840t611r916b649],
34	the	DT	O	the	det	35	SENT_412	[p24l934t592r1030b649],
35	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	32	SENT_412	[p24l1048t592r1612b666],
36	of	IN	O	of	_	0	SENT_412	[p24l1633t592r1699b649],
37	risperidone	NN	O	risperidone	prep_of	35	SENT_412	[p24l1711t592r2072b666],
38	in	IN	O	in	_	0	SENT_412	[p24l2091t594r2150b648],
39	man	NN	O	man	prep_in	37	SENT_412	[p24l161t694r314b731],
40	.	.	O	.	_	0	SENT_412	[p24l161t694r314b731],

1	Psychopharmacology	NN	O	psychopharmacology	dep	6	SENT_413	[p24l334t675r1007b750],
2	122:223	CD	NUMBER	122:223	dep	1	SENT_413	[p24l1030t681r1404b731],
3	—	NN	O	—	dep	6	SENT_413	[p24l1030t681r1404b731],
4	229	CD	NUMBER	229	num	3	SENT_413	[p24l1030t681r1404b731],
5	Spina	NNP	O	Spina	nn	6	SENT_413	[p24l163t760r335b832],
6	E	NNP	O	E	dep	28	SENT_413	[p24l358t763r415b823],
7	,	,	O	,	_	0	SENT_413	[p24l358t763r415b823],
8	Avenoso	NNP	PERSON	Avenoso	nn	9	SENT_413	[p24l433t762r695b814],
9	A	NNP	O	A	appos	6	SENT_413	[p24l718t762r784b823],
10	,	,	O	,	_	0	SENT_413	[p24l718t762r784b823],
11	Facciola	NNP	PERSON	Facciola	nn	12	SENT_413	[p24l806t758r1059b814],
12	G	NNP	PERSON	G	appos	6	SENT_413	[p24l1083t762r1147b823],
13	,	,	O	,	_	0	SENT_413	[p24l1083t762r1147b823],
14	Salemi	NNP	PERSON	Salemi	nn	15	SENT_413	[p24l1170t758r1377b814],
15	M	NNP	O	M	appos	6	SENT_413	[p24l1400t763r1480b823],
16	,	,	O	,	_	0	SENT_413	[p24l1400t763r1480b823],
17	Scordo	NNP	O	Scordo	nn	18	SENT_413	[p24l1503t758r1715b814],
18	MG	NN	O	mg	appos	6	SENT_413	[p24l1741t762r1872b823],
19	,	,	O	,	_	0	SENT_413	[p24l1741t762r1872b823],
20	Ancione	NN	O	ancione	nn	21	SENT_413	[p24l1890t760r2150b814],
21	M	NN	O	m	appos	6	SENT_413	[p24l160t846r240b907],
22	,	,	O	,	_	0	SENT_413	[p24l160t846r240b907],
23	Madila	NNP	ORGANIZATION	Madila	nn	24	SENT_413	[p24l266t841r482b898],
24	AG	NNP	ORGANIZATION	AG	appos	6	SENT_413	[p24l508t845r622b907],
25	,	,	O	,	_	0	SENT_413	[p24l508t845r622b907],
26	Perucca	NNP	PERSON	Perucca	nn	27	SENT_413	[p24l648t846r892b898],
27	E	NNP	O	E	appos	6	SENT_413	[p24l921t846r960b897],
28	(	VBD	O	(	_	0	SENT_413	[p24l994t842r1184b910],
29	2001	CD	DATE	2001	num	31	SENT_413	[p24l994t842r1184b910],
30	)	CD	NUMBER	)	num	31	SENT_413	[p24l994t842r1184b910],
31	Relationship	NN	O	relationship	dobj	28	SENT_413	[p24l1218t841r1609b916],
32	between	IN	O	between	_	0	SENT_413	[p24l1638t841r1898b898],
33	plasma	NN	O	plasma	nn	34	SENT_413	[p24l1928t841r2151b916],
34	risperidone	NN	O	risperidone	prep_between	28	SENT_413	[p24l161t924r522b999],
35	and	CC	O	and	_	0	SENT_413	[p24l545t924r661b981],
36	9	CD	NUMBER	9	num	39	SENT_413	[p24l683t924r1365b999],
37	—	NN	O	—	nn	39	SENT_413	[p24l683t924r1365b999],
38	hydroXyrisperidone	NN	O	hydroxyrisperidone	nn	39	SENT_413	[p24l683t924r1365b999],
39	concentrations	NNS	O	concentration	prep_between	28	SENT_413	[p24l1388t926r1850b981],
40	and	CC	O	and	_	0	SENT_413	[p24l1874t924r1989b981],
41	clinical	JJ	O	clinical	amod	42	SENT_413	[p24l2011t924r2148b981, p24l161t1007r268b1063],
42	response	NN	O	response	prep_between	28	SENT_413	[p24l289t1026r563b1081],
43	in	IN	O	in	_	0	SENT_413	[p24l585t1009r645b1063],
44	patients	NNS	O	patient	prep_in	42	SENT_413	[p24l666t1009r914b1081],
45	with	IN	O	with	_	0	SENT_413	[p24l935t1007r1074b1063],
46	schizophrenia	NN	O	schizophrenia	prep_with	28	SENT_413	[p24l1097t1007r1550b1081],
47	.	.	O	.	_	0	SENT_413	[p24l1097t1007r1550b1081],

1	Psychopharmacol	NN	O	psychopharmacol	nn	3	SENT_414	[p24l1570t1007r2148b1082],
2	—	NN	O	—	nn	3	SENT_414	[p24l1570t1007r2148b1082],
3	ogy	NN	O	ogy	dep	8	SENT_414	[p24l162t1108r276b1163],
4	153:238	CD	NUMBER	153:238	dep	3	SENT_414	[p24l300t1094r673b1144],
5	—	NN	O	—	dep	8	SENT_414	[p24l300t1094r673b1144],
6	243	CD	NUMBER	243	num	5	SENT_414	[p24l300t1094r673b1144],
7	Spina	NNP	O	Spina	nn	8	SENT_414	[p24l162t1174r333b1245],
8	E	NNP	O	E	dep	30	SENT_414	[p24l359t1176r415b1236],
9	,	,	O	,	_	0	SENT_414	[p24l359t1176r415b1236],
10	Avenoso	NNP	PERSON	Avenoso	nn	11	SENT_414	[p24l434t1176r696b1227],
11	A	NNP	O	A	appos	8	SENT_414	[p24l720t1176r785b1236],
12	,	,	O	,	_	0	SENT_414	[p24l720t1176r785b1236],
13	Facciola	NNP	PERSON	Facciola	nn	14	SENT_414	[p24l809t1171r1061b1227],
14	G	NNP	PERSON	G	appos	8	SENT_414	[p24l1087t1175r1150b1236],
15	,	,	O	,	_	0	SENT_414	[p24l1087t1175r1150b1236],
16	Scordo	NNP	O	Scordo	nn	17	SENT_414	[p24l1174t1171r1386b1227],
17	MG	NN	O	mg	appos	8	SENT_414	[p24l1413t1175r1544b1236],
18	,	,	O	,	_	0	SENT_414	[p24l1413t1175r1544b1236],
19	Ancione	NN	O	ancione	nn	20	SENT_414	[p24l1563t1173r1822b1227],
20	M	NN	O	m	appos	8	SENT_414	[p24l1848t1176r1928b1236],
21	,	,	O	,	_	0	SENT_414	[p24l1848t1176r1928b1236],
22	Madia	NNP	ORGANIZATION	Madia	nn	23	SENT_414	[p24l1950t1171r2145b1227],
23	AG	NNP	ORGANIZATION	AG	appos	8	SENT_414	[p24l160t1257r273b1318],
24	,	,	O	,	_	0	SENT_414	[p24l160t1257r273b1318],
25	Ventimiglia	NNP	PERSON	Ventimiglia	nn	26	SENT_414	[p24l312t1253r674b1327],
26	A	NNP	O	A	appos	8	SENT_414	[p24l717t1257r783b1318],
27	,	,	O	,	_	0	SENT_414	[p24l717t1257r783b1318],
28	Perucca	NNP	PERSON	Perucca	nn	29	SENT_414	[p24l827t1258r1070b1309],
29	E	NNP	O	E	appos	8	SENT_414	[p24l1117t1258r1156b1308],
30	(	VBD	O	(	_	0	SENT_414	[p24l1207t1254r1397b1320],
31	2001	CD	DATE	2001	num	33	SENT_414	[p24l1207t1254r1397b1320],
32	)	CD	NUMBER	)	num	33	SENT_414	[p24l1207t1254r1397b1320],
33	Relationship	NN	O	relationship	nsubj	48	SENT_414	[p24l1449t1253r1838b1326],
34	between	IN	O	between	_	0	SENT_414	[p24l1885t1253r2144b1309],
35	plasma	NN	O	plasma	nn	36	SENT_414	[p24l160t1335r383b1408],
36	concentrations	NNS	O	concentration	prep_between	33	SENT_414	[p24l405t1337r866b1391],
37	of	IN	O	of	_	0	SENT_414	[p24l890t1335r955b1391],
38	clozapine	NN	O	clozapine	prep_of	36	SENT_414	[p24l973t1335r1267b1408],
39	and	CC	O	and	_	0	SENT_414	[p24l1290t1335r1406b1391],
40	norclozapine	NN	O	norclozapine	prep_of	36	SENT_414	[p24l1427t1335r1832b1408],
41	and	CC	O	and	_	0	SENT_414	[p24l1855t1335r1971b1391],
42	therapeutic	JJ	O	therapeutic	amod	43	SENT_414	[p24l1991t1335r2142b1391, p24l161t1420r388b1491],
43	response	NN	O	response	conj_and	36	SENT_414	[p24l406t1436r679b1491],
44	in	IN	O	in	_	0	SENT_414	[p24l697t1420r757b1473],
45	patients	NNS	O	patient	prep_in	43	SENT_414	[p24l774t1420r1021b1491],
46	with	IN	O	with	_	0	SENT_414	[p24l1038t1418r1177b1473],
47	schizophrenia	NN	O	schizophrenia	prep_with	45	SENT_414	[p24l1195t1418r1632b1491],
48	resistant	JJ	O	resistant	xcomp	30	SENT_414	[p24l1649t1420r1913b1473],
49	to	TO	O	to	_	0	SENT_414	[p24l1930t1428r1988b1473],
50	conventional	JJ	O	conventional	amod	51	SENT_414	[p24l2008t1437r2142b1473, p24l159t1500r450b1556],
51	neuroleptics	NNS	O	neuroleptic	prep_to	48	SENT_414	[p24l471t1500r872b1574],
52	.	.	O	.	_	0	SENT_414	[p24l471t1500r872b1574],

1	Psychopharmacology	NNP	O	Psychopharmacology	nn	6	SENT_415	[p24l891t1500r1562b1574],
2	148:83	CD	NUMBER	148:83	num	6	SENT_415	[p24l1585t1506r1886b1556],
3	—	CD	NUMBER	—	num	6	SENT_415	[p24l1585t1506r1886b1556],
4	89	CD	NUMBER	89	num	6	SENT_415	[p24l1585t1506r1886b1556],
5	Stahl	NNP	ORGANIZATION	Stahl	nn	6	SENT_415	[p24l162t1582r315b1638],
6	SM	NNP	ORGANIZATION	SM	_	0	SENT_415	[p24l336t1586r432b1638],
7	(	CD	NUMBER	(	num	8	SENT_415	[p24l456t1583r645b1650],
8	1999	CD	DATE	1999	dep	6	SENT_415	[p24l456t1583r645b1650],
9	)	CD	NUMBER	)	num	11	SENT_415	[p24l456t1583r645b1650],
10	Antipsychotic	JJ	O	antipsychotic	amod	11	SENT_415	[p24l666t1582r1100b1656],
11	polypharmacy	NN	O	polypharmacy	dep	6	SENT_415	[p24l1119t1582r1585b1656],
12	,	,	O	,	_	0	SENT_415	[p24l1119t1582r1585b1656],
13	Part	NNP	O	Part	appos	11	SENT_415	[p24l1602t1587r1730b1638],
14	1	CD	NUMBER	1	num	13	SENT_415	[p24l1755t1588r1797b1638],
15	:	:	O	:	_	0	SENT_415	[p24l1755t1588r1797b1638],
16	Therapeutic	JJ	O	therapeutic	amod	17	SENT_415	[p24l1819t1582r2141b1656, p24l160t1666r237b1720],
17	option	NN	O	option	dep	6	SENT_415	[p24l258t1666r461b1737],
18	or	CC	O	or	_	0	SENT_415	[p24l483t1683r548b1720],
19	dirty	JJ	O	dirty	amod	21	SENT_415	[p24l569t1664r723b1738],
20	little	JJ	O	little	amod	21	SENT_415	[p24l739t1664r880b1720],
21	secret	NN	O	secret	dep	6	SENT_415	[p24l902t1668r1105b1720],
22	?	.	O	?	_	0	SENT_415	[p24l902t1668r1105b1720],

1	J	NNP	O	J	nn	3	SENT_416	[p24l1127t1669r1149b1731],
2	Clin	NNP	O	Clin	nn	3	SENT_416	[p24l1172t1664r1299b1720],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_416	[p24l1321t1664r1646b1738],
4	60	CD	NUMBER	60	num	5	SENT_416	[p24l1664t1665r2098b1731],
5	(	NN	O	(	dep	3	SENT_416	[p24l1664t1665r2098b1731],
6	7	CD	NUMBER	7	number	7	SENT_416	[p24l1664t1665r2098b1731],
7	)	CD	NUMBER	)	dep	5	SENT_416	[p24l1664t1665r2098b1731],
8	:425	CD	NUMBER	:425	num	9	SENT_416	[p24l1664t1665r2098b1731],
9	—	NN	O	—	dep	3	SENT_416	[p24l1664t1665r2098b1731],
10	426	CD	NUMBER	426	num	17	SENT_416	[p24l1664t1665r2098b1731],
11	Stahl	NNP	O	Stahl	nn	17	SENT_416	[p24l162t1746r315b1802],
12	SM	NNP	O	SM	nn	17	SENT_416	[p24l332t1750r429b1802],
13	(	CD	NUMBER	(	num	17	SENT_416	[p24l450t1746r639b1813],
14	1999	CD	DATE	1999	num	17	SENT_416	[p24l450t1746r639b1813],
15	)	CD	NUMBER	)	num	17	SENT_416	[p24l450t1746r639b1813],
16	Antipsychotic	JJ	O	antipsychotic	amod	17	SENT_416	[p24l657t1746r1091b1820],
17	polypharmacy	NN	O	polypharmacy	rcmod	9	SENT_416	[p24l1107t1746r1573b1820],
18	,	,	O	,	_	0	SENT_416	[p24l1107t1746r1573b1820],
19	Part	NN	O	part	appos	3	SENT_416	[p24l1587t1751r1715b1802],
20	2	CD	NUMBER	2	num	19	SENT_416	[p24l1731t1752r1780b1801],
21	:	:	O	:	_	0	SENT_416	[p24l1731t1752r1780b1801],
22	Tips	NNP	O	Tips	dep	19	SENT_416	[p24l1798t1748r1930b1819],
23	on	IN	O	on	_	0	SENT_416	[p24l1949t1765r2025b1802],
24	use	NN	O	use	prep_on	22	SENT_416	[p24l2043t1765r2144b1802],
25	and	CC	O	and	_	0	SENT_416	[p24l161t1828r277b1884],
26	misuse	NN	O	misuse	prep_on	22	SENT_416	[p24l297t1831r528b1884],
27	.	.	O	.	_	0	SENT_416	[p24l297t1831r528b1884],

1	I	PRP	O	I	nsubj	2	SENT_417	[p24l546t1833r568b1896],
2	Clin	VBP	O	clin	_	0	SENT_417	[p24l591t1828r718b1884],
3	Psychiatry	NNP	O	Psychiatry	dobj	2	SENT_417	[p24l739t1828r1065b1903],
4	60	CD	NUMBER	60	num	3	SENT_417	[p24l1083t1829r1517b1896],
5	(	CD	NUMBER	(	number	6	SENT_417	[p24l1083t1829r1517b1896],
6	8	CD	NUMBER	8	num	7	SENT_417	[p24l1083t1829r1517b1896],
7	)	NN	O	)	dep	3	SENT_417	[p24l1083t1829r1517b1896],
8	:506	CD	NUMBER	:506	num	9	SENT_417	[p24l1083t1829r1517b1896],
9	—	NN	O	—	dep	3	SENT_417	[p24l1083t1829r1517b1896],
10	507	CD	NUMBER	507	num	12	SENT_417	[p24l1083t1829r1517b1896],
11	Sumiyoshi	NNP	ORGANIZATION	Sumiyoshi	nn	12	SENT_417	[p24l162t1910r486b1984],
12	T	NN	ORGANIZATION	t	dep	9	SENT_417	[p24l540t1913r592b1975],
13	,	,	O	,	_	0	SENT_417	[p24l540t1913r592b1975],
14	Kido	NNP	PERSON	Kido	nn	15	SENT_417	[p24l644t1910r791b1966],
15	H	NNP	O	H	appos	3	SENT_417	[p24l848t1915r918b1975],
16	,	,	O	,	_	0	SENT_417	[p24l848t1915r918b1975],
17	Sakamoto	NNP	PERSON	Sakamoto	nn	18	SENT_417	[p24l971t1910r1276b1966],
18	H	NNP	O	H	appos	15	SENT_417	[p24l1333t1915r1403b1975],
19	,	,	O	,	_	0	SENT_417	[p24l1333t1915r1403b1975],
20	et	FW	O	et	dep	15	SENT_417	[p24l1455t1921r1509b1966],
21	al.	FW	O	al.	nn	22	SENT_417	[p24l1524t1910r1590b1966],
22	(	FW	O	(	dep	15	SENT_417	[p24l1647t1911r1836b1978],
23	1994	CD	DATE	1994	num	24	SENT_417	[p24l1647t1911r1836b1978],
24	)	CD	NUMBER	)	dep	22	SENT_417	[p24l1647t1911r1836b1978],
25	In	FW	O	in	nn	27	SENT_417	[p24l1896t1915r1959b1965],
26	vivo	FW	O	vivo	nn	27	SENT_417	[p24l2013t1912r2142b1966],
27	dopamine-D2	NN	O	dopamine-d2	dep	22	SENT_417	[p24l161t1992r590b2065],
28	and	CC	O	and	_	0	SENT_417	[p24l624t1992r739b2048],
29	serotonin-5HT-2	NN	O	serotonin-5ht-2	nn	32	SENT_417	[p24l771t1994r1289b2048],
30	receptor	NN	O	receptor	nn	32	SENT_417	[p24l1323t2002r1581b2065],
31	binding	NN	O	binding	nn	32	SENT_417	[p24l1610t1992r1854b2066],
32	study	NN	O	study	appos	3	SENT_417	[p24l1886t1992r2057b2066],
33	of	IN	O	of	_	0	SENT_417	[p24l2086t1992r2152b2048],
34	risperidone	NN	O	risperidone	prep_of	32	SENT_417	[p24l161t2074r521b2147],
35	and	CC	O	and	_	0	SENT_417	[p24l586t2074r702b2130],
36	Haloperidol	NN	O	haloperidol	conj_and	34	SENT_417	[p24l766t2074r1155b2147],
37	.	.	O	.	_	0	SENT_417	[p24l766t2074r1155b2147],

1	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_418	[p24l1218t2074r1555b2130],
2	Biochem	NNP	O	Biochem	nn	3	SENT_418	[p24l1620t2074r1892b2130],
3	Behav	NNP	O	Behav	_	0	SENT_418	[p24l1958t2074r2147b2130],
4	47:553	CD	NUMBER	47:553	dep	3	SENT_418	[p24l160t2162r504b2212],
5	—	CD	NUMBER	—	number	6	SENT_418	[p24l160t2162r504b2212],
6	557	CD	NUMBER	557	dep	4	SENT_418	[p24l160t2162r504b2212],
7	Van	NNP	O	Van	nn	9	SENT_418	[p24l160t2244r279b2295],
8	Beijsterveldt	NNP	ORGANIZATION	Beijsterveldt	nn	9	SENT_418	[p24l311t2239r702b2313],
9	LEC	NNP	ORGANIZATION	LEC	dep	3	SENT_418	[p24l734t2243r879b2304],
10	,	,	O	,	_	0	SENT_418	[p24l734t2243r879b2304],
11	Geerts	NNP	ORGANIZATION	Geerts	nn	12	SENT_418	[p24l910t2243r1107b2295],
12	RIF	NNP	ORGANIZATION	RIF	appos	9	SENT_418	[p24l1141t2244r1260b2307],
13	,	,	O	,	_	0	SENT_418	[p24l1141t2244r1260b2307],
14	Leysen	NNP	PERSON	Leysen	nn	15	SENT_418	[p24l1290t2244r1501b2313],
15	IE	NN	O	ie	appos	12	SENT_418	[p24l1533t2244r1616b2307],
16	,	,	O	,	_	0	SENT_418	[p24l1533t2244r1616b2307],
17	et	FW	O	et	dep	12	SENT_418	[p24l1645t2250r1699b2295],
18	al.	FW	O	al.	nn	19	SENT_418	[p24l1714t2239r1781b2295],
19	(	FW	O	(	dep	3	SENT_418	[p24l1814t2240r2004b2307],
20	1998	CD	DATE	1998	dep	19	SENT_418	[p24l1814t2240r2004b2307],
21	)	CD	NUMBER	)	num	24	SENT_418	[p24l1814t2240r2004b2307],
22	Regional	NNP	O	Regional	nn	24	SENT_418	[p24l2041t2244r2141b2295, p24l160t2321r353b2395],
23	brain	NN	O	brain	nn	24	SENT_418	[p24l367t2321r533b2377],
24	distribution	NN	O	distribution	dep	3	SENT_418	[p24l551t2321r924b2377],
25	of	IN	O	of	_	0	SENT_418	[p24l942t2321r1008b2377],
26	risperidone	NN	O	risperidone	prep_of	24	SENT_418	[p24l1019t2321r1378b2394],
27	and	CC	O	and	_	0	SENT_418	[p24l1396t2321r1512b2377],
28	its	PRP$	O	its	poss	31	SENT_418	[p24l1528t2323r1599b2377],
29	active	JJ	O	active	amod	31	SENT_418	[p24l1617t2323r1796b2377],
30	metabolite	NN	O	metabolite	nn	31	SENT_418	[p24l1813t2321r2144b2377],
31	9-hydroxyrisperidone	NN	O	9-hydroxyrisperidone	dep	3	SENT_418	[p24l161t2403r842b2477],
32	in	IN	O	in	_	0	SENT_418	[p24l865t2405r925b2458],
33	the	DT	O	the	det	34	SENT_418	[p24l948t2403r1043b2459],
34	brain	NN	O	brain	prep_in	31	SENT_418	[p24l1065t2403r1231b2459],
35	and	CC	O	and	_	0	SENT_418	[p24l1255t2403r1370b2459],
36	other	JJ	O	other	amod	37	SENT_418	[p24l1393t2403r1558b2459],
37	tissues	NNS	O	tissue	conj_and	24	SENT_418	[p24l1579t2405r1786b2459],
38	of	IN	O	of	_	0	SENT_418	[p24l1811t2403r1877b2459],
39	rat	NN	O	rat	prep_of	37	SENT_418	[p24l1894t2413r1994b2459],
40	.	.	O	.	_	0	SENT_418	[p24l1894t2413r1994b2459],

1	Psychopharmacol	NN	O	psychopharmacol	_	0	SENT_419	[p24l2015t2408r2142b2477, p24l161t2485r609b2558],
2	139:356	CD	NUMBER	139:356	num	1	SENT_419	[p24l635t2490r1007b2540],
3	—	NN	O	—	nn	6	SENT_419	[p24l635t2490r1007b2540],
4	363	CD	NUMBER	363	num	6	SENT_419	[p24l635t2490r1007b2540],
5	Yasui-Furukori	NN	O	yasui-furukorus	nn	6	SENT_419	[p24l160t2567r629b2623],
6	N	NN	O	n	dep	1	SENT_419	[p24l650t2572r718b2632],
7	,	,	O	,	_	0	SENT_419	[p24l650t2572r718b2632],
8	Mihara	NNP	LOCATION	Mihara	nn	9	SENT_419	[p24l735t2567r961b2623],
9	K	NNP	LOCATION	K	appos	6	SENT_419	[p24l982t2572r1046b2632],
10	,	,	O	,	_	0	SENT_419	[p24l982t2572r1046b2632],
11	Kondo	NNP	PERSON	Kondo	nn	12	SENT_419	[p24l1064t2567r1268b2623],
12	T	NN	O	t	appos	6	SENT_419	[p24l1291t2571r1343b2632],
13	,	,	O	,	_	0	SENT_419	[p24l1291t2571r1343b2632],
14	Kubota	NNP	ORGANIZATION	Kubota	nn	15	SENT_419	[p24l1361t2567r1585b2623],
15	T	NN	ORGANIZATION	t	appos	6	SENT_419	[p24l1606t2571r1658b2632],
16	,	,	O	,	_	0	SENT_419	[p24l1606t2571r1658b2632],
17	Iga	NN	O	iga	nn	18	SENT_419	[p24l1676t2572r1770b2641],
18	T	NN	O	t	appos	6	SENT_419	[p24l1790t2571r1842b2632],
19	,	,	O	,	_	0	SENT_419	[p24l1790t2571r1842b2632],
20	Takarada	NNP	PERSON	Takarada	nn	21	SENT_419	[p24l1860t2567r2145b2623],
21	Y	NN	PERSON	y	appos	6	SENT_419	[p24l160t2654r213b2714],
22	,	,	O	,	_	0	SENT_419	[p24l160t2654r213b2714],
23	De	NNP	ORGANIZATION	De	nn	25	SENT_419	[p24l242t2654r325b2705],
24	Vries	NNP	ORGANIZATION	Vries	nn	25	SENT_419	[p24l353t2651r509b2705],
25	R	NNP	ORGANIZATION	R	appos	6	SENT_419	[p24l543t2654r606b2714],
26	,	,	O	,	_	0	SENT_419	[p24l543t2654r606b2714],
27	Kaneko	NNP	PERSON	Kaneko	nn	28	SENT_419	[p24l635t2649r866b2705],
28	S	NNP	O	S	appos	6	SENT_419	[p24l901t2653r950b2715],
29	,	,	O	,	_	0	SENT_419	[p24l901t2653r950b2715],
30	Tateishi	NNP	PERSON	Tateishi	nn	31	SENT_419	[p24l979t2649r1218b2705],
31	T	NN	O	t	appos	6	SENT_419	[p24l1249t2652r1291b2704],
32	(	CD	NUMBER	(	num	35	SENT_419	[p24l1327t2650r1516b2717],
33	2003	CD	DATE	2003	num	35	SENT_419	[p24l1327t2650r1516b2717],
34	)	CD	NUMBER	)	num	35	SENT_419	[p24l1327t2650r1516b2717],
35	Effects	NNS	O	effect	dep	1	SENT_419	[p24l1552t2649r1758b2705],
36	of	IN	O	of	_	0	SENT_419	[p24l1792t2649r1858b2705],
37	CYP2D6	NN	O	cyp2d6	nn	38	SENT_419	[p24l1885t2653r2143b2705],
38	genotypes	NNS	O	genotype	prep_of	35	SENT_419	[p24l160t2742r477b2806],
39	on	IN	O	on	_	0	SENT_419	[p24l506t2751r583b2788],
40	plasma	NN	O	plasma	nn	41	SENT_419	[p24l609t2732r832b2805],
41	concentrations	NNS	O	concentration	prep_on	38	SENT_419	[p24l860t2734r1320b2788],
42	of	IN	O	of	_	0	SENT_419	[p24l1349t2732r1415b2788],
43	risperidone	NN	O	risperidone	prep_of	41	SENT_419	[p24l1437t2732r1796b2805],
44	and	CC	O	and	_	0	SENT_419	[p24l1825t2732r1941b2788],
45	enantiomers	NNS	O	enantiomer	prep_of	41	SENT_419	[p24l1968t2751r2142b2788, p24l160t2816r398b2870],
46	of	IN	O	of	_	0	SENT_419	[p24l447t2814r513b2870],
47	9-hydroxyrisperidone	NN	O	9-hydroxyrisperidone	prep_of	35	SENT_419	[p24l556t2814r1236b2888],
48	in	IN	O	in	_	0	SENT_419	[p24l1285t2816r1344b2869],
49	Japanese	JJ	MISC	japanese	amod	50	SENT_419	[p24l1391t2819r1664b2887],
50	patients	NNS	O	patient	prep_in	47	SENT_419	[p24l1712t2816r1958b2887],
51	with	IN	O	with	_	0	SENT_419	[p24l2005t2814r2145b2870],
52	schizophrenia	NN	O	schizophrenia	prep_with	50	SENT_419	[p24l161t2896r613b2970],
53	.	.	O	.	_	0	SENT_419	[p24l161t2896r613b2970],

1	J	NNP	O	J	nn	3	SENT_420	[p24l631t2901r653b2964],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_420	[p24l676t2896r803b2952],
3	Pharmacol	NNP	PERSON	Pharmacol	dep	12	SENT_420	[p24l824t2896r1161b2952],
4	43	CD	NUMBER	43	num	5	SENT_420	[p24l1181t2897r1616b2964],
5	(	NN	O	(	dep	3	SENT_420	[p24l1181t2897r1616b2964],
6	2	CD	NUMBER	2	number	7	SENT_420	[p24l1181t2897r1616b2964],
7	)	CD	NUMBER	)	dep	5	SENT_420	[p24l1181t2897r1616b2964],
8	:122	CD	NUMBER	:122	num	9	SENT_420	[p24l1181t2897r1616b2964],
9	—	NN	O	—	dep	12	SENT_420	[p24l1181t2897r1616b2964],
10	127	CD	NUMBER	127	num	12	SENT_420	[p24l1181t2897r1616b2964],
11	Yoshimura	NNP	PERSON	Yoshimura	nn	12	SENT_420	[p24l160t2978r495b3034],
12	R	NN	PERSON	r	dep	19	SENT_420	[p24l519t2983r581b3043],
13	,	,	O	,	_	0	SENT_420	[p24l519t2983r581b3043],
14	Ueda	NNP	PERSON	Ueda	nn	15	SENT_420	[p24l602t2978r764b3034],
15	N	NNP	O	N	appos	12	SENT_420	[p24l788t2983r856b3043],
16	,	,	O	,	_	0	SENT_420	[p24l788t2983r856b3043],
17	Nakamura	NNP	PERSON	Nakamura	appos	12	SENT_420	[p24l877t2978r1204b3034],
18	I	PRP	O	I	nsubj	19	SENT_420	[p24l1227t2983r1249b3046],
19	(	VBP	O	(	_	0	SENT_420	[p24l1277t2979r1467b3046],
20	2001	CD	DATE	2001	num	21	SENT_420	[p24l1277t2979r1467b3046],
21	)	CD	NUMBER	)	dobj	19	SENT_420	[p24l1277t2979r1467b3046],
22	Possible	JJ	O	possible	amod	23	SENT_420	[p24l1496t2978r1746b3034],
23	relationship	NN	O	relationship	dep	21	SENT_420	[p24l1771t2978r2142b3052],
24	between	IN	O	between	_	0	SENT_420	[p24l159t3060r418b3116],
25	combined	JJ	O	combined	amod	27	SENT_420	[p24l436t3060r745b3116],
26	plasma	NN	O	plasma	nn	27	SENT_420	[p24l762t3060r984b3133],
27	concentrations	NNS	O	concentration	prep_between	23	SENT_420	[p24l1002t3062r1463b3116],
28	of	IN	O	of	_	0	SENT_420	[p24l1482t3060r1548b3116],
29	risperidone	NN	O	risperidone	prep_of	27	SENT_420	[p24l1561t3060r1920b3133],
30	plus	CC	O	plus	_	0	SENT_420	[p24l1937t3060r2065b3133],
31	9hydroxyrisperidone	NN	O	9hydroxyrisperidone	dobj	19	SENT_420	[p24l2085t3066r2141b3116, p24l159t3142r778b3216],
32	and	CC	O	and	_	0	SENT_420	[p24l824t3142r940b3198],
33	extrapyramidal	JJ	O	extrapyramidal	amod	34	SENT_420	[p24l984t3142r1466b3216],
34	symptoms	NNS	O	symptom	conj_plus	21	SENT_420	[p24l1510t3152r1848b3216],
35	.	.	O	.	_	0	SENT_420	[p24l1510t3152r1848b3216],

1	Preliminary	JJ	O	preliminary	amod	2	SENT_421	[p24l1892t3142r2142b3198, p24l161t3243r305b3298],
2	study	NN	O	study	_	0	SENT_421	[p24l324t3224r502b3298],
3	.	.	O	.	_	0	SENT_421	[p24l324t3224r502b3298],

1	Neuropsychobiology	NNP	O	Neuropsychobiology	dep	7	SENT_422	[p24l520t3224r1169b3298],
2	44	CD	NUMBER	44	num	1	SENT_422	[p24l1186t3224r1619b3291],
3	(	CD	NUMBER	(	dep	1	SENT_422	[p24l1186t3224r1619b3291],
4	3	CD	NUMBER	3	num	5	SENT_422	[p24l1186t3224r1619b3291],
5	)	NN	O	)	dep	7	SENT_422	[p24l1186t3224r1619b3291],
6	:129	CD	NUMBER	:129	num	7	SENT_422	[p24l1186t3224r1619b3291],
7	—	NN	O	—	dep	10	SENT_422	[p24l1186t3224r1619b3291],
8	133	CD	NUMBER	133	dep	7	SENT_422	[p24l1186t3224r1619b3291],
9	Zackrisson	NNP	O	Zackrisson	nn	10	SENT_422	[p24l161t3306r504b3362],
10	AL	NNP	O	AL	dep	14	SENT_422	[p24l523t3311r630b3372],
11	,	,	O	,	_	0	SENT_422	[p24l523t3311r630b3372],
12	Lindblom	NNP	PERSON	Lindblom	nn	13	SENT_422	[p24l649t3306r952b3362],
13	B	NNP	O	B	nsubj	14	SENT_422	[p24l975t3311r1014b3361],
14	(	VBD	O	(	_	0	SENT_422	[p24l1040t3307r1230b3374],
15	2003	CD	DATE	2003	num	17	SENT_422	[p24l1040t3307r1230b3374],
16	)	CD	NUMBER	)	num	17	SENT_422	[p24l1040t3307r1230b3374],
17	Identiﬁcation	NN	O	identiﬁcation	dobj	14	SENT_422	[p24l1257t3306r1678b3362],
18	of	IN	O	of	_	0	SENT_422	[p24l1701t3306r1767b3362],
19	CYP2D6	NN	O	cyp2d6	nn	20	SENT_422	[p24l1784t3310r2043b3362],
20	alleles	NNS	O	allele	prep_of	17	SENT_422	[p24l2067t3306r2142b3362, p24l159t3388r293b3444],
21	by	IN	O	by	_	0	SENT_422	[p24l315t3388r392b3462],
22	single	JJ	O	single	amod	25	SENT_422	[p24l411t3388r592b3462],
23	nucleotide	NN	O	nucleotide	nn	25	SENT_422	[p24l614t3388r940b3444],
24	polymorphism	NN	O	polymorphism	nn	25	SENT_422	[p24l962t3388r1429b3462],
25	analysis	NN	O	analysis	prep_by	14	SENT_422	[p24l1452t3388r1696b3462],
26	using	VBG	O	use	partmod	25	SENT_422	[p24l1720t3390r1889b3462],
27	pyrosequencing	NN	O	pyrosequencing	dobj	26	SENT_422	[p24l1909t3407r2142b3462, p24l161t3472r464b3544],
28	.	.	O	.	_	0	SENT_422	[p24l1909t3407r2142b3462, p24l161t3472r464b3544],

1	Eur	NNP	MISC	Eur	nsubj	3	SENT_423	[p24l480t3475r589b3526],
2	I	PRP	O	I	dep	1	SENT_423	[p24l605t3475r627b3537],
3	Clin	VBP	O	clin	_	0	SENT_423	[p24l647t3470r774b3526],
4	Pharmacol	NNP	O	Pharmacol	dobj	3	SENT_423	[p24l792t3470r1129b3526],
5	59	CD	NUMBER	59	number	6	SENT_423	[p24l1147t3471r1597b3537],
6	(	CD	NUMBER	(	dep	4	SENT_423	[p24l1147t3471r1597b3537],
7	7	CD	NUMBER	7	num	8	SENT_423	[p24l1147t3471r1597b3537],
8	)	NN	O	)	dep	6	SENT_423	[p24l1147t3471r1597b3537],
9	:521	CD	NUMBER	:521	num	10	SENT_423	[p24l1147t3471r1597b3537],
10	—	NN	O	—	tmod	3	SENT_423	[p24l1147t3471r1597b3537],
11	526	CD	NUMBER	526	dep	10	SENT_423	[p24l1147t3471r1597b3537],
12	.	.	O	.	_	0	SENT_423	[p24l1147t3471r1597b3537],

1	Epub	NNP	O	Epub	_	0	SENT_424	[p24l1613t3470r1771b3543],
2	2003	CD	DATE	2003	num	5	SENT_424	[p24l1790t3476r1929b3526],
3	Sep	NNP	DATE	Sep	nn	5	SENT_424	[p24l1950t3474r2056b3543],
4	06	CD	DATE	06	num	5	SENT_424	[p24l2075t3475r2143b3526],
5	Zubenko	NNP	O	Zubenko	dep	1	SENT_424	[p24l161t3552r435b3607],
6	GS	NN	O	g	dep	1	SENT_424	[p24l463t3556r564b3616],
7	,	,	O	,	_	0	SENT_424	[p24l463t3556r564b3616],
8	Sunderland	NNP	ORGANIZATION	Sunderland	dep	13	SENT_424	[p24l587t3552r946b3607],
9	T	NN	ORGANIZATION	t	nn	13	SENT_424	[p24l971t3555r1012b3607],
10	(	CD	NUMBER	(	num	13	SENT_424	[p24l1042t3552r1231b3619],
11	2000	CD	DATE	2000	num	13	SENT_424	[p24l1042t3552r1231b3619],
12	)	NNP	O	)	nn	13	SENT_424	[p24l1042t3552r1231b3619],
13	Geriatric	NNP	MISC	Geriatric	appos	1	SENT_424	[p24l1262t3554r1538b3607],
14	psychopharmacology	NN	O	psychopharmacology	dep	13	SENT_424	[p24l1563t3552r2142b3626, p24l161t3654r291b3708],
15	:	:	O	:	_	0	SENT_424	[p24l1563t3552r2142b3626, p24l161t3654r291b3708],
16	why	WRB	O	why	advmod	17	SENT_424	[p24l311t3634r441b3708],
17	does	VBZ	O	do	dep	13	SENT_424	[p24l459t3634r599b3690],
18	age	NN	O	age	nn	19	SENT_424	[p24l622t3654r723b3708],
19	matter	NN	O	matter	dobj	17	SENT_424	[p24l744t3638r972b3690],
20	?	.	O	?	_	0	SENT_424	[p24l744t3638r972b3690],

1	Har	NNP	O	Har	nn	3	SENT_425	[p24l996t3639r1112b3690],
2	Rev	NN	O	rev	nn	3	SENT_425	[p24l1133t3639r1248b3690],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_425	[p24l1267t3634r1592b3708],
4	7	CD	NUMBER	7	number	5	SENT_425	[p24l1611t3635r2007b3702],
5	(	CD	NUMBER	(	dep	3	SENT_425	[p24l1611t3635r2007b3702],
6	6	CD	NUMBER	6	num	7	SENT_425	[p24l1611t3635r2007b3702],
7	)	NN	O	)	dep	5	SENT_425	[p24l1611t3635r2007b3702],
8	:311	CD	NUMBER	:311	num	9	SENT_425	[p24l1611t3635r2007b3702],
9	—	NN	O	—	dep	5	SENT_425	[p24l1611t3635r2007b3702],
10	333	CD	NUMBER	333	dep	3	SENT_425	[p24l1611t3635r2007b3702],

